Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
ABHD14B	"CIB, MGC15429"	ENSG00000114779	"Abhydrolase domain containing 14B"	Q96IU4	3	51968510-51983409	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 313.2;Proximal tubular cells: 265.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 190.8"	"Low region specificity"	"Detected in all"							"HPA036444, HPA036642"	Supported		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA		2100000	"Cluster 44: Non-specific - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA036444: AB_10672221, HPA036642: AB_10672225"	"unprognostic (8.97e-2)"	"prognostic favorable (6.92e-5)"	"unprognostic (1.84e-1)"	"prognostic favorable (5.42e-5)"	"unprognostic (1.07e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.06e-3)"	"unprognostic (1.35e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.95e-2)"	"prognostic favorable (2.93e-5)"	"unprognostic (1.16e-1)"	"unprognostic (3.55e-1)"	"unprognostic (9.70e-2)"	"unprognostic (3.70e-2)"	69.2	81.9	21.3	26.1	22.3	37.4	66.0	21.4	25.3	49.7	29.9	60.0	81.5	39.3	44.7	46.1	58.3	35.2	31.0	20.2	21.4	97.3	155.6	37.8	48.3	22.2	22.2	51.2	65.2	51.3	36.5	15.4	22.7	48.5	55.3	40.4	64.8	36.6	25.1	42.7	74.8	26.9	22.4	47.1	51.0	9.6	22.9	39.0	57.1	22.6	43.1	47.9	42.9	22.3	37.6	32.9	2.7	37.3	100.6	91.3	9.2	14.5	18.4	27.2	32.5	25.3	72.6	41.7	11.4	54.2	12.6	18.5	23.5	22.2	21.0	57.6	27.2	66.6	30.6	106.6	55.3	37.8	64.9	115.1	74.4	27.8	36.9	41.9	34.0	64.2	39.1	66.8	55.8	40.5	16.8	29.9	3.5	43.6	88.5	42.1	5.2	190.8	51.8	16.7	15.2	16.6	37.3	68.0	121.8	5.7	97.7	25.8	31.5	13.8	64.8	32.3	8.7	82.1	41.6	17.4	30.4	118.9	24.8	41.7	24.3	10.9	42.2	19.9	63.3	58.3	53.0	52.0	38.1	42.9	52.4	49.2	1.9	24.5	12.9	28.4	42.4	37.5	21.3	22.3	21.4	25.3	20.2	21.4	22.2	22.2	22.7	22.4	22.9	22.3	40.4	6.4	26.2	7.8	69.4	30.2	62.4	68.5	38.1	12.7	88.1	81.0	4.7	72.9	28.7	69.9	14.6	16.7	50.7	79.6	146.8	34.8	1.4	19.6	22.4	36.8	75.9	41.2	10.1	46.8	19.0	43.4	35.2	20.9	50.8	14.8	39.7	122.1	55.4	8.4	10.8	97.1	42.7	60.7	36.3	2.4	65.0	39.0	55.2	14.0	37.7	14.8	50.4	4.5	9.4	30.0	74.5	46.6	37.4	39.6	313.2	265.3	25.2	39.9	39.5	34.7	35.6	0.4	3.9	57.1	30.4	11.8	63.9	47.7	127.9	64.4
ACE2		ENSG00000130234	"Angiotensin I converting enzyme 2"	Q9BYF1	X	15494566-15607236	"Enzymes, Metabolic proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Host-virus interaction"	"Carboxypeptidase, Host cell receptor for virus entry, Hydrolase, Metalloprotease, Protease, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 65.5;intestine: 242.2;kidney: 87.6"	"Cell type enriched"	"Detected in many"	5	"Proximal enterocytes: 294.8"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 13.9;renal cancer: 26.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NB-4: 1.2;NTERA-2: 1.2;SuSa: 1.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA000288, CAB026174, CAB026213, CAB080024, CAB080025, CAB080027, CAB080028"	Enhanced				"Secreted to blood"	NA	NA		400000		"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 45: Enterocytes - Digestion"			"CAB026174: , CAB026213: , CAB080024: AB_10864415, CAB080025: AB_2809589, CAB080027: AB_2665870, CAB080028: AB_2665871, HPA000288: AB_1078160"	"unprognostic (1.40e-1)"	"unprognostic (7.26e-2)"	"unprognostic (2.76e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.26e-2)"	"prognostic favorable (4.21e-4)"	"unprognostic (2.34e-2)"	"unprognostic (6.74e-3)"	"unprognostic (2.54e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (2.12e-5)"	"unprognostic (1.94e-1)"	"unprognostic (9.62e-2)"	"unprognostic (2.11e-1)"	"unprognostic (7.10e-2)"	8.9	0.5	0.1	1.4	0.1	0.6	4.3	0.4	0.3	0.6	1.9	9.9	183.3	0.5	0.5	1.8	1.5	65.5	42.7	0.2	0.2	87.6	5.7	0.8	0.4	0.2	0.2	1.8	2.5	1.5	0.1	1.2	0.2	0.4	5.9	0.3	1.4	4.1	0.7	0.3	242.2	0.5	0.1	0.1	2.6	49.7	0.2	0.5	4.5	0.5	0.2	0.8	1.2	0.2	0.0	0.0	0.3	0.0	0.2	0.0	0.8	0.1	0.0	0.2	0.2	0.2	0.3	0.4	0.3	0.0	0.3	0.7	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.5	1.2	1.2	0.0	0.0	0.3	0.2	0.5	0.2	0.4	0.2	0.9	0.0	0.4	0.0	1.9	0.4	0.4	0.1	0.0	0.0	0.3	0.4	0.1	0.5	0.5	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.4	0.3	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.4	0.0	0.5	1.3	1.4	0.1	0.5	5.0	0.0	0.0	1.6	0.0	11.2	55.8	2.6	0.0	0.0	4.2	0.1	22.9	3.9	1.2	0.5	1.1	0.3	1.0	7.2	0.0	0.8	0.8	0.3	4.6	0.0	0.6	0.0	3.9	0.0	0.9	0.8	0.0	0.8	8.2	0.0	0.0	0.0	1.4	8.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.9	5.1	6.0	0.0	1.0	294.8	48.8	2.0	0.0	19.7	0.0	8.9	1.1	1.0	0.0	0.1	12.7	0.3	0.1	10.6	2.2
ACVR1B	"ActRIB, ACVRLK4, ALK4, SKR2"	ENSG00000135503	"Activin A receptor type 1B"	P36896	12	51951699-51997078	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 3.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026126, HPA063761"	Approved		Approved	Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"CAB026126: , HPA063761: AB_2685115"	"unprognostic (8.66e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.23e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.00e-1)"	"unprognostic (7.68e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.52e-2)"	"unprognostic (9.02e-2)"	"unprognostic (6.60e-2)"	"unprognostic (8.96e-2)"	"unprognostic (4.79e-2)"	16.5	10.3	20.7	10.0	20.8	13.5	13.2	13.6	23.4	13.9	9.1	24.6	28.2	8.8	18.0	20.9	15.3	12.2	10.1	21.5	13.3	34.3	29.9	14.7	6.4	12.5	13.9	9.4	40.7	52.7	14.7	11.1	13.1	14.0	24.4	17.4	32.8	15.3	13.1	45.6	26.1	8.1	9.5	8.8	24.9	15.7	16.1	7.6	11.4	8.8	7.4	12.6	18.8	18.3	11.4	24.3	18.6	10.3	20.9	16.2	10.5	12.6	14.2	13.1	9.9	49.5	17.1	5.0	17.2	13.8	14.6	19.6	17.8	15.2	13.5	7.3	21.0	12.3	5.9	15.6	23.8	19.9	43.8	32.0	19.4	14.8	18.6	13.9	18.7	17.7	13.3	14.9	11.8	23.2	19.1	17.2	18.0	24.0	8.5	10.2	14.4	6.4	37.2	17.0	23.5	19.5	13.6	19.2	9.0	13.1	21.1	12.8	12.0	9.0	13.6	10.2	6.1	9.0	6.8	6.7	9.7	9.4	11.8	2.5	1.2	3.9	0.3	1.8	0.5	0.0	0.3	0.3	0.7	0.2	0.8	0.4	1.0	0.0	2.2	0.3	0.5	0.3	20.7	20.8	13.6	23.4	21.5	13.3	12.5	13.9	13.1	9.5	16.1	18.3	8.0	3.2	13.4	8.1	2.9	18.6	10.1	9.2	23.3	45.3	11.3	8.6	5.9	17.2	12.0	25.8	29.2	0.7	2.0	49.7	3.9	17.7	2.9	12.3	8.1	10.9	24.6	0.8	34.8	14.4	0.8	12.6	19.9	9.0	11.4	9.4	17.9	24.4	4.0	37.0	30.2	28.7	2.0	16.7	5.3	8.4	9.9	10.0	7.2	9.4	10.1	8.8	1.0	21.6	11.3	13.3	22.1	9.4	2.3	15.1	31.8	17.0	15.8	24.5	6.6	17.5	12.2	3.8	16.5	17.7	25.3	0.5	4.6	5.6	24.7	15.5
ACY1		ENSG00000243989	"Aminoacylase 1"	Q03154	3	51983340-51989197	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	9	"intestine: 181.5;kidney: 449.9;liver: 274.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 31.6;Gastric mucus-secreting cells: 32.6;Proximal enterocytes: 144.8;Proximal tubular cells: 92.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 128.0"									"CAB003695, HPA036174, HPA036175"	Enhanced					NA	NA		23000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB003695: AB_425286, HPA036174: AB_2674988, HPA036175: AB_2674989"	"unprognostic (4.28e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.48e-3)"	"unprognostic (3.15e-1)"	"unprognostic (6.51e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.08e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.70e-2)"	"prognostic favorable (2.93e-4)"	"unprognostic (3.57e-1)"	"unprognostic (3.75e-1)"	"unprognostic (7.88e-2)"	"prognostic favorable (6.77e-4)"	19.2	24.0	5.6	7.3	5.7	8.8	20.7	6.4	7.3	13.9	11.6	30.6	181.5	4.3	21.8	10.7	13.0	10.7	14.5	5.1	6.0	449.9	274.9	9.2	7.2	6.5	5.9	4.8	8.7	28.2	4.7	9.7	6.6	14.3	30.5	1.9	16.4	11.1	20.2	8.2	138.2	6.9	6.7	8.1	23.6	3.2	6.1	5.1	21.0	34.6	9.2	12.5	7.1	6.6	15.9	26.2	13.2	34.1	28.9	39.4	40.5	12.6	28.2	29.4	14.9	41.2	67.9	7.2	12.2	22.0	13.2	20.0	14.7	81.2	11.5	21.8	10.7	25.3	13.9	128.0	49.7	19.8	21.0	48.0	67.2	25.4	69.1	25.8	11.5	14.6	47.1	23.9	29.9	35.2	0.6	38.9	23.4	92.1	39.3	8.0	14.1	63.5	74.5	50.8	16.9	18.2	12.6	62.6	29.5	7.5	42.3	27.9	7.1	22.0	21.9	24.8	18.8	61.7	16.9	12.1	28.1	42.9	29.0	9.1	15.7	0.4	10.7	15.1	5.7	7.4	2.6	4.5	21.2	6.1	4.1	4.7	0.0	20.4	6.4	2.8	3.8	9.7	5.6	5.7	6.4	7.3	5.1	6.0	6.5	5.9	6.6	6.7	6.1	6.6	0.5	3.2	3.2	0.0	4.9	0.6	1.0	1.9	17.1	0.2	2.7	1.3	0.2	1.5	2.5	5.5	0.0	3.9	0.3	31.6	9.8	16.6	0.2	0.2	0.9	0.9	2.4	15.8	0.0	8.3	4.5	4.3	32.6	0.6	7.0	0.2	1.1	13.1	1.9	0.0	0.0	11.2	4.1	1.9	0.3	0.8	0.6	4.2	0.0	0.0	9.3	0.8	1.0	0.0	0.0	16.4	23.3	0.0	14.9	0.6	144.8	92.0	1.7	1.1	0.0	0.6	2.0	0.1	0.2	18.5	0.4	4.1	2.6	1.0	14.5	0.4
ACY3	"ACY-3, HCBP1, MGC9740"	ENSG00000132744	"Aminoacylase 3"	Q96HD9	11	67642555-67650730	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Host-virus interaction"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 77.7;kidney: 58.2;liver: 33.8;pancreas: 22.2"	"Group enriched"	"Detected in many"	8	"Proximal enterocytes: 255.7;Proximal tubular cells: 437.6"	"Cancer enhanced"	"Detected in many"		"renal cancer: 24.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 34.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 8.7;monocytes: 34.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 9.6;CAPAN-2: 15.3;Daudi: 57.7;OE19: 15.3;RPMI-8226: 9.8"	"Low region specificity"	"Detected in all"							"HPA039219, HPA048187"	Enhanced					NA	NA		13000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA039219: AB_10671872, HPA048187: AB_2680306"	"unprognostic (8.37e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.04e-1)"	"prognostic favorable (4.80e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.43e-1)"	"unprognostic (7.37e-4)"	"unprognostic (2.44e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.63e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.24e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.48e-3)"	0.1	0.1	4.0	4.2	3.0	1.4	0.9	3.6	3.5	10.5	2.0	6.7	77.7	0.5	0.8	0.8	0.9	1.9	0.0	4.1	5.0	58.2	33.8	0.2	7.0	5.0	3.5	0.2	22.2	0.4	0.3	0.2	4.3	0.6	4.5	0.0	2.4	0.4	0.0	0.2	70.8	0.3	5.7	1.4	11.9	0.1	5.1	1.9	0.1	0.0	8.9	0.3	0.1	4.6	0.2	1.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	9.6	15.3	57.7	0.6	0.0	1.4	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	5.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.5	0.0	0.1	2.1	2.5	0.0	15.3	0.0	1.8	0.0	9.8	0.0	0.0	0.0	0.1	0.3	1.3	0.1	0.0	0.1	2.8	0.2	0.0	0.1	0.0	0.0	0.0	0.1	1.0	0.0	6.4	0.5	0.0	0.7	0.0	0.2	7.6	0.7	1.3	0.4	0.2	3.8	1.4	1.3	0.9	0.0	3.9	34.1	8.7	0.0	1.9	4.0	3.0	3.6	3.5	4.1	5.0	5.0	3.5	4.3	5.7	5.1	4.6	0.1	0.0	1.7	0.0	4.7	0.0	0.1	0.7	0.0	0.0	1.6	2.2	0.5	8.6	1.6	22.0	0.0	0.2	0.1	9.2	31.3	4.1	0.0	0.5	0.2	0.1	1.2	0.0	0.0	10.4	0.3	0.1	19.4	0.9	0.0	0.0	0.0	25.3	2.2	0.0	0.0	40.8	0.0	0.6	0.9	0.0	0.0	3.0	5.4	10.3	0.4	0.0	0.0	0.0	0.0	5.7	10.6	0.0	3.3	0.5	255.7	437.6	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	2.7	0.1	14.7	0.9
AKR1A1	"ALR, DD3"	ENSG00000117448	"Aldo-keto reductase family 1 member A1"	P14550	1	45550543-45570049	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 872.9;Proximal tubular cells: 1215.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006246, HPA017919, HPA019649, HPA027734"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		7600000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"CAB006246: AB_425840, HPA017919: AB_1844695, HPA019649: AB_1844696, HPA027734: AB_10600976"	"unprognostic (1.73e-1)"	"prognostic favorable (2.66e-6)"	"unprognostic (4.03e-1)"	"prognostic favorable (2.92e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.77e-2)"	"unprognostic (6.54e-3)"	"unprognostic (1.31e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.43e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.57e-2)"	68.8	72.7	37.6	73.4	41.4	48.6	123.1	41.3	38.9	84.0	49.1	106.6	188.7	59.9	90.7	151.9	88.9	61.7	67.6	37.2	41.0	323.5	323.7	75.8	97.3	44.0	39.3	61.8	158.1	60.8	99.4	63.9	44.1	75.9	115.4	23.2	123.0	60.0	46.5	73.5	171.6	79.0	43.3	92.5	112.9	21.1	44.4	77.3	80.7	42.6	117.0	72.3	70.9	53.2	74.3	94.5	91.2	73.7	173.1	124.8	67.9	78.3	178.0	68.8	133.5	40.1	50.3	179.5	68.5	86.2	71.6	94.5	94.0	118.3	60.0	74.3	92.6	101.2	82.2	167.8	152.0	132.4	102.7	140.2	104.7	87.0	157.4	123.4	154.7	125.1	59.4	131.2	77.1	49.1	147.3	61.2	106.0	219.4	68.2	170.1	119.5	211.9	185.5	89.3	117.5	65.3	71.8	271.1	108.5	113.2	80.3	72.3	97.2	30.2	72.0	113.1	54.2	97.0	140.5	87.6	59.1	168.7	26.6	141.8	229.5	45.4	65.3	224.5	71.6	99.8	59.6	63.5	196.8	108.9	51.4	52.4	11.1	66.1	174.8	170.0	81.9	182.7	37.6	41.4	41.3	38.9	37.2	41.0	44.0	39.3	44.1	43.3	44.4	53.2	53.0	48.1	57.3	7.2	96.6	49.2	99.3	210.0	87.6	21.2	121.0	94.7	46.1	95.8	173.8	79.1	37.5	115.2	45.1	113.7	181.9	195.9	5.4	48.7	49.1	58.6	118.4	48.0	8.3	156.5	142.1	82.0	135.5	54.7	112.1	59.2	78.1	294.5	399.3	16.8	7.1	201.9	118.0	141.8	153.7	9.6	68.3	142.1	81.8	20.6	140.3	33.6	49.4	9.0	16.2	123.6	199.9	56.1	187.2	115.1	872.9	1215.0	131.6	38.0	6.6	40.3	132.5	5.9	32.2	158.5	47.0	67.9	49.5	59.0	198.5	129.6
AP001273.2		ENSG00000284057	"Novel protein, C11orf54-MED17 readthrough"		11	93741664-93812378	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"kidney: 9.5"	"Cell type enriched"	"Detected in single"	7	"Respiratory ciliated cells: 4.4"					"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA040511, HPA046619"	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	"Nuclear speckles"	Cytosol	"HPA040511: AB_10795369, HPA046619: "																		1.3	2.1	0.6	2.1	0.5	0.0	1.1	0.5	1.0	1.5	0.3	1.8	4.9	1.2	0.4	0.3	1.4	1.9	1.5	0.4	0.6	9.5	4.6	1.1	0.8	0.6	0.5	2.3	0.3	2.0	0.5	1.7	0.7	2.3	1.6	1.4	1.6	1.0	1.1	1.6	3.3	0.5	0.5	0.7	1.8	1.3	0.5	1.6	1.5	1.8	1.2	0.9	0.2	0.7	0.6	0.0	3.3	0.6	1.9	0.0	1.9	0.0	1.0	0.7	1.3	0.6	1.4	2.2	4.0	2.5	1.0	2.2	4.0	0.9	0.4	3.3	0.3	0.7	1.4	0.0	1.4	0.0	0.7	1.4	0.6	0.0	1.5	2.9	1.0	1.7	1.3	0.5	3.9	0.0	2.6	2.2	1.4	6.0	0.1	0.8	2.3	1.3	3.5	0.0	0.7	0.3	2.1	2.4	4.9	2.8	2.5	0.9	2.8	0.3	0.8	0.4	1.3	0.6	1.3	2.9	0.2	1.8	1.3	1.9	1.2	1.8	1.1	1.2	1.3	1.0	1.1	1.4	1.5	0.4	1.1	1.4	1.8	1.2	1.4	0.8	2.1	1.2	0.6	0.5	0.5	1.0	0.4	0.6	0.6	0.5	0.7	0.5	0.5	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AP1AR	"2C18, C4orf16, gamma-BAR, PRO0971"	ENSG00000138660	"Adaptor related protein complex 1 associated regulatory protein"	Q63HQ0	4	112231740-112273110	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 91.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035863, HPA058115"	Approved		Supported	"Golgi apparatus"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Golgi apparatus"		"HPA035863: AB_10672098, HPA058115: AB_2683610"	"unprognostic (1.11e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.49e-3)"	"unprognostic (9.14e-2)"	"unprognostic (2.19e-1)"	"unprognostic (9.16e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.78e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.69e-2)"	"unprognostic (6.15e-2)"	"prognostic favorable (4.05e-7)"	"unprognostic (2.50e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.10e-3)"	"prognostic favorable (7.79e-4)"	9.0	15.7	6.4	12.6	7.6	3.7	16.9	9.4	9.7	8.4	5.7	18.0	22.2	11.3	8.2	13.3	6.5	12.8	7.9	8.7	8.4	22.1	20.5	9.1	12.1	6.2	7.2	11.6	8.3	40.9	4.8	12.0	6.5	9.0	16.3	7.6	12.1	10.0	7.4	14.2	23.8	9.8	5.9	13.2	13.0	14.5	7.6	10.9	10.8	7.5	12.1	13.0	9.9	7.9	20.7	10.1	24.5	23.8	20.7	15.2	22.3	18.9	45.9	13.6	16.2	10.0	39.0	46.0	15.3	12.7	16.2	9.2	24.4	14.5	23.2	53.1	13.3	15.5	13.6	32.8	31.9	38.0	23.9	16.9	32.3	11.9	33.7	11.1	21.2	24.2	16.7	38.5	13.5	19.6	34.7	23.5	18.2	47.0	10.8	30.0	26.2	23.5	26.4	14.5	24.5	32.1	12.7	45.2	34.5	12.2	14.9	12.8	19.0	18.1	23.1	27.4	15.2	34.5	68.0	56.2	19.0	14.4	16.3	6.7	7.4	2.6	4.0	10.0	5.6	6.8	6.3	6.4	9.5	5.9	8.5	8.9	1.1	9.0	8.4	4.4	7.5	5.2	6.4	7.6	9.4	9.7	8.7	8.4	6.2	7.2	6.5	5.9	7.6	7.9	21.3	9.6	19.5	9.4	12.9	21.0	8.9	7.0	22.2	8.9	34.2	22.7	20.5	17.2	14.9	16.5	2.1	5.5	14.5	38.4	11.7	9.8	91.7	21.3	17.2	17.7	31.7	6.3	24.8	10.1	3.8	15.2	18.3	29.5	6.3	8.2	9.3	27.3	15.7	10.1	20.6	16.0	6.1	20.1	16.5	59.9	4.7	17.4	23.2	15.0	12.0	12.3	1.0	13.6	16.3	12.7	24.0	10.1	6.8	13.1	24.9	28.6	16.0	8.0	0.0	16.0	20.4	9.6	12.2	28.2	31.3	3.1	12.5	15.2	20.8	14.7
ARHGEF16	"GEF16, NBR"	ENSG00000130762	"Rho guanine nucleotide exchange factor 16"	Q5VV41	1	3454665-3481113	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 44.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 101.1;Extravillous trophoblasts: 55.6;Gastric mucus-secreting cells: 67.2;Intestinal goblet cells: 49.6;Paneth cells: 68.2;Proximal enterocytes: 72.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 56.4;MCF7: 32.4;OE19: 38.2;SK-BR-3: 34.9"	"Region enhanced"	"Detected in many"		"olfactory bulb: 4.7"	"Low region specificity"	"Detected in many"			HPA010609	Approved					NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA010609: AB_1845004"	"unprognostic (1.28e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.31e-1)"	"unprognostic (2.09e-2)"	"prognostic unfavorable (1.82e-4)"	"unprognostic (2.65e-1)"	"unprognostic (5.59e-2)"	"unprognostic (1.79e-2)"	"unprognostic (5.39e-2)"	"unprognostic (9.16e-2)"	"prognostic favorable (1.24e-10)"	"unprognostic (6.46e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.71e-2)"	"unprognostic (3.29e-2)"	3.8	0.5	1.4	2.7	2.0	0.0	4.8	3.0	2.0	3.5	5.2	19.7	44.0	1.1	2.7	17.9	2.5	11.1	1.0	1.1	4.0	17.7	6.5	3.3	0.2	5.3	2.6	1.3	11.1	8.0	11.4	5.0	5.1	9.4	11.9	2.7	17.0	5.7	1.4	5.9	34.2	0.5	2.6	0.8	28.1	3.2	3.3	0.4	10.0	1.5	2.0	5.0	9.0	3.3	18.3	6.8	1.8	0.2	0.0	0.0	12.6	0.3	0.4	0.5	1.4	20.7	56.4	0.0	13.5	0.1	3.4	18.8	3.0	12.1	0.1	0.0	6.3	0.0	8.8	16.2	0.6	0.0	0.1	0.3	11.4	1.2	0.6	1.2	0.1	0.3	2.3	0.0	0.1	32.4	0.0	0.4	13.8	38.2	0.4	0.0	0.0	2.7	14.2	9.1	9.8	1.8	3.6	34.9	0.8	7.1	15.7	0.6	0.0	0.2	4.0	0.3	0.4	0.1	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	2.0	3.0	2.0	1.1	4.0	5.3	2.6	5.1	2.6	3.3	3.3	0.6	9.6	5.4	2.0	0.5	3.2	15.0	9.1	14.2	1.1	8.1	4.6	1.6	12.8	11.7	16.5	6.2	3.2	0.1	101.1	15.6	16.5	0.1	4.3	0.8	0.8	10.2	0.0	0.4	12.7	55.6	0.8	67.2	9.9	0.0	17.3	0.4	4.3	1.2	3.3	0.5	49.6	20.3	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.6	36.7	0.0	0.5	5.2	28.6	68.2	0.0	2.8	3.6	72.1	11.5	6.5	8.8	0.0	0.0	3.0	0.3	3.9	12.2	1.0	6.7	0.5	2.0	40.0	13.3
ASAH2B	"ASAH2C, ASAH2L, bA449O16.3, bA98I6.3"	ENSG00000204147	"N-acylsphingosine amidohydrolase 2B"	P0C7U1	10	50739318-50816495	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in all"		"intestine: 17.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"PC-3: 25.8"					"Low region specificity"	"Detected in many"			HPA061171	Supported		Approved	"Focal adhesion sites"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 56: Bipolar cells - Visual perception"	"Focal adhesion sites"		"HPA061171: AB_2684442"	"unprognostic (6.86e-3)"	"unprognostic (1.91e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.18e-2)"	"unprognostic (5.42e-3)"	"unprognostic (5.03e-3)"	"unprognostic (2.21e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.79e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.21e-3)"	"unprognostic (2.80e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.46e-1)"	1.5	3.7	1.9	1.9	1.8	1.3	2.8	2.0	2.3	2.1	1.7	2.8	17.2	1.6	3.4	2.6	2.6	2.4	5.2	1.9	2.5	4.4	6.4	2.0	1.7	2.4	2.2	3.0	3.5	4.6	3.3	1.0	2.1	3.6	3.2	7.0	2.6	2.4	3.7	1.8	11.1	2.6	1.6	0.9	3.9	3.0	2.6	1.6	3.7	4.0	1.7	1.8	1.7	2.7	2.5	3.7	3.9	6.3	1.4	3.1	3.0	12.9	7.1	7.5	6.1	8.3	7.4	0.1	4.5	3.4	2.4	2.4	4.3	5.4	6.1	4.6	5.4	1.6	10.5	6.4	5.1	2.2	2.3	3.9	5.6	7.1	10.4	2.3	1.7	0.0	8.0	3.0	5.9	6.0	3.7	0.2	5.0	7.6	25.8	0.1	8.9	3.1	4.2	9.7	7.2	14.7	4.1	5.0	4.3	4.0	8.5	1.4	8.0	3.0	14.0	6.3	16.2	3.9	0.5	0.0	15.5	0.0	5.7	0.3	0.0	0.0	1.1	0.0	3.2	0.4	1.9	1.3	0.0	0.7	2.6	2.5	0.2	0.3	0.0	1.8	2.4	0.8	1.9	1.8	2.0	2.3	1.9	2.5	2.4	2.2	2.1	1.6	2.6	2.7	0.6	3.2	1.1	1.0	1.1	1.7	1.0	1.5	3.4	7.0	2.9	1.7	5.1	5.7	2.1	5.5	8.4	1.7	0.6	1.4	5.9	4.4	0.2	1.6	1.4	1.3	6.7	0.8	6.4	4.8	1.5	2.0	3.6	1.0	0.0	2.3	1.8	7.3	0.3	0.0	6.4	4.2	2.0	0.0	0.0	1.0	1.8	0.1	1.8	2.8	0.2	4.1	2.1	7.1	0.5	4.4	2.5	1.2	2.2	1.3	3.5	6.0	2.0	4.6	0.0	1.0	2.4	4.3	3.0	3.4	0.4	0.5	2.2	2.3	3.9	1.0
ATP1A1		ENSG00000163399	"ATPase Na+/K+ transporting subunit alpha 1"	P05023	1	116372668-116410261	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"	Translocase	"Cancer-related genes, Charcot-Marie-Tooth disease, Epilepsy, FDA approved drug targets, Mental retardation, Neurodegeneration, Neuropathy, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 1482.3"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 1879.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 2979.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018702, CAB069993"	Enhanced					NA	NA		420000	"Cluster 35: T-regs - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 45: Enterocytes - Digestion"			"CAB018702: AB_626713, CAB069993: AB_2060979"	"unprognostic (6.18e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.42e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (1.42e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.21e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.65e-1)"	"prognostic favorable (8.98e-8)"	"unprognostic (4.75e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.11e-2)"	"prognostic unfavorable (4.01e-4)"	150.9	206.6	115.5	144.1	135.7	104.3	220.2	176.4	264.7	137.6	209.2	580.5	785.5	92.3	304.6	255.9	143.6	361.3	233.1	176.0	133.9	1127.5	132.5	255.7	89.7	140.8	103.5	137.7	661.3	1482.3	160.6	120.0	196.3	176.4	542.6	301.2	721.9	294.1	147.3	316.6	813.9	146.1	117.4	78.1	201.5	140.0	104.1	92.8	744.4	117.7	132.4	149.7	187.4	142.2	399.8	144.8	147.2	74.5	288.8	277.5	750.8	232.9	462.9	281.6	396.6	583.9	278.5	314.2	321.3	279.0	284.4	505.1	293.8	493.7	406.2	116.1	324.2	183.5	249.2	498.4	220.1	465.2	246.1	311.6	808.0	328.4	429.0	395.5	350.8	187.4	306.9	294.2	253.0	793.7	189.6	167.7	346.0	630.5	285.6	179.7	343.4	278.6	1023.2	405.1	143.8	126.7	363.0	679.6	2979.2	358.2	179.1	265.9	311.9	159.4	221.4	415.4	479.5	140.7	118.1	238.0	488.2	263.1	956.1	19.2	36.6	17.2	59.7	56.6	62.8	26.4	66.9	64.2	59.6	15.2	76.5	55.5	4.5	30.8	86.0	30.4	57.6	53.6	115.5	135.7	176.4	264.7	176.0	133.9	140.8	103.5	196.3	117.4	104.1	142.2	199.2	275.7	295.3	26.8	84.6	276.8	336.8	220.5	390.9	101.0	189.2	145.2	74.1	579.0	238.4	770.6	398.2	83.7	89.1	789.9	373.7	625.6	31.2	205.4	54.3	201.6	176.4	89.2	130.5	315.6	160.6	141.6	134.6	372.1	43.8	212.6	144.2	71.2	129.8	102.6	123.9	353.4	463.9	98.8	254.2	19.3	117.8	145.5	208.1	36.5	56.9	556.8	64.9	77.9	60.9	187.6	307.8	100.8	73.2	271.6	1879.9	308.2	171.6	147.7	32.9	109.8	147.4	20.2	35.8	320.7	268.9	67.6	133.3	58.3	498.6	280.6
ATRN	"DPPT-L, MGCA"	ENSG00000088812	Attractin	O75882	20	3471018-3651118	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Inflammatory response"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 101.6;Inhibitory neurons: 101.1;Oligodendrocyte precursor cells: 89.5;Oligodendrocytes: 85.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008853	Approved		Approved	Cytosol	"Secreted to blood"	NA	NA		27000000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"HPA008853: AB_1078248"	"unprognostic (6.42e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.52e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.99e-2)"	"unprognostic (4.28e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.59e-1)"	"prognostic favorable (2.19e-6)"	"unprognostic (3.71e-2)"	"unprognostic (9.49e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.91e-2)"	12.8	19.1	10.5	10.3	12.2	8.6	17.2	9.3	13.2	16.5	8.9	11.8	55.8	11.8	15.6	10.4	11.7	13.9	19.1	13.4	12.2	23.9	62.8	14.4	7.5	8.0	8.7	14.0	20.2	40.1	8.7	22.6	9.0	12.8	12.3	24.2	13.9	13.2	11.6	14.9	33.4	14.9	11.3	13.8	24.0	16.6	10.8	7.8	32.3	14.2	9.6	15.7	9.1	15.8	40.8	37.6	21.9	18.4	37.9	61.5	28.1	26.6	37.5	27.4	23.1	16.3	27.1	0.0	17.5	37.4	33.8	55.6	15.0	58.1	36.4	4.5	12.8	12.7	10.0	35.1	22.8	27.2	8.3	33.1	46.0	29.0	27.8	34.3	36.0	8.7	20.2	19.2	27.0	11.7	11.1	10.4	14.7	13.2	22.3	9.2	50.9	30.8	24.8	28.5	12.9	20.2	26.7	48.9	36.3	21.3	26.2	25.5	44.7	29.0	17.0	30.8	26.6	13.4	20.1	0.1	17.9	17.9	29.6	3.6	3.2	2.0	2.3	2.8	1.0	1.4	1.2	1.4	2.8	1.7	2.0	1.7	0.0	1.5	3.1	2.6	1.8	1.0	10.5	12.2	9.3	13.2	13.4	12.2	8.0	8.7	9.0	11.3	10.8	15.8	11.1	16.0	10.4	70.2	5.8	6.4	4.3	14.1	6.8	22.5	9.9	8.8	12.6	20.0	10.3	11.0	37.5	7.4	8.0	6.5	1.9	8.2	7.1	9.9	15.1	11.1	9.6	7.4	101.6	14.6	8.4	12.7	20.4	11.8	7.0	39.3	17.9	50.9	10.4	37.0	101.1	10.7	4.1	14.2	6.7	5.4	12.5	11.5	7.2	64.6	10.1	11.8	5.2	89.5	85.7	10.0	14.3	7.9	11.4	7.0	34.6	7.3	10.2	20.1	32.9	14.3	10.9	21.3	21.1	8.5	7.2	5.1	5.8	21.0	12.6	5.2
BAIAP2L2	"FLJ22582, pinkbar"	ENSG00000128298	"BAR/IMD domain containing adaptor protein 2 like 2"	Q6UXY1	22	38084652-38111015	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 98.6;kidney: 42.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 68.2;Intestinal goblet cells: 58.4;Oligodendrocytes: 31.0;Paneth cells: 32.6;Proximal enterocytes: 125.8;Undifferentiated cells: 41.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 14.1;OE19: 44.2;RPTEC TERT1: 27.3;SK-MEL-30: 38.4;WM-115: 29.8"	"Region enhanced"	"Detected in many"		"olfactory bulb: 3.7"	"Low region specificity"	"Detected in many"			HPA003043	Approved					NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 45: Enterocytes - Digestion"			"HPA003043: AB_2227864"	"unprognostic (2.15e-1)"	"unprognostic (4.23e-2)"	"unprognostic (9.82e-2)"	"unprognostic (5.91e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.57e-3)"	"unprognostic (1.37e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.88e-3)"	"unprognostic (1.77e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.23e-2)"	"unprognostic (4.51e-2)"	2.5	1.1	3.1	2.8	3.0	0.1	1.8	2.6	6.1	3.7	2.8	41.0	98.6	2.1	0.4	9.7	1.9	14.9	0.8	3.1	2.6	42.5	3.7	0.9	0.3	2.8	2.8	1.5	2.7	0.1	3.5	0.2	2.9	2.5	12.7	0.4	1.9	0.3	1.2	2.4	81.6	0.8	2.6	1.4	8.5	5.9	2.7	0.6	3.1	0.1	0.4	1.2	3.4	3.7	0.2	12.3	0.0	0.0	0.3	1.9	1.5	3.0	0.0	0.0	0.2	9.6	0.8	0.2	4.6	2.7	0.0	1.6	0.0	0.4	0.0	0.3	0.4	0.9	0.0	14.1	0.6	0.0	0.8	0.3	0.7	7.0	0.5	0.0	0.0	0.5	0.4	0.0	0.1	0.1	0.6	0.3	1.1	44.2	0.0	0.4	0.0	0.8	27.3	0.1	0.2	0.2	0.0	5.3	38.4	0.1	0.3	0.2	0.1	0.1	0.4	0.0	0.0	0.9	0.1	0.2	0.0	0.0	29.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	3.0	2.6	6.1	3.1	2.6	2.8	2.8	2.9	2.6	2.7	3.7	0.2	0.0	0.0	7.8	0.5	0.8	0.2	1.0	1.2	2.8	0.3	0.3	1.1	17.2	0.2	0.0	2.1	0.3	0.2	68.2	1.9	0.6	0.7	2.2	3.8	0.3	27.6	0.0	17.2	0.0	1.2	0.8	21.9	12.8	0.0	0.5	0.4	0.9	0.5	6.7	13.1	58.4	0.0	0.3	0.2	0.5	1.2	0.2	5.4	5.6	0.1	0.2	1.0	7.5	31.0	5.4	32.6	1.2	0.3	0.2	125.8	19.1	0.1	1.4	0.0	0.2	1.3	1.3	4.4	1.4	1.1	0.4	0.5	0.3	41.4	0.5
BCO1	"BCDO, BCDO1, BCMO, BCMO1, FLJ10730"	ENSG00000135697	"Beta-carotene oxygenase 1"	Q9HAY6	16	81238689-81291142	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 5.0;intestine: 14.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 6.2;Distal enterocytes: 4.8;Excitatory neurons: 8.0;Intestinal goblet cells: 5.5;Proximal enterocytes: 13.6;Proximal tubular cells: 8.8"	"Cancer enhanced"	"Detected in many"		"renal cancer: 3.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 11.5;EFO-21: 8.7;HAP1: 3.3;NTERA-2: 4.6;RPTEC TERT1: 8.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA043811			Uncertain	"Actin filaments,Centriolar satellite"		NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Actin filaments, Centriolar satellite"		"HPA043811: AB_10962487"	"unprognostic (2.78e-1)"	"unprognostic (3.88e-3)"	"unprognostic (2.61e-1)"	"unprognostic (3.32e-1)"	"unprognostic (4.05e-2)"	"unprognostic (8.01e-4)"	"unprognostic (1.65e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.58e-3)"	"unprognostic (7.26e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.09e-1)"	0.0	0.0	1.8	0.2	1.3	0.0	0.1	0.0	1.2	0.2	5.0	2.6	9.3	0.6	0.2	0.3	0.4	1.2	0.0	2.5	0.2	3.5	0.8	0.2	0.0	0.4	0.4	0.9	0.3	0.0	0.7	0.0	0.1	0.5	3.0	0.2	0.5	1.5	0.1	0.3	14.6	0.3	0.1	0.0	1.9	0.1	0.7	0.2	0.1	0.0	0.0	0.2	0.4	0.6	0.0	11.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.3	2.3	0.0	8.7	0.0	0.3	0.1	3.3	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	4.6	0.8	0.0	0.0	0.0	0.0	8.6	0.3	0.3	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.3	0.0	1.2	2.5	0.2	0.4	0.4	0.1	0.1	0.7	0.6	0.0	0.0	0.0	6.2	0.0	0.0	0.3	0.0	0.6	0.0	0.1	0.0	0.2	0.0	0.0	1.8	0.0	0.5	0.0	4.8	0.0	0.6	0.1	0.9	1.1	0.1	1.2	0.0	8.0	0.0	0.0	0.2	0.0	4.0	0.0	0.1	0.4	0.3	0.1	0.0	3.7	5.5	0.0	0.0	0.0	0.3	1.5	0.1	0.0	1.0	0.0	0.0	0.0	2.5	1.0	0.6	2.1	1.2	0.0	0.1	13.6	8.8	0.0	0.0	0.0	0.1	0.1	0.4	0.2	0.7	0.0	0.3	0.1	0.0	3.0	0.7
BEND7	"C10orf30, FLJ40283"	ENSG00000165626	"BEN domain containing 7"	Q8N7W2	10	13438484-13528974	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Early spermatids: 167.3;Late spermatids: 268.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 17.5;hTERT-RPE1: 17.3"									HPA037835	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"		Yes	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nucleoli fibrillar center, Vesicles"		"HPA037835: AB_10669722"	"unprognostic (6.22e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.18e-2)"	"unprognostic (4.62e-3)"	"unprognostic (3.24e-3)"	"unprognostic (3.52e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.02e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.19e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.20e-3)"	8.0	6.0	4.7	2.4	4.9	0.7	9.4	6.5	4.7	7.4	4.9	11.2	16.5	7.3	13.6	2.2	12.4	6.5	7.4	5.0	4.9	18.5	9.0	9.1	1.1	5.1	5.9	8.3	12.1	14.8	10.3	4.3	5.9	5.7	6.6	15.4	15.1	6.5	16.4	3.2	19.3	6.1	4.7	3.0	11.2	16.3	5.6	0.5	23.5	13.3	1.0	6.8	4.4	4.4	9.9	5.9	6.0	2.2	0.1	0.0	8.7	3.8	0.1	9.3	5.6	2.4	17.5	0.0	5.1	7.3	5.2	0.4	9.8	2.1	8.3	0.0	8.7	0.0	0.0	11.4	3.9	0.0	0.0	0.2	5.7	1.2	0.0	17.3	10.3	1.4	4.3	0.0	9.3	4.0	0.1	0.0	1.8	0.0	1.0	0.0	4.4	0.0	8.0	1.3	0.4	4.7	10.7	0.0	0.1	9.1	0.1	4.7	9.2	1.1	13.8	11.6	4.8	0.0	0.0	0.0	3.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	4.7	4.9	6.5	4.7	5.0	4.9	5.1	5.9	5.9	4.7	5.6	4.4	33.6	22.4	11.6	23.5	1.9	3.4	23.6	1.1	1.8	14.4	15.4	11.4	11.0	22.8	9.8	20.2	8.4	3.0	2.6	13.2	3.9	13.0	167.3	25.0	5.8	16.7	7.8	0.0	7.5	16.5	2.9	8.0	9.7	36.2	6.3	14.7	22.5	9.6	3.0	1.7	10.2	8.5	6.1	9.4	1.9	268.7	5.0	2.5	3.6	24.4	4.5	20.3	12.3	47.7	0.7	21.8	9.5	6.0	0.5	23.9	45.2	52.0	9.7	32.2	0.0	14.1	8.4	21.5	20.0	3.3	1.8	2.5	3.5	3.4	10.3	36.1
C1orf210	"MGC52423, TEMP"	ENSG00000253313	"Chromosome 1 open reading frame 210"	Q8IVY1	1	43281877-43285617	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 43.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 125.9;Paneth cells: 100.8;Proximal enterocytes: 128.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	14	"basophil: 2.2"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 2.2"	"Cell line enhanced"	"Detected in some"		"A-431: 12.1;BEWO: 13.0;CACO-2: 12.6;CAPAN-2: 39.8;OE19: 33.1;SK-BR-3: 13.8;T-47d: 15.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA013788	Uncertain		Uncertain	"Nucleoli,Nucleoli rim"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoli, Nucleoli rim"		"HPA013788: AB_1845637"	"unprognostic (1.38e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.01e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (7.57e-3)"	"unprognostic (3.94e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.61e-2)"	0.2	0.1	0.3	2.9	0.3	0.2	14.5	0.7	0.5	8.2	0.3	32.4	43.9	1.3	13.0	17.0	6.1	9.9	0.1	0.3	0.2	21.8	6.2	9.0	0.1	0.3	0.4	0.1	22.8	10.3	8.4	1.6	0.4	8.1	30.2	0.5	19.5	3.8	0.0	16.2	38.7	1.2	0.2	0.1	29.1	0.3	0.3	1.0	16.9	0.0	2.3	3.2	8.1	0.8	12.1	0.0	0.0	0.1	0.0	0.0	13.0	0.0	0.0	0.0	0.0	12.6	39.8	0.0	0.3	0.0	0.0	9.0	0.0	5.6	0.0	0.0	0.0	0.1	0.2	0.7	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	8.0	0.0	0.2	0.1	33.1	0.0	0.1	0.1	0.4	1.0	7.8	4.6	0.3	0.1	13.8	0.0	2.1	15.2	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.3	0.3	0.7	0.5	0.3	0.2	0.3	0.4	0.4	0.2	0.3	0.8	0.1	22.4	16.1	0.3	0.6	1.1	6.2	11.5	2.8	0.0	22.4	12.8	0.0	28.6	13.8	22.0	0.0	12.9	0.0	125.9	29.4	21.3	0.1	8.5	1.4	0.2	33.6	0.0	0.0	33.7	3.9	0.2	25.5	14.2	0.0	0.0	0.0	1.2	0.7	0.0	0.0	42.4	8.2	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	18.3	100.8	0.0	0.0	6.6	128.1	39.6	7.3	0.0	0.0	0.0	0.7	0.3	0.0	8.9	2.6	4.7	0.3	0.0	37.0	8.8
C1QTNF12	"ADIPOLIN, C1QDC2, CTRP12, FAM132A, MGC105127"	ENSG00000184163	"C1q and TNF related 12"	Q5T7M4	1	1242446-1246722	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 6.8;skin 1: 6.6"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 19.5;Extravillous trophoblasts: 11.2;Proximal tubular cells: 45.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"EFO-21: 4.1;U-2 OS: 4.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA024107	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA	38200000		"Cluster 40: NK-cells - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"HPA024107: AB_2101207"	"unprognostic (1.10e-2)"	"unprognostic (5.68e-3)"	"unprognostic (3.45e-1)"	"unprognostic (1.24e-2)"	"unprognostic (6.60e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.01e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.05e-2)"	"unprognostic (8.02e-3)"	"unprognostic (1.10e-2)"	"unprognostic (9.68e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.20e-1)"	1.3	0.1	0.4	0.2	0.4	0.0	0.7	0.3	0.5	0.5	0.0	3.4	6.8	0.3	0.0	1.3	0.5	0.1	0.8	0.4	0.7	3.4	0.5	0.4	0.0	0.8	0.4	0.2	0.2	0.0	0.3	0.2	0.5	0.3	0.7	0.0	0.3	0.0	0.4	6.6	6.7	0.0	0.4	0.2	0.4	2.4	0.9	0.0	0.4	0.0	0.1	0.3	0.6	0.5	0.1	0.0	0.0	0.3	0.2	0.0	0.8	0.6	0.0	0.0	0.0	0.3	0.2	0.0	4.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.1	0.1	0.4	0.3	0.1	0.1	0.0	0.7	0.0	0.0	0.6	0.1	0.0	0.0	0.4	0.0	0.3	0.1	0.0	0.0	4.0	0.0	0.0	0.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.4	0.4	0.3	0.5	0.4	0.7	0.8	0.4	0.5	0.4	0.9	0.5	19.5	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.6	2.9	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	3.9	0.5	0.0	0.6	1.2	0.7	0.0	0.0	0.0	0.8	11.2	0.5	0.0	0.7	2.5	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	45.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.4	0.3	0.0	0.0
CA13	"CAXIII, FLJ37995, MGC59868"	ENSG00000185015	"Carbonic anhydrase 13"	Q8N1Q1	8	85220587-85284073	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		Lyase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 14.6"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 33.3;Proximal enterocytes: 52.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 15.6;OE19: 30.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024689, CAB025567"	Enhanced		Approved	Nucleoplasm,Nucleoli,Vesicles		NA	NA		27000	"Cluster 46: Basophils - DNA binding"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Nucleoli	"Nucleoplasm, Vesicles"	"CAB025567: , HPA024689: AB_1846004"	"unprognostic (1.12e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.75e-1)"	"unprognostic (9.16e-5)"	"unprognostic (2.21e-2)"	"unprognostic (2.08e-1)"	"unprognostic (9.39e-2)"	"unprognostic (7.90e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.13e-1)"	"prognostic favorable (9.40e-4)"	"unprognostic (7.59e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.00e-1)"	1.8	2.1	1.2	1.2	1.2	0.3	2.3	1.4	1.3	2.1	0.7	2.5	12.0	0.9	0.6	5.0	1.1	5.4	3.6	1.0	1.7	5.7	3.7	2.4	0.6	0.9	1.5	1.1	1.1	9.0	2.9	0.3	0.8	1.2	3.0	2.3	4.8	0.7	0.4	5.6	14.6	0.8	0.6	0.7	5.9	0.7	1.1	0.7	5.0	0.3	2.9	2.1	2.5	1.3	0.2	0.4	0.8	0.1	0.5	0.6	0.4	1.0	1.1	0.1	2.9	7.2	5.4	0.4	0.5	1.2	6.0	2.3	2.2	2.9	0.2	1.6	0.9	15.6	2.0	6.7	1.4	0.2	0.6	2.2	0.5	0.2	1.2	1.8	1.6	0.6	4.0	2.9	2.6	0.0	0.3	0.2	0.4	30.6	0.4	0.2	2.2	0.1	8.1	0.3	0.2	0.0	0.5	0.0	1.6	1.0	0.5	0.8	1.5	2.8	3.9	0.1	1.6	1.1	0.6	1.9	5.7	2.2	2.6	0.7	0.6	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.1	0.0	0.2	0.2	0.0	0.2	1.2	1.2	1.4	1.3	1.0	1.7	0.9	1.5	0.8	0.6	1.1	1.3	1.7	3.2	12.4	7.2	2.9	1.8	2.7	2.7	3.4	1.8	7.0	4.7	6.4	4.3	10.5	12.9	33.3	0.3	2.1	12.3	9.8	4.0	11.3	4.7	2.5	2.7	4.8	3.2	12.2	1.6	0.3	2.9	9.7	7.7	0.0	0.3	8.6	5.8	1.1	0.0	13.7	4.3	2.0	2.5	3.3	13.1	0.0	3.0	5.4	1.9	1.0	1.9	8.2	16.1	4.4	4.4	4.3	0.0	6.9	1.9	52.6	21.0	9.5	5.1	0.0	8.1	1.9	1.3	2.1	9.1	3.1	0.3	2.2	1.0	5.4	2.4
CAAP1	"C9orf82, CAAP, FLJ13657"	ENSG00000120159	"Caspase activity and apoptosis inhibitor 1"	Q9H8G2	9	26840685-26892803	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA020404, HPA024029, HPA024100"	Uncertain		Approved	Vesicles		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA020404: AB_1845841, HPA024029: AB_1845842, HPA024100: AB_1845843"	"unprognostic (1.07e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.73e-2)"	"unprognostic (6.74e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.35e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.11e-2)"	"prognostic favorable (1.27e-5)"	"unprognostic (1.46e-1)"	"unprognostic (1.89e-1)"	"prognostic favorable (7.94e-9)"	"unprognostic (2.74e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.43e-2)"	7.0	20.4	4.3	10.5	4.5	7.7	10.8	4.8	6.2	9.1	11.0	18.6	17.4	8.2	16.9	11.3	9.2	9.8	5.7	4.4	5.1	16.3	23.8	7.8	14.7	4.4	4.3	6.6	10.8	18.9	7.4	9.7	4.3	10.6	19.5	8.6	11.2	9.5	7.1	10.2	12.7	10.0	4.0	8.5	11.2	12.6	4.6	14.2	27.4	7.5	15.1	10.6	6.8	4.7	24.2	14.9	24.3	23.9	15.9	13.4	18.5	17.4	17.1	16.4	20.1	4.4	14.9	28.6	17.5	14.9	9.4	12.8	25.3	17.0	22.4	39.0	15.4	49.6	22.6	28.2	26.4	21.7	23.9	13.7	21.4	12.7	29.7	18.5	27.8	18.4	14.1	21.0	19.1	13.9	33.8	9.0	32.2	23.8	12.3	23.1	10.9	19.0	42.6	17.7	19.4	38.5	15.9	17.5	16.3	21.5	14.9	25.6	16.7	0.0	24.5	10.1	16.4	9.6	19.2	33.0	8.0	22.3	10.3	14.9	11.3	8.2	16.2	17.6	20.9	18.8	17.7	18.9	18.4	18.7	14.7	15.3	1.4	20.1	15.7	17.2	18.8	16.0	4.3	4.5	4.8	6.2	4.4	5.1	4.4	4.3	4.3	4.0	4.6	4.7	13.9	22.4	21.6	42.1	20.3	9.9	11.3	18.4	15.9	10.8	18.2	14.6	9.7	14.3	27.6	31.3	8.4	18.3	16.4	28.1	58.7	20.6	18.8	25.6	15.3	14.9	15.5	21.7	34.0	19.8	14.7	13.4	18.8	25.5	18.3	15.8	10.4	34.3	12.1	8.4	42.5	26.0	26.4	11.1	10.3	5.4	8.4	17.7	8.8	26.2	15.6	22.1	12.3	41.2	33.8	22.6	23.1	6.4	26.0	17.5	13.4	29.5	23.7	12.7	13.1	16.9	14.8	41.9	18.4	31.6	14.6	10.8	20.1	28.0	32.1	12.6
CARMIL1	"CARMIL, dJ501N12.1, FLJ20048, LRRC16, LRRC16A"	ENSG00000079691	"Capping protein regulator and myosin 1 linker 1"	Q5VZK9	6	25279078-25620530	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 27.9;Collecting duct cells: 35.0;Distal tubular cells: 46.9;Endometrial ciliated cells: 37.3;Glandular and luminal cells: 39.3;Granulosa cells: 31.8;Proximal tubular cells: 58.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 36.0;RPTEC TERT1: 34.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029038, HPA029039"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol		"HPA029038: AB_10601668, HPA029039: AB_10611382"	"unprognostic (2.34e-2)"	"unprognostic (9.45e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.71e-2)"	"unprognostic (3.94e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.66e-3)"	"unprognostic (3.82e-1)"	"unprognostic (4.02e-1)"	"unprognostic (7.15e-3)"	"unprognostic (8.25e-3)"	"unprognostic (5.86e-2)"	"unprognostic (1.28e-3)"	"unprognostic (3.08e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.31e-1)"	4.4	3.9	2.7	2.8	4.1	0.7	6.5	6.4	5.9	5.2	0.0	10.7	15.3	2.5	7.1	4.3	5.5	5.8	3.7	2.2	2.5	8.5	2.1	8.0	3.6	1.0	3.5	4.3	4.5	5.1	1.2	4.6	0.8	3.3	10.0	1.0	5.3	2.7	0.4	5.9	15.8	2.7	1.3	2.8	7.4	11.4	3.2	7.6	5.2	2.0	3.7	5.2	3.7	1.2	12.9	12.7	3.5	4.5	3.2	1.6	12.1	4.3	9.7	4.5	7.9	13.7	9.4	4.4	13.8	6.9	13.2	13.7	13.6	12.2	3.3	11.1	7.2	10.7	14.0	1.7	8.9	0.5	1.6	1.7	8.2	8.7	13.3	5.6	0.2	1.6	0.3	3.5	2.9	10.0	0.7	0.0	4.8	22.7	5.2	1.5	2.1	36.0	34.7	11.5	9.0	1.9	19.1	32.4	12.4	10.1	7.8	0.3	0.2	3.3	5.8	15.8	4.4	0.5	0.2	7.0	5.2	3.9	12.6	0.0	0.4	0.0	0.0	0.5	0.0	0.2	0.1	0.1	0.4	1.3	1.0	0.1	0.0	0.6	1.3	0.9	0.0	0.1	2.7	4.1	6.4	5.9	2.2	2.5	1.0	3.5	0.8	1.3	3.2	1.2	3.2	19.2	27.9	0.0	7.7	0.0	0.0	0.0	0.0	0.0	17.5	11.6	0.0	0.0	4.3	35.0	0.0	20.8	0.4	0.0	46.9	16.7	0.0	37.3	7.0	4.0	0.0	0.0	0.0	15.6	7.9	12.8	0.0	39.3	8.8	31.8	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	3.6	0.0	0.0	0.0	0.0	17.6	0.0	0.0	7.6	0.0	0.0	58.8	3.6	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	10.9	1.6	14.9	0.0	0.0
CD164	"DFNA66, MGC-24, MUC-24"	ENSG00000135535	"CD164 molecule"	Q04900	6	109366514-109382467	"CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Myogenesis"		"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010636	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA010636: AB_1078447"	"unprognostic (1.23e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.97e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.11e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.51e-1)"	260.9	123.6	43.6	119.1	53.6	213.9	211.2	57.4	69.5	151.0	68.9	264.8	252.0	117.0	161.9	95.0	124.8	159.3	91.8	40.6	57.7	298.1	256.8	121.9	137.8	65.3	56.1	126.4	124.1	219.2	89.5	190.1	64.1	146.1	270.5	36.4	303.8	112.7	96.0	89.2	277.6	116.1	52.3	121.0	272.8	113.6	50.7	132.0	360.4	91.7	122.9	154.2	76.0	70.7	130.0	73.0	34.6	242.9	503.0	496.6	235.7	230.8	304.0	213.7	308.0	148.1	194.9	105.7	218.0	261.5	198.0	125.4	136.9	152.7	315.4	220.1	144.5	177.8	72.0	173.9	294.9	209.5	399.0	384.6	279.7	211.3	186.5	270.3	196.9	86.9	178.9	279.9	287.8	141.1	191.5	251.2	52.9	273.1	119.6	126.3	109.0	135.1	292.2	180.5	40.2	80.9	144.6	184.0	348.6	168.0	167.7	265.0	205.6	138.8	99.1	199.5	188.6	96.3	147.4	121.2	244.0	242.8	147.2	349.0	192.3	167.0	166.8	198.6	175.0	126.2	135.2	155.1	189.7	111.0	138.0	150.1	128.5	255.2	197.5	214.1	192.9	413.8	43.6	53.6	57.4	69.5	40.6	57.7	65.3	56.1	64.1	52.3	50.7	70.7	76.5	163.5	78.9	22.5	168.1	200.1	180.2	149.6	128.7	33.8	251.1	123.3	70.9	174.5	153.5	281.4	25.0	244.9	372.7	600.0	93.9	178.8	103.8	111.9	109.2	89.2	166.5	92.8	22.1	136.8	407.2	176.3	175.8	151.2	128.6	76.7	98.2	177.4	311.9	33.7	16.4	427.3	215.7	360.4	223.9	97.3	158.8	237.3	247.3	38.4	147.1	113.3	266.8	15.6	83.1	177.6	430.0	182.1	173.6	230.3	425.5	348.0	351.2	44.4	124.9	110.0	138.1	160.5	184.4	143.0	231.0	674.5	165.9	87.7	285.0	334.7
CD2AP	CMS	ENSG00000198087	"CD2 associated protein"	Q9Y5K6	6	47477789-47627263	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 204.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 9.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003267, HPA003326, CAB004352"	Enhanced		Supported	"Plasma membrane,Centriolar satellite"		NA	NA		58000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	"Centriolar satellite"	"CAB004352: AB_627009, HPA003267: AB_1078458, HPA003326: AB_1078457"	"unprognostic (5.98e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.71e-2)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (5.53e-5)"	"unprognostic (2.21e-1)"	"unprognostic (3.09e-3)"	"unprognostic (6.12e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.84e-1)"	"prognostic favorable (7.57e-5)"	14.0	10.5	3.4	15.0	3.4	14.3	17.8	6.3	4.6	18.1	8.8	40.0	56.9	12.0	13.2	19.2	14.1	15.0	7.7	2.7	3.8	34.1	20.2	17.1	15.9	4.3	3.9	6.4	20.2	35.6	6.0	21.6	4.7	19.7	36.9	6.9	17.0	13.5	6.9	18.0	59.5	10.9	4.3	13.7	40.4	9.4	3.9	34.0	18.2	10.3	17.4	30.1	10.1	4.6	58.0	22.5	6.9	14.3	9.4	13.6	54.8	13.9	16.9	18.5	23.3	37.3	39.9	74.5	56.9	18.2	24.0	21.2	23.0	34.7	29.9	29.9	37.2	41.3	18.4	33.6	12.5	23.3	15.4	9.7	32.1	17.7	25.5	35.7	30.1	24.4	73.5	23.2	16.9	18.2	44.6	8.7	20.3	69.6	8.1	23.6	17.6	34.1	115.6	101.7	20.9	8.1	27.9	36.9	27.7	31.1	35.0	14.8	36.2	36.9	30.8	12.0	39.9	17.5	31.3	52.6	39.4	12.4	19.2	1.8	0.5	3.2	1.2	0.4	1.8	0.9	1.0	1.1	1.2	1.0	0.9	1.5	0.1	3.1	0.4	9.9	0.9	0.5	3.4	3.4	6.3	4.6	2.7	3.8	4.3	3.9	4.7	4.3	3.9	4.6	81.7	96.1	67.1	32.0	40.5	32.2	52.1	26.5	39.9	10.0	40.4	26.4	17.2	35.8	68.9	71.7	16.7	53.0	96.1	204.1	21.5	84.6	10.4	97.9	25.0	56.6	55.8	42.9	40.7	98.0	17.1	20.6	101.4	136.7	24.1	28.5	37.5	24.2	17.4	15.2	45.3	97.3	40.7	26.2	12.6	10.5	16.8	30.6	14.2	83.4	18.0	12.5	22.6	28.6	30.8	151.3	114.0	10.9	27.7	89.0	182.3	67.4	60.0	13.0	26.3	34.9	27.8	38.9	27.2	44.2	41.1	40.9	29.4	48.0	68.8	143.6
CDH1	"CD324, UVO, uvomorulin"	ENSG00000039068	"Cadherin 1"	P12830	16	68737292-68835537	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes, Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 197.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 451.6;Glandular and luminal cells: 321.0;Pancreatic endocrine cells: 264.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	13	"myeloid DC: 1.7;plasmacytoid DC: 4.7"	"Lineage enriched"	"Detected in single"	19	"dendritic cells: 4.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 683.3;CACO-2: 241.9;CAPAN-2: 328.1;HaCaT: 318.7;hTCEpi: 217.2;MCF7: 199.6;OE19: 207.2;RT4: 237.7;T-47d: 209.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000087, HPA004812, CAB028364, CAB072855, CAB072856, CAB072857"	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Cell Junctions"		NA	NA		78000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cell Junctions"	"Golgi apparatus"	"CAB000087: AB_2533003, CAB028364: AB_2076812, CAB072855: AB_2665698, CAB072856: AB_2665699, CAB072857: AB_2665700, HPA004812: AB_1078369"	"unprognostic (3.95e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.78e-1)"	"unprognostic (5.04e-3)"	"unprognostic (1.63e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.61e-1)"	"prognostic favorable (2.06e-4)"	"unprognostic (1.21e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.51e-1)"	"unprognostic (5.92e-2)"	1.0	0.2	1.5	16.1	2.0	6.5	64.2	0.6	1.9	30.0	19.3	127.5	133.9	9.6	39.5	76.9	51.5	45.7	0.3	1.5	1.3	39.8	97.2	36.8	5.6	2.0	1.3	1.3	84.0	197.8	8.0	60.9	1.3	91.7	131.0	0.1	71.9	41.7	0.3	107.7	127.9	5.1	2.1	10.3	104.2	0.4	2.3	20.1	162.7	0.1	29.0	58.2	38.1	2.7	147.0	14.8	0.0	0.5	0.0	0.0	683.3	0.0	0.0	0.0	0.0	241.9	328.1	0.0	3.1	0.0	0.0	318.7	0.0	156.3	0.0	28.6	3.5	0.1	0.7	48.0	0.0	0.0	0.6	0.0	217.2	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.0	199.6	0.2	1.0	5.5	207.2	0.8	0.1	0.1	2.1	53.9	237.7	8.5	0.8	1.4	0.2	58.9	91.8	209.2	0.4	0.0	0.4	0.9	0.7	0.6	0.1	0.3	0.2	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.7	0.0	0.0	0.0	0.0	0.2	0.0	4.7	0.0	0.1	1.5	2.0	0.6	1.9	1.5	1.3	2.0	1.3	1.3	2.1	2.3	2.7	0.6	131.4	69.8	0.7	1.4	94.1	130.3	73.8	45.5	0.0	137.6	83.6	0.9	128.7	95.3	163.7	0.0	117.6	2.5	451.6	1.9	129.1	0.1	159.3	29.2	4.4	86.7	9.0	0.7	113.5	29.6	3.4	132.0	321.0	1.3	2.8	0.4	63.4	11.7	0.0	1.4	208.3	75.3	1.2	13.4	0.0	0.3	3.2	53.4	1.0	3.3	0.0	0.0	0.5	32.1	264.6	204.6	0.4	2.2	195.5	159.5	4.5	118.2	0.0	0.0	0.0	7.1	0.1	0.1	100.6	131.6	50.5	2.7	0.0	154.8	251.5
CDS1		ENSG00000163624	"CDP-diacylglycerol synthase 1"	Q92903	4	84583127-84651334	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 129.8;Respiratory ciliated cells: 210.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 46.1;hTCEpi: 56.9;OE19: 45.5;SK-BR-3: 62.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036187, HPA064546"	Enhanced					NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA036187: AB_10601797, HPA064546: AB_2732714"	"unprognostic (8.74e-2)"	"unprognostic (7.11e-2)"	"prognostic favorable (5.22e-4)"	"unprognostic (2.73e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.10e-3)"	"unprognostic (3.11e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.67e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (2.23e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.06e-1)"	1.0	6.1	8.8	1.5	9.5	0.6	10.2	11.1	17.8	6.3	19.0	20.0	40.2	3.0	29.0	20.1	32.2	8.0	0.5	8.9	11.6	14.9	0.5	10.7	0.6	15.9	11.2	5.2	4.7	28.3	4.8	7.2	16.6	9.4	21.3	22.4	12.5	4.7	0.1	15.4	34.4	1.2	9.9	1.6	18.4	7.4	14.7	3.5	30.4	0.1	5.1	6.7	9.2	8.2	26.5	0.6	1.5	0.3	0.1	0.0	26.5	0.0	0.4	0.6	0.5	11.2	46.1	0.0	2.0	0.0	5.4	27.2	8.5	23.2	0.3	1.8	12.6	0.0	3.8	2.7	0.0	0.8	1.8	0.2	56.9	0.0	8.2	1.0	0.0	1.5	0.1	0.0	0.1	18.8	0.2	0.1	3.8	45.5	1.8	0.1	0.0	5.7	12.7	20.0	10.6	0.2	2.9	62.1	0.1	4.9	19.0	0.5	0.0	0.0	1.4	2.8	3.5	0.0	0.0	0.0	2.6	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	9.5	11.1	17.8	8.9	11.6	15.9	11.2	16.6	9.9	14.7	8.2	0.8	16.0	42.3	33.3	0.4	29.1	27.7	26.4	26.7	16.7	26.6	13.6	1.4	24.3	39.5	40.5	10.4	60.0	0.4	63.0	3.9	26.4	12.1	129.8	3.8	3.3	22.3	0.0	43.1	22.8	12.1	3.5	41.3	45.2	0.0	15.4	1.4	0.7	12.7	21.9	64.6	53.9	48.8	3.5	13.9	4.5	0.6	3.5	0.0	9.4	1.2	29.0	0.0	3.5	2.4	40.8	30.4	0.4	0.1	30.8	80.0	15.9	210.7	32.0	0.0	1.2	4.3	13.1	6.6	41.1	54.1	57.3	1.6	4.8	51.6	38.3
CGN	KIAA1319	ENSG00000143375	Cingulin	Q9P2M7	1	151510510-151538692	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 56.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 118.6;Distal enterocytes: 173.2;Paneth cells: 108.7;Proximal enterocytes: 88.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 91.4;CAPAN-2: 59.1;OE19: 58.6;RT4: 44.0"	"Low region specificity"	"Detected in many"							"CAB017193, HPA027586, HPA027587, HPA027657"	Enhanced		Supported	"Plasma membrane,Cell Junctions"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cell Junctions"		"CAB017193: , HPA027586: AB_10600208, HPA027587: AB_10601884, HPA027657: AB_10611527"	"unprognostic (1.57e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.74e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.98e-1)"	"unprognostic (8.38e-2)"	"unprognostic (4.61e-1)"	"unprognostic (2.11e-2)"	"unprognostic (2.96e-3)"	"unprognostic (7.10e-2)"	"prognostic favorable (5.84e-10)"	"unprognostic (2.66e-1)"	"unprognostic (3.00e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.10e-2)"	5.8	1.1	1.9	6.0	3.3	0.4	9.0	8.5	3.3	4.9	6.5	37.2	52.7	1.4	1.5	8.6	13.2	13.6	0.6	2.0	3.7	12.2	32.1	27.3	0.4	5.5	3.0	2.0	24.2	32.1	3.7	1.6	5.6	10.1	25.1	3.7	21.1	7.0	0.2	17.9	56.4	1.5	1.7	0.4	30.4	6.6	3.4	0.7	4.9	0.1	2.3	8.3	6.2	6.7	28.9	3.2	2.7	4.6	0.0	0.0	35.4	0.1	0.1	0.8	0.9	91.4	59.1	1.3	9.4	0.0	4.9	27.0	8.6	5.0	0.6	17.3	6.0	2.4	1.3	1.8	0.0	0.4	3.6	0.0	1.0	1.3	0.7	0.0	0.3	7.8	1.2	8.1	0.0	26.8	5.0	0.6	22.9	58.6	2.5	5.4	2.8	4.3	17.9	44.0	8.9	4.4	1.8	27.1	1.0	10.3	33.5	0.3	0.5	0.3	8.3	0.5	1.2	7.7	8.4	5.2	0.3	3.3	2.4	0.2	0.1	0.0	0.5	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.4	0.2	0.1	0.1	0.1	0.0	1.9	3.3	8.5	3.3	2.0	3.7	5.5	3.0	5.6	1.7	3.4	6.7	0.1	118.6	33.3	2.3	0.2	0.3	3.3	5.9	0.6	4.3	14.9	9.1	0.7	24.3	22.4	3.7	0.0	3.5	0.5	173.2	0.0	21.5	0.3	13.8	2.1	0.6	10.3	2.7	0.8	25.4	0.3	2.3	54.6	27.3	0.0	0.5	0.0	29.6	0.3	0.0	10.4	32.7	8.2	0.0	0.4	1.2	0.6	0.5	3.6	0.0	2.1	13.5	0.0	3.5	11.7	49.5	108.7	0.7	0.5	11.9	88.7	3.0	46.8	1.5	0.0	0.1	1.0	1.5	6.9	4.2	1.8	0.4	0.6	1.8	27.2	18.3
CHMP4C	"MGC22825, Shax3, VPS32C"	ENSG00000164695	"Charged multivesicular body protein 4C"	Q96CF2	8	81732448-81759515	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 41.8"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 71.6;Pancreatic endocrine cells: 78.7;Proximal enterocytes: 80.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A-431: 37.2;CAPAN-2: 41.5;hTCEpi: 51.4;hTERT-HME1: 41.6;OE19: 73.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA023763, HPA023799"	Enhanced		Approved	"Microtubules,Cytokinetic bridge"		Yes	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 1: Pancreatic cells - Digestion"	"Microtubules, Cytokinetic bridge"		"HPA023763: , HPA023799: AB_1846670"	"unprognostic (3.98e-2)"	"unprognostic (6.75e-3)"	"unprognostic (1.58e-1)"	"unprognostic (5.19e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.45e-2)"	"unprognostic (5.75e-2)"	"prognostic unfavorable (9.33e-5)"	"unprognostic (7.54e-2)"	"unprognostic (8.08e-2)"	"prognostic unfavorable (6.99e-5)"	"unprognostic (1.99e-2)"	"prognostic favorable (1.96e-6)"	"unprognostic (3.29e-3)"	"unprognostic (4.95e-1)"	"unprognostic (2.67e-1)"	"prognostic favorable (6.45e-4)"	1.7	5.8	1.2	2.1	1.3	1.2	16.6	1.6	1.3	7.5	2.8	16.2	41.8	2.3	5.8	22.6	8.7	8.0	3.6	1.1	1.0	13.9	7.7	7.2	0.5	1.5	1.4	0.5	20.1	15.8	10.1	5.8	1.5	10.0	14.8	0.2	28.1	7.6	0.2	29.1	31.7	0.8	1.1	8.5	23.7	1.1	1.4	1.9	17.5	0.5	5.2	9.7	14.2	2.0	37.2	7.6	0.0	0.2	0.0	0.0	16.6	1.9	2.2	0.1	0.0	14.3	41.5	0.1	28.8	0.0	6.4	22.1	0.2	15.7	0.0	0.0	17.9	0.7	9.9	13.6	0.8	0.1	0.1	0.0	51.4	0.0	41.6	15.3	0.0	0.0	10.0	12.4	0.0	18.4	0.1	0.3	0.1	73.1	14.9	0.1	0.0	8.3	36.3	22.0	7.9	0.1	9.9	16.3	0.1	8.5	23.9	0.2	0.0	0.1	8.9	0.1	0.2	6.5	4.3	0.2	0.0	0.1	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.4	1.9	0.0	0.1	0.0	0.1	1.2	1.3	1.6	1.3	1.1	1.0	1.5	1.4	1.5	1.1	1.4	2.0	5.3	25.6	21.5	0.0	3.2	4.6	35.4	17.1	18.2	0.0	27.2	29.3	4.1	21.5	22.4	5.5	0.0	40.2	0.6	42.0	25.4	47.4	0.4	18.6	2.9	4.0	9.1	1.7	0.1	71.6	38.9	1.0	25.5	31.0	1.3	6.5	4.2	7.6	4.4	0.0	0.1	36.4	12.2	0.3	0.7	1.3	0.0	0.9	8.8	1.0	0.0	0.0	1.0	0.0	0.1	78.7	52.8	0.0	5.7	28.9	80.4	22.6	19.1	0.0	0.0	0.2	7.0	0.3	0.7	25.0	17.5	44.5	1.3	0.1	34.4	33.6
CHMP5	"C9orf83, CGI-34, HSPC177, SNF7DC2, Vps60"	ENSG00000086065	"Charged multivesicular body protein 5"	Q9NZZ3	9	33264879-33282070	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033874, HPA042883, HPA056437"	Enhanced		Supported	Microtubules,Midbody,Cytosol		Yes	No		22000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Microtubules, Cytosol"	Midbody	"CAB033874: AB_10608611, HPA042883: AB_2678212, HPA056437: AB_2683133"	"unprognostic (1.10e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.56e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.18e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.14e-3)"	"unprognostic (7.94e-2)"	"unprognostic (2.66e-1)"	"prognostic favorable (2.87e-7)"	"unprognostic (2.22e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.31e-2)"	54.6	54.6	48.3	36.7	49.2	30.5	49.6	50.4	63.8	56.4	50.0	55.7	55.2	41.3	48.1	64.6	43.8	42.1	50.8	49.0	50.3	77.8	56.3	53.5	41.6	50.4	49.7	42.9	32.7	63.9	49.7	63.8	50.7	54.8	55.9	53.8	43.7	39.4	48.2	47.0	59.2	33.9	52.7	43.5	54.6	36.2	49.4	44.9	55.8	44.3	38.1	49.7	56.5	56.9	92.2	66.5	67.0	43.5	99.0	89.0	61.9	90.1	99.7	138.3	152.6	50.9	56.9	49.0	96.3	84.3	95.9	39.2	70.5	72.8	111.1	102.5	49.3	41.5	129.7	55.8	85.9	53.4	78.8	95.6	131.3	93.6	86.4	114.5	73.3	68.3	44.9	63.6	110.5	41.3	56.1	164.1	61.8	70.1	80.6	34.0	59.2	32.9	115.2	48.7	32.7	83.6	91.0	53.4	87.2	77.8	54.2	82.7	74.4	69.5	73.0	60.2	80.8	42.3	87.6	57.0	100.5	36.0	45.6	98.6	50.3	106.3	25.3	56.5	27.6	31.0	33.7	33.8	46.5	26.4	30.6	29.4	129.4	47.4	67.3	71.2	43.4	51.3	48.3	49.2	50.4	63.8	49.0	50.3	50.4	49.7	50.7	52.7	49.4	56.9	182.7	89.8	59.0	14.0	52.9	188.1	156.2	372.5	71.7	63.7	85.2	75.1	64.7	94.4	228.6	110.3	27.1	172.0	77.4	241.0	285.7	141.7	245.2	228.0	90.6	133.8	80.2	90.1	19.6	86.1	186.1	104.4	56.1	167.0	58.4	66.5	97.5	70.5	154.9	26.9	19.0	137.9	246.2	100.9	103.2	35.9	93.2	95.3	117.4	15.0	166.3	156.2	38.1	14.6	26.8	151.9	247.9	104.6	45.2	182.4	226.3	355.2	328.9	68.2	85.5	97.0	130.0	99.5	68.7	70.1	236.3	259.0	68.5	71.4	78.5	246.0
CLDN3	"C7orf1, CPE-R2, CPETR2, HRVP1, RVP1"	ENSG00000165215	"Claudin 3"	O15551	7	73768997-73770270	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Cancer-related genes, Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 263.1;thyroid gland: 116.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 1839.9;Endometrial ciliated cells: 1221.7;Glandular and luminal cells: 1555.7;Intestinal goblet cells: 1471.3;Paneth cells: 2326.0;Proximal enterocytes: 3162.1;Undifferentiated cells: 1266.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 529.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 230.7;PC-3: 47.6;RPMI-8226: 40.5;SCLC-21H: 58.0;T-47d: 105.4"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.5"	"Region enhanced"	"Detected in many"		"midbrain: 9.7"	HPA014361	Enhanced		Supported	"Cell Junctions"		NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 44: Endometrium - Transcription"	"Cell Junctions"		"HPA014361: AB_2668982"	"unprognostic (1.84e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.27e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.79e-2)"	"unprognostic (8.26e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.42e-1)"	"prognostic favorable (3.39e-5)"	"unprognostic (1.46e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.18e-2)"	"unprognostic (6.72e-2)"	0.7	0.2	0.2	7.8	0.3	0.2	26.7	4.2	0.3	12.3	37.6	263.1	54.4	7.5	1.4	1.3	29.6	2.2	0.1	1.1	1.2	46.5	40.4	10.7	0.2	1.3	1.9	0.5	96.6	1.5	27.7	1.0	0.6	58.3	17.5	0.4	72.9	8.3	0.1	9.6	169.5	0.8	0.5	0.2	1.4	0.7	0.9	1.0	116.3	0.0	1.2	1.5	0.2	0.2	2.5	3.6	0.0	0.4	0.0	0.0	17.8	0.0	0.0	0.0	0.0	4.2	35.7	0.0	9.9	0.0	0.0	1.0	0.4	0.0	0.0	0.1	4.9	0.0	0.8	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	230.7	0.4	1.2	2.1	9.1	47.6	0.1	0.0	40.5	2.1	0.2	58.0	0.7	0.0	33.6	0.0	0.2	105.4	0.0	0.2	0.2	0.6	0.9	0.1	0.2	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	4.2	0.3	1.1	1.2	1.3	1.9	0.6	0.5	0.9	0.2	1.6	38.5	37.8	0.0	13.2	0.1	60.3	43.7	0.0	0.7	289.9	182.5	0.6	287.4	86.3	126.9	4.2	63.9	5.1	1839.9	9.8	297.5	0.0	1221.7	130.5	10.3	606.1	5.3	0.0	19.1	17.7	4.1	16.8	1555.7	28.0	1.5	0.4	40.5	5.1	0.0	0.0	1471.3	116.0	0.3	0.0	0.3	2.5	9.9	10.6	0.0	2.0	11.8	0.0	0.0	0.0	36.7	2326.0	0.0	4.4	433.2	3162.1	58.6	498.4	10.6	0.0	0.0	20.3	0.1	0.3	2.7	0.0	72.4	17.5	0.0	1266.0	607.3
CLN3	"BTN1, BTS, JNCL"	ENSG00000188603	"CLN3 lysosomal/endosomal transmembrane protein, battenin"	Q13286	16	28474111-28495575	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 315.9;Extravillous trophoblasts: 106.9;Syncytiotrophoblasts: 451.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 178.0;SK-BR-3: 186.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063280	Uncertain					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA063280: AB_2684975"	"unprognostic (2.38e-3)"	"unprognostic (2.41e-2)"	"unprognostic (7.06e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.69e-2)"	"unprognostic (6.38e-3)"	"unprognostic (8.16e-2)"	"unprognostic (6.27e-2)"	"unprognostic (5.26e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.05e-2)"	18.1	30.5	13.1	19.6	14.2	13.4	21.4	14.2	16.0	16.9	16.5	38.3	21.9	15.9	9.9	22.2	16.0	15.2	11.7	13.2	13.6	21.2	31.9	23.6	13.8	14.6	13.6	16.8	27.7	30.0	8.2	36.9	15.1	17.3	29.2	3.1	34.5	21.0	14.5	24.1	25.7	13.3	13.5	20.4	26.1	7.9	15.6	14.0	24.7	13.8	12.1	19.3	15.6	17.1	23.1	39.2	15.4	38.4	41.1	19.9	178.0	14.8	40.7	28.3	34.9	19.7	52.9	16.0	45.8	24.8	52.0	23.5	25.8	24.7	12.9	38.0	38.5	15.6	24.1	60.6	60.5	23.3	64.7	28.0	66.8	21.9	14.7	26.3	32.9	24.9	30.9	55.0	28.8	61.9	20.7	45.1	21.8	35.3	26.0	37.2	13.4	54.5	30.2	53.0	20.8	19.6	5.7	186.5	18.3	14.0	62.2	32.4	20.2	19.2	10.1	24.9	22.5	58.3	64.2	15.9	28.4	47.3	11.9	63.4	59.8	98.4	57.6	47.6	42.7	24.3	43.6	53.6	63.8	29.3	38.3	40.6	23.8	41.2	38.7	68.1	53.5	46.6	13.1	14.2	14.2	16.0	13.2	13.6	14.6	13.6	15.1	13.5	15.6	17.1	1.2	22.4	15.9	11.1	10.8	0.1	17.2	0.0	23.9	10.9	1.7	0.6	0.0	38.6	6.2	1.8	12.5	315.9	25.8	46.4	0.0	2.2	1.1	1.8	1.3	11.2	17.0	17.5	7.5	0.5	106.9	9.3	20.9	2.6	2.5	7.6	21.0	39.0	70.1	13.5	8.1	39.3	0.0	36.7	0.4	2.5	19.0	17.7	0.0	2.8	17.5	25.0	40.2	7.1	11.4	1.5	43.7	12.4	13.1	10.6	53.1	0.8	1.5	12.1	13.1	9.9	3.5	3.2	8.4	17.1	0.1	451.4	15.9	3.6	50.2	13.3
CNDP2	"CN2, CPGL, FLJ10830, HsT2298, PEPA"	ENSG00000133313	"Carnosine dipeptidase 2"	Q96KP4	18	74495816-74523454	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 334.7;Proximal enterocytes: 629.1;Proximal tubular cells: 487.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 458.7;RPMI-8226: 616.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026196, HPA036898, HPA036899"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		2600000	"Cluster 27: Non-specific - Gene expression"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Cytosol"		"CAB026196: , HPA036898: AB_2675370, HPA036899: AB_2675371"	"unprognostic (2.81e-2)"	"unprognostic (9.96e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.19e-3)"	"unprognostic (2.57e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.84e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.15e-1)"	"prognostic favorable (3.50e-6)"	"unprognostic (2.37e-3)"	"unprognostic (4.65e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.34e-1)"	54.8	40.7	125.3	75.0	147.0	25.1	60.4	139.4	156.9	136.8	113.0	83.6	190.1	44.2	122.8	78.4	140.8	94.4	63.7	123.7	133.2	327.3	261.1	82.3	86.3	143.1	137.4	34.4	100.7	58.5	48.0	75.4	144.7	122.5	79.5	42.1	57.4	101.7	26.6	47.0	255.0	37.9	140.4	137.0	103.5	20.9	143.9	52.5	159.1	22.4	82.2	94.5	47.4	157.6	64.6	85.0	60.5	57.4	72.2	42.5	252.3	66.0	61.7	88.3	87.4	49.6	67.1	80.3	81.4	72.1	69.0	95.0	92.7	124.9	62.7	121.3	36.7	80.2	42.1	79.6	104.6	158.7	119.3	64.5	93.9	76.4	136.6	50.1	78.3	94.6	86.3	458.7	59.1	71.6	84.9	75.6	91.0	42.4	50.3	91.3	69.4	616.6	346.1	264.1	65.3	34.2	51.6	360.2	91.6	143.0	151.5	64.0	82.5	93.9	79.5	21.2	45.2	85.5	380.6	108.1	63.6	113.8	80.2	37.1	115.4	49.0	77.6	166.3	84.4	102.4	61.6	72.2	185.1	110.5	65.5	72.4	15.9	124.6	174.1	161.3	94.5	135.7	125.3	147.0	139.4	156.9	123.7	133.2	143.1	137.4	144.7	140.4	143.9	157.6	39.2	73.7	62.7	16.6	55.7	9.2	40.3	48.6	12.5	33.6	76.5	36.4	26.9	77.2	56.8	119.5	16.7	157.9	47.8	99.0	187.9	168.1	3.3	187.7	49.7	49.6	65.3	23.3	8.8	154.7	130.9	23.5	63.7	334.7	12.0	34.0	40.0	119.8	216.3	43.7	10.8	82.9	75.3	122.9	24.9	4.1	18.6	79.0	17.8	13.1	90.8	86.6	55.6	15.6	51.7	108.9	103.5	16.6	44.4	65.2	629.1	487.6	73.3	31.6	13.1	15.2	22.3	8.3	7.2	27.1	9.7	109.0	38.2	32.8	99.8	53.8
CRYL1	"GDH, lambda-CRY, MGC149525, MGC149526"	ENSG00000165475	"Crystallin lambda 1"	Q9Y2S2	13	20403666-20525873	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 329.8;liver: 254.1"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 485.2;Hepatocytes: 306.1;Proximal enterocytes: 509.9;Proximal tubular cells: 1033.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 68.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040403, HPA058848"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Plasma membrane"		NA	NA		690000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Nucleoli"	"Golgi apparatus, Plasma membrane"	"HPA040403: AB_10795632, HPA058848: "	"unprognostic (1.84e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.25e-2)"	"prognostic favorable (1.76e-5)"	"unprognostic (3.10e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.09e-3)"	"unprognostic (4.75e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.12e-2)"	"unprognostic (8.80e-2)"	"prognostic favorable (2.30e-9)"	"unprognostic (9.00e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.11e-1)"	33.7	31.8	69.5	15.4	81.3	11.2	27.1	75.4	78.1	33.0	65.6	62.1	190.2	30.5	51.7	24.7	26.5	30.0	30.4	65.2	79.0	329.8	254.1	19.9	19.4	76.3	71.9	19.8	46.9	31.4	38.1	16.1	76.1	32.2	49.3	20.7	41.6	36.5	17.0	16.3	131.6	22.8	77.2	23.3	45.2	4.9	71.9	18.0	35.0	20.7	16.3	20.9	23.6	89.8	8.1	6.9	6.4	42.7	31.6	36.1	5.8	11.1	20.0	4.8	3.9	2.6	7.8	0.1	20.6	15.5	10.9	1.9	5.7	9.9	4.9	19.4	4.7	14.2	0.8	55.1	18.1	4.6	12.2	21.5	6.4	3.9	22.0	17.1	51.7	20.3	1.0	5.8	12.7	29.2	12.7	7.2	0.4	68.7	10.2	6.4	3.8	1.0	40.8	16.9	4.2	5.0	6.6	3.1	51.0	3.0	21.2	18.0	50.1	5.8	2.6	14.3	7.1	7.6	1.6	0.0	11.1	7.9	24.5	5.8	50.7	3.2	23.2	59.6	18.9	20.5	30.6	22.1	60.5	23.1	23.5	22.2	1.7	15.6	50.6	6.4	37.5	43.8	69.5	81.3	75.4	78.1	65.2	79.0	76.3	71.9	76.1	77.2	71.9	89.8	29.2	6.4	10.3	57.8	17.7	10.3	15.9	29.7	6.2	6.1	22.0	11.6	10.5	35.8	25.6	77.3	12.5	22.0	10.0	138.5	485.2	26.1	3.6	32.5	8.8	29.1	9.1	6.9	54.5	31.6	11.2	29.8	34.1	27.2	25.3	8.8	50.7	306.1	71.4	1.7	35.3	89.0	32.6	91.6	34.3	4.3	26.1	51.3	37.4	13.1	19.3	112.2	9.2	33.7	114.1	43.2	219.1	24.0	14.3	23.0	509.9	1033.9	20.9	12.6	19.7	23.4	14.7	1.0	2.7	13.0	9.2	20.8	20.1	20.7	105.2	15.0
CTSA	"GSL, PPGB"	ENSG00000064601	"Cathepsin A"	P10619	20	45890144-45898824	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 368.3"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 445.6;Proximal enterocytes: 301.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 856.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB024930, HPA031068, HPA072487"	Enhanced		Enhanced	Vesicles	"Intracellular and membrane"	NA	NA		28000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 51: Myeloid cells - Hemostasis"	Vesicles		"CAB024930: , HPA031068: AB_10601205, HPA072487: "	"unprognostic (8.61e-2)"	"unprognostic (3.37e-1)"	"unprognostic (4.30e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (6.33e-2)"	"unprognostic (9.53e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.85e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.40e-2)"	80.4	368.3	56.8	75.3	58.1	75.6	61.9	63.6	65.6	47.6	96.0	178.6	100.9	55.1	39.0	60.4	39.3	89.7	97.2	59.7	63.8	188.1	95.7	90.9	61.6	62.6	59.1	62.2	52.9	104.4	43.8	76.4	61.4	38.5	170.4	44.0	61.3	48.4	56.0	95.2	109.2	67.3	59.4	108.5	63.3	33.5	70.2	23.0	47.4	61.7	58.8	82.8	49.2	68.4	111.9	114.1	17.6	89.2	856.5	438.6	47.0	150.3	424.0	169.6	217.5	214.4	291.8	24.1	176.2	299.9	638.1	168.6	55.9	105.6	95.7	47.6	53.6	54.3	53.4	375.9	187.3	98.0	240.9	349.0	123.6	107.9	22.5	421.9	190.1	28.2	61.0	355.1	186.9	232.1	25.8	82.4	19.4	172.6	272.1	37.8	107.3	135.7	138.2	96.7	36.9	37.8	263.2	450.3	444.4	51.5	108.5	141.8	172.5	335.0	76.2	178.9	123.7	162.1	238.5	15.7	599.3	128.6	142.4	480.7	305.9	530.5	44.9	168.8	185.5	42.0	75.6	78.3	102.4	25.7	26.6	39.8	152.4	81.2	120.1	40.6	155.4	378.1	56.8	58.1	63.6	65.6	59.7	63.8	62.6	59.1	61.4	59.4	70.2	68.4	53.7	35.3	32.6	26.1	38.2	24.2	38.9	88.8	17.6	58.4	18.4	15.9	12.6	65.8	64.1	71.7	60.5	104.1	27.5	445.6	39.2	246.0	3.3	22.3	39.5	56.0	54.0	22.1	20.4	166.4	109.2	86.8	29.6	62.4	9.5	50.8	102.1	67.9	297.1	47.1	25.2	74.5	95.6	177.1	25.1	4.8	32.9	273.1	112.1	12.2	135.6	86.6	37.0	7.1	10.2	135.0	216.0	27.4	41.9	18.6	301.8	245.8	34.2	46.1	26.3	33.7	54.5	15.3	31.9	24.0	22.9	144.1	49.1	91.3	113.9	36.2
CTSH	"ACC-4, ACC-5, ACC4, ACC5, CPSB"	ENSG00000103811	"Cathepsin H"	P09668	15	78921058-78949574	"Cancer-related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 349.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 1569.9;Proximal tubular cells: 523.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 208.5;intermediate monocyte: 137.7;memory B-cell: 83.3;myeloid DC: 183.6;naive B-cell: 56.0;non-classical monocyte: 94.8"	"Group enriched"	"Detected in all"	5	"B-cells: 83.3;dendritic cells: 183.6;monocytes: 208.5"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 306.4;HaCaT: 228.2;HDLM-2: 183.0;OE19: 197.4;RT4: 362.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000458, HPA003524"	Enhanced		Supported	"Vesicles,Cytosol,Cytoplasmic bodies"	"Intracellular and membrane"	NA	NA		8700000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 11: Alveolar cells - Smell perception"	"Vesicles, Cytosol, Cytoplasmic bodies"		"CAB000458: , HPA003524: AB_1846075"	"unprognostic (6.47e-2)"	"unprognostic (4.65e-3)"	"unprognostic (1.05e-1)"	"prognostic favorable (6.90e-4)"	"unprognostic (4.37e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.18e-2)"	"unprognostic (3.30e-3)"	"unprognostic (2.22e-1)"	"unprognostic (5.96e-2)"	"unprognostic (4.10e-2)"	"unprognostic (3.89e-2)"	"unprognostic (6.63e-3)"	"unprognostic (3.83e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.70e-3)"	"unprognostic (1.79e-3)"	34.3	36.4	29.4	100.6	30.2	36.9	48.8	29.9	47.1	112.8	31.4	32.5	77.8	46.7	26.8	37.9	57.6	104.6	51.3	29.6	32.9	238.2	89.5	349.6	191.8	30.8	31.4	30.0	75.5	77.6	10.1	25.7	31.5	59.7	27.3	4.7	63.0	70.7	16.3	48.4	56.7	43.1	30.7	51.8	93.9	10.1	32.7	51.8	27.7	37.7	131.3	202.2	30.6	32.4	122.0	10.0	1.2	30.5	5.4	0.5	20.3	8.6	3.0	13.9	7.0	17.6	306.4	34.6	12.6	0.0	13.5	228.2	5.2	52.6	10.1	183.0	0.4	3.0	1.3	38.4	12.1	0.4	7.1	5.6	10.7	0.2	0.0	59.4	1.0	5.9	76.0	0.0	17.9	2.8	32.6	87.8	8.9	197.4	4.9	0.3	0.4	5.9	49.9	362.1	2.6	5.2	41.5	27.8	75.4	10.1	12.5	48.0	16.4	0.2	6.2	0.0	5.3	0.8	92.4	19.5	0.1	89.2	12.3	0.0	208.5	2.0	7.6	137.7	29.7	83.3	20.5	7.4	183.6	56.0	1.8	3.8	8.7	3.2	94.8	22.9	18.3	147.5	29.4	30.2	29.9	47.1	29.6	32.9	30.8	31.4	31.5	30.7	32.7	32.4	169.8	237.2	1569.9	59.1	127.4	24.2	280.7	363.9	30.1	1.3	45.5	41.7	26.2	358.9	258.7	367.8	4.2	19.8	8.1	9.1	84.1	225.0	25.3	67.0	86.0	124.5	9.1	3.0	2.2	142.0	39.6	53.8	106.0	42.8	32.8	2.7	14.3	115.5	256.7	0.0	2.9	18.6	101.7	177.8	259.6	22.6	73.0	350.4	80.0	15.9	360.9	22.6	5.2	1.5	1.1	84.6	16.0	6.0	155.8	112.0	153.0	523.2	261.6	6.6	19.7	4.5	22.3	12.3	56.4	41.6	18.6	23.4	29.4	17.8	40.1	340.4
DARS2	"FLJ10514, mtAspRS"	ENSG00000117593	"Aspartyl-tRNA synthetase 2, mitochondrial"	Q6PI48	1	173824653-173858808	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026506, HPA026528"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Mitochondria	Nucleoplasm	"HPA026506: AB_1847482, HPA026528: AB_1847483"	"unprognostic (3.14e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.85e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.05e-3)"	"unprognostic (4.10e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.42e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.15e-1)"	"prognostic favorable (1.74e-4)"	"unprognostic (3.30e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.73e-3)"	8.8	9.8	3.1	7.6	3.5	5.4	7.5	3.7	4.3	7.1	11.5	14.6	8.7	4.3	4.7	6.4	5.2	4.8	8.4	3.1	3.8	19.9	13.5	5.7	9.2	3.3	3.6	4.4	5.7	15.5	2.9	7.6	3.4	5.3	15.4	5.2	5.2	5.0	5.6	3.4	10.4	5.6	3.5	6.2	9.3	6.2	3.9	10.6	7.6	13.5	12.0	6.7	4.1	3.7	74.8	50.5	26.3	18.7	24.0	34.2	38.6	32.3	30.0	49.2	37.0	47.5	68.2	41.6	45.2	27.2	31.3	77.5	86.6	56.5	66.7	48.6	41.5	35.2	22.7	31.8	24.0	30.9	30.8	23.2	25.3	50.9	44.5	15.4	49.8	30.5	74.7	31.0	39.6	19.9	38.8	16.1	60.2	83.0	63.2	44.3	40.6	78.2	43.7	24.9	40.4	34.2	36.3	79.6	51.3	47.0	84.5	39.7	21.2	22.9	35.3	32.6	52.5	21.7	60.4	46.3	13.3	33.3	51.5	3.9	4.4	3.3	3.8	7.0	5.4	6.0	3.4	3.2	6.4	4.4	3.8	2.6	0.2	3.5	5.0	2.5	3.9	3.5	3.1	3.5	3.7	4.3	3.1	3.8	3.3	3.6	3.4	3.5	3.9	3.7	3.7	3.2	3.1	7.2	5.7	1.8	4.1	3.1	6.2	2.3	3.3	2.5	12.6	4.3	4.2	5.5	0.0	9.7	3.1	4.8	7.9	3.9	2.5	3.9	4.9	4.5	4.2	9.4	5.3	2.7	16.0	3.9	7.1	4.5	5.7	4.5	1.8	5.4	10.3	3.3	6.5	5.2	0.0	4.4	2.2	1.5	3.1	5.1	1.8	8.4	5.6	2.9	3.1	4.0	5.1	3.8	1.9	1.5	7.1	2.6	5.9	7.1	3.0	2.7	0.0	6.2	4.0	8.9	7.1	8.0	1.6	4.2	4.4	9.2	7.2	2.9
DDC	AADC	ENSG00000132437	"Dopa decarboxylase"	P20711	7	50458436-50565405	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Catecholamine biosynthesis"	"Decarboxylase, Lyase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 165.8;kidney: 314.9;retina: 175.6"	"Group enriched"	"Detected in many"	4	"Enteroendocrine cells: 410.3;Proximal enterocytes: 391.5;Proximal tubular cells: 429.5;Rod photoreceptor cells: 498.9"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 23.5;liver cancer: 13.4;pancreatic cancer: 6.4;renal cancer: 18.7;stomach cancer: 9.9"	"Group enriched"	"Detected in many"	9	"midbrain: 86.3;pons: 29.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"CACO-2: 54.5;Hep G2: 49.3;OE19: 83.6;SCLC-21H: 130.9;SH-SY5Y: 135.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"midbrain: 74.5;pons: 29.4"	HPA017742	Enhanced		Approved	"Actin filaments"		NA	NA		120000		"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Actin filaments"		"HPA017742: AB_1847832"	"unprognostic (1.04e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.57e-2)"	"unprognostic (3.49e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.15e-2)"	"unprognostic (4.69e-2)"	"unprognostic (5.44e-2)"	"unprognostic (9.36e-3)"	"unprognostic (5.24e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.55e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.16e-1)"	0.5	48.9	0.1	2.3	0.7	0.0	1.0	0.0	0.6	0.0	0.2	36.5	154.8	0.0	9.1	0.1	0.0	0.1	0.0	0.2	2.2	314.9	54.6	2.0	0.1	6.1	86.3	0.8	15.8	0.0	0.0	0.0	29.4	0.6	37.5	175.6	0.0	0.0	0.0	0.1	165.8	1.7	0.0	0.1	18.1	1.5	1.9	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	1.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	54.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.3	0.0	0.0	11.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	83.6	0.0	0.0	0.0	0.7	1.3	0.0	130.9	135.9	0.0	4.4	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.6	0.2	2.2	6.1	86.3	29.4	0.0	1.9	0.2	0.0	0.0	12.2	0.0	2.5	0.0	0.0	0.0	0.0	89.3	0.1	0.1	0.4	2.8	0.6	3.7	41.7	0.0	0.0	34.4	25.4	0.1	6.6	0.1	0.0	1.8	410.3	0.0	0.3	0.9	0.1	0.1	0.0	0.4	0.0	0.0	1.1	67.2	0.1	3.3	0.4	67.8	0.0	1.3	0.0	5.4	0.0	2.5	0.0	0.0	0.0	45.1	0.0	0.0	0.1	0.2	31.8	0.0	0.0	0.3	391.5	429.5	0.0	498.9	0.0	0.0	0.0	4.0	0.4	0.0	0.0	0.1	1.3	0.1	88.7	0.2
DHDH	HUM2DD	ENSG00000104808	"Dihydrodiol dehydrogenase"	Q9UQ10	19	48933699-48944969	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 17.3;kidney: 18.0"	"Group enriched"	"Detected in many"	11	"Proximal enterocytes: 213.7;Proximal tubular cells: 77.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 4.2"	"Group enriched"	"Detected in many"	33	"granulocytes: 4.2;T-cells: 2.3"	"Cell line enhanced"	"Detected in some"		"JURKAT: 3.2;U-266/70: 3.2;U-266/84: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044131	Approved		Approved	"Nucleoplasm,Actin filaments"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Actin filaments"		"HPA044131: AB_10966968"	"unprognostic (1.54e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (9.91e-4)"	"unprognostic (3.33e-3)"	"unprognostic (1.45e-1)"	"unprognostic (5.81e-6)"	"unprognostic (1.56e-2)"	"unprognostic (5.88e-2)"	"unprognostic (4.96e-2)"	"unprognostic (3.30e-2)"	"unprognostic (5.08e-2)"	"prognostic favorable (3.15e-4)"	"unprognostic (2.93e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.54e-1)"	0.2	0.4	1.6	0.0	1.6	0.1	0.2	1.9	3.3	0.3	1.0	0.3	10.5	0.1	0.0	0.8	0.3	0.2	0.1	1.7	1.7	18.0	0.4	1.1	0.2	1.2	1.3	0.6	0.4	0.5	1.8	1.3	1.2	3.2	0.0	1.7	0.4	0.1	0.2	0.2	17.3	0.0	1.3	1.7	0.7	1.9	2.7	0.1	0.1	0.0	0.2	0.3	0.4	1.6	1.4	0.0	0.1	0.7	0.4	0.3	0.5	0.0	0.2	0.2	0.7	1.4	1.1	0.0	0.2	0.0	0.9	0.4	0.5	1.0	0.4	0.5	1.1	2.0	0.5	0.5	0.0	0.0	0.4	0.2	0.1	0.5	0.0	0.3	0.0	3.2	0.7	0.2	0.0	0.3	0.0	0.1	0.3	2.1	0.9	0.7	0.1	1.0	0.1	0.4	2.1	1.1	0.2	0.1	0.5	0.1	1.0	0.0	0.0	0.0	0.8	0.3	0.0	3.2	2.8	0.8	0.7	0.0	0.2	4.2	0.0	0.5	0.7	0.0	0.4	0.0	0.8	0.3	0.0	0.0	2.3	1.5	0.0	0.0	0.0	0.0	0.6	0.2	1.6	1.6	1.9	3.3	1.7	1.7	1.2	1.3	1.2	1.3	2.7	1.6	0.5	3.2	6.4	1.0	1.0	0.8	2.4	3.3	2.2	2.4	1.0	3.4	0.7	1.5	4.6	3.7	0.0	0.2	0.4	1.5	9.8	2.2	0.7	0.3	0.5	0.8	0.0	0.4	1.0	0.4	0.2	0.5	4.1	0.8	1.3	0.1	0.0	0.0	12.9	0.0	1.2	5.0	2.0	0.8	0.0	2.4	0.0	1.7	0.0	0.0	0.0	1.6	0.0	0.0	0.5	1.5	3.6	0.0	0.0	3.5	213.7	77.8	0.5	4.5	0.0	1.2	0.4	0.0	0.8	3.1	0.1	0.1	0.6	0.4	2.7	3.2
DNAAF2	"C14orf104, CILD10, FLJ10563, KTU, PF13"	ENSG00000165506	"Dynein axonemal assembly factor 2"	Q9NVR5	14	49625174-49635244	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002894, HPA004113"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 57: B-cells - Immune response"	Cytosol		"HPA002894: AB_1078316, HPA004113: AB_1078315"	"unprognostic (3.88e-2)"	"unprognostic (2.11e-1)"	"unprognostic (7.57e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.65e-1)"	"unprognostic (9.50e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.47e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.25e-2)"	"prognostic favorable (6.74e-7)"	"unprognostic (6.72e-2)"	"unprognostic (2.54e-1)"	"unprognostic (5.04e-2)"	"unprognostic (3.44e-2)"	3.8	4.6	3.2	4.4	3.1	3.4	5.7	3.8	3.3	4.3	6.0	5.4	7.6	4.0	4.1	4.4	8.6	3.7	4.3	3.0	3.5	6.8	9.3	3.7	5.5	3.5	4.3	3.5	6.9	3.9	3.4	3.4	3.5	4.0	4.7	4.8	5.5	3.0	5.0	3.2	6.2	3.3	3.6	4.1	5.1	6.3	3.4	4.7	5.3	5.3	4.6	4.6	3.3	3.6	14.2	8.3	18.0	14.1	8.6	9.9	17.1	7.5	8.3	8.2	9.0	8.1	13.4	20.7	11.6	5.0	6.7	15.3	15.0	10.6	10.2	14.6	8.9	10.6	6.2	14.1	6.7	17.3	8.6	6.6	11.3	7.0	9.5	8.4	8.5	11.3	16.0	13.8	8.2	17.7	11.4	17.8	19.6	14.7	15.1	14.0	13.9	7.0	11.7	11.8	27.4	20.4	11.2	12.0	13.8	11.3	13.7	6.9	7.0	7.6	21.7	7.9	9.5	27.5	18.4	17.1	2.9	10.5	8.5	7.8	4.9	6.8	7.4	4.5	8.9	11.6	8.2	9.9	5.7	9.3	7.9	7.8	1.8	12.4	5.8	5.1	8.5	4.8	3.2	3.1	3.8	3.3	3.0	3.5	3.5	4.3	3.5	3.6	3.4	3.6	9.8	3.2	5.6	5.9	38.5	41.0	25.0	38.9	41.5	7.0	21.4	20.3	10.6	15.7	14.6	12.9	0.0	21.6	16.2	13.0	31.3	28.4	25.9	30.3	22.9	17.1	9.6	13.9	6.8	24.0	29.4	17.6	19.4	13.8	12.0	12.2	19.2	26.6	14.0	3.3	8.0	15.3	48.8	9.2	21.1	7.5	18.3	10.2	19.6	2.8	10.5	11.3	19.6	6.6	6.2	25.7	13.0	16.6	43.7	36.2	30.8	37.9	27.2	11.9	6.6	16.0	15.4	22.4	17.9	38.6	44.0	12.4	28.0	30.2	22.8	20.0
DNASE1	DNL1	ENSG00000213918	"Deoxyribonuclease 1"	P24855	16	3611728-3680143	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	Apoptosis	"Actin-binding, Endonuclease, Hydrolase, Nuclease"	"Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 34.5;kidney: 34.2"	"Cell type enriched"	"Detected in many"	11	"Proximal enterocytes: 715.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA010703	Enhanced		Supported	Vesicles	"Secreted in other tissues"	NA	NA		420000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 45: Enterocytes - Digestion"	Vesicles		"HPA010703: AB_10600806"	"unprognostic (5.18e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.90e-2)"	"unprognostic (3.73e-2)"	"unprognostic (3.82e-1)"	"unprognostic (3.20e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.69e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (1.14e-4)"	4.6	5.0	5.1	6.6	5.6	4.3	4.6	13.4	6.4	9.8	6.9	6.1	29.7	5.2	5.0	7.1	6.8	2.7	5.5	5.8	4.9	34.2	5.9	4.9	10.0	6.0	5.2	7.5	23.6	2.7	16.3	4.2	6.6	11.6	5.0	4.4	4.9	2.5	3.7	7.8	34.5	2.7	3.2	9.2	11.2	9.2	5.8	9.4	7.4	1.3	8.7	6.0	8.5	9.7	2.9	6.5	11.4	5.9	3.3	2.8	5.2	4.7	0.8	3.7	5.3	8.0	6.9	12.3	3.6	0.7	7.8	4.8	4.2	1.3	3.9	5.5	6.4	4.4	11.3	5.4	1.7	2.9	9.6	2.3	4.8	5.0	1.2	5.8	2.5	10.3	11.2	5.0	3.2	12.3	6.3	13.6	6.9	8.7	3.6	14.9	5.3	5.7	3.1	2.5	8.1	7.6	3.5	10.5	1.9	5.7	10.4	7.7	3.4	6.8	5.0	4.3	2.5	4.8	7.5	21.4	1.7	5.7	6.6	2.7	1.1	3.2	1.5	0.7	1.0	1.4	1.2	1.3	0.6	2.1	1.3	1.8	5.0	1.0	0.7	1.1	1.4	0.5	5.1	5.6	13.4	6.4	5.8	4.9	6.0	5.2	6.6	3.2	5.8	9.7	4.9	9.6	10.3	27.1	9.1	2.7	8.6	3.1	10.8	27.3	5.5	4.8	6.0	4.3	9.7	16.5	22.9	8.6	9.3	11.8	56.7	5.3	19.3	9.8	10.0	7.7	14.3	7.6	20.5	11.0	4.1	7.4	13.3	8.4	2.5	23.3	7.5	1.8	3.9	25.2	22.0	38.6	20.3	5.0	4.2	52.4	8.4	4.4	1.8	15.9	13.2	8.6	30.9	22.1	20.6	5.3	61.4	7.9	7.2	12.4	715.5	2.4	9.1	17.9	0.0	13.6	6.3	28.5	24.5	5.8	3.8	6.2	12.2	10.4	33.4	6.3
DNMBP	"ARHGEF36, KIAA1010, Tuba"	ENSG00000107554	"Dynamin binding protein"	Q6XZF7	10	99875577-100009947	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 75.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037878, HPA058216"	Uncertain		Approved	"Nucleoli,Nuclear bodies,Golgi apparatus,Cytosol"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 41: Macrophages - Immune response"	"Nucleoli, Golgi apparatus, Cytosol"	"Nuclear bodies"	"HPA037878: AB_10675622, HPA058216: AB_2683640"	"unprognostic (3.25e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.86e-1)"	"prognostic favorable (4.95e-6)"	"unprognostic (3.92e-2)"	"unprognostic (4.13e-1)"	"unprognostic (9.79e-2)"	"unprognostic (4.07e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.67e-3)"	"unprognostic (4.03e-2)"	"unprognostic (5.07e-3)"	"unprognostic (6.52e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.28e-1)"	"prognostic favorable (6.15e-4)"	13.6	6.0	3.6	5.5	3.7	10.3	10.2	6.2	5.3	15.8	8.6	17.7	22.5	9.6	12.5	10.2	11.3	11.0	7.5	4.7	4.2	20.6	13.1	8.4	4.6	3.7	3.6	11.5	17.6	31.7	3.9	10.5	3.8	8.9	20.7	15.8	8.4	12.8	13.4	27.4	27.2	8.8	3.0	7.7	23.8	6.9	5.2	20.1	8.1	11.1	5.2	19.8	17.7	3.1	25.7	20.7	18.4	29.2	32.9	27.4	4.4	45.2	43.6	21.5	20.7	14.2	38.0	26.6	18.9	34.9	11.8	19.9	21.6	26.1	29.9	1.4	6.7	3.8	23.7	10.0	17.1	2.6	1.8	13.0	5.7	26.6	23.4	75.5	52.1	8.5	3.6	0.0	44.1	3.2	4.5	5.1	17.7	18.0	12.3	5.5	18.7	1.4	36.6	21.9	3.1	4.2	7.4	1.9	5.7	25.3	1.5	2.4	63.4	16.0	15.3	13.1	29.8	2.1	1.7	36.3	15.2	8.4	12.2	0.0	0.8	0.2	0.7	1.2	0.7	1.2	0.1	0.4	0.3	1.9	0.1	0.3	0.7	2.1	1.2	0.3	0.0	0.6	3.6	3.7	6.2	5.3	4.7	4.2	3.7	3.6	3.8	3.0	5.2	3.1	6.8	9.6	11.0	11.1	14.8	35.1	7.2	5.0	5.2	6.3	9.3	6.3	6.1	12.8	11.2	12.9	35.5	7.7	4.4	36.7	3.9	7.5	1.0	27.0	11.0	12.6	3.6	0.0	15.9	14.3	1.4	17.6	26.0	43.9	2.5	4.1	11.4	12.8	4.7	13.5	24.8	25.0	6.1	10.7	9.6	3.2	13.7	20.5	3.6	23.4	3.3	4.3	0.0	10.6	2.6	19.3	23.6	9.1	6.1	4.0	36.5	3.7	19.9	26.6	0.0	4.3	6.9	4.2	9.3	9.0	45.6	3.7	4.3	15.0	28.4	21.8
DPP4	"ADCP2, CD26, DPPIV"	ENSG00000197635	"Dipeptidyl peptidase 4"	P27487	2	161992245-162074394	"CD markers, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	"Aminopeptidase, Hydrolase, Protease, Receptor, Serine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 137.9;parathyroid gland: 155.7;placenta: 134.1;prostate: 107.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 140.3;Proximal enterocytes: 291.1;Proximal tubular cells: 101.4;Syncytiotrophoblasts: 172.0"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 55.2"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 52.3"	"Lineage enriched"	"Detected in many"	10	"T-cells: 52.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 194.4;ASC TERT1: 212.6;BJ hTERT+: 207.0;RPTEC TERT1: 263.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB045970, HPA068778, HPA071236"	Enhanced				"Secreted to blood"	NA	NA		190000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB045970: AB_11140529, HPA068778: , HPA071236: "	"unprognostic (4.47e-2)"	"unprognostic (4.47e-2)"	"unprognostic (8.89e-2)"	"unprognostic (3.36e-1)"	"unprognostic (7.25e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.58e-1)"	"unprognostic (4.73e-1)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (1.98e-4)"	"prognostic favorable (1.35e-6)"	"unprognostic (4.68e-2)"	"unprognostic (6.33e-2)"	"prognostic favorable (4.99e-4)"	"unprognostic (1.21e-2)"	13.3	3.1	0.2	5.3	0.2	0.6	8.4	0.1	0.6	10.9	0.1	14.6	107.0	3.6	4.0	3.0	7.4	6.7	3.4	0.2	0.1	94.9	57.2	16.0	5.8	0.2	0.2	3.5	3.5	155.7	0.1	134.1	0.3	107.3	16.9	0.1	84.5	23.5	1.5	5.7	137.9	3.0	0.1	11.2	7.6	1.3	0.8	12.4	5.0	3.9	4.4	5.7	3.5	0.4	0.2	0.2	1.0	0.0	194.4	212.6	0.6	37.7	207.0	10.9	37.2	38.0	1.0	0.0	13.6	71.0	30.2	1.1	0.4	0.0	6.2	12.3	0.0	0.0	0.0	57.1	77.0	0.0	0.0	22.0	0.1	66.3	0.5	9.1	6.6	0.7	0.0	0.0	3.6	0.0	3.6	0.5	2.0	1.3	72.7	0.0	0.0	0.6	263.3	0.0	0.1	0.4	0.0	0.0	0.0	4.4	0.0	0.3	37.0	21.8	1.1	0.7	0.0	0.0	0.0	0.0	22.5	0.0	0.0	0.0	0.0	0.0	6.6	0.0	52.3	0.2	16.2	10.7	1.2	0.0	15.7	6.6	0.4	5.3	0.0	4.0	2.0	4.7	0.2	0.2	0.1	0.6	0.2	0.1	0.2	0.2	0.3	0.1	0.8	0.4	10.8	6.4	26.0	0.3	2.1	4.1	0.4	0.1	0.0	1.8	0.2	0.8	3.3	12.8	2.8	14.7	10.4	140.3	10.4	27.4	1.9	3.0	15.0	2.3	7.1	9.4	55.2	0.4	31.6	0.0	59.1	35.3	2.0	68.0	13.9	5.3	9.3	34.5	14.5	0.0	6.3	16.4	0.0	0.9	7.6	7.9	0.0	4.8	5.4	3.7	1.1	0.0	1.0	2.5	0.7	1.4	23.8	0.0	2.1	32.7	291.1	101.4	2.2	0.1	0.0	2.1	1.5	4.0	1.1	0.1	4.1	172.0	25.8	29.2	29.1	0.3
DSG2	CDHF5	ENSG00000046604	"Desmoglein 2"	Q14126	18	31498177-31549008	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 105.3;parathyroid gland: 157.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 404.6;Pancreatic endocrine cells: 254.9;Undifferentiated cells: 216.8"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	13	"basophil: 8.4"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 8.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 172.9;HaCaT: 269.2;HBEC3-KT: 201.2;hTERT-HME1: 212.1;OE19: 229.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA004896, CAB025122"	Enhanced		Supported	"Cell Junctions"		NA	NA		140000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Cell Junctions"		"CAB025122: , HPA004896: AB_1078643"	"unprognostic (1.56e-3)"	"prognostic unfavorable (8.22e-4)"	"prognostic favorable (7.81e-4)"	"unprognostic (8.77e-3)"	"unprognostic (3.53e-4)"	"prognostic unfavorable (5.63e-4)"	"unprognostic (2.86e-3)"	"prognostic unfavorable (2.43e-4)"	"unprognostic (5.21e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (4.94e-5)"	"unprognostic (3.40e-1)"	"prognostic favorable (3.14e-10)"	"unprognostic (1.76e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.72e-1)"	"unprognostic (8.57e-3)"	23.6	1.2	0.2	14.6	0.2	0.8	40.2	0.6	0.2	13.0	26.4	105.3	79.1	8.6	10.6	10.2	22.4	31.4	31.4	0.7	0.1	33.8	15.1	15.0	1.6	0.3	0.5	13.6	39.5	157.8	1.6	22.9	0.7	31.5	100.0	0.3	68.6	6.5	1.2	6.7	84.6	7.3	0.0	0.4	77.1	3.7	0.4	24.2	42.2	0.7	4.6	41.6	5.7	0.5	119.2	45.3	4.0	0.1	0.6	7.2	143.0	0.0	0.0	0.3	0.0	31.7	172.9	0.0	64.2	0.0	54.4	269.2	54.7	201.2	0.0	0.2	33.9	0.1	46.7	35.9	20.2	15.2	0.3	9.9	136.7	4.2	212.1	102.4	0.0	34.7	47.8	0.2	0.0	31.5	32.2	2.0	55.4	229.5	23.1	52.8	0.0	76.2	65.8	58.5	23.9	0.2	88.3	61.8	0.3	117.8	44.3	12.7	0.1	0.2	25.0	0.3	29.3	5.7	0.2	0.2	19.8	0.1	25.3	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.2	0.2	0.6	0.2	0.7	0.1	0.3	0.5	0.7	0.0	0.4	0.5	120.8	54.5	45.4	0.0	1.3	13.5	79.4	76.2	28.5	0.4	68.9	49.3	57.3	101.5	79.6	12.9	0.0	80.1	4.4	404.6	3.9	105.5	1.0	48.6	9.4	13.1	79.9	9.0	3.3	76.1	116.2	12.0	70.3	82.1	4.5	18.8	2.2	26.4	10.3	1.7	0.3	165.7	79.3	0.8	4.0	2.5	1.5	2.2	17.8	0.0	6.3	5.3	1.0	0.5	0.1	254.9	152.0	0.4	0.3	133.5	145.1	10.0	75.4	0.7	0.0	0.6	8.2	2.7	8.9	23.1	6.0	59.9	2.6	6.6	216.8	179.9
ELMOD2	MGC10084	ENSG00000179387	"ELMO domain containing 2"	Q8IZ81	4	140524168-140553770	"Predicted intracellular proteins"	"Antiviral defense"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047600	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 16: U-266 - Nucleosome"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoli, Cytosol"	Nucleoplasm	"HPA047600: AB_2680098"	"unprognostic (1.39e-1)"	"unprognostic (1.91e-1)"	"unprognostic (6.70e-3)"	"unprognostic (2.10e-3)"	"unprognostic (4.91e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.65e-1)"	"prognostic favorable (1.17e-8)"	"unprognostic (3.17e-1)"	"unprognostic (4.03e-1)"	"prognostic unfavorable (6.35e-4)"	"unprognostic (1.82e-2)"	10.7	13.8	6.8	8.7	7.4	8.6	14.2	9.7	6.9	9.9	12.3	12.2	12.9	10.9	13.2	8.6	10.7	9.1	11.4	6.0	7.8	14.5	15.6	8.5	8.8	8.3	7.6	8.5	8.8	15.5	7.4	9.6	8.0	13.0	13.0	18.0	9.2	9.7	4.3	9.4	15.3	10.2	8.7	7.6	10.3	8.0	7.2	12.5	16.8	5.3	10.2	9.4	6.0	10.6	11.3	12.4	24.9	19.1	25.4	29.2	16.0	26.3	24.7	14.3	17.1	12.2	23.7	18.5	11.3	16.5	17.3	10.1	23.8	16.7	17.6	18.1	14.2	15.3	10.2	16.0	23.1	23.6	13.0	20.1	27.2	12.2	12.5	22.6	15.9	22.2	19.9	29.6	24.8	8.2	25.6	8.1	13.2	16.4	10.1	29.7	19.2	12.0	20.7	17.9	11.8	43.6	17.3	17.5	19.3	27.7	17.1	9.7	16.3	32.7	11.6	15.5	27.6	30.8	47.1	23.1	23.9	18.2	25.3	2.3	6.6	8.0	6.6	7.1	7.4	3.2	5.8	7.2	5.6	6.0	5.9	5.9	15.3	7.5	5.7	9.8	7.3	4.4	6.8	7.4	9.7	6.9	6.0	7.8	8.3	7.6	8.0	8.7	7.2	10.6	14.6	28.9	17.7	22.5	13.1	9.2	11.0	30.3	11.4	20.7	14.7	10.5	14.3	7.2	26.4	18.4	18.8	23.2	19.9	17.6	1.9	22.2	3.9	29.0	24.4	14.5	9.1	7.4	20.2	26.5	8.7	15.5	9.2	15.7	19.7	17.8	11.4	27.1	19.0	15.2	15.6	10.9	22.4	16.4	11.0	1.5	13.1	13.8	17.8	19.7	14.1	16.3	9.2	20.6	35.3	25.6	12.9	10.9	21.7	10.3	27.1	15.9	44.9	24.7	6.6	10.0	18.3	26.9	19.1	12.4	11.6	20.1	13.9	10.9	12.0	8.6
ENPEP	"CD249, gp160"	ENSG00000138792	"Glutamyl aminopeptidase"	Q07075	4	110365733-110565285	"CD markers, Enzymes, Plasma proteins, Predicted membrane proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 163.6;kidney: 90.0"	"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 663.2;Proximal tubular cells: 177.6;Sertoli cells: 157.8"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 41.0"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.7;HEK 293: 7.5;MOLT-4: 1.8;SuSa: 5.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA005128	Enhanced					NA	NA		55000000		"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 45: Enterocytes - Digestion"			"HPA005128: AB_1844795"	"unprognostic (2.73e-3)"	"unprognostic (2.84e-3)"	"unprognostic (5.16e-3)"	"unprognostic (3.48e-1)"	"unprognostic (2.90e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.93e-1)"	"unprognostic (9.47e-2)"	"unprognostic (4.49e-3)"	"unprognostic (3.43e-3)"	"unprognostic (1.52e-2)"	"unprognostic (8.46e-2)"	"unprognostic (2.49e-3)"	11.6	2.2	0.4	1.5	0.5	0.1	4.8	0.4	2.5	1.6	1.8	1.2	36.6	12.9	4.1	1.7	2.3	4.4	4.3	0.6	0.5	90.0	29.0	4.6	0.8	0.9	0.8	1.2	1.3	45.2	1.2	15.5	0.7	1.8	0.8	0.0	1.1	1.2	2.3	0.7	163.6	10.6	0.5	9.2	1.2	0.5	0.4	4.4	5.0	8.9	0.3	2.6	1.6	0.8	0.0	0.2	0.0	0.0	0.1	0.1	2.7	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	1.8	0.3	0.3	0.1	0.0	0.1	0.0	0.3	0.0	0.3	0.1	0.1	0.0	1.3	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.4	2.5	0.6	0.5	0.9	0.8	0.7	0.5	0.4	0.8	10.7	0.0	2.0	1.6	1.1	1.7	0.1	0.0	0.0	0.0	0.2	0.1	3.9	0.0	0.3	11.0	0.0	37.0	0.0	1.5	17.6	0.0	0.5	3.1	40.7	2.2	1.8	0.0	7.3	0.0	3.5	15.4	0.0	2.3	0.0	0.0	1.4	31.4	2.7	0.0	2.9	28.4	2.0	1.0	1.9	0.2	0.6	1.1	0.0	1.0	0.0	0.0	1.0	0.0	0.8	0.0	31.6	0.4	0.1	0.2	663.2	177.6	1.7	0.0	157.8	0.8	54.1	0.0	0.2	0.1	1.0	58.6	1.9	0.5	42.1	0.1
ERI2	"EXOD1, KIAA1504, MGC16943, ZGRF5"	ENSG00000196678	"ERI1 exoribonuclease family member 2"	A8K979	16	20780193-20900349	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 39.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 13.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 13.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035384, HPA035385"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Golgi apparatus"		"HPA035384: AB_10602316, HPA035385: AB_2674600"	"unprognostic (1.25e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.01e-3)"	"unprognostic (4.36e-2)"	"unprognostic (8.64e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.99e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.05e-2)"	"unprognostic (9.28e-3)"	4.7	6.8	4.3	3.7	4.9	6.4	9.2	4.4	5.5	3.9	4.8	7.4	8.1	4.1	7.6	6.7	5.7	4.5	4.4	4.1	4.4	6.5	12.1	4.7	3.8	4.9	4.4	4.5	7.4	14.0	5.0	5.4	4.9	7.5	10.2	4.2	5.1	4.8	5.1	7.1	7.8	4.6	4.6	3.6	8.4	13.1	4.7	7.5	6.2	3.7	4.4	4.5	4.7	5.7	17.1	7.9	21.6	9.5	6.5	8.3	13.0	13.3	7.9	11.8	14.9	10.2	17.0	4.8	14.6	7.3	8.2	12.7	21.8	13.7	21.8	15.3	11.4	11.5	9.7	17.6	6.0	22.3	9.0	7.5	16.7	15.9	13.2	6.3	7.2	0.0	37.1	13.5	20.0	15.3	3.2	19.8	13.4	17.5	4.5	25.5	17.7	10.5	11.0	13.4	11.0	13.5	8.5	16.0	10.3	11.4	33.7	24.7	5.5	12.5	7.0	12.2	17.9	8.3	13.4	2.9	11.9	17.9	17.6	13.8	1.8	1.7	0.4	1.3	0.3	0.5	0.4	0.4	1.9	0.0	0.3	0.2	0.1	0.5	2.6	0.6	0.8	0.4	4.3	4.9	4.4	5.5	4.1	4.4	4.9	4.4	4.9	4.6	4.7	5.7	4.0	16.0	6.7	18.3	1.0	5.0	5.3	5.6	8.0	5.3	11.3	5.8	7.3	5.7	8.5	9.2	0.0	8.3	0.9	8.0	9.8	4.1	22.5	6.9	5.5	3.0	0.0	22.7	10.4	5.2	9.1	4.3	9.7	6.0	0.0	7.1	2.9	10.9	8.4	3.3	10.6	9.6	6.1	8.2	4.1	14.7	6.2	5.8	1.8	5.6	6.7	5.0	3.1	10.6	20.3	4.7	6.6	5.3	2.8	4.5	7.5	6.8	12.6	3.5	0.0	5.6	3.5	39.3	20.0	9.7	3.7	3.7	2.5	4.5	8.5	5.7
ERICH4	"C19orf69, LOC100170765"	ENSG00000204978	"Glutamate rich 4"	A6NGS2	19	41443156-41444765	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"intestine: 42.5;kidney: 16.6"	"Group enriched"	"Detected in some"	10	"Proximal enterocytes: 189.7;Proximal tubular cells: 90.2"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"CACO-2: 2.6;Hep G2: 6.2;THP-1: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA042632, HPA048484"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA042632: AB_2678090, HPA048484: AB_2680415"	"unprognostic (1.41e-1)"	"unprognostic (3.05e-1)"	"unprognostic (9.52e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.76e-1)"		"unprognostic (4.03e-5)"	"unprognostic (8.53e-2)"		"unprognostic (7.54e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.16e-1)"		0.6	0.0	0.3	0.1	0.1	0.0	0.6	0.1	0.1	0.4	0.1	0.3	42.5	0.6	0.0	0.2	0.5	0.3	2.0	0.0	0.0	16.6	0.0	1.1	0.3	0.3	0.1	0.2	0.1	0.0	0.0	0.2	0.2	0.2	0.0	0.1	0.3	0.0	1.7	0.2	39.2	0.0	0.1	0.6	0.2	0.8	0.2	0.0	0.3	0.0	0.0	0.3	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.3	0.1	0.2	0.1	0.2	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.1	13.7	0.2	3.7	0.7	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	4.7	0.0	0.0	0.0	1.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.1	189.7	90.2	0.0	0.0	0.0	0.7	0.2	0.8	0.6	0.0	0.0	0.0	0.3	0.1	3.0	0.0
F2RL1	"GPR11, PAR2"	ENSG00000164251	"F2R like trypsin receptor 1"	P55085	5	76818933-76835315	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 59.4;stomach 1: 44.0"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 109.9;Distal enterocytes: 124.7;Gastric mucus-secreting cells: 74.5;Glandular and luminal cells: 74.7;Paneth cells: 86.1;Suprabasal keratinocytes: 168.4;Urothelial cells: 116.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 42.0"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 42.0"	"Cell line enhanced"	"Detected in many"		"PC-3: 126.0;RPTEC TERT1: 205.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB012989, HPA014091"	Approved		Approved	"Plasma membrane"		NA	Yes			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"CAB012989: AB_2533199, HPA014091: AB_2668939"	"unprognostic (1.29e-2)"	"unprognostic (4.05e-2)"	"prognostic favorable (3.88e-4)"	"unprognostic (1.98e-2)"	"unprognostic (8.22e-2)"	"prognostic unfavorable (5.88e-4)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (8.92e-4)"	"unprognostic (6.13e-2)"	"unprognostic (4.07e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.52e-2)"	"prognostic favorable (5.86e-7)"	"unprognostic (1.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.76e-2)"	"unprognostic (9.73e-2)"	1.0	1.3	0.8	6.2	0.9	1.7	8.0	0.5	0.8	3.6	8.9	59.4	45.8	2.9	4.8	8.2	8.2	29.9	4.6	0.5	0.8	31.8	7.1	4.1	1.4	1.7	2.2	0.5	23.6	5.2	1.5	3.9	1.4	5.0	53.0	2.6	8.9	11.5	0.3	37.5	41.0	2.7	1.0	3.8	44.0	0.6	0.9	1.1	8.3	0.2	1.6	27.5	5.8	0.8	32.7	52.1	4.3	0.2	1.5	4.0	33.1	1.6	17.1	0.9	2.7	45.0	81.8	0.0	69.5	3.7	78.1	54.4	27.1	24.0	1.5	0.1	26.8	0.8	1.0	32.8	10.6	0.0	0.3	5.5	67.3	8.0	49.8	8.0	84.9	7.8	0.4	0.0	0.1	17.6	3.8	0.1	5.7	17.9	126.0	0.1	0.0	0.8	205.9	58.5	2.1	0.4	12.3	12.6	0.3	48.5	5.3	0.3	57.1	0.1	31.8	0.1	0.3	4.8	1.0	0.1	18.7	0.0	1.4	11.9	10.0	1.8	0.4	3.2	2.1	0.5	3.8	1.9	4.7	0.1	3.4	2.1	42.0	0.7	0.5	0.5	1.0	4.0	0.8	0.9	0.5	0.8	0.5	0.8	1.7	2.2	1.4	1.0	0.9	0.8	0.3	9.6	3.7	0.0	0.9	109.9	17.8	4.5	10.8	0.5	10.5	6.3	0.3	32.9	12.7	31.3	0.0	5.4	0.2	124.7	1.9	28.0	0.0	40.9	5.1	1.2	13.1	2.5	0.2	15.0	7.9	2.9	74.5	74.7	2.5	1.0	1.1	9.6	0.9	0.0	1.4	50.8	4.1	1.9	3.8	0.0	0.0	2.1	1.8	1.0	2.6	0.0	0.0	0.0	0.0	44.7	86.1	0.0	0.1	34.1	62.9	19.3	25.0	2.0	0.0	0.4	2.8	0.9	1.3	37.0	168.4	2.1	2.1	0.1	50.7	116.0
FAHD1	"C16orf36, DKFZP566J2046"	ENSG00000180185	"Fumarylacetoacetate hydrolase domain containing 1"	Q6P587	16	1826941-1840207	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 64.1"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 112.2;Proximal tubular cells: 210.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025530, HPA043226, HPA043534"	Enhanced		Enhanced	Nucleoplasm,Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria	Nucleoplasm	"CAB025530: , HPA043226: AB_2678370, HPA043534: AB_2678535"	"unprognostic (3.71e-1)"	"unprognostic (1.25e-2)"	"prognostic favorable (8.27e-4)"	"unprognostic (1.99e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.89e-2)"	"unprognostic (4.32e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (2.80e-14)"	"unprognostic (1.02e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.31e-2)"	12.3	21.4	9.1	8.5	9.4	10.0	9.4	9.3	11.1	8.3	9.2	22.6	36.1	9.7	8.0	19.3	6.9	12.1	19.9	10.9	11.1	64.1	58.5	7.1	7.4	10.7	10.0	8.0	15.8	12.1	9.5	7.5	10.1	9.4	14.2	6.7	11.2	10.7	30.7	17.1	27.1	8.7	8.8	8.4	21.0	10.1	9.4	7.9	7.8	24.7	6.4	11.3	11.1	9.9	20.1	44.6	20.9	36.9	27.0	19.5	12.9	32.4	16.0	21.1	22.9	28.6	20.4	12.8	26.6	20.2	32.7	40.5	16.4	25.8	19.0	19.3	39.0	11.5	38.7	67.0	26.2	20.0	21.2	25.8	33.3	19.3	12.9	17.8	27.8	15.3	12.1	12.8	26.8	92.5	10.9	30.1	12.4	18.4	33.0	24.6	28.3	36.4	76.8	24.9	40.4	33.6	42.3	33.5	52.0	13.8	49.4	13.4	41.1	34.4	24.6	20.5	17.8	18.6	42.3	15.1	22.0	14.5	15.1	15.8	40.8	16.5	25.1	51.5	22.5	37.2	24.7	27.3	42.6	32.7	27.0	24.8	3.5	38.1	38.4	33.1	28.4	24.3	9.1	9.4	9.3	11.1	10.9	11.1	10.7	10.0	10.1	8.8	9.4	9.9	14.6	25.6	16.4	2.9	11.2	14.0	13.3	29.6	13.1	19.8	12.4	15.7	42.9	27.1	17.2	42.3	27.1	22.6	10.9	50.8	50.9	57.2	89.8	16.8	19.8	16.3	29.3	36.4	8.0	39.2	14.2	15.5	17.3	18.2	5.1	13.8	9.7	35.5	30.5	18.5	8.6	25.6	24.4	9.1	14.2	45.0	14.6	13.7	16.0	4.7	18.9	17.4	20.6	3.0	6.4	34.9	36.7	15.4	4.0	11.2	112.2	210.9	14.4	24.2	13.1	12.7	16.5	9.9	9.1	27.2	24.0	15.3	9.8	30.3	52.7	9.6
FAM13A	"ARHGAP48, FAM13A1, KIAA0914"	ENSG00000138640	"Family with sequence similarity 13 member A"	O94988	4	88725955-89111398	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 178.0;Oligodendrocyte precursor cells: 157.8;Syncytiotrophoblasts: 279.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 55.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038108, HPA038109"	Uncertain		Approved	"Nucleoli,Cell Junctions,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Cell Junctions, Cytosol"	Nucleoli	"HPA038108: AB_2675837, HPA038109: AB_10672619"	"unprognostic (1.14e-1)"	"unprognostic (1.53e-2)"	"unprognostic (6.29e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.79e-1)"	"unprognostic (2.81e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.46e-3)"	"unprognostic (6.36e-2)"	"unprognostic (4.71e-1)"	"unprognostic (3.49e-3)"	"unprognostic (1.90e-2)"	"unprognostic (7.44e-2)"	"prognostic favorable (4.28e-4)"	49.2	12.8	8.5	9.9	9.0	12.7	31.8	14.2	11.8	17.6	13.2	18.3	50.5	12.5	7.5	7.6	23.5	16.3	9.9	9.7	7.3	21.9	39.1	11.8	6.3	8.6	8.4	27.8	38.6	49.2	8.4	35.1	9.5	10.6	14.8	15.9	23.4	10.5	9.7	20.4	29.0	13.3	8.3	5.4	16.3	13.9	9.0	5.6	32.8	21.9	4.8	16.9	10.4	8.8	4.5	6.7	9.8	12.8	55.5	22.7	16.0	10.2	12.4	4.0	3.6	5.6	10.3	0.1	4.0	7.4	6.3	2.7	14.5	7.4	8.9	0.6	10.0	7.5	8.9	0.7	16.3	6.3	1.0	21.9	5.9	10.1	3.6	17.5	6.9	2.5	19.7	0.7	8.7	0.2	0.7	2.8	12.1	0.8	6.9	10.2	16.6	4.0	7.4	21.8	24.6	6.5	2.5	7.9	9.9	9.6	5.5	0.2	2.5	11.2	6.2	5.5	5.9	3.4	2.1	0.1	16.6	0.6	5.9	0.0	4.1	0.0	1.0	2.0	0.7	0.0	2.7	0.3	3.5	0.0	2.9	0.7	0.9	0.4	0.6	1.2	1.5	1.6	8.5	9.0	14.2	11.8	9.7	7.3	8.6	8.4	9.5	8.3	9.0	8.8	42.6	12.8	34.9	95.3	4.3	10.1	22.3	20.4	28.5	16.3	29.7	20.6	25.9	38.6	39.3	11.0	35.5	72.9	12.9	50.4	29.4	10.7	3.4	82.0	33.6	14.1	4.9	31.3	178.0	16.9	35.3	42.1	33.1	98.2	1.3	70.2	12.8	143.0	20.7	0.0	46.5	54.1	26.4	29.6	11.9	5.1	45.1	21.7	19.6	104.9	16.9	22.6	5.2	157.8	17.4	20.7	73.4	33.4	10.3	13.6	37.5	50.4	74.6	11.3	0.0	24.7	31.9	5.3	10.2	14.4	7.7	279.5	9.7	41.2	22.3	19.5
FAM3C	"GS3876, ILEI"	ENSG00000196937	"FAM3 metabolism regulating signaling molecule C"	Q92520	7	121348878-121396364	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Developmental protein"	Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Pancreatic endocrine cells: 415.8;Urothelial cells: 425.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"memory B-cell: 22.5;naive B-cell: 19.9"	"Lineage enriched"	"Detected in many"	7	"B-cells: 22.5"	"Cell line enhanced"	"Detected in all"		"CAPAN-2: 1257.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043376, HPA050548"	Enhanced		Enhanced	"Golgi apparatus"	"Secreted in other tissues"	NA	NA		48000000	"Cluster 37: B-cells - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Golgi apparatus"		"HPA043376: AB_2678452, HPA050548: AB_2681169"	"unprognostic (9.44e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.75e-1)"	"unprognostic (8.11e-3)"	"unprognostic (1.26e-2)"	"unprognostic (3.09e-3)"	"unprognostic (3.38e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.48e-1)"	"unprognostic (9.60e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.06e-2)"	40.4	45.9	23.8	38.5	26.8	9.6	42.1	20.4	46.5	96.5	15.9	46.5	177.0	51.4	57.5	32.0	34.5	35.3	64.0	33.8	22.6	62.9	49.5	34.5	44.6	29.3	20.7	36.7	74.0	57.3	29.6	44.5	30.4	31.7	54.0	47.8	38.1	32.3	19.0	32.2	158.2	44.3	19.1	47.4	61.8	24.5	21.8	17.1	111.1	24.5	44.8	56.6	31.3	25.4	133.1	33.2	60.7	64.9	100.3	164.2	55.6	139.7	61.5	41.2	52.1	26.4	1257.1	125.4	65.4	72.5	116.7	85.2	35.1	77.7	87.3	15.3	72.5	35.6	19.3	27.4	73.5	59.0	65.3	165.7	52.1	58.9	57.1	110.4	74.8	24.6	23.3	152.3	326.6	22.3	24.6	45.2	108.1	45.4	45.3	34.2	63.8	51.1	256.7	75.1	38.6	38.1	41.4	167.4	80.6	126.2	24.0	32.5	178.8	105.1	37.7	236.1	96.9	148.0	71.3	48.7	114.0	60.6	192.5	0.0	1.1	0.8	2.1	1.2	2.0	22.5	0.9	1.7	1.0	19.9	1.3	0.9	0.2	3.0	0.9	1.5	0.7	0.8	23.8	26.8	20.4	46.5	33.8	22.6	29.3	20.7	30.4	19.1	21.8	25.4	49.8	9.6	33.3	17.3	103.0	71.8	257.1	183.0	61.5	137.3	47.5	28.8	65.7	71.4	134.4	55.2	22.9	88.1	44.8	66.8	60.7	182.2	3.5	76.0	81.8	58.9	52.3	10.3	64.6	191.0	188.6	104.3	46.4	170.1	19.7	33.3	50.0	37.0	43.6	45.4	64.3	49.1	101.7	29.6	88.4	6.7	96.0	30.9	99.6	24.4	31.7	49.4	58.7	42.3	24.7	415.8	71.9	95.9	129.8	325.0	327.0	66.8	63.9	67.1	72.3	93.6	68.7	23.8	22.4	61.7	66.3	120.4	44.3	35.6	86.7	425.8
FASTKD3	"FLJ23274, MGC5297"	ENSG00000124279	"FAST kinase domains 3"	Q14CZ7	5	7859159-7869037	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA068525, HPA074462"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 20: HeLa - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Mitochondria"		"HPA068525: AB_2685999, HPA074462: AB_2686692"	"unprognostic (5.27e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.41e-3)"	"prognostic unfavorable (1.87e-5)"	"unprognostic (6.66e-3)"	"unprognostic (4.56e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.61e-2)"	"unprognostic (5.82e-3)"	"unprognostic (5.68e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.19e-1)"	"prognostic favorable (8.53e-4)"	3.5	5.4	2.5	3.8	2.6	4.4	6.2	2.4	3.4	4.0	3.2	5.6	5.3	3.3	4.0	3.1	3.1	3.2	3.2	2.4	2.5	9.1	6.7	3.6	5.5	2.4	2.4	4.5	3.0	5.8	2.8	3.3	2.6	4.2	6.6	3.5	3.3	3.4	5.7	4.7	5.9	3.9	2.5	4.6	4.8	2.7	2.2	5.2	4.1	4.3	6.5	3.4	2.6	3.0	10.5	9.0	8.5	11.1	5.2	6.6	16.8	8.5	7.2	13.0	9.9	13.6	10.8	36.0	16.6	9.3	16.5	10.8	21.5	12.0	18.7	9.9	11.1	12.6	28.7	10.7	7.2	21.0	9.8	7.7	5.0	12.3	7.3	5.8	7.2	14.1	17.5	6.1	10.0	7.6	14.2	12.2	7.8	10.9	12.7	16.0	10.4	8.3	10.8	11.1	5.9	5.6	25.9	11.1	12.6	7.7	10.0	9.5	4.8	12.8	13.2	13.6	14.3	7.0	7.2	22.9	8.7	18.9	10.8	2.9	4.2	5.9	4.6	5.7	6.1	7.7	6.6	4.8	5.2	5.7	7.2	6.8	0.2	4.2	4.7	3.0	8.1	3.6	2.5	2.6	2.4	3.4	2.4	2.5	2.4	2.4	2.6	2.5	2.2	3.0	5.3	16.0	5.9	3.9	5.7	2.5	2.3	11.6	1.8	3.3	5.4	4.7	5.0	5.7	5.1	0.0	0.0	7.8	8.8	6.5	5.9	9.1	0.4	3.1	5.4	5.3	7.2	4.6	5.6	11.8	7.1	4.8	4.1	3.3	3.8	4.2	6.4	9.7	8.4	5.0	4.9	6.5	12.2	7.0	5.1	1.1	5.3	5.2	1.8	0.0	12.1	3.5	10.3	2.0	5.9	11.6	4.4	4.5	4.9	3.0	12.4	21.3	6.5	5.3	0.0	3.5	4.0	4.0	6.0	6.6	5.5	4.2	6.8	8.0	7.7	2.1
FRK	"GTK, PTK5, RAK"	ENSG00000111816	"Fyn related Src family tyrosine kinase"	P42685	6	115931149-116060891	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"FDA approved drug targets, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 13.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 89.4;Oligodendrocytes: 97.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"OE19: 18.3;RT4: 7.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB025217, HPA030479, HPA072590"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"CAB025217: , HPA030479: AB_2732457, HPA072590: "	"unprognostic (7.70e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.68e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.23e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.45e-1)"	"unprognostic (7.54e-2)"	"prognostic favorable (9.66e-7)"	"unprognostic (1.52e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.10e-1)"	0.8	1.1	1.3	1.2	2.1	1.5	2.4	5.8	5.0	1.8	13.7	4.6	6.2	1.0	2.5	2.9	2.6	2.6	1.8	1.8	0.0	9.0	6.8	1.8	0.7	0.3	0.1	0.9	2.8	1.0	0.4	0.8	1.0	2.2	4.8	2.9	4.0	2.4	2.2	1.9	6.3	0.8	0.2	0.9	4.9	1.9	1.1	1.2	1.0	0.8	1.6	2.1	1.0	5.7	2.5	4.0	0.5	0.9	0.2	0.2	0.6	0.5	0.1	0.0	0.1	3.1	3.8	0.9	3.5	0.5	0.5	5.8	0.2	1.1	0.1	3.3	0.3	1.3	3.3	2.7	0.2	0.9	0.7	0.2	1.5	0.3	0.4	0.4	0.2	0.6	0.6	2.3	1.0	1.3	0.7	0.5	1.0	18.3	0.7	1.1	3.3	1.2	4.8	7.6	0.7	0.8	0.7	5.1	0.5	0.9	1.5	0.7	0.8	1.0	1.0	0.7	0.5	3.6	2.7	1.6	1.1	0.6	0.6	0.9	0.2	0.2	0.4	0.1	0.5	0.2	0.3	0.4	0.1	0.4	0.2	0.3	0.8	0.3	0.2	0.3	0.2	0.0	1.3	2.1	5.8	5.0	1.8	0.0	0.3	0.1	1.0	0.2	1.1	5.7	0.4	0.0	10.3	10.4	0.5	2.7	20.8	23.3	6.8	0.6	7.3	2.9	9.2	11.5	22.6	23.9	0.0	4.4	0.1	34.9	11.7	20.3	89.4	28.1	1.7	0.7	19.8	0.0	12.2	16.4	4.3	3.5	29.0	30.4	3.8	0.2	1.4	21.9	0.9	6.7	7.7	14.5	34.6	0.6	0.4	38.1	0.6	0.6	0.0	1.0	1.0	0.2	0.0	2.5	97.8	21.9	23.3	1.2	0.5	23.4	49.3	28.4	36.6	0.3	13.1	9.9	16.2	4.6	1.0	16.4	3.1	0.8	1.0	2.3	19.1	46.2
GALK2	GK2	ENSG00000156958	"Galactokinase 2"	Q01415	15	49155656-49367869	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 92.2;Inhibitory neurons: 90.1;Oligodendrocytes: 109.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043564, HPA048267"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		24000	"Cluster 44: Non-specific - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 16: U-266 - Nucleosome"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Cytosol"		"HPA043564: AB_2678557, HPA048267: AB_2680335"	"unprognostic (2.27e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.38e-1)"	"prognostic favorable (7.31e-4)"	"unprognostic (3.04e-1)"	"unprognostic (9.78e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.30e-1)"	"unprognostic (8.67e-3)"	"unprognostic (2.25e-2)"	"unprognostic (2.43e-1)"	"prognostic favorable (1.88e-5)"	"unprognostic (2.33e-1)"	"unprognostic (9.79e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.93e-1)"	10.3	16.8	8.5	8.5	9.3	6.6	11.2	10.1	9.3	12.5	14.8	15.2	20.2	8.5	8.7	8.1	12.2	8.9	12.8	8.7	8.5	30.4	21.1	10.5	8.3	8.6	9.0	9.3	12.2	17.5	9.6	9.9	9.0	9.7	16.2	7.7	9.9	10.9	10.5	9.0	16.6	10.7	8.5	8.9	13.2	7.0	8.3	12.6	14.8	16.9	10.0	9.3	8.5	11.4	14.7	17.1	7.5	10.1	19.1	29.7	21.9	14.7	20.2	14.7	17.2	21.6	15.0	4.8	11.6	15.9	18.0	20.5	30.2	21.6	20.6	26.2	9.1	26.8	15.7	18.4	20.9	19.2	8.2	15.4	38.4	15.7	37.4	16.8	30.2	11.0	27.4	25.5	16.1	15.9	13.9	15.3	3.3	44.0	15.9	16.7	9.5	71.0	27.3	13.8	9.1	6.0	16.6	33.3	29.6	15.0	16.9	18.3	16.6	14.1	9.6	58.4	14.3	20.9	76.2	8.9	22.2	70.1	19.8	45.4	15.3	28.4	18.1	16.7	18.9	14.0	18.0	17.3	15.2	11.1	14.2	14.3	7.6	19.6	17.2	13.3	35.3	13.1	8.5	9.3	10.1	9.3	8.7	8.5	8.6	9.0	9.0	8.5	8.3	11.4	13.6	3.2	14.9	48.6	12.7	5.6	13.6	16.8	9.1	13.3	12.1	10.3	3.1	27.1	14.5	5.5	37.5	14.8	10.6	14.5	29.4	20.0	12.0	19.2	15.7	12.0	9.0	12.0	92.2	13.1	29.0	12.7	18.3	12.0	2.5	9.8	22.9	25.7	20.4	15.2	90.1	25.1	20.3	16.8	5.7	4.8	11.5	12.6	14.2	63.7	16.5	11.6	20.6	41.7	109.5	10.7	16.2	11.3	27.9	8.3	30.5	56.5	34.1	25.8	0.0	13.4	11.6	22.3	5.9	9.0	6.3	25.7	13.9	13.8	19.0	9.7
GALM		ENSG00000143891	"Galactose mutarotase"	Q96C23	2	38666081-38741237	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism"	Isomerase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 86.5;kidney: 120.2"	"Cell type enhanced"	"Detected in many"		"Peritubular cells: 97.8;Proximal enterocytes: 161.1;Proximal tubular cells: 222.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 68.3"	"Group enriched"	"Detected in all"	5	"granulocytes: 39.1;T-cells: 68.3"	"Cell line enhanced"	"Detected in many"		"Hep G2: 62.7;Karpas-707: 71.1;U-266/70: 76.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035472, HPA035473, HPA064835"	Enhanced		Approved	Nucleoplasm		NA	NA		620000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA035472: AB_10669906, HPA035473: AB_2674642, HPA064835: AB_2732723"	"unprognostic (5.02e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.67e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.88e-2)"	"unprognostic (9.99e-3)"	"unprognostic (1.63e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.87e-1)"	"unprognostic (7.17e-2)"	"unprognostic (6.65e-2)"	"unprognostic (6.45e-2)"	"prognostic favorable (9.06e-5)"	"unprognostic (1.70e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.34e-1)"	"prognostic favorable (1.32e-4)"	9.0	86.5	5.2	12.2	5.1	3.8	10.4	6.0	6.1	9.3	8.3	34.7	71.4	8.1	23.0	5.8	35.8	16.5	13.0	4.9	4.8	120.2	72.5	14.3	16.0	5.4	6.1	15.5	15.0	21.3	3.0	7.7	5.4	10.2	33.3	4.4	8.7	20.8	13.1	3.8	52.8	10.4	5.7	6.6	14.9	4.4	7.0	11.0	15.1	12.3	10.2	10.8	6.4	6.0	0.2	27.1	8.1	0.0	27.3	15.4	14.9	3.2	10.3	7.5	12.2	32.4	14.4	10.9	18.9	15.3	14.5	4.3	11.7	0.7	14.5	49.5	19.3	5.9	7.1	62.7	10.0	2.4	0.4	11.1	0.4	17.5	0.0	10.5	8.2	0.0	17.2	71.1	13.9	0.9	23.4	41.0	12.4	59.2	8.6	15.2	0.6	21.3	9.3	45.1	1.5	11.2	0.1	18.9	14.7	10.2	9.0	5.4	3.4	2.5	0.5	18.6	1.0	76.4	54.3	0.3	17.9	7.0	0.3	39.1	4.8	4.2	21.5	3.3	31.8	6.8	33.1	31.2	10.3	4.7	11.7	10.2	11.3	5.5	0.7	0.8	68.3	11.9	5.2	5.1	6.0	6.1	4.9	4.8	5.4	6.1	5.4	5.7	7.0	6.0	9.7	28.9	11.0	13.4	10.0	6.6	6.7	3.4	10.8	3.6	7.8	4.2	23.4	24.3	6.5	69.9	0.0	23.6	19.0	83.2	25.4	12.1	1.4	28.5	11.6	10.0	13.2	8.2	2.3	15.1	31.4	16.1	17.9	10.1	7.0	16.8	14.6	48.1	94.8	3.3	1.4	40.5	4.1	18.6	43.6	1.3	20.2	34.7	17.8	4.7	9.9	38.2	18.6	0.5	1.3	6.8	64.5	97.8	14.7	5.7	161.1	222.1	14.8	6.8	6.6	16.6	10.4	1.0	2.3	3.2	6.0	6.3	44.0	43.3	80.4	5.7
GCNT2	"bA360O19.2, bA421M1.1, CCAT, GCNT5, IGNT, II, NACGT1, NAGCT1, ULG3"	ENSG00000111846	"Glucosaminyl (N-acetyl) transferase 2 (I blood group)"	Q8N0V5	6	10492223-10629368	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 13.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 76.9;Endometrial ciliated cells: 79.1;Glandular and luminal cells: 105.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 1.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 44.2;Hep G2: 19.7;SK-MEL-30: 17.1;SuSa: 21.4"	"Region enriched"	"Detected in all"	4	"basal ganglia: 61.1"	"Low region specificity"	"Detected in all"			HPA026776	Approved		Approved	"Golgi apparatus"		No	No		750000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Golgi apparatus"		"HPA026776: AB_1849573"	"unprognostic (2.47e-1)"	"unprognostic (6.87e-3)"	"unprognostic (3.12e-1)"	"unprognostic (1.42e-2)"	"unprognostic (9.31e-2)"	"unprognostic (2.51e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.11e-2)"	"unprognostic (6.28e-4)"	"unprognostic (3.96e-2)"	"unprognostic (1.58e-3)"	"unprognostic (6.54e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.53e-1)"	0.6	0.3	0.7	1.0	0.6	0.3	10.1	2.5	1.1	4.2	4.5	3.6	5.2	1.4	0.2	1.4	0.8	1.5	6.6	0.8	1.1	5.7	5.1	3.9	1.8	1.2	1.0	0.3	1.3	0.4	1.4	2.6	1.4	13.5	2.0	0.3	4.2	0.3	0.7	1.4	5.8	1.6	0.9	1.5	5.9	2.5	0.9	0.5	1.2	1.8	2.4	1.0	0.7	1.0	6.3	4.9	1.5	4.8	0.0	0.0	9.6	0.0	4.1	1.1	0.5	11.0	5.2	3.5	44.2	0.0	3.2	0.3	0.4	5.1	2.9	3.1	1.8	0.5	2.6	19.7	0.0	1.7	4.7	0.0	0.0	0.5	0.0	2.4	9.1	0.0	0.4	0.0	0.4	0.0	0.0	4.0	4.4	0.0	3.6	0.2	3.8	6.0	16.0	2.9	4.0	1.2	0.0	14.4	17.1	21.4	0.3	0.8	6.4	0.8	0.5	0.0	5.0	0.1	0.0	2.4	0.8	0.3	2.3	1.9	1.1	0.5	0.1	0.8	0.0	0.7	0.1	0.1	0.8	0.4	0.1	0.2	0.1	0.2	0.2	0.2	0.0	0.3	0.7	0.6	2.5	1.1	0.8	1.1	1.2	1.0	1.4	0.9	0.9	1.0	1.4	76.9	32.4	1.0	9.5	4.6	6.6	15.5	9.6	5.1	30.5	16.1	18.4	2.8	28.6	7.3	0.0	27.9	6.4	15.5	11.7	2.9	4.3	79.1	5.5	11.0	2.4	25.9	0.7	24.7	2.1	2.0	16.8	105.5	2.5	0.0	12.8	32.0	15.8	3.3	11.8	5.6	6.1	7.7	9.4	8.2	0.3	7.8	49.8	52.5	11.1	2.4	0.0	18.6	1.1	12.0	11.9	0.0	1.0	16.6	44.3	13.4	27.9	0.6	0.0	0.7	2.2	6.2	27.6	11.2	1.7	10.9	3.1	0.0	16.3	8.1
GFPT1	"GFA, GFAT, GFAT1, GFPT"	ENSG00000198380	"Glutamine--fructose-6-phosphate transaminase 1"	Q06210	2	69319780-69387250	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms"	"Aminotransferase, Transferase"	"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 184.2;Intestinal goblet cells: 244.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047240			Approved	"Nucleoplasm,Nucleoli,Nucleoli fibrillar center"		NA	NA		93000	"Cluster 46: Basophils - DNA binding"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nucleoplasm, Nucleoli"	"Nucleoli fibrillar center"	"HPA047240: "	"unprognostic (4.38e-3)"	"unprognostic (8.20e-2)"	"prognostic favorable (7.13e-5)"	"unprognostic (2.97e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.14e-1)"	"unprognostic (4.84e-2)"	"unprognostic (5.00e-2)"	"unprognostic (3.83e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.58e-1)"	31.2	17.9	6.6	21.5	6.5	15.0	22.4	5.5	7.1	37.8	31.5	74.3	38.4	15.6	41.6	16.4	24.3	32.5	24.8	7.0	11.0	21.6	23.1	17.0	10.6	4.9	10.5	12.0	33.7	26.2	18.9	36.0	10.8	36.7	76.6	10.4	42.4	25.9	10.2	6.0	41.2	23.2	5.3	9.5	64.3	46.6	8.0	10.2	91.8	13.9	15.9	21.8	9.2	6.8	46.6	42.7	34.7	20.9	107.7	75.8	73.5	97.1	94.5	44.7	59.3	109.5	50.5	31.7	31.9	92.9	61.4	22.6	47.1	28.6	73.6	38.4	18.4	38.2	25.0	94.5	123.0	27.9	17.9	47.8	132.5	88.7	158.8	55.5	43.4	29.8	34.8	58.3	85.2	30.9	31.3	22.9	37.0	116.7	27.4	28.2	79.1	18.3	70.6	42.0	25.2	11.9	35.2	52.4	93.7	73.5	22.7	17.2	61.8	37.2	62.3	64.6	47.5	39.5	32.2	25.4	65.7	18.3	46.9	9.2	3.5	4.9	7.5	4.3	7.0	6.4	6.5	8.3	4.7	3.6	6.3	6.2	1.2	5.2	5.2	4.4	5.0	4.2	6.6	6.5	5.5	7.1	7.0	11.0	4.9	10.5	10.8	5.3	8.0	6.8	14.6	51.3	49.5	15.7	29.8	28.4	21.6	31.7	26.7	13.7	50.6	16.5	43.1	42.9	54.5	44.1	12.5	28.6	30.3	184.2	17.6	34.1	123.9	54.4	54.1	17.2	75.1	3.8	49.2	89.5	70.3	37.6	110.1	60.0	24.1	19.2	17.9	53.6	17.0	6.7	56.3	244.0	16.2	10.0	31.4	23.7	23.3	16.0	53.4	27.2	28.1	10.6	13.4	42.7	43.8	66.0	83.3	28.2	82.1	72.3	62.5	30.0	89.7	14.0	19.7	21.6	41.8	134.1	45.3	20.3	21.0	34.3	33.4	15.7	135.3	56.3
GGT1	"CD224, D22S672, D22S732, GGT"	ENSG00000100031	"Gamma-glutamyltransferase 1"	P19440	22	24594811-24629005	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Glutathione biosynthesis, Lipid metabolism"	"Acyltransferase, Hydrolase, Protease, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 174.8;liver: 115.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 80.1;Cholangiocytes: 48.6;Distal enterocytes: 54.1;Ductal cells: 82.6;Hepatocytes: 40.8;Proximal enterocytes: 111.7;Proximal tubular cells: 62.9"	"Cancer enhanced"	"Detected in all"		"renal cancer: 37.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 103.6;Karpas-707: 165.8;OE19: 169.5;RPMI-8226: 210.3;RPTEC TERT1: 203.2"									"HPA045635, HPA047534, HPA065444"	Supported		Uncertain	Vesicles	"Intracellular and membrane"	NA	NA		3600000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Vesicles		"HPA045635: AB_2679400, HPA047534: AB_2680079, HPA065444: AB_2685491"	"unprognostic (8.13e-3)"	"unprognostic (4.76e-1)"	"unprognostic (8.29e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.60e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.21e-1)"	"prognostic favorable (7.44e-4)"	"unprognostic (4.55e-2)"	"unprognostic (2.55e-2)"	"prognostic favorable (4.83e-4)"	"unprognostic (1.44e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.10e-2)"	3.3	2.4	5.5	6.4	6.7	12.0	24.7	7.0	7.5	28.7	5.1	20.3	84.7	3.0	72.0	3.3	3.3	47.1	7.2	5.1	5.1	174.8	115.7	42.6	5.4	7.2	6.6	3.2	63.1	0.2	5.5	2.4	7.8	48.8	11.0	1.6	9.9	21.6	1.9	4.1	80.4	2.2	5.9	13.3	31.3	18.4	7.1	6.5	15.9	0.4	6.2	5.7	4.3	9.2	1.0	79.7	1.0	0.3	0.0	0.5	2.2	0.5	1.7	0.8	1.0	11.7	18.3	1.0	16.2	0.1	14.8	11.0	6.2	0.8	0.5	103.6	12.3	0.6	40.8	64.3	5.5	1.5	33.2	2.1	0.9	2.5	1.7	1.4	0.5	19.0	8.4	165.8	1.0	1.7	1.6	52.4	6.4	169.5	0.7	0.7	6.8	210.3	203.2	2.9	0.5	1.2	0.4	33.3	0.8	22.2	32.4	39.6	6.4	10.6	9.3	46.6	0.9	48.2	18.4	0.7	19.0	58.7	0.5	4.8	12.3	0.2	1.0	6.0	2.9	2.2	5.0	2.4	6.5	0.2	0.6	1.4	15.9	4.9	4.0	0.1	6.5	5.6	5.5	6.7	7.0	7.5	5.1	5.1	7.2	6.6	7.8	5.9	7.1	9.2	0.2	80.1	22.8	3.3	2.8	0.8	0.1	0.3	4.6	0.5	5.9	2.3	0.7	48.6	4.9	1.8	0.0	1.4	0.7	54.1	1.9	82.6	1.8	1.2	0.6	0.7	1.2	5.3	4.4	8.1	0.4	3.9	15.3	5.1	5.7	0.1	1.8	40.8	4.9	0.0	4.1	4.4	4.1	2.5	1.7	6.7	0.0	2.9	1.8	1.0	5.8	2.5	0.0	1.5	5.7	20.9	20.1	0.4	12.8	2.0	111.7	62.9	1.6	0.1	0.0	0.1	1.0	0.6	0.8	0.4	0.4	0.8	4.0	0.0	6.5	0.1
GIPC2	"FLJ20075, SEMCAP-2"	ENSG00000137960	"GIPC PDZ domain containing family member 2"	Q8TF65	1	77979542-78138444	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 38.0;kidney: 41.4;lymphoid tissue: 27.9"	"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 122.1;Proximal tubular cells: 267.7;Undifferentiated cells: 63.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 6.1;HaCaT: 6.0;Hep G2: 23.0;HUVEC TERT2: 23.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA051212, HPA062684"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA051212: , HPA062684: AB_2684833"	"unprognostic (1.72e-2)"	"unprognostic (9.37e-2)"	"prognostic favorable (5.49e-4)"	"unprognostic (1.09e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.35e-1)"	"unprognostic (7.63e-2)"	"unprognostic (2.22e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (2.11e-6)"	"unprognostic (6.55e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.29e-1)"	3.9	23.8	0.5	1.7	0.4	0.3	3.0	0.4	0.5	1.8	0.5	15.6	38.0	2.1	0.9	2.1	3.1	5.5	1.5	0.5	0.4	41.4	18.4	2.7	0.8	0.4	0.4	2.4	18.1	2.3	0.9	3.5	0.4	1.7	14.9	0.1	4.2	0.9	1.1	4.7	38.0	2.8	0.4	27.9	6.0	1.0	0.5	0.4	1.0	1.6	0.8	2.0	1.9	0.4	0.0	0.0	0.0	0.1	2.4	6.1	0.0	1.0	0.0	0.5	1.1	5.1	3.3	1.5	0.1	0.5	0.0	6.0	0.0	0.0	3.2	0.2	0.0	0.8	0.0	23.0	1.2	0.0	0.0	1.0	0.1	3.5	0.1	0.0	23.5	0.0	0.0	0.1	2.9	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.4	0.5	0.5	0.4	0.4	0.4	0.4	0.4	0.5	0.4	33.6	0.0	1.3	2.0	2.0	12.9	2.4	0.9	4.0	0.4	5.2	1.5	3.2	27.1	2.5	9.2	2.1	6.7	0.0	43.7	33.2	11.8	2.5	13.3	0.9	21.6	3.0	0.4	14.7	33.0	3.1	2.9	8.6	7.2	0.0	5.9	22.9	43.3	13.2	0.0	15.2	34.4	0.0	0.8	1.9	1.2	1.2	2.1	0.0	14.0	1.0	0.0	0.0	4.5	8.9	16.5	39.3	0.0	0.0	0.8	122.1	267.7	11.7	0.5	0.0	1.3	1.3	0.6	2.5	7.9	21.7	1.6	1.3	32.4	63.8	6.0
GK	"GK1, GKD"	ENSG00000198814	"Glycerol kinase"	P32189	X	30653359-30731462	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Glycerol metabolism"	"Kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 90.7;kidney: 107.7;liver: 79.2"	"Cell type enhanced"	"Detected in many"		"Langerhans cells: 139.2;Macrophages: 133.4;Proximal enterocytes: 144.2;Proximal tubular cells: 161.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	8	"neutrophil: 178.4"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 178.4"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 37.4;Hep G2: 46.4"	"Low region specificity"	"Detected in all"							HPA060687	Supported					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 41: Macrophages - Immune response"			"HPA060687: AB_2684343"	"unprognostic (8.78e-3)"	"unprognostic (8.41e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.15e-1)"	"unprognostic (4.15e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.85e-1)"	"unprognostic (8.56e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.58e-2)"	"prognostic favorable (3.24e-9)"	"unprognostic (1.59e-1)"	"unprognostic (9.35e-2)"	"unprognostic (4.57e-3)"	"unprognostic (4.11e-3)"	8.8	9.8	3.1	51.5	2.8	6.6	4.8	3.7	17.2	4.8	8.4	13.0	86.6	3.6	12.3	9.6	7.7	23.8	4.8	2.3	4.1	107.7	79.2	19.7	10.6	7.2	4.2	2.6	4.5	14.0	5.4	8.2	6.8	3.6	10.9	10.3	11.2	2.2	2.6	6.3	90.7	4.4	3.6	10.1	6.2	2.9	14.5	5.4	6.6	3.1	14.5	30.2	2.7	8.0	4.5	3.5	4.5	7.7	2.7	10.4	1.8	10.6	37.4	7.6	8.6	5.8	4.1	12.6	1.7	4.1	6.9	0.3	8.5	3.5	10.1	8.2	9.6	7.5	6.6	46.4	17.2	14.2	15.4	6.3	4.9	24.2	22.3	1.9	6.0	9.6	4.0	17.3	2.1	6.2	11.0	14.6	7.5	4.9	4.0	15.0	7.1	13.1	5.7	14.8	4.8	6.1	9.4	9.4	21.5	4.5	10.6	10.1	2.3	5.5	2.3	0.3	4.9	9.1	10.7	12.5	9.5	9.1	5.6	5.0	22.8	7.9	1.7	7.2	1.3	3.1	3.1	2.2	14.2	5.6	1.8	1.9	178.4	4.8	9.1	4.2	11.5	6.2	3.1	2.8	3.7	17.2	2.3	4.1	7.2	4.2	6.8	3.6	14.5	8.0	2.0	16.0	27.4	19.6	15.8	6.9	12.3	12.6	4.6	3.2	9.4	3.9	4.3	12.8	22.5	7.3	16.7	1.2	5.6	54.7	35.2	21.9	61.5	15.1	2.7	3.8	12.1	6.3	41.5	11.1	1.1	12.4	20.9	1.7	14.5	6.9	3.6	38.1	34.8	5.0	37.2	14.7	0.0	26.6	139.2	29.9	1.2	133.4	14.2	10.3	42.6	29.1	3.1	28.6	19.6	10.6	39.9	2.2	12.4	17.0	144.2	161.1	47.7	17.7	0.0	9.2	7.0	15.3	1.7	14.7	16.9	0.8	15.7	3.7	11.0	26.8
GLOD4	"C17orf25, CGI-150, HC71"	ENSG00000167699	"Glyoxalase domain containing 4"	Q9HC38	17	757097-783390	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA021623, HPA023246, HPA023248"	Enhanced		Approved	Cytosol		NA	NA		3500000	"Cluster 27: Non-specific - Gene expression"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA021623: AB_1844365, HPA023246: AB_1844366, HPA023248: AB_1844367"	"unprognostic (2.82e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.88e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.13e-2)"	"unprognostic (6.27e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.96e-2)"	"prognostic favorable (2.18e-6)"	"unprognostic (6.21e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.02e-1)"	42.5	46.8	27.4	33.5	31.0	22.5	34.5	25.4	33.3	28.4	33.4	71.3	80.5	31.6	33.6	42.9	44.9	32.6	37.3	30.6	36.4	75.7	67.7	31.5	46.9	27.8	27.9	39.9	40.5	37.6	23.2	36.7	28.8	37.8	48.3	25.6	39.5	27.3	39.8	44.3	72.7	31.9	28.3	36.8	85.3	19.4	35.3	35.2	47.4	23.0	40.0	41.5	22.4	27.5	121.1	106.8	120.9	67.1	52.0	51.5	73.8	94.4	57.6	75.0	56.7	87.4	84.0	142.9	100.2	42.8	69.7	85.5	106.6	60.1	78.0	105.4	91.2	69.0	55.7	115.5	51.6	72.1	87.5	36.2	81.9	75.5	66.0	47.7	70.4	116.9	115.1	90.4	80.2	73.9	124.1	55.3	88.7	118.8	36.3	122.7	49.0	65.9	74.5	81.2	54.8	91.8	74.8	53.6	124.6	75.3	66.6	75.2	92.2	71.0	56.8	99.9	120.4	50.3	100.0	89.1	83.6	79.5	75.9	26.1	51.8	48.7	68.1	64.1	73.2	70.0	81.0	82.2	45.9	75.4	68.9	75.7	7.1	64.0	70.4	47.2	99.1	75.9	27.4	31.0	25.4	33.3	30.6	36.4	27.8	27.9	28.8	28.3	35.3	27.5	52.2	57.7	35.2	11.4	48.5	47.9	40.4	91.1	40.5	39.6	39.2	36.3	30.9	54.3	70.4	101.2	29.2	104.5	43.2	39.3	178.1	77.3	34.0	44.0	34.3	43.8	28.9	54.7	12.7	57.4	85.9	41.5	71.4	40.8	40.4	42.1	31.1	58.8	82.3	13.5	13.6	52.0	97.6	30.1	26.5	63.3	38.8	40.8	67.6	7.5	61.7	39.8	44.3	10.1	13.2	58.7	52.0	46.6	27.5	39.4	110.5	186.1	66.8	38.7	46.0	30.3	45.8	23.5	32.9	53.6	54.8	69.1	53.3	57.2	63.7	39.3
GLOD5		ENSG00000171433	"Glyoxalase domain containing 5"	A6NK44	X	48761747-48773648	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"epididymis: 5.8;intestine: 10.6;kidney: 11.2;liver: 8.2"	"Group enriched"	"Detected in some"	4	"Proximal enterocytes: 45.2;Proximal tubular cells: 70.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"MCF7: 2.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA010667	Enhanced		Uncertain	Mitochondria		NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA010667: AB_1078975"	"unprognostic (1.03e-1)"	"unprognostic (2.61e-1)"	"unprognostic (7.78e-2)"	"unprognostic (7.04e-2)"		"unprognostic (3.14e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.80e-2)"		"unprognostic (2.64e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.05e-8)"	"unprognostic (2.08e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.07e-2)"	"unprognostic (6.79e-4)"	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.1	0.3	0.0	4.7	10.6	0.0	5.8	0.1	1.9	0.8	0.0	0.0	0.0	11.2	8.2	1.3	0.0	0.1	0.0	0.0	0.7	0.1	0.3	0.0	0.1	0.2	6.1	1.9	0.3	0.3	0.0	0.0	10.0	0.1	0.0	0.0	1.4	0.1	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.1	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	3.2	2.6	1.3	0.5	0.0	0.3	0.2	0.0	0.6	8.3	1.0	0.0	4.3	0.3	7.3	0.0	0.1	0.0	14.4	13.7	0.6	0.2	3.0	0.1	0.0	1.2	2.7	0.2	0.9	0.1	0.0	0.0	1.1	0.0	0.1	0.0	8.0	0.0	0.0	0.3	7.3	0.0	0.3	0.0	0.2	0.0	0.5	0.0	0.0	0.6	0.5	0.0	0.5	0.5	0.8	13.9	0.0	0.1	0.3	45.2	70.5	2.7	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	8.9	0.7
GLS	"GLS1, KIAA0838"	ENSG00000115419	Glutaminase	O94925	2	190880821-190965552	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Cataract, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 316.8"	"Cell type enhanced"	"Detected in all"		"Collecting duct cells: 391.8;Excitatory neurons: 427.1;Proximal tubular cells: 539.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"EFO-21: 907.3;RPTEC TERT1: 419.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036223	Enhanced		Supported	Mitochondria	"Intracellular and membrane"	No	No		92000	"Cluster 44: Non-specific - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA036223: AB_10669984"	"unprognostic (7.45e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.21e-1)"	"prognostic unfavorable (3.45e-4)"	"unprognostic (1.17e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.51e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.40e-1)"	"unprognostic (8.01e-2)"	"unprognostic (9.06e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.03e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.12e-1)"	37.0	77.4	38.5	45.7	50.5	28.7	32.0	40.5	74.6	31.0	35.6	32.0	92.2	28.8	26.6	16.8	25.1	41.8	34.7	55.5	35.9	316.8	11.7	55.6	68.0	44.7	19.8	28.9	36.9	62.0	19.9	35.8	52.5	20.8	30.1	81.8	20.4	31.2	15.8	28.5	103.4	36.9	12.0	49.3	18.7	16.2	24.1	41.7	35.7	23.6	57.9	36.5	23.6	44.8	43.6	47.2	32.4	43.1	99.7	68.9	84.0	126.8	95.7	90.6	103.1	58.1	42.1	88.5	907.3	269.3	46.1	55.6	58.0	50.0	131.5	219.8	37.7	147.3	69.1	72.2	90.8	87.2	66.5	62.9	51.0	71.2	48.4	90.1	119.3	36.7	69.3	175.2	203.3	22.8	59.2	83.7	86.9	25.7	76.7	74.2	83.7	77.4	419.2	78.9	44.9	46.8	172.8	37.9	169.2	115.1	14.9	53.0	85.3	129.4	94.5	65.9	156.8	56.2	138.9	122.1	46.7	70.6	105.5	6.4	1.0	1.9	3.7	1.5	6.5	3.4	4.4	4.8	1.6	3.8	4.5	5.5	2.1	2.8	1.1	3.6	4.1	1.1	38.5	50.5	40.5	74.6	55.5	35.9	44.7	19.8	52.5	12.0	24.1	44.8	81.0	189.1	122.5	61.0	89.3	174.5	44.7	15.6	60.9	93.5	51.8	49.5	38.2	35.8	28.4	391.8	210.6	4.4	128.0	100.6	50.9	21.4	6.6	33.7	66.8	68.3	59.2	17.9	427.1	24.5	15.6	66.0	46.4	97.9	36.8	48.2	63.5	4.3	29.1	26.9	270.5	36.7	14.2	31.2	230.0	7.3	28.6	84.3	88.9	143.4	68.4	11.9	55.6	163.3	146.9	29.8	92.9	43.2	118.4	70.1	165.9	539.1	17.0	111.9	19.7	71.6	76.0	11.3	12.9	61.7	162.8	4.0	114.0	97.8	43.6	56.7
GMCL1	"BTBD13, FLJ13057, GCL1, SPATA29"	ENSG00000087338	"Germ cell-less 1, spermatogenesis associated"	Q96IK5	2	69829660-69881384	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 264.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 93.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA039579	Approved					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA039579: AB_10805480"	"unprognostic (1.89e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.79e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.20e-2)"	"unprognostic (2.60e-3)"	"unprognostic (1.27e-1)"	"unprognostic (8.80e-2)"	"unprognostic (3.04e-1)"	"unprognostic (5.94e-2)"	"unprognostic (2.48e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.01e-1)"	9.4	6.5	4.4	8.1	4.8	13.6	10.6	5.3	6.7	8.6	11.6	10.7	15.9	7.7	8.8	8.2	7.9	8.5	4.8	5.2	4.4	11.5	10.7	7.7	12.0	4.4	4.7	8.5	9.1	19.1	6.5	9.3	4.3	11.1	12.2	6.1	9.4	8.7	4.1	8.8	13.1	6.4	4.6	9.1	8.6	16.3	4.5	18.5	9.2	5.4	12.2	8.3	6.3	5.3	14.7	10.3	17.2	18.4	15.0	13.1	18.4	12.1	8.0	8.1	13.7	9.9	13.5	30.7	9.7	8.0	9.5	14.2	20.3	10.5	14.1	14.2	21.2	48.0	11.3	22.8	9.9	36.1	32.4	7.2	11.3	6.4	14.9	10.5	14.5	23.2	19.5	21.8	12.9	12.6	37.1	33.7	18.4	24.9	9.6	26.1	22.6	23.6	11.9	22.2	27.0	22.5	13.2	19.1	14.8	13.4	12.6	22.2	9.0	12.4	15.5	19.4	14.7	22.1	28.6	18.9	12.8	29.5	13.0	93.5	8.0	40.1	11.1	6.3	19.1	8.8	10.9	13.7	7.5	8.3	15.6	15.5	26.8	26.8	10.3	7.9	15.5	9.4	4.4	4.8	5.3	6.7	5.2	4.4	4.4	4.7	4.3	4.6	4.5	5.3	17.9	28.9	27.4	22.9	25.9	26.8	21.4	19.5	27.3	22.5	28.3	20.4	7.6	74.4	22.0	18.4	27.1	38.3	42.5	40.0	41.1	36.1	264.8	26.7	21.8	19.5	23.4	29.0	68.1	17.5	51.9	19.4	16.3	18.4	22.2	24.2	26.4	25.4	15.9	21.9	63.8	37.0	44.7	23.8	13.1	50.8	15.8	15.0	16.0	11.2	22.8	44.2	50.4	42.7	45.6	15.2	21.7	22.6	28.2	33.0	42.1	23.2	38.4	37.0	13.1	26.0	21.1	44.2	45.1	38.4	27.7	81.5	36.7	17.5	30.6	25.7
GPAT3	"AGPAT10, AGPAT9, HMFN0839, LPAAT-theta, MAG1, MGC11324"	ENSG00000138678	"Glycerol-3-phosphate acyltransferase 3"	Q53EU6	4	83535914-83605875	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 88.4"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 60.0;Early spermatids: 82.3;Macrophages: 60.5;Proximal enterocytes: 56.2;Proximal tubular cells: 67.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"basophil: 182.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 157.6;GAMG: 116.4;HMC-1: 57.4;U-87 MG: 66.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA029414	Approved					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 41: Macrophages - Immune response"			"HPA029414: AB_10601562"	"unprognostic (9.51e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.50e-3)"	"unprognostic (2.61e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.92e-1)"	"prognostic favorable (2.71e-9)"	"unprognostic (3.74e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.53e-3)"	"prognostic unfavorable (8.21e-4)"	14.0	1.0	0.9	5.7	1.1	11.9	6.5	3.9	2.7	5.5	8.9	13.7	39.9	3.7	1.2	8.3	3.6	8.6	25.3	1.0	2.8	88.4	18.1	4.2	2.0	5.5	3.4	16.1	1.2	23.2	5.0	1.5	5.5	1.6	11.1	1.2	3.5	3.6	37.6	2.6	35.6	3.5	2.0	4.7	15.2	7.4	2.7	1.7	19.8	12.5	2.1	6.0	6.3	1.8	30.6	29.6	0.0	0.4	1.5	3.7	0.6	2.4	4.3	0.6	0.6	2.2	157.6	0.0	3.2	5.9	116.4	6.8	14.3	2.8	0.5	2.1	6.7	0.0	9.2	29.7	4.2	8.9	57.4	2.0	0.2	1.1	3.5	11.5	15.0	8.5	25.1	23.7	0.6	3.1	2.3	2.2	0.7	45.6	12.5	0.3	6.7	11.6	29.8	2.0	0.7	0.0	5.8	6.1	17.3	1.6	1.2	1.6	0.7	6.9	12.3	6.9	28.9	1.1	2.2	0.0	66.4	17.6	52.2	182.5	33.2	4.0	0.6	27.8	6.0	0.1	3.5	2.0	81.4	0.1	2.5	1.2	91.1	1.6	23.6	0.3	2.3	10.4	0.9	1.1	3.9	2.7	1.0	2.8	5.5	3.4	5.5	2.0	2.7	1.8	4.8	6.4	6.8	0.0	1.3	0.0	60.0	0.0	8.0	0.8	10.2	4.1	0.0	4.3	5.0	11.0	0.0	0.4	0.8	18.6	15.6	4.8	82.3	1.0	1.1	5.4	1.2	6.1	0.0	6.8	1.3	5.5	34.7	2.4	7.6	0.8	7.5	13.2	14.8	5.0	0.0	9.9	0.0	11.3	0.0	21.7	1.2	60.5	0.0	0.0	28.7	0.1	1.0	0.0	0.0	10.4	6.7	0.7	1.2	32.4	56.2	67.4	1.5	0.3	6.6	5.8	1.7	10.6	1.9	5.2	0.0	1.0	7.3	4.9	3.6	28.9
GPR39		ENSG00000183840	"G protein-coupled receptor 39"	O43194	2	132416805-132646582	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 6.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 16.0;Astrocytes: 12.1;Early spermatids: 20.6;Late spermatids: 19.4;Oligodendrocyte precursor cells: 18.6;Spermatocytes: 32.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	6	"plasmacytoid DC: 1.4"	"Lineage enriched"	"Detected in single"	14	"dendritic cells: 1.4"	"Cell line enhanced"	"Detected in many"		"A-431: 32.0;CAPAN-2: 26.9;hTEC/SVTERT24-B: 30.8;RT4: 27.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA022111	Approved					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA022111: AB_1849298"	"unprognostic (4.06e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.50e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.54e-3)"	"unprognostic (3.81e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (7.50e-4)"	"unprognostic (2.28e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.72e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.58e-3)"	0.2	0.0	0.7	0.9	0.7	0.0	2.1	0.5	0.7	4.4	1.3	6.8	4.6	0.4	0.8	0.8	3.6	2.2	0.0	0.4	0.7	2.6	3.3	3.9	0.0	1.6	2.2	0.0	3.9	5.1	0.1	0.1	2.0	0.5	5.7	0.0	0.5	1.0	0.0	1.0	3.7	0.3	1.2	0.0	6.1	0.2	0.7	0.0	1.3	0.0	0.2	2.6	0.6	0.2	32.0	18.1	0.3	0.0	0.5	3.6	0.0	2.8	11.1	5.8	3.3	17.7	26.9	0.0	9.7	1.9	13.1	18.6	0.0	12.9	5.7	0.1	0.0	0.0	1.9	0.7	0.6	0.0	0.0	1.1	9.7	30.8	3.1	7.0	0.1	0.0	0.0	0.0	4.2	3.0	0.0	0.0	0.3	7.3	10.5	0.0	0.5	0.0	21.2	27.9	0.0	0.1	2.0	10.3	0.1	1.1	5.8	0.0	5.6	12.4	12.2	4.2	16.8	0.0	0.0	0.1	18.9	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.7	0.7	0.5	0.7	0.4	0.7	1.6	2.2	2.0	1.2	0.7	0.2	0.0	16.0	8.7	12.1	0.0	0.1	0.7	2.4	0.0	0.2	1.5	0.9	0.2	2.8	6.7	0.0	0.0	0.0	2.7	10.3	0.0	5.6	20.6	2.6	0.2	0.1	2.4	0.0	3.9	3.1	0.0	0.2	4.1	1.8	0.0	0.0	0.0	3.6	0.0	0.0	4.9	1.6	0.0	0.6	0.3	19.4	0.3	0.3	0.0	1.0	0.6	1.4	0.0	18.6	1.8	5.9	3.0	0.4	0.1	0.3	1.9	0.7	6.1	0.0	0.0	0.1	0.3	32.4	1.2	0.5	0.0	0.0	0.0	0.0	4.9	1.2
GSR		ENSG00000104687	"Glutathione-disulfide reductase"	P00390	8	30678066-30727846	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes, Disease variant, FDA approved drug targets, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 32.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001538, CAB008632, HPA064806"	Approved		Supported	Cytosol		NA	NA		81000000	"Cluster 46: Basophils - DNA binding"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"CAB008632: AB_1616690, HPA001538: AB_1078986, HPA064806: "	"unprognostic (1.23e-1)"	"prognostic favorable (3.37e-4)"	"prognostic favorable (4.08e-5)"	"unprognostic (2.89e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.50e-1)"	"prognostic unfavorable (3.26e-5)"	"unprognostic (3.61e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.15e-2)"	"unprognostic (2.83e-2)"	"unprognostic (6.92e-3)"	"prognostic favorable (1.80e-4)"	"unprognostic (2.31e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.29e-1)"	13.6	23.3	12.3	18.7	11.1	25.9	11.0	10.6	11.7	28.5	25.8	42.5	54.3	16.0	21.6	37.3	21.6	30.5	25.4	12.9	12.5	45.3	35.8	17.4	23.6	9.5	14.2	23.1	26.5	82.3	14.8	23.5	12.0	35.3	46.6	12.8	25.8	29.4	28.9	12.8	50.8	17.9	10.7	22.1	41.8	11.6	17.6	26.7	16.9	21.3	24.0	22.5	27.7	11.2	49.4	197.8	35.9	40.1	35.8	38.3	29.1	23.4	46.8	31.8	36.7	66.0	31.3	95.8	94.8	32.0	96.1	59.2	62.3	51.1	33.1	22.6	40.7	104.6	67.0	197.8	88.4	38.6	159.7	72.6	28.5	48.9	20.9	33.5	43.3	57.3	73.2	55.1	67.9	44.1	147.1	32.0	65.4	191.9	31.5	43.8	41.9	59.3	56.0	124.3	28.2	31.8	31.2	87.8	58.8	40.7	37.5	32.6	63.8	21.0	34.7	37.3	35.2	20.2	29.4	70.0	51.9	51.8	62.4	32.3	5.9	15.0	5.0	5.4	8.8	3.6	4.5	5.4	6.0	2.3	2.8	3.7	8.2	3.6	7.9	3.9	4.5	3.1	12.3	11.1	10.6	11.7	12.9	12.5	9.5	14.2	12.0	10.7	17.6	11.2	8.2	3.2	20.8	12.7	13.7	4.2	15.2	9.4	52.3	6.7	6.7	5.0	26.8	30.0	15.0	12.9	16.7	17.0	20.3	61.8	9.8	11.4	8.4	61.4	13.4	9.9	34.1	28.6	18.1	19.8	6.3	10.0	33.1	41.3	6.3	64.3	12.1	43.4	18.2	3.3	27.4	51.7	8.2	40.5	5.8	18.9	7.2	22.1	8.8	11.2	20.6	12.6	17.5	12.5	10.0	15.2	32.0	10.9	15.6	27.5	75.7	19.0	11.7	8.0	6.6	7.0	8.6	1.2	3.4	39.6	5.4	6.4	17.3	17.2	47.5	33.5
HAVCR1	"CD365, HAVCR, HAVCR-1, KIM1, TIM-1, TIM1, TIMD1"	ENSG00000113249	"Hepatitis A virus cellular receptor 1"	Q96D42	5	157029413-157059119	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 4.6;kidney: 7.5"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 1.9;Inhibitory neurons: 1.3;Microglial cells: 5.6;Oligodendrocytes: 1.8;Proximal tubular cells: 2.3"	"Cancer enriched"	"Detected in many"	12	"renal cancer: 26.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"A549: 93.0;CACO-2: 113.9;RPTEC TERT1: 43.5"					"Low region specificity"	"Detected in many"			"HPA007173, CAB075697"	Uncertain		Approved	Vesicles		NA	NA	155000		"Cluster 15: NK-cells - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"CAB075697: , HPA007173: AB_1080282"	"unprognostic (1.24e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.76e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.99e-2)"	"unprognostic (2.46e-3)"	"unprognostic (4.75e-3)"	"unprognostic (3.20e-2)"		"unprognostic (3.21e-1)"	"unprognostic (8.70e-4)"	"unprognostic (3.81e-3)"	"unprognostic (7.10e-3)"	"prognostic unfavorable (7.81e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (1.32e-4)"	0.3	0.0	0.3	0.4	0.3	0.9	0.1	0.6	0.4	0.1	0.5	4.6	0.2	0.1	0.2	0.0	0.1	0.5	0.0	0.4	0.3	7.5	0.3	0.3	0.6	0.7	0.4	0.1	0.0	0.1	0.0	0.1	0.5	0.0	3.5	0.3	0.1	0.0	0.0	0.2	0.1	0.2	0.3	0.3	0.3	0.9	0.5	0.1	0.1	0.0	0.3	0.1	0.0	0.8	0.0	93.0	0.2	0.0	0.3	0.0	13.8	0.0	0.0	0.0	0.0	113.9	0.0	0.0	14.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	4.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	43.5	3.4	0.2	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	5.6	0.1	0.0	0.0	0.0	0.5	0.2	0.1	0.1	0.1	0.2	0.2	0.3	0.1	0.1	0.2	0.6	0.5	0.2	0.4	0.1	0.1	0.6	0.4	0.3	0.3	0.6	0.4	0.4	0.3	0.7	0.4	0.5	0.3	0.5	0.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.2	1.0	0.1	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.9	0.0	0.1	0.0	5.6	0.0	0.0	0.0	1.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.2	0.1	0.0
HDHD3	"C9orf158, MGC12904"	ENSG00000119431	"Haloacid dehalogenase like hydrolase domain containing 3"	Q9BSH5	9	113373419-113376999	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 156.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 214.0;Exocrine glandular cells: 156.4;Paneth cells: 208.6;Proximal enterocytes: 254.0;Proximal tubular cells: 275.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 73.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020427, HPA024158, HPA024585"	Enhanced		Enhanced	Nucleoli,Vesicles		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoli	Vesicles	"HPA020427: AB_1850561, HPA024158: AB_1850563, HPA024585: AB_1850565"	"unprognostic (1.30e-1)"	"prognostic favorable (2.72e-4)"	"unprognostic (3.01e-2)"	"unprognostic (1.31e-2)"	"unprognostic (8.24e-3)"	"unprognostic (1.57e-2)"	"unprognostic (6.66e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.92e-2)"	"unprognostic (5.87e-2)"	"prognostic favorable (3.54e-7)"	"unprognostic (2.16e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.68e-1)"	"unprognostic (1.19e-3)"	12.2	156.4	16.8	11.1	18.0	8.4	19.5	16.2	19.3	19.9	14.5	59.7	82.9	13.4	14.9	42.1	16.5	17.8	22.4	15.8	17.7	56.3	122.8	10.2	10.2	15.7	17.0	19.9	53.0	68.4	23.1	5.0	16.2	30.4	35.9	8.0	52.2	16.1	8.8	28.3	68.5	7.7	15.7	17.6	50.1	7.0	18.5	6.7	38.7	5.7	7.6	17.6	21.1	15.5	7.4	20.8	4.4	12.3	10.7	4.7	37.0	5.4	10.1	8.6	9.3	38.3	36.1	16.2	6.6	3.0	17.0	28.3	7.0	8.3	2.9	22.9	16.1	22.4	12.5	24.1	12.5	1.4	16.6	7.4	17.4	7.0	19.7	9.9	4.5	14.9	18.0	4.0	4.1	48.3	10.4	6.5	9.9	73.7	16.1	8.5	0.0	13.2	11.0	15.4	11.1	7.0	9.3	39.4	14.0	9.5	24.8	4.7	4.5	1.7	0.1	1.4	1.9	9.7	20.2	6.8	2.1	0.1	1.3	0.2	3.7	8.2	12.4	2.1	14.0	14.8	14.2	11.5	6.1	16.6	14.5	11.1	2.4	8.2	0.2	14.1	17.1	8.5	16.8	18.0	16.2	19.3	15.8	17.7	15.7	17.0	16.2	15.7	18.5	15.5	4.1	9.6	10.1	24.5	19.7	9.9	20.6	26.6	10.8	10.3	38.6	31.2	15.8	80.1	32.6	23.9	10.4	29.4	11.7	214.0	86.1	84.8	0.2	20.9	6.4	9.4	40.3	15.4	9.2	156.4	16.5	8.6	112.7	22.3	7.6	122.4	9.7	85.4	20.6	1.7	10.4	80.4	28.5	6.5	3.7	2.0	14.3	6.9	10.6	6.5	13.7	12.1	15.5	5.5	4.9	104.8	208.6	9.1	9.3	23.7	254.0	275.1	33.3	13.8	6.6	5.5	11.1	0.3	6.0	42.9	14.6	31.6	14.0	26.0	94.6	51.4
HSD11B2	SDR9C3	ENSG00000176387	"Hydroxysteroid 11-beta dehydrogenase 2"	P80365	16	67430652-67437553	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 249.9;kidney: 335.2;salivary gland: 260.2"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 191.3;Distal enterocytes: 476.1;Intestinal goblet cells: 288.8;Paneth cells: 226.2;Proximal enterocytes: 270.2;Syncytiotrophoblasts: 114.5;Undifferentiated cells: 170.9"	"Cancer enhanced"	"Detected in all"		"renal cancer: 62.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 11.4;OE19: 29.0;RPMI-8226: 13.9;RT4: 13.9;SCLC-21H: 14.9;SK-BR-3: 13.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB032443, HPA042186, HPA056385"	Enhanced		Approved	"Nucleoplasm,Lipid droplets"		NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Lipid droplets"	Nucleoplasm	"CAB032443: AB_2233199, HPA042186: AB_2677888, HPA056385: AB_2683110"	"unprognostic (2.87e-3)"	"unprognostic (5.24e-2)"	"unprognostic (7.10e-2)"	"unprognostic (6.55e-2)"	"unprognostic (9.29e-3)"	"unprognostic (3.14e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.21e-3)"	"unprognostic (2.25e-3)"	"unprognostic (3.27e-2)"	"unprognostic (2.34e-1)"	"prognostic favorable (9.51e-5)"	"unprognostic (7.20e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.84e-1)"	2.1	5.4	1.6	13.4	4.6	0.1	14.0	2.8	2.8	15.5	0.7	249.9	40.0	11.8	4.0	10.9	10.4	6.8	1.9	1.6	1.3	335.2	5.5	3.2	1.0	2.7	1.3	9.3	7.4	3.6	0.5	13.0	3.3	12.9	102.2	0.0	260.2	6.2	0.9	66.1	141.8	18.3	1.5	7.0	9.8	2.5	2.0	0.4	11.1	0.2	0.9	5.3	23.6	2.4	3.6	1.1	0.4	1.4	0.1	1.7	3.6	0.0	0.0	0.1	0.1	6.1	1.3	0.0	2.7	0.1	0.1	7.8	5.1	0.5	0.0	0.0	1.8	0.0	0.7	6.6	0.6	0.7	0.0	1.7	3.0	0.3	0.1	0.0	0.0	4.6	0.4	0.0	0.0	3.8	0.2	0.2	11.4	29.0	1.0	0.0	0.2	13.9	0.5	13.9	14.9	1.0	0.8	13.4	0.6	1.3	6.5	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	4.6	2.8	2.8	1.6	1.3	2.7	1.3	3.3	1.5	2.0	2.4	0.7	0.0	0.5	0.0	1.1	1.5	7.2	1.3	1.2	0.0	4.8	2.2	0.5	30.0	2.3	191.3	0.0	1.2	0.3	476.1	45.0	2.1	0.2	17.4	25.2	0.5	26.9	0.0	1.1	3.0	0.7	7.1	7.1	43.5	8.9	43.4	1.1	1.2	1.4	0.0	0.8	288.8	4.1	0.3	0.5	0.5	25.4	0.7	1.8	0.0	0.0	0.0	0.0	0.5	0.3	0.6	226.2	6.8	0.2	13.5	270.2	16.3	0.4	0.0	13.1	0.3	3.9	0.2	1.6	3.5	3.4	114.5	1.2	16.7	170.9	10.5
HYKK	"AGPHD1, LOC123688"	ENSG00000188266	"Hydroxylysine kinase"	A2RU49	15	78507564-78537372	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 29.4;Late spermatids: 33.7;Proximal enterocytes: 37.0;Proximal tubular cells: 39.4;Skeletal myocytes: 28.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 3.0"	"Lineage enriched"	"Detected in single"	6	"T-cells: 3.0"	"Cell line enhanced"	"Detected in many"		"HEK 293: 22.2;U-266/84: 24.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040706	Approved		Approved	Vesicles,Aggresome		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles	Aggresome	"HPA040706: AB_10795528"	"unprognostic (9.26e-2)"	"unprognostic (1.98e-4)"	"unprognostic (7.84e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.64e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.00e-3)"	"unprognostic (2.73e-1)"	"unprognostic (5.16e-2)"	"unprognostic (6.24e-3)"	"unprognostic (6.37e-2)"	"unprognostic (3.44e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.11e-3)"	"unprognostic (3.90e-2)"	4.5	4.8	2.8	1.0	3.1	1.3	4.5	2.2	3.2	5.6	1.6	4.6	7.3	3.8	5.9	2.8	4.3	2.4	5.3	2.7	2.2	12.3	5.7	2.1	2.0	2.0	2.0	6.1	6.8	4.8	3.5	0.7	1.8	4.1	3.4	2.6	3.5	4.1	6.2	2.8	7.2	3.6	1.6	1.3	5.1	5.3	2.3	1.9	4.5	5.4	1.7	3.9	3.8	2.9	4.3	6.3	1.0	11.3	2.3	5.3	2.7	1.5	2.7	3.7	4.2	2.2	4.9	3.1	1.4	2.5	6.3	5.2	10.0	3.3	3.5	1.5	22.2	1.7	3.8	5.6	6.0	0.5	1.9	4.8	6.4	1.4	2.7	1.8	2.7	13.8	4.0	8.4	2.2	5.0	4.2	1.0	0.7	9.8	8.3	2.4	12.4	2.7	7.1	5.1	1.3	1.6	2.9	8.6	10.9	1.9	9.5	0.4	1.9	2.4	1.8	4.3	4.4	12.9	24.2	0.2	3.2	0.2	3.4	0.4	0.1	0.2	0.1	0.0	0.1	0.1	1.1	0.1	0.0	0.1	3.0	0.6	0.3	0.1	0.0	0.3	0.5	0.4	2.8	3.1	2.2	3.2	2.7	2.2	2.0	2.0	1.8	1.6	2.3	2.9	4.1	12.8	4.1	4.6	1.4	3.6	7.7	4.5	6.2	2.0	4.5	9.8	6.7	0.0	2.9	7.3	2.1	7.3	1.5	2.8	29.4	2.5	14.0	2.7	3.3	4.1	4.2	1.3	2.8	7.9	4.4	5.4	5.1	1.5	0.0	2.4	6.8	7.1	0.8	0.0	2.7	3.9	2.0	1.0	0.9	33.7	5.3	1.0	7.2	2.8	0.3	7.5	0.0	0.5	1.1	2.9	3.6	3.8	1.7	3.7	37.0	39.4	3.5	1.9	0.0	28.1	4.0	5.4	8.0	4.9	1.6	3.4	1.6	3.9	5.7	4.7
IQGAP2		ENSG00000145703	"IQ motif containing GTPase activating protein 2"	Q13576	5	76403285-76708132	"Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 113.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 1011.9;Late spermatids: 351.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"basophil: 21.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 74.2;Hep G2: 61.7;HMC-1: 211.8;RPMI-8226: 81.6;U-937: 57.0"	"Region enhanced"	"Detected in many"		"hippocampal formation: 30.5"	"Low region specificity"	"Detected in all"			"CAB004241, HPA037403, HPA037404"	Uncertain		Approved	"Vesicles,Plasma membrane"		NA	NA		3700000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Vesicles, Plasma membrane"		"CAB004241: AB_2125909, HPA037403: AB_2675459, HPA037404: AB_2675460"	"unprognostic (9.46e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.48e-1)"	"unprognostic (9.03e-3)"	"unprognostic (8.85e-2)"	"prognostic favorable (5.65e-4)"	"unprognostic (5.96e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.41e-1)"	"prognostic favorable (9.44e-12)"	"unprognostic (3.29e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.27e-2)"	7.9	12.2	0.8	11.7	0.6	25.0	27.1	0.5	0.7	19.6	2.4	25.7	56.5	3.3	9.5	2.8	3.4	18.6	2.9	0.4	0.9	35.2	113.1	9.9	14.4	2.2	2.5	8.9	25.7	44.3	1.1	30.7	1.9	15.2	23.0	23.9	34.6	15.4	0.3	2.7	31.4	4.3	1.4	13.2	39.1	51.1	2.4	7.3	28.6	1.3	8.2	6.5	1.5	2.4	0.0	9.6	31.5	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	74.2	0.1	0.7	2.7	0.0	2.7	0.2	12.1	0.0	0.1	8.6	12.0	27.6	6.8	61.7	0.2	15.7	211.8	0.0	0.0	0.0	0.0	0.0	1.2	14.9	24.6	21.4	0.0	0.0	13.5	42.4	14.8	25.4	0.3	4.9	0.1	81.6	0.0	0.1	0.6	3.2	17.3	0.9	0.1	31.4	0.0	9.3	0.4	0.0	0.5	0.0	0.3	19.8	0.0	18.7	0.1	57.0	3.0	21.3	3.1	1.9	4.5	2.5	3.7	0.5	4.7	3.9	2.9	0.2	1.8	3.3	6.0	4.3	3.4	7.7	6.2	1.4	0.8	0.6	0.5	0.7	0.4	0.9	2.2	2.5	1.9	1.4	2.4	2.4	9.1	12.8	12.2	0.7	27.3	4.7	21.5	2.4	0.0	6.7	68.9	34.5	3.5	107.2	9.1	35.0	108.4	14.2	230.3	96.2	7.9	44.5	1011.9	43.8	3.3	7.7	9.1	76.3	2.3	66.7	1.2	22.0	99.4	37.5	94.9	8.7	18.5	235.7	65.9	1.7	19.0	52.9	61.1	132.6	63.3	351.0	7.5	141.3	16.0	47.8	63.4	14.0	114.4	0.5	1.1	18.7	37.5	5.3	148.3	21.5	87.1	65.2	16.1	121.8	0.0	3.9	3.5	25.5	11.4	1.2	3.8	7.3	112.1	82.7	43.7	6.5
KCNH6	"erg2, HERG2, Kv11.2"	ENSG00000173826	"Potassium voltage-gated channel subfamily H member 6"	Q9H252	17	63523334-63548977	"FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 4.8;kidney: 7.0;pituitary gland: 5.3;prostate: 3.9;retina: 4.4"	"Group enriched"	"Detected in some"	8	"Bipolar cells: 44.8;Cardiomyocytes: 25.6;Cone photoreceptor cells: 31.3;Enteroendocrine cells: 34.6;Proximal enterocytes: 40.3;Proximal tubular cells: 14.1"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 5.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"SCLC-21H: 3.3;SH-SY5Y: 1.1"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"medulla oblongata: 1.1;olfactory bulb: 2.4;spinal cord: 2.5"	HPA061704	Approved					NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA061704: "	"unprognostic (8.00e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.46e-2)"	"unprognostic (5.68e-2)"	"unprognostic (5.98e-5)"	"unprognostic (3.39e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.74e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.19e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.66e-1)"	"unprognostic (8.05e-2)"	"unprognostic (9.15e-2)"	0.0	0.1	0.9	0.0	1.1	0.2	0.0	0.9	1.1	0.0	0.3	0.2	2.2	0.0	0.0	0.0	0.1	0.0	0.0	0.6	1.6	7.0	0.0	0.3	0.0	1.6	1.5	0.0	1.3	0.0	5.3	0.1	1.7	3.9	0.2	4.4	0.0	0.0	0.1	0.1	4.8	0.0	1.1	0.1	0.8	1.2	1.5	0.7	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.3	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	1.1	0.9	1.1	0.6	1.6	1.6	1.5	1.7	1.1	1.5	1.1	0.0	0.0	0.0	0.3	0.0	0.3	0.2	0.0	0.0	44.8	0.0	0.3	25.6	0.0	0.0	0.0	31.3	0.0	0.0	0.1	0.0	0.0	3.0	0.6	0.1	1.3	34.6	0.0	1.1	0.0	0.0	0.8	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.9	3.8	0.0	0.0	0.0	3.4	0.0	0.1	1.8	0.0	0.0	1.1	0.0	0.5	0.1	0.1	1.2	0.0	0.0	1.4	40.3	14.1	0.0	3.1	0.0	0.2	1.0	0.0	0.7	0.0	0.1	0.1	0.1	0.0	0.8	0.1
KCNK5	"K2p5.1, TASK-2, TASK2"	ENSG00000164626	"Potassium two pore domain channel subfamily K member 5"	O95279	6	39188971-39229475	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 35.4;kidney: 37.2"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 48.6;Distal enterocytes: 55.6;Gastric mucus-secreting cells: 31.6;Proximal enterocytes: 66.5;Proximal tubular cells: 45.4;Syncytiotrophoblasts: 45.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 34.9;HEL: 36.1;HMC-1: 31.8;K-562: 34.3;OE19: 27.4;T-47d: 25.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA059148	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA059148: AB_2683929"	"unprognostic (1.46e-1)"	"prognostic favorable (3.29e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.92e-3)"	"unprognostic (8.09e-4)"	"unprognostic (3.97e-2)"	"unprognostic (2.33e-1)"	"unprognostic (9.57e-3)"	"unprognostic (7.14e-2)"	"unprognostic (3.43e-1)"	"prognostic unfavorable (5.85e-4)"	"unprognostic (2.98e-1)"	"prognostic favorable (4.98e-7)"	"unprognostic (2.34e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.03e-2)"	"prognostic favorable (4.45e-4)"	4.0	3.7	0.1	2.2	0.1	9.6	5.3	0.0	0.1	4.4	0.1	14.2	28.4	2.1	0.2	6.1	2.3	18.8	1.7	0.0	0.2	37.2	23.5	6.1	2.7	0.2	0.2	6.4	20.4	1.9	1.2	8.6	0.1	3.5	8.5	0.1	27.1	2.4	0.2	29.4	35.4	1.3	0.1	2.2	16.7	0.7	0.3	1.8	10.0	0.1	1.9	3.2	6.7	0.0	6.6	5.9	7.7	2.9	0.0	0.0	6.6	0.0	0.0	0.0	0.0	34.9	14.3	0.0	10.2	0.0	0.8	13.2	6.0	0.2	0.0	0.0	4.5	36.1	3.1	0.2	0.0	7.5	31.8	0.0	0.1	0.2	0.0	0.0	0.0	7.8	34.3	0.1	0.0	11.4	16.7	8.1	14.4	27.4	0.0	0.0	1.4	13.6	5.3	5.4	1.9	1.5	5.7	7.3	0.0	2.9	25.9	12.1	0.2	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.2	0.2	0.1	0.1	0.3	0.0	2.3	0.0	19.2	0.0	0.1	3.7	2.5	1.5	5.7	0.0	4.2	3.2	0.6	48.6	7.7	1.8	0.0	28.8	0.8	55.6	5.9	14.5	0.1	2.6	0.3	6.9	0.0	6.1	0.0	11.8	5.3	3.2	31.6	5.3	0.0	2.2	0.0	27.5	2.1	0.0	0.0	15.3	8.2	0.6	3.5	0.7	0.6	0.8	1.8	0.0	0.6	0.0	0.0	0.0	0.0	12.1	25.1	0.0	0.4	2.6	66.5	45.4	1.0	0.0	0.0	2.4	0.6	0.0	1.1	8.2	2.7	45.6	3.5	1.4	11.1	10.4
KDELR1	"ERD2, ERD2.1, HDEL"	ENSG00000105438	"KDEL endoplasmic reticulum protein retention receptor 1"	P24390	19	48382575-48391551	"Predicted membrane proteins, Transporters"	"ER-Golgi transport, Protein transport, Transport"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 605.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 856.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB017455	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"	"Vesicles, Cytosol"	"CAB017455: AB_10615208"	"unprognostic (3.10e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (3.49e-4)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (2.35e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.55e-2)"	"unprognostic (4.97e-2)"	"unprognostic (3.81e-1)"	"unprognostic (2.74e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.68e-2)"	109.3	124.4	58.0	61.7	56.5	45.8	106.6	54.5	59.7	132.5	78.1	120.3	132.5	110.0	117.3	107.3	112.2	100.9	96.6	56.1	62.5	119.5	127.2	101.4	53.3	61.1	59.1	165.8	138.9	191.7	116.2	128.7	59.0	102.5	128.5	39.0	137.7	105.0	76.8	103.8	114.5	100.6	56.2	79.5	120.1	93.7	62.9	51.6	121.8	58.4	73.2	102.5	102.4	58.0	216.2	305.3	173.1	184.7	379.7	440.6	126.5	207.4	363.9	247.0	281.0	202.3	238.7	89.1	132.6	456.4	154.4	187.6	211.1	222.2	234.0	72.7	224.5	74.4	99.4	382.2	329.6	84.1	133.4	419.6	268.0	168.5	178.5	387.4	233.0	75.3	131.7	160.9	333.1	173.6	79.4	856.7	126.3	426.8	122.5	112.1	103.4	141.0	316.2	176.3	172.9	134.5	182.1	160.6	113.1	196.7	126.6	102.1	182.6	173.4	142.6	145.3	179.3	451.1	382.0	60.2	110.1	112.4	181.1	10.8	41.0	12.6	18.1	34.7	20.8	17.0	17.6	19.7	30.6	14.3	14.3	16.1	9.9	20.2	30.2	45.4	20.4	18.2	58.0	56.5	54.5	59.7	56.1	62.5	61.1	59.1	59.0	56.2	62.9	58.0	150.8	35.3	54.2	8.5	82.2	75.3	130.6	147.1	124.7	39.4	141.0	154.4	28.8	98.7	110.9	93.8	6.2	231.7	59.5	153.0	56.7	224.1	6.2	72.0	188.8	111.4	145.0	56.8	8.7	169.0	605.5	161.0	120.3	166.3	62.7	149.2	102.8	79.6	180.0	40.4	12.7	379.6	93.6	107.6	73.5	14.2	163.5	103.1	92.5	8.4	102.3	89.8	35.0	10.6	10.6	190.3	199.8	132.0	365.9	161.2	213.8	149.6	49.2	28.1	85.5	87.9	131.6	41.8	69.1	127.7	70.2	387.7	55.4	191.3	202.9	157.6
KIF16B	"C20orf23, dJ971B4.1, FLJ20135, SNX23"	ENSG00000089177	"Kinesin family member 16B"	Q96L93	20	16272104-16573448	"Predicted intracellular proteins"	Transport	"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 94.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 38.1"	"Low region specificity"	"Detected in all"							HPA051198	Approved		Uncertain	Mitochondria		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA051198: AB_2681385"	"unprognostic (3.33e-1)"	"unprognostic (1.74e-1)"	"unprognostic (6.18e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.32e-3)"	"unprognostic (7.85e-2)"	"unprognostic (2.38e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.95e-2)"	"unprognostic (5.52e-1)"	"prognostic favorable (7.61e-6)"	"unprognostic (4.04e-2)"	"unprognostic (2.78e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.61e-2)"	10.1	27.4	5.4	6.4	6.1	5.9	15.8	4.9	8.6	6.3	3.6	24.5	16.7	6.1	12.5	9.4	5.1	8.3	11.5	4.3	6.4	18.1	11.7	8.8	5.3	6.4	5.4	12.8	6.5	31.5	5.2	4.8	6.0	7.3	19.1	9.7	7.3	10.8	17.1	11.9	20.8	7.4	3.9	8.2	12.8	5.1	6.3	5.9	11.1	13.1	4.7	7.9	6.2	7.9	7.7	19.3	9.1	8.3	6.8	5.0	8.8	7.4	4.5	4.6	5.0	9.5	18.5	10.7	4.7	8.0	12.7	6.9	10.8	11.0	6.8	5.7	6.2	4.8	4.7	17.6	4.2	0.0	10.5	8.0	21.4	5.5	10.6	7.0	1.8	8.1	8.7	0.0	7.5	12.2	0.1	2.0	2.6	24.9	8.7	8.1	7.2	18.9	7.2	12.2	4.0	7.9	8.0	38.1	23.9	10.7	11.3	6.3	3.7	7.0	5.9	11.4	3.4	0.0	4.9	3.2	6.6	3.2	14.3	0.0	2.1	0.5	2.0	1.7	2.7	2.7	2.2	1.5	3.4	2.6	2.3	1.7	0.2	4.5	1.8	1.6	1.6	1.7	5.4	6.1	4.9	8.6	4.3	6.4	6.4	5.4	6.0	3.9	6.3	7.9	13.1	19.2	31.7	54.9	9.8	19.1	16.1	11.0	37.5	8.7	30.5	16.0	29.2	4.3	14.8	5.5	18.8	15.7	7.7	60.6	3.9	6.5	12.6	13.2	14.2	13.6	23.4	5.0	67.6	12.3	5.5	15.1	18.3	20.8	9.5	13.6	12.5	15.9	19.1	37.0	84.2	38.9	4.1	12.2	35.7	9.8	11.5	19.8	10.6	59.0	4.9	8.6	10.3	60.3	94.1	13.3	40.9	14.7	6.9	11.1	36.8	21.1	11.6	11.5	6.6	22.7	13.4	12.9	15.0	26.3	22.4	37.5	9.4	12.9	24.8	19.3
LETMD1	"HCCR, HCCR-1, HCCR-2, HCCR1, HCCR2, SLC55A3"	ENSG00000050426	"LETM1 domain containing 1"	Q6P1Q0	12	51047962-51060424	"Predicted intracellular proteins, Predicted membrane proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074361			Supported	Nucleoplasm,Nucleoli,Mitochondria		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Mitochondria	"Nucleoplasm, Nucleoli"	"HPA074361: AB_2686682"	"unprognostic (2.16e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.48e-2)"	"unprognostic (5.05e-2)"	"unprognostic (7.86e-2)"	"unprognostic (6.57e-2)"	"prognostic favorable (3.26e-4)"	"unprognostic (4.07e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.58e-1)"	"prognostic favorable (3.16e-4)"	31.2	27.0	17.5	11.7	19.2	22.3	29.9	17.8	24.2	19.6	22.8	24.3	36.0	19.4	23.8	13.1	32.4	17.1	18.9	20.0	19.0	32.7	40.3	17.6	18.2	19.3	17.2	36.6	37.1	32.4	19.4	13.7	20.0	18.9	28.3	20.9	27.5	19.4	23.6	19.7	24.5	19.8	18.3	16.5	24.5	13.3	18.7	22.4	37.2	27.8	20.8	17.0	15.5	19.5	19.1	16.7	12.7	33.5	54.9	89.9	12.6	19.4	31.7	19.9	22.2	41.2	38.6	50.2	23.4	20.9	14.2	34.7	25.8	26.1	22.6	18.3	32.4	36.5	23.6	32.8	36.1	32.8	25.6	75.4	82.3	23.7	55.5	60.4	20.3	47.7	38.1	35.4	27.5	29.5	23.2	33.1	8.4	23.6	45.2	19.5	15.0	27.4	25.2	28.3	37.3	16.7	14.7	32.2	45.4	12.4	51.1	29.2	15.6	12.8	13.4	20.9	11.2	32.2	53.8	21.6	23.1	21.1	9.1	3.7	9.6	3.9	10.1	10.8	15.1	15.0	17.0	12.8	9.3	9.2	20.5	19.1	3.0	12.6	16.2	8.3	17.0	12.5	17.5	19.2	17.8	24.2	20.0	19.0	19.3	17.2	20.0	18.3	18.7	19.5	27.0	22.4	29.5	41.1	38.8	49.6	40.0	51.9	66.0	20.9	66.2	64.8	12.6	35.8	20.5	23.9	10.4	49.6	31.7	20.3	92.0	17.2	9.3	23.6	22.2	26.2	27.7	35.5	22.6	32.7	23.3	32.9	31.6	18.4	25.4	29.7	25.7	19.1	30.3	18.5	26.5	36.0	28.5	56.3	35.7	17.0	32.6	27.9	39.2	13.1	31.5	31.8	23.7	16.1	25.4	15.6	26.8	30.5	29.5	26.0	87.0	65.7	25.1	18.9	26.3	33.5	31.8	20.5	26.0	44.2	44.3	27.9	38.8	55.4	52.7	26.6
LMBRD2	DKFZp434H2226	ENSG00000164187	"LMBR1 domain containing 2"	Q68DH5	5	36098407-36151887	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 71.4;Inhibitory neurons: 51.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"basophil: 10.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 10.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012165	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 20: HeLa - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"		"HPA012165: AB_2136131"	"unprognostic (9.43e-3)"	"unprognostic (3.03e-1)"	"unprognostic (1.80e-2)"	"unprognostic (7.09e-2)"	"unprognostic (1.79e-1)"	"unprognostic (9.53e-3)"	"unprognostic (6.58e-2)"	"unprognostic (8.46e-3)"	"unprognostic (6.45e-3)"	"unprognostic (2.80e-1)"	"unprognostic (8.61e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.30e-3)"	"unprognostic (7.53e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.65e-2)"	"unprognostic (5.35e-2)"	4.6	6.6	4.8	5.0	7.2	1.7	6.1	3.6	9.5	4.7	2.2	6.3	7.0	3.4	4.9	4.7	3.2	4.1	6.0	9.0	4.1	7.2	10.3	4.1	5.9	2.1	3.8	3.2	5.0	10.7	4.7	6.1	2.6	6.6	6.3	6.9	6.0	4.4	5.5	5.5	7.1	3.8	3.7	5.1	7.3	3.8	4.7	5.9	9.0	8.6	5.4	4.2	2.9	5.2	5.5	4.0	4.8	7.9	9.7	8.5	16.8	11.1	5.8	8.0	8.0	5.0	11.7	9.8	5.5	5.9	8.2	7.3	6.4	3.9	13.1	14.1	3.9	7.6	13.6	0.9	6.2	9.3	9.7	5.1	6.7	6.9	6.8	6.0	4.4	7.4	9.1	10.0	9.8	3.6	8.0	6.1	2.6	8.5	5.0	6.0	11.1	6.0	6.8	4.7	8.9	6.9	16.1	9.4	3.9	4.7	10.7	11.1	5.9	9.5	2.5	12.3	6.0	8.2	12.8	8.5	9.0	10.4	6.7	10.6	0.8	1.4	1.0	0.8	0.7	1.0	0.9	0.9	0.7	0.8	1.2	1.2	0.6	0.7	0.8	0.8	1.6	0.5	4.8	7.2	3.6	9.5	9.0	4.1	2.1	3.8	2.6	3.7	4.7	5.2	8.8	9.6	9.8	33.3	10.2	6.9	4.8	6.3	7.4	11.9	10.8	6.1	24.1	12.8	7.3	12.9	8.4	9.0	7.5	19.4	3.9	5.0	2.1	6.8	6.4	7.3	6.7	9.0	71.4	7.6	6.6	10.3	15.8	6.5	7.0	7.3	9.3	30.2	11.8	15.2	51.1	12.6	8.2	11.0	6.0	1.4	4.7	8.7	7.2	14.0	9.7	14.3	6.2	36.2	37.8	6.0	6.5	7.2	11.9	6.3	13.0	12.3	12.0	11.2	13.1	10.5	9.7	27.5	10.0	9.7	10.1	19.4	10.0	7.2	12.0	4.0
LRBA	"BGL, CDC4L, LAB300, LBA"	ENSG00000198589	"LPS responsive beige-like anchor protein"	P50851	4	150264435-151015727	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 213.7;Inhibitory neurons: 192.6;Microglial cells: 161.1;Oligodendrocyte precursor cells: 239.8;Oligodendrocytes: 217.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019366, HPA023597"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA		340000	"Cluster 44: Non-specific - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 68: Oligodendrocytes - Mixed function"	"Golgi apparatus"	Cytosol	"HPA019366: AB_2138441, HPA023597: AB_1853256"	"unprognostic (2.60e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.49e-3)"	"unprognostic (4.38e-1)"	"unprognostic (8.65e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.09e-2)"	"unprognostic (6.92e-2)"	"unprognostic (2.29e-2)"	"unprognostic (5.88e-2)"	"prognostic favorable (2.22e-16)"	"unprognostic (7.15e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.79e-1)"	"unprognostic (3.00e-1)"	7.3	10.7	3.4	9.3	6.9	11.1	22.7	11.1	3.8	13.1	18.6	16.7	13.3	6.9	14.2	13.9	15.2	9.9	8.3	2.9	2.2	23.5	13.4	11.0	15.8	5.1	4.5	8.9	13.5	34.2	6.5	7.0	6.1	20.0	17.4	14.9	13.8	8.9	7.2	19.3	11.5	6.6	3.4	9.6	17.0	9.4	3.7	18.7	19.1	8.9	17.7	12.3	7.0	6.3	27.6	14.3	11.9	11.1	12.2	18.5	17.0	6.0	15.8	10.9	10.2	30.9	35.6	33.7	7.2	8.6	7.5	13.7	22.1	36.6	15.3	25.9	15.8	20.8	19.8	19.0	7.5	29.0	16.2	14.6	21.1	16.0	24.6	23.9	32.9	14.8	22.4	24.3	12.9	21.9	21.9	7.7	10.7	23.7	10.3	18.4	12.0	12.6	42.0	33.7	39.3	13.0	15.1	32.1	7.4	18.1	32.4	6.1	17.2	16.8	12.2	8.7	11.4	20.9	20.5	20.5	26.2	16.0	6.6	5.7	0.6	1.2	5.0	0.2	3.3	4.9	3.3	4.7	1.0	2.1	2.3	4.0	0.1	3.2	2.1	2.1	4.6	1.8	3.4	6.9	11.1	3.8	2.9	2.2	5.1	4.5	6.1	3.4	3.7	6.3	10.4	16.0	14.9	148.5	42.5	17.5	16.4	21.0	28.5	33.5	30.8	18.2	55.9	21.5	21.5	51.5	148.0	23.7	37.7	19.7	9.8	15.2	25.5	51.2	11.0	13.3	42.0	40.2	213.7	13.5	10.6	12.8	56.6	61.8	6.3	22.4	10.0	20.5	6.1	30.3	192.6	23.8	24.4	11.1	12.8	5.5	9.6	17.7	16.0	161.1	8.2	17.7	46.4	239.8	217.4	17.2	20.2	10.1	38.3	22.4	22.0	15.8	36.7	72.6	6.6	13.7	9.8	16.6	22.3	37.3	23.7	24.2	45.6	25.9	27.2	24.0
LRRC19	FLJ21302	ENSG00000184434	"Leucine rich repeat containing 19"	Q9H756	9	26993136-27005672	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 36.2;kidney: 42.8"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 152.3;Paneth cells: 36.0;Proximal enterocytes: 82.1;Proximal tubular cells: 57.0;Undifferentiated cells: 36.0"	"Group enriched"	"Detected in some"	5	"colorectal cancer: 6.0;renal cancer: 5.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA		190000		"Cluster 87: Intestine & Kidney - Transmembrane transport"		"Cluster 53: Intestinal epithelial cells - Unknown function"				"unprognostic (2.27e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.23e-2)"	"unprognostic (6.30e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.85e-2)"	"unprognostic (4.16e-2)"	"unprognostic (9.21e-5)"	"unprognostic (1.87e-2)"	"unprognostic (4.48e-2)"	"prognostic favorable (7.08e-8)"	"unprognostic (2.46e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.32e-2)"	0.0	0.1	0.1	2.7	0.1	0.3	0.0	0.4	0.1	0.0	1.0	36.2	23.4	0.1	0.0	0.0	0.0	5.9	0.0	0.1	0.1	42.8	1.4	0.2	0.1	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	32.6	0.2	0.0	0.1	0.2	0.2	31.4	0.8	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.3	0.0	0.2	0.0	0.0	0.1	0.9	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.4	0.1	0.1	0.1	0.2	0.3	0.1	0.0	0.2	0.4	0.1	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	18.6	0.0	23.9	0.0	0.0	0.1	152.3	9.8	0.1	0.1	0.4	0.4	0.2	6.0	0.0	0.7	0.4	0.0	0.1	0.0	0.3	0.0	0.1	0.0	3.7	0.0	0.0	0.7	20.3	0.0	0.3	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.1	36.0	0.4	0.0	0.0	82.1	57.0	0.0	0.9	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.4	0.2	36.0	0.0
LUZP1	LUZP	ENSG00000169641	"Leucine zipper protein 1"	Q86V48	1	23084023-23177808	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 349.1;Early spermatids: 291.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 39.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 127.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028506, HPA028542"	Enhanced		Approved	"Actin filaments"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Actin filaments"		"HPA028506: AB_10600083, HPA028542: AB_10601986"	"unprognostic (3.04e-2)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (7.35e-3)"	"unprognostic (7.20e-2)"	"unprognostic (3.96e-2)"	"unprognostic (8.27e-2)"	"unprognostic (8.46e-3)"	"unprognostic (9.77e-3)"	"unprognostic (7.34e-2)"	"unprognostic (2.56e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.50e-1)"	"prognostic favorable (1.46e-7)"	"unprognostic (4.49e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.33e-1)"	11.5	14.3	6.0	9.2	8.1	14.2	7.3	6.3	24.6	10.1	4.1	13.1	22.7	11.9	5.4	9.3	6.3	13.0	13.6	7.6	10.9	10.7	3.6	10.4	6.4	13.7	8.1	7.6	6.1	20.1	3.8	12.7	13.9	9.8	13.2	5.4	6.9	9.6	3.3	8.9	24.7	12.8	5.1	10.7	5.2	11.4	12.3	9.8	9.5	6.6	7.1	10.4	7.4	11.0	26.4	17.7	24.5	28.5	24.6	31.3	17.8	25.3	40.1	31.0	32.4	10.1	12.0	0.5	22.6	43.0	19.9	34.8	24.5	68.5	37.6	9.6	16.2	36.6	21.8	9.6	16.2	18.5	22.5	27.7	26.4	45.6	35.6	25.6	70.6	10.0	13.6	2.0	25.2	7.0	12.6	7.9	20.8	8.1	18.9	18.9	36.7	3.1	14.0	17.1	4.5	11.6	60.4	16.8	20.3	48.9	9.6	9.6	127.0	36.2	27.2	27.2	25.4	3.0	7.8	9.8	15.9	29.8	31.8	39.8	7.6	8.4	11.5	5.4	13.1	3.2	8.7	7.5	7.6	5.8	6.9	6.9	4.1	7.1	10.9	15.8	5.1	3.3	6.0	8.1	6.3	24.6	7.6	10.9	13.7	8.1	13.9	5.1	12.3	11.0	103.5	9.6	14.1	58.1	17.1	135.2	349.1	64.7	117.8	23.7	31.3	41.7	54.7	27.1	33.7	20.2	2.1	25.6	34.1	100.3	15.6	58.6	291.4	35.6	83.0	138.2	21.5	9.5	113.2	30.6	53.7	49.4	14.3	54.1	22.8	21.9	68.6	11.5	27.3	21.9	111.3	55.8	61.1	18.0	77.9	52.9	36.4	36.4	33.8	65.6	83.7	17.4	33.0	38.2	7.2	75.9	54.0	43.6	19.5	83.5	117.3	23.3	24.0	8.4	32.9	43.7	67.5	84.6	85.9	72.9	70.8	24.8	46.3	38.4	54.9	183.0
MARVELD2	"DFNB49, FLJ30532, MRVLDC2, TRIC"	ENSG00000152939	"MARVEL domain containing 2"	Q8N4S9	5	69415065-69444330	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Hearing		"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 15.7"	"Cell type enhanced"	"Detected in many"		"Urothelial cells: 46.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 29.5;CAPAN-2: 24.1;HaCaT: 18.9;RT4: 21.1;SCLC-21H: 26.7;T-47d: 18.3"	"Region enriched"	"Detected in some"	8	"cerebellum: 7.9"	"Low region specificity"	"Detected in all"			"HPA018119, HPA061726"	Uncertain		Supported	"Cell Junctions"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 22: Epithelial cell types - Mixed function"	"Cell Junctions"		"HPA018119: AB_2669771, HPA061726: AB_2684595"	"unprognostic (4.11e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.44e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.84e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.47e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.75e-1)"	"prognostic favorable (2.84e-13)"	"unprognostic (1.78e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.82e-1)"	0.3	0.2	0.5	0.9	0.5	0.2	4.0	0.5	0.6	2.1	3.2	5.7	7.7	1.1	1.3	6.9	3.9	2.9	0.4	0.5	0.5	8.0	10.7	5.6	0.1	0.7	0.7	0.1	9.3	4.6	2.9	1.8	0.7	3.0	6.2	0.3	4.6	2.6	0.0	4.3	7.7	0.4	0.4	0.2	8.1	1.5	0.7	1.0	15.7	0.0	1.3	3.0	3.4	0.7	10.8	3.5	0.1	0.0	0.0	0.0	29.5	0.2	0.2	0.2	0.7	14.1	24.1	0.1	2.0	1.8	0.0	18.9	0.0	14.0	0.5	0.2	5.8	0.0	1.1	7.8	1.7	0.0	0.1	0.4	15.3	0.1	1.9	0.7	0.9	0.1	0.0	0.1	0.0	9.8	0.0	0.0	1.8	6.3	0.3	0.0	0.1	0.5	10.0	21.1	26.7	0.0	2.3	2.0	0.3	4.3	18.3	0.0	1.5	0.0	0.1	0.0	0.0	0.1	3.5	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.5	0.5	0.5	0.6	0.5	0.5	0.7	0.7	0.7	0.4	0.7	0.7	1.0	22.4	26.5	0.7	1.0	5.0	22.2	14.8	10.2	0.3	15.5	8.5	2.8	35.8	23.1	16.5	2.1	22.9	0.2	31.4	17.6	25.1	5.8	33.5	3.4	4.1	16.8	3.4	0.5	25.8	8.2	1.1	17.9	30.4	1.3	3.7	5.0	37.9	1.9	0.0	0.4	23.1	18.3	0.6	0.9	3.2	0.0	0.6	1.8	1.0	7.8	0.5	0.0	0.5	0.6	25.0	29.7	0.0	0.6	25.5	33.5	6.1	38.4	0.6	0.0	0.8	1.5	4.1	2.4	19.4	6.5	12.0	0.9	2.9	25.6	46.9
MARVELD3	MRVLDC3	ENSG00000140832	"MARVEL domain containing 3"	Q96A59	16	71626161-71642114	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 33.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 150.1;Intestinal goblet cells: 68.2;Paneth cells: 102.9;Proximal enterocytes: 199.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"basophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 21.7;BEWO: 30.9;CACO-2: 23.6;CAPAN-2: 22.5;HaCaT: 21.4;MCF7: 40.8;RT4: 18.8;SK-BR-3: 18.5;T-47d: 26.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043514, HPA045471"			Approved	"Vesicles,Intermediate filaments"		No	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 45: Enterocytes - Digestion"	Vesicles	"Intermediate filaments"	"HPA043514: AB_10959475, HPA045471: "	"unprognostic (1.18e-1)"	"unprognostic (3.92e-1)"	"unprognostic (9.92e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.16e-3)"	"unprognostic (2.04e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.54e-1)"	"unprognostic (8.75e-3)"	"unprognostic (3.29e-1)"	"unprognostic (5.16e-2)"	"prognostic favorable (6.80e-10)"	"unprognostic (2.63e-3)"	"unprognostic (4.76e-1)"	"unprognostic (3.59e-2)"	"unprognostic (2.43e-1)"	0.2	0.3	0.5	3.1	0.6	0.6	6.2	1.8	0.9	4.0	6.5	23.6	31.1	1.8	7.3	4.2	4.2	4.8	0.3	1.1	0.5	12.9	5.3	2.4	0.5	0.4	0.5	0.5	17.1	12.5	1.0	5.7	0.5	6.0	18.7	2.1	11.6	2.5	0.8	3.3	33.1	0.6	0.1	0.4	2.8	0.9	0.5	0.9	3.9	0.0	1.7	3.8	2.5	0.9	21.7	0.7	0.5	0.9	0.0	0.1	30.9	0.0	0.0	0.0	0.0	23.6	22.5	0.2	2.3	0.0	0.1	21.4	1.9	10.3	0.1	0.0	12.1	0.0	0.4	6.2	0.0	0.1	0.2	0.9	12.5	0.1	0.2	0.1	0.0	0.1	0.3	0.1	0.0	40.8	0.2	0.3	3.5	13.4	0.2	0.0	0.1	8.8	0.3	18.8	3.7	0.2	0.4	18.5	0.0	2.4	26.3	0.3	0.0	0.0	0.4	0.4	0.2	0.2	0.3	0.1	0.2	0.2	0.2	1.8	0.2	0.2	0.2	0.1	0.1	0.2	0.2	0.2	0.1	0.4	0.2	0.2	1.2	0.4	0.1	0.3	0.2	0.1	0.5	0.6	1.8	0.9	1.1	0.5	0.4	0.5	0.5	0.1	0.5	0.9	0.3	9.6	8.4	0.3	0.8	7.9	28.7	9.6	22.8	7.0	25.4	10.7	0.6	40.0	17.9	9.2	0.0	36.5	1.5	150.1	1.9	29.8	4.4	14.2	1.5	1.0	61.5	0.0	0.6	33.7	2.5	1.5	6.1	19.4	0.0	3.8	0.4	9.1	3.1	0.0	0.6	68.2	14.2	1.0	1.0	3.3	0.3	1.2	0.0	0.0	0.8	1.0	0.0	0.0	0.6	26.3	102.9	0.7	0.0	38.4	199.3	27.6	17.4	19.6	0.0	4.1	1.6	9.6	5.0	19.6	3.7	4.8	1.4	0.0	61.3	44.3
MFSD8	"CLN7, MGC33302"	ENSG00000164073	"Major facilitator superfamily domain containing 8"	Q8NHS3	4	127917799-127966034	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease variant, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044802	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 16: U-266 - Nucleosome"	"Cluster 52: Non-specific - Transcription"	Vesicles	Nucleoplasm	"HPA044802: AB_10963221"	"unprognostic (1.67e-1)"	"unprognostic (1.95e-1)"	"unprognostic (4.47e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.19e-2)"	"unprognostic (8.69e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.93e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.61e-3)"	"unprognostic (3.14e-1)"	"prognostic favorable (2.21e-4)"	4.6	5.7	1.3	6.8	1.3	2.6	6.9	1.9	1.6	6.2	1.1	6.8	10.0	5.6	3.9	5.4	5.5	4.8	3.8	1.1	1.7	6.4	10.0	4.8	5.4	1.4	1.3	6.8	8.1	9.1	7.1	5.9	1.5	5.5	8.2	4.6	5.8	4.4	3.7	5.9	7.6	5.8	1.1	7.3	6.4	3.9	0.8	5.2	7.0	4.4	7.9	5.3	5.9	2.2	10.9	7.3	9.5	4.6	7.2	6.9	7.0	8.3	10.3	10.2	10.5	5.2	14.3	5.2	14.5	14.3	14.8	7.8	10.2	7.4	14.4	10.8	7.9	5.7	9.1	8.0	9.4	6.0	6.6	8.3	2.7	8.6	7.7	5.0	10.6	6.6	9.5	5.9	14.6	8.9	5.0	1.9	1.7	11.8	5.2	5.3	0.6	4.7	7.5	13.9	8.5	2.9	9.0	12.0	3.5	6.4	5.6	5.1	6.7	2.9	3.1	10.7	7.8	12.5	22.1	9.6	10.3	5.3	8.8	1.9	1.6	2.8	2.5	2.4	2.4	2.5	2.7	2.2	1.6	1.1	2.4	2.6	2.5	2.4	3.7	2.2	3.4	1.2	1.3	1.3	1.9	1.6	1.1	1.7	1.4	1.3	1.5	1.1	0.8	2.2	9.5	12.8	14.1	17.0	18.8	3.2	4.9	8.5	10.2	17.2	8.1	5.3	3.0	5.7	14.0	16.5	20.9	12.5	17.9	7.2	1.9	8.5	10.4	7.7	7.2	7.2	4.2	3.8	32.1	7.0	7.3	8.6	11.7	8.2	12.7	18.4	8.9	10.1	7.6	11.8	34.9	6.8	10.2	8.5	3.3	14.7	9.3	6.5	3.6	27.2	10.5	8.6	20.6	20.6	24.6	7.8	9.5	9.4	19.9	5.4	11.1	6.3	12.1	24.9	6.6	5.8	6.6	12.6	8.4	8.9	5.7	22.0	13.7	11.4	7.3	4.8
MGAM	MGA	ENSG00000257335	Maltase-glucoamylase	O43451	7	141907813-142106747	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase, Multifunctional enzyme"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 25.5;intestine: 87.6"	"Group enriched"	"Detected in some"	5	"Late spermatids: 156.4;Proximal enterocytes: 521.4"	"Cancer enriched"	"Detected in some"	7	"renal cancer: 4.9"	"Region enhanced"	"Detected in single"		"cerebral cortex: 2.3"	"Immune cell enriched"	"Detected in some"	7	"neutrophil: 13.5"	"Lineage enriched"	"Detected in single"	102	"granulocytes: 13.5"	"Cell line enhanced"	"Detected in some"		"A549: 1.8;BJ hTERT+: 1.6;HL-60: 2.8;U-937: 4.3;WM-115: 1.0"	"Region enriched"	"Detected in single"	12	"olfactory bulb: 2.0"	"Low region specificity"	"Detected in many"			HPA002270	Enhanced					NA	NA		310000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 32: U-937 - Innate immune response"	"Cluster 45: Enterocytes - Digestion"			"HPA002270: AB_1079366"	"unprognostic (1.02e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.95e-3)"	"unprognostic (2.80e-1)"	"unprognostic (7.81e-2)"	"unprognostic (7.32e-3)"	"unprognostic (3.83e-2)"	"unprognostic (4.97e-1)"	"unprognostic (2.17e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.99e-1)"	"prognostic favorable (6.16e-5)"	"unprognostic (1.82e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.34e-3)"	"unprognostic (3.03e-1)"	2.6	0.1	0.2	2.5	0.4	18.1	0.2	0.2	2.3	0.4	0.3	0.5	58.9	0.1	25.5	0.3	1.2	0.4	0.3	0.1	0.3	18.7	0.5	3.2	0.1	0.5	0.4	0.1	0.2	0.0	0.1	0.3	0.6	0.1	0.2	0.0	0.1	7.1	0.1	0.1	87.6	0.4	0.2	12.6	1.8	1.3	0.6	0.4	0.1	1.0	0.0	0.5	0.1	0.4	0.0	1.8	0.1	0.0	0.0	0.0	0.2	0.0	1.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.1	0.0	0.0	0.0	4.3	1.0	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.2	2.3	0.1	0.3	0.5	0.4	0.6	0.2	0.6	0.4	0.0	0.0	2.5	3.3	0.1	0.0	0.0	0.6	0.0	0.2	0.5	0.1	1.4	0.0	3.2	12.9	0.0	0.0	2.8	1.8	1.9	0.1	59.7	0.1	0.2	0.3	1.2	0.0	0.7	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.7	17.8	0.0	0.0	2.5	156.4	0.6	1.1	0.0	0.0	0.7	0.6	5.2	1.5	0.6	0.2	16.3	0.4	0.0	0.1	521.4	24.4	6.7	0.0	0.0	0.5	0.1	1.8	1.2	0.0	0.0	0.0	0.4	0.0	7.3	0.3
MIA2	"cTAGE-5A, cTAGE-5B, cTAGE-5C, cTAGE-5D, CTAGE5, FLJ22404, MEA6, MGEA, MGEA11, MGEA6, TALI"	ENSG00000150527	"MIA SH3 domain ER export factor 2"	Q96PC5	14	39230231-39388513	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 138.9"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 44.1;Ductal cells: 42.9;Endometrial ciliated cells: 78.7;Exocrine glandular cells: 42.7;Glandular and luminal cells: 93.5;Pancreatic endocrine cells: 41.3;Proximal tubular cells: 61.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CAPAN-2: 125.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000387, HPA000922, HPA054066, HPA055459"	Approved		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 7: Non-specific - Mitochondria"	"Endoplasmic reticulum"		"HPA000387: AB_1078582, HPA000922: AB_1078581, HPA054066: AB_2682368, HPA055459: AB_2682819"	"unprognostic (2.62e-1)"	"unprognostic (7.17e-3)"	"unprognostic (2.33e-1)"	"unprognostic (5.27e-4)"	"unprognostic (3.21e-4)"	"unprognostic (2.63e-1)"	"unprognostic (2.48e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (2.81e-4)"	"unprognostic (6.93e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.91e-1)"	"unprognostic (3.97e-2)"	12.1	26.6	5.6	16.8	6.9	23.6	22.1	5.8	7.9	29.7	58.0	30.8	80.4	15.7	40.2	26.9	22.2	30.3	16.6	9.4	6.5	78.4	138.9	15.5	16.2	5.6	4.7	9.6	43.6	40.5	15.5	11.2	6.4	21.1	34.6	12.8	52.5	19.2	54.5	9.9	78.4	12.3	4.1	14.5	45.3	21.0	5.1	14.3	46.7	20.7	19.8	16.2	17.2	7.1	23.0	25.1	10.4	18.5	20.6	23.2	14.5	13.3	13.9	9.3	9.6	19.7	125.4	27.5	40.1	15.0	18.9	34.1	12.7	15.0	11.0	21.4	10.6	17.2	11.5	106.1	48.2	23.2	30.7	14.4	83.7	9.2	69.2	59.0	15.3	31.8	16.6	68.3	14.0	22.1	14.9	18.9	12.0	87.2	20.8	15.2	18.3	34.9	42.7	24.7	8.7	5.1	31.0	32.5	20.4	13.1	31.2	24.8	24.3	14.1	9.2	10.4	8.8	38.7	35.7	27.2	7.9	14.5	12.0	40.9	16.3	25.9	15.4	18.0	14.0	11.7	11.6	14.4	17.8	13.1	14.2	13.2	34.5	14.6	21.0	12.3	11.8	11.8	5.6	6.9	5.8	7.9	9.4	6.5	5.6	4.7	6.4	4.1	5.1	7.1	26.7	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	33.1	19.9	0.0	5.7	0.0	44.1	0.0	5.6	35.9	0.8	7.9	42.9	0.5	78.7	30.7	7.1	0.0	0.0	0.1	42.7	5.0	4.6	0.0	93.5	0.0	10.3	0.0	3.8	7.6	0.0	0.1	1.8	0.0	0.0	0.0	0.6	0.0	12.7	0.0	0.0	23.8	0.0	1.0	0.0	0.0	41.3	0.0	0.0	8.1	0.0	6.6	61.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	7.0	13.6	20.0	0.2	0.0
MLEC	KIAA0152	ENSG00000110917	Malectin	Q14165	12	120687149-120701859	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Carbohydrate metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Undifferentiated cells: 397.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"													NA	NA		880000	"Cluster 52: Eosinophils - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 32: U-937 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"				"unprognostic (1.50e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.01e-2)"	"prognostic favorable (9.60e-6)"	"unprognostic (4.99e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.41e-2)"	"unprognostic (3.94e-1)"	"unprognostic (3.39e-1)"	"unprognostic (9.77e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.15e-2)"	"prognostic favorable (8.77e-4)"	"unprognostic (1.98e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.05e-1)"	51.7	93.1	35.4	51.8	36.7	34.6	44.3	33.0	34.5	52.8	40.3	127.0	78.3	37.2	138.1	24.5	48.5	48.5	65.9	34.7	40.0	73.5	78.2	34.9	30.3	42.3	39.4	49.2	62.7	101.2	36.7	45.7	37.8	62.4	117.3	25.3	50.7	64.9	79.8	27.8	86.0	50.0	40.0	30.1	45.3	69.1	42.9	33.3	101.0	82.9	37.3	34.1	17.4	37.6	122.7	177.9	113.6	151.8	196.3	107.4	127.9	144.5	126.3	108.9	80.1	127.5	75.1	100.3	129.0	142.2	85.4	101.9	140.4	87.4	138.7	86.5	76.9	142.4	79.4	100.6	72.1	199.3	123.1	82.2	82.7	116.0	91.4	174.1	97.2	93.9	85.9	112.2	116.3	127.8	106.4	122.2	158.1	156.6	91.7	115.7	82.0	109.1	132.2	204.0	58.2	69.2	166.5	85.9	86.0	143.0	127.0	144.6	79.2	115.8	108.5	112.8	100.3	83.3	165.0	76.8	147.6	147.9	120.1	0.5	6.0	8.0	3.8	7.5	4.1	4.7	2.3	3.4	5.0	6.9	4.0	3.4	1.6	3.9	6.5	18.6	2.4	2.2	35.4	36.7	33.0	34.5	34.7	40.0	42.3	39.4	37.8	40.0	42.9	37.6	151.4	25.6	62.2	23.2	65.7	72.8	70.6	32.0	55.2	40.9	99.7	76.3	145.3	97.2	40.0	86.5	45.9	88.4	105.7	155.3	37.2	134.2	243.3	78.3	127.6	94.1	80.3	68.5	21.4	183.7	176.9	90.5	69.3	80.2	49.5	99.8	27.1	206.1	126.8	84.1	24.7	199.2	30.5	61.7	73.2	228.0	82.6	70.1	193.9	34.7	56.4	81.8	74.2	32.2	23.0	95.8	86.0	108.0	217.4	152.6	135.4	121.7	41.9	45.3	85.5	61.4	78.5	165.6	153.4	52.8	58.7	115.6	51.2	142.5	397.0	82.2
MME	"CALLA, CD10, NEP"	ENSG00000196549	"Membrane metalloendopeptidase"	P08473	3	155024124-155183704	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Charcot-Marie-Tooth disease, Disease variant, FDA approved drug targets, Neurodegeneration, Neuropathy, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 333.5;kidney: 302.5"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 273.3;Proximal enterocytes: 372.4;Proximal tubular cells: 125.7;Syncytiotrophoblasts: 126.0"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 17.6"	"Group enriched"	"Detected in many"	5	"basal ganglia: 17.3;medulla oblongata: 9.3;pons: 10.9;thalamus: 4.6"	"Immune cell enriched"	"Detected in some"	122	"neutrophil: 139.4"	"Lineage enriched"	"Detected in many"	122	"granulocytes: 139.4"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 684.4;BJ hTERT+: 1116.9;HSkMC: 651.1"	"Region enhanced"	"Detected in many"		"basal ganglia: 28.1"	"Group enriched"	"Detected in many"	4	"basal ganglia: 32.3;olfactory bulb: 8.5;spinal cord: 15.9"	"CAB000013, HPA052583, HPA056072"	Enhanced					NA	NA		320000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"			"CAB000013: AB_563478, HPA052583: AB_2681872, HPA056072: AB_2683027"	"unprognostic (1.36e-1)"	"unprognostic (1.02e-3)"	"unprognostic (8.52e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.78e-2)"	"unprognostic (6.52e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.67e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.30e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.50e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.37e-2)"	103.9	1.0	0.7	4.5	17.3	11.5	38.5	1.5	1.9	22.7	0.3	1.9	333.5	13.3	22.5	2.3	1.9	13.4	4.3	0.1	0.6	302.5	56.1	27.6	10.3	9.3	2.3	0.9	1.2	0.5	0.6	73.0	10.9	79.6	3.4	0.1	6.1	44.5	20.3	1.9	289.7	1.5	0.9	7.9	1.6	1.3	4.6	16.6	1.2	23.5	12.3	6.0	7.6	0.4	0.1	0.0	0.9	0.3	280.1	684.4	1.6	160.3	1116.9	82.2	209.8	0.0	0.3	172.9	0.1	130.1	107.4	0.5	5.2	6.1	201.3	0.0	0.8	0.0	0.1	0.2	229.6	0.0	0.0	651.1	1.0	40.4	308.1	89.4	59.5	0.4	0.2	0.3	135.1	0.7	0.4	1.0	6.1	0.5	1.1	303.3	139.9	1.6	5.2	1.9	0.5	1.5	0.1	0.5	31.9	68.3	0.2	0.2	165.8	356.4	0.8	115.7	27.9	0.1	0.0	217.3	42.5	0.1	7.3	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	139.4	0.0	0.0	1.1	0.0	0.0	0.7	17.3	1.5	1.9	0.1	0.6	9.3	2.3	10.9	0.9	4.6	0.4	5.9	9.6	13.0	0.3	2.3	0.8	74.1	2.5	0.0	0.0	1.5	64.1	1.6	21.5	11.2	22.0	0.0	82.1	6.9	0.0	9.8	0.2	0.5	6.2	273.3	6.6	0.0	0.0	2.2	0.0	57.8	40.6	0.0	5.7	2.5	0.0	2.9	53.2	8.9	0.0	8.1	9.9	2.0	3.1	1.2	0.5	4.1	10.7	0.0	0.0	0.2	0.0	0.0	0.5	0.3	0.6	13.8	1.2	0.1	40.0	372.4	125.7	1.6	0.0	0.0	17.4	11.1	0.2	0.5	0.1	0.3	126.0	2.5	0.1	12.6	33.6
MPDU1	"CDGIf, Lec35, PQLC5, SL15, SLC66A5"	ENSG00000129255	"Mannose-P-dolichol utilization defect 1"	O75352	17	7583529-7592789	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	Transport		"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 157.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014845	Uncertain		Supported	"Endoplasmic reticulum,Mitochondria"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Endoplasmic reticulum"	Mitochondria	"HPA014845: AB_1854072"	"unprognostic (1.96e-1)"	"unprognostic (8.75e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.36e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.65e-1)"	"unprognostic (4.70e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.34e-3)"	"unprognostic (9.00e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.48e-3)"	"unprognostic (2.93e-1)"	31.9	41.1	33.0	32.8	34.1	63.3	39.2	35.5	34.5	33.3	41.9	65.5	53.3	17.4	33.5	37.7	32.0	35.7	20.4	31.7	34.2	72.2	107.0	33.3	30.7	34.3	33.9	10.9	39.7	57.4	15.6	37.1	33.7	33.7	69.6	25.4	33.6	18.4	21.3	29.0	48.5	28.7	34.2	28.4	54.5	14.5	36.2	25.9	35.7	21.3	38.0	43.2	21.9	34.9	51.0	111.8	75.9	54.1	83.8	74.4	50.5	81.1	104.6	142.4	98.6	58.0	85.0	28.8	54.8	128.1	65.0	98.4	102.2	134.3	116.6	63.8	118.8	55.7	65.8	98.7	101.0	49.3	89.8	77.9	105.2	133.4	76.4	64.7	105.8	84.9	87.1	38.6	151.6	70.1	35.9	48.4	85.2	107.4	55.8	81.6	56.4	60.7	145.1	52.1	45.8	90.1	104.4	75.9	34.4	59.5	83.8	50.1	76.5	67.5	36.9	36.8	111.2	20.3	34.6	27.0	97.1	62.3	103.5	16.8	44.2	14.0	16.9	73.1	12.8	18.1	16.1	22.1	52.4	16.5	15.4	18.3	6.5	17.4	69.1	48.5	26.4	24.9	33.0	34.1	35.5	34.5	31.7	34.2	34.3	33.9	33.7	34.2	36.2	34.9	30.1	9.6	23.0	5.5	30.4	10.7	34.9	51.0	22.2	18.1	34.7	22.7	5.1	34.3	31.0	23.9	12.5	111.5	26.5	106.8	35.2	62.7	3.2	22.2	23.3	28.2	37.2	96.8	4.5	76.1	93.8	27.5	53.5	28.1	14.5	28.6	25.0	49.7	79.7	16.8	5.6	68.9	40.7	30.5	23.6	5.7	17.1	46.1	24.9	4.7	35.9	28.5	21.6	6.6	9.3	69.7	76.8	6.4	38.5	37.1	78.0	48.0	20.3	23.3	26.3	30.6	24.7	22.9	26.4	20.7	12.6	157.6	26.0	37.1	77.1	40.9
MTM1		ENSG00000171100	"Myotubularin 1"	Q13496	X	150568621-150673143	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Protein transport, Transport"	"Hydrolase, Protein phosphatase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 52.2;Oligodendrocytes: 47.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010008, HPA010665"	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	"Plasma membrane"		"HPA010008: AB_1079426, HPA010665: AB_1079425"	"unprognostic (3.66e-3)"	"unprognostic (8.43e-3)"	"unprognostic (3.52e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.45e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.74e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.59e-2)"	"prognostic favorable (7.40e-7)"	"unprognostic (4.46e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.46e-1)"	6.8	11.1	7.4	9.7	8.3	11.3	7.6	8.0	8.4	5.7	6.1	19.8	11.7	6.5	8.4	7.5	9.6	7.1	7.3	6.9	8.5	12.9	18.4	11.2	12.4	7.8	8.6	11.7	4.9	16.0	3.8	6.3	8.0	8.0	19.2	5.4	6.3	10.7	11.8	8.2	12.1	6.9	7.7	11.9	7.8	11.5	8.8	8.4	11.2	10.1	9.7	7.1	4.7	8.8	14.3	6.1	8.5	3.1	7.5	7.3	5.4	6.1	8.5	7.0	7.9	4.7	7.3	22.2	11.4	8.3	21.9	9.9	6.1	11.5	8.6	6.4	5.2	5.6	5.4	15.0	5.8	25.2	19.1	4.5	14.3	5.7	11.9	6.9	9.4	9.3	3.9	19.8	8.8	4.5	6.9	25.2	4.3	13.4	7.4	8.0	4.9	4.5	11.7	6.9	2.2	2.4	5.5	11.3	8.5	11.9	4.1	35.2	8.2	5.0	3.1	12.4	7.1	4.2	10.0	20.3	6.0	14.8	8.0	34.8	9.5	27.9	2.0	10.8	6.8	8.0	9.6	7.3	12.0	10.6	9.0	5.4	11.6	14.6	9.8	7.4	12.2	7.1	7.4	8.3	8.0	8.4	6.9	8.5	7.8	8.6	8.0	7.7	8.8	8.8	9.9	9.6	20.0	52.2	13.9	15.2	8.3	5.8	2.2	0.0	5.8	3.9	15.0	4.3	6.0	3.7	0.0	2.1	8.4	33.0	1.9	3.4	35.6	7.7	5.0	11.5	9.6	7.4	44.0	4.3	2.8	6.6	8.2	4.8	8.8	3.3	16.4	13.2	8.0	0.0	41.5	17.7	2.0	16.3	10.4	18.8	6.2	13.0	5.4	24.4	12.0	0.0	0.0	27.6	47.7	4.7	9.5	12.8	8.0	6.8	11.2	14.7	13.4	0.0	0.0	5.2	6.9	5.1	4.1	4.9	19.0	7.3	12.8	4.8	13.8	9.7
MYO6	"DFNA22, DFNB37, KIAA0389"	ENSG00000196586	"Myosin VI"	Q9UM54	6	75749192-75919537	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Hearing, Protein transport, Transport"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Cardiomyopathy, Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 409.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 5.5;MAIT T-cell: 3.0;memory CD4 T-cell: 1.8;memory CD8 T-cell: 3.1;naive CD8 T-cell: 3.0;NK-cell: 2.9"	"Group enriched"	"Detected in many"	7	"NK-cells: 2.9;T-cells: 5.5"	"Cell line enhanced"	"Detected in many"		"RT4: 103.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010762, HPA035482, HPA035483"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 15: RT4 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"CAB010762: AB_477166, HPA035482: , HPA035483: AB_2674647"	"unprognostic (6.29e-2)"	"unprognostic (6.34e-2)"	"unprognostic (3.63e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.98e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.41e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.66e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.78e-2)"	"prognostic favorable (1.27e-12)"	"unprognostic (1.57e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.49e-2)"	9.9	9.5	18.6	7.1	29.3	0.3	28.3	22.6	32.0	18.5	32.6	22.1	33.0	7.6	22.9	32.0	11.5	27.0	5.3	19.6	19.5	51.4	15.2	23.2	4.7	23.7	24.4	4.7	21.6	40.4	14.5	7.6	24.3	17.2	19.2	49.0	25.9	19.9	3.4	16.8	33.9	5.7	16.0	7.6	27.6	14.6	23.9	5.1	15.9	3.1	12.8	24.0	15.8	34.6	52.2	13.0	12.3	8.9	29.7	23.7	42.6	20.7	23.6	12.3	18.3	22.2	44.2	0.1	16.1	25.7	14.0	40.0	15.3	29.2	18.6	17.0	30.3	17.4	5.6	14.1	25.0	0.0	22.2	17.5	21.6	19.3	14.5	24.0	43.3	7.9	22.4	7.2	15.4	48.3	0.2	0.8	7.7	44.1	3.8	0.7	29.1	1.6	51.1	103.6	26.8	14.8	5.6	46.6	6.8	28.3	16.5	35.8	59.4	13.7	9.3	0.6	20.0	13.2	16.1	0.3	10.9	0.2	5.3	0.2	0.1	0.1	5.5	0.0	3.0	0.2	1.8	3.1	0.0	0.1	0.4	3.0	0.6	2.9	0.1	0.1	0.2	0.8	18.6	29.3	22.6	32.0	19.6	19.5	23.7	24.4	24.3	16.0	23.9	34.6	74.8	141.1	207.0	286.3	4.7	30.1	87.5	49.2	18.2	83.6	99.6	35.9	8.1	38.6	91.3	150.8	120.9	32.0	14.7	112.2	54.8	128.9	7.0	86.9	26.9	57.2	85.0	0.0	147.8	120.3	23.8	30.5	91.7	169.2	26.0	81.0	37.9	33.8	6.3	95.9	167.2	76.4	116.0	2.9	6.1	9.6	30.1	6.7	30.2	105.9	2.7	307.3	12.3	179.4	409.1	197.0	99.7	43.2	11.4	165.9	105.7	97.6	109.5	188.4	13.1	26.5	32.7	14.4	32.1	28.3	34.1	78.4	13.4	191.8	77.5	199.7
NAPEPLD	"C7orf18, FMP30, NAPE-PLD"	ENSG00000161048	"N-acyl phosphatidylethanolamine phospholipase D"	Q6IQ20	7	103099776-103149560	"Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 128.0;Excitatory neurons: 99.2;Oligodendrocyte precursor cells: 126.7;Oligodendrocytes: 193.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019832, HPA024338"	Approved		Approved	Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 18: U-2197 - ECM organization"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol		"HPA019832: AB_1844422, HPA024338: AB_2671533"	"unprognostic (3.62e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.57e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.02e-2)"	"unprognostic (6.39e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.21e-1)"	"prognostic favorable (7.32e-6)"	"unprognostic (8.83e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.41e-2)"	2.0	4.6	1.6	3.6	3.7	2.0	1.7	1.5	4.2	3.6	0.0	7.7	14.5	3.6	2.2	1.9	5.3	5.9	4.0	1.7	0.0	14.9	7.4	3.0	3.3	0.4	1.1	8.6	3.5	6.0	1.5	2.2	0.8	4.5	7.5	4.8	1.7	3.4	2.4	3.1	9.7	3.0	0.5	6.4	9.9	6.7	2.5	3.0	8.2	2.4	2.7	3.5	1.8	9.2	6.9	7.4	5.1	4.3	4.9	4.9	0.9	5.4	3.1	1.6	3.3	2.7	6.3	5.2	7.7	1.7	6.3	5.6	3.3	0.5	3.8	6.9	6.0	1.9	4.1	1.5	1.1	3.3	2.2	2.8	0.9	1.6	0.0	12.5	3.5	3.5	2.0	4.8	5.0	2.2	5.1	2.4	4.7	9.4	9.7	3.6	2.8	1.9	10.5	2.9	3.8	4.6	10.7	3.7	2.7	3.1	2.4	4.4	4.6	7.7	4.0	17.8	4.9	6.8	8.6	3.7	7.6	2.9	14.8	0.1	1.9	3.7	2.7	2.9	2.3	4.6	3.1	3.4	2.1	4.5	4.4	3.2	0.2	1.5	1.9	1.7	2.9	1.4	1.6	3.7	1.5	4.2	1.7	0.0	0.4	1.1	0.8	0.5	2.5	9.2	4.6	19.2	10.0	38.8	13.2	6.6	5.5	5.3	9.6	78.1	5.7	5.0	12.3	17.2	6.8	53.3	52.1	8.1	5.6	37.5	9.8	5.3	128.0	27.5	10.7	5.2	13.8	36.6	99.2	2.6	4.0	7.3	41.3	42.9	4.5	12.0	4.6	19.1	3.9	50.5	56.7	27.0	4.1	5.5	1.8	43.8	31.7	4.4	14.2	21.5	7.2	16.1	18.6	126.7	193.3	5.0	28.7	33.4	10.6	6.5	46.5	32.6	3.0	35.4	6.6	7.8	6.3	21.1	12.2	3.1	2.8	2.9	8.1	18.9	26.8	7.8
NBEAL1	"ALS2CR16, ALS2CR17, MGC164581"	ENSG00000144426	"Neurobeachin like 1"	Q6ZS30	2	203014879-203226378	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 1030.4;Langerhans cells: 1016.1;Suprabasal keratinocytes: 1304.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049189, HPA049447"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 15: RT4 - Unknown function"	"Cluster 32: Non-specific - Translation"	Nucleoplasm	Cytosol	"HPA049189: AB_2680669, HPA049447: AB_2680771"	"unprognostic (3.66e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.52e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.40e-2)"	"unprognostic (6.77e-3)"	"unprognostic (2.01e-3)"	"unprognostic (7.20e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.22e-1)"	"unprognostic (7.98e-3)"	"unprognostic (7.59e-2)"	3.0	2.1	1.5	1.7	3.3	1.1	3.3	4.1	1.9	2.7	8.5	6.9	4.6	2.6	2.1	2.1	3.4	3.1	2.6	1.2	2.2	6.5	5.7	4.4	1.1	2.7	2.2	3.7	2.9	2.9	0.9	2.8	2.7	2.2	6.7	3.9	1.7	1.8	1.5	2.2	5.5	2.7	1.6	1.7	7.1	3.6	2.6	1.3	4.6	3.9	1.3	2.9	1.7	3.6	4.2	3.9	1.6	1.4	9.7	7.5	2.3	4.0	2.9	2.1	3.2	4.4	2.1	0.9	3.2	6.8	4.1	3.4	3.2	4.7	4.8	1.9	1.4	1.6	6.0	2.5	2.3	1.5	1.8	2.9	3.0	3.4	4.2	5.0	3.3	1.7	2.9	1.4	4.8	2.9	0.6	0.8	0.8	1.8	3.6	0.7	2.6	1.0	5.8	7.8	1.0	0.8	3.4	2.5	2.5	3.9	2.9	1.5	5.7	5.5	4.6	2.6	1.8	2.4	1.9	1.2	3.3	0.6	1.9	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.6	0.0	1.5	3.3	4.1	1.9	1.2	2.2	2.7	2.2	2.7	1.6	2.6	3.6	53.0	38.5	72.2	103.5	145.5	1030.4	399.8	231.1	117.8	18.4	81.2	89.2	21.4	223.1	94.4	38.6	27.1	205.9	58.8	173.8	84.1	57.4	30.9	57.8	73.5	155.1	293.5	49.0	88.0	99.2	276.5	154.4	103.9	69.3	107.2	43.3	287.0	203.7	154.5	82.4	79.7	515.3	91.6	531.4	1016.1	49.5	274.3	78.0	629.7	81.5	186.0	19.5	171.9	105.1	130.9	78.5	335.8	129.4	52.4	304.8	343.9	103.1	59.2	26.9	118.3	388.6	265.6	45.1	41.2	118.4	1304.2	229.3	182.3	31.4	528.3	305.2
NCR3LG1	"B7-H6, DKFZp686O24166"	ENSG00000188211	"Natural killer cell cytotoxicity receptor 3 ligand 1"	Q68D85	11	17351800-17377341	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 7.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 32.2;Inhibitory neurons: 29.3"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"cerebellum: 4.7;cerebral cortex: 4.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HL-60: 53.8;K-562: 30.8"									HPA024137	Uncertain					NA	NA		21000		"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA024137: AB_1859534"	"unprognostic (1.23e-1)"	"unprognostic (3.65e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.03e-5)"	"unprognostic (6.24e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.59e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.36e-1)"	"prognostic favorable (4.21e-12)"	"unprognostic (7.88e-3)"	"unprognostic (1.72e-1)"	"unprognostic (3.52e-3)"	"unprognostic (1.36e-1)"	1.1	0.5	0.3	1.1	0.5	1.9	0.5	4.7	4.7	0.6	3.7	3.4	4.5	1.0	0.4	0.7	1.4	0.9	1.0	0.3	0.6	2.5	0.4	1.1	0.5	0.1	0.0	1.2	0.8	7.5	1.7	0.4	0.1	0.6	5.1	1.9	0.8	0.6	0.4	0.8	3.3	1.0	0.0	0.6	1.3	2.3	0.0	1.3	2.6	0.1	0.7	1.1	0.5	0.7	3.9	1.3	8.8	1.2	3.0	8.1	0.6	2.8	5.2	3.8	9.0	7.3	1.5	22.4	0.4	3.1	1.2	4.0	14.4	3.6	3.1	3.9	23.8	20.6	10.0	7.2	12.5	53.8	0.9	6.7	1.8	5.3	12.8	1.6	4.2	8.1	30.8	0.1	1.2	0.4	5.2	4.7	0.5	14.4	2.1	1.7	4.6	0.3	3.1	1.4	9.3	3.5	3.1	0.7	2.5	0.1	2.1	11.9	6.1	0.7	1.2	2.3	1.6	2.4	4.5	25.1	3.9	17.6	1.8	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	4.7	4.7	0.3	0.6	0.1	0.0	0.1	0.0	0.0	0.7	0.8	0.0	2.0	8.1	1.4	2.5	2.1	2.1	5.2	7.2	1.9	0.4	0.8	2.8	1.7	1.8	2.1	0.1	3.1	6.8	0.0	2.3	13.6	2.3	3.2	1.6	1.8	1.3	32.2	0.9	0.0	4.0	5.6	3.2	0.0	1.5	3.6	0.5	0.9	5.0	29.3	6.6	0.0	1.6	13.6	2.5	0.6	4.4	3.6	4.7	0.4	1.4	2.1	8.5	1.7	1.2	5.4	0.4	0.8	1.8	4.1	1.1	5.3	1.1	0.0	3.1	1.9	0.7	1.1	4.1	3.7	1.5	1.6	5.6	7.5	0.9
NCSTN	"APH2, KIAA0253"	ENSG00000162736	Nicastrin	Q92542	1	160343316-160358952	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Notch signaling pathway"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 147.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021982, HPA054846, HPA070642"	Approved		Approved	Cytosol		NA	NA		130000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"CAB021982: , HPA054846: AB_2682624, HPA070642: AB_2686289"	"unprognostic (1.08e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.89e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.62e-2)"	"unprognostic (8.21e-2)"	"unprognostic (2.06e-2)"	"prognostic unfavorable (7.75e-9)"	"unprognostic (1.36e-3)"	"unprognostic (3.15e-1)"	"unprognostic (3.14e-2)"	"unprognostic (4.89e-2)"	51.0	36.6	30.6	42.1	36.1	38.1	43.9	38.5	32.5	52.4	42.0	58.4	80.4	40.3	56.4	35.1	49.7	42.9	50.6	29.9	35.8	59.7	59.3	56.0	38.3	40.0	34.0	51.7	63.8	86.0	30.1	98.7	41.6	45.2	60.9	48.1	60.5	47.3	37.6	38.9	63.5	52.1	37.3	46.2	45.7	41.8	36.4	40.0	63.8	38.4	43.0	45.6	31.5	48.9	52.1	57.4	100.4	82.8	301.0	153.4	108.3	104.0	177.0	95.4	109.9	47.9	140.0	36.6	208.6	209.3	67.1	81.5	47.3	95.9	82.4	56.5	42.3	36.6	70.9	70.0	118.6	82.8	152.0	155.7	92.3	94.3	93.6	207.2	139.9	54.3	66.9	100.2	142.2	34.3	26.8	39.8	82.2	130.6	33.8	35.1	59.9	103.6	130.5	69.9	34.2	75.6	109.1	118.5	70.9	158.0	108.2	186.3	125.5	70.3	46.4	48.8	79.9	130.8	194.4	38.6	106.6	49.8	129.4	71.4	79.0	67.8	27.4	79.0	26.2	31.1	23.5	24.0	75.1	27.8	23.9	23.3	69.2	36.6	79.6	45.1	26.5	52.2	30.6	36.1	38.5	32.5	29.9	35.8	40.0	34.0	41.6	37.3	36.4	48.9	28.0	6.4	9.3	0.0	23.0	10.5	23.8	59.5	15.9	20.0	27.9	23.1	14.6	45.8	42.6	53.3	52.1	107.7	27.8	53.3	7.9	38.9	2.6	19.2	19.7	23.9	20.3	17.2	0.0	27.0	95.7	33.7	17.9	30.2	13.3	25.8	29.6	31.4	58.0	18.5	0.0	31.8	46.8	47.1	18.8	4.7	27.1	33.4	17.8	0.0	31.7	35.0	20.6	0.0	0.0	34.8	33.4	21.1	33.2	15.6	66.1	24.7	28.7	26.3	26.3	23.8	19.6	44.6	35.9	15.5	11.4	147.4	16.5	32.5	29.6	20.5
NR3C2	"MLR, MR"	ENSG00000151623	"Nuclear receptor subfamily 3 group C member 2"	P08235	4	148078762-148444698	"Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 265.8;Excitatory neurons: 275.7;Inhibitory neurons: 269.9;Microglial cells: 176.1;Oligodendrocyte precursor cells: 230.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 1.8"	"Lineage enriched"	"Detected in single"	6	"T-cells: 1.8"	"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 9.7;HUVEC TERT2: 6.0;Karpas-707: 6.9;PC-3: 6.1;RPTEC TERT1: 7.8;TIME: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009155, HPA074979"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"CAB009155: AB_2155949, HPA074979: AB_2686724"	"unprognostic (2.75e-3)"	"unprognostic (2.63e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.52e-1)"	"unprognostic (4.09e-1)"	"unprognostic (7.82e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.35e-2)"	"unprognostic (4.97e-2)"	"unprognostic (2.39e-1)"	"prognostic favorable (3.10e-11)"	"unprognostic (1.42e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.27e-1)"	4.6	4.5	4.5	3.7	5.6	1.0	4.8	9.2	11.7	5.6	4.0	21.8	8.7	6.2	3.8	3.1	5.9	5.8	9.4	13.7	3.5	12.1	8.5	7.3	3.1	3.0	5.9	14.7	7.6	12.5	5.5	1.8	3.0	3.7	26.2	8.5	10.7	4.3	12.1	3.0	15.3	4.9	3.2	5.2	8.3	4.3	6.1	2.9	19.7	14.1	2.1	5.9	3.3	4.8	0.0	0.0	0.0	0.0	0.4	0.3	0.4	0.0	0.0	0.0	0.4	0.0	0.0	1.4	2.6	1.0	0.2	0.0	1.3	0.7	0.1	0.2	2.3	0.2	0.6	0.0	0.0	1.7	0.3	0.1	0.0	0.0	0.0	9.7	6.0	0.9	0.0	6.9	2.0	0.0	0.0	0.0	0.1	1.2	6.1	0.5	0.0	0.1	7.8	0.1	0.1	0.0	0.0	1.4	0.6	0.1	0.7	0.0	8.7	4.3	2.5	0.1	0.8	0.0	0.0	0.1	1.4	0.6	1.0	0.0	0.0	0.0	0.5	0.0	1.8	0.1	0.7	0.4	0.0	0.2	1.0	1.1	0.0	0.0	0.2	0.0	0.2	0.1	4.5	5.6	9.2	11.7	13.7	3.5	3.0	5.9	3.0	3.2	6.1	4.8	11.9	28.9	13.9	265.8	5.1	2.0	2.2	0.4	6.2	10.3	6.2	5.8	20.3	7.2	6.7	11.0	18.8	0.9	1.0	76.1	9.8	3.0	68.2	2.1	1.1	8.2	18.0	0.0	275.7	5.8	0.5	5.9	13.7	2.6	5.7	6.4	8.6	7.0	0.6	13.5	269.9	44.6	6.1	2.9	2.4	41.8	4.4	1.7	7.2	176.1	1.2	8.1	1.0	230.2	95.7	3.2	26.8	3.8	0.8	1.8	26.4	2.3	4.7	9.6	0.0	14.7	5.1	1.8	5.6	2.6	1.7	0.1	4.9	1.8	21.5	2.1
NUDT12	DKFZP761I172	ENSG00000112874	"Nudix hydrolase 12"	Q9BQG2	5	103548855-103562790	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 58.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045449	Supported					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA045449: AB_2679327"	"unprognostic (1.94e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.53e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.61e-1)"	"unprognostic (8.79e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.92e-1)"	"prognostic favorable (2.86e-5)"	"unprognostic (1.13e-1)"	"unprognostic (4.23e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.92e-2)"	5.7	12.1	5.2	3.6	7.3	0.9	11.9	7.1	7.1	9.2	6.9	13.3	16.9	6.4	12.0	7.7	8.5	7.4	10.4	4.6	6.4	26.6	28.4	6.5	2.7	6.2	6.2	6.7	12.3	24.4	4.0	5.0	7.1	14.6	14.4	12.5	12.9	7.8	13.4	7.4	14.3	6.0	7.0	4.4	14.2	5.0	6.3	4.7	16.0	8.9	3.5	6.0	4.0	9.2	6.2	2.7	14.6	5.5	9.8	20.3	0.0	10.7	10.1	9.5	12.2	5.3	22.0	0.0	6.9	6.2	10.6	9.9	13.8	22.3	13.2	0.0	8.3	6.4	10.1	2.8	10.1	0.0	0.0	9.7	19.1	6.3	16.3	11.2	6.6	0.0	10.5	0.0	16.8	11.5	0.5	0.3	7.5	0.0	8.4	0.0	12.9	5.0	15.9	10.7	11.0	11.4	6.9	10.3	16.5	11.5	22.6	6.4	8.0	12.0	4.3	10.5	8.7	7.2	11.6	0.0	12.3	0.0	8.9	0.0	0.3	0.0	0.0	0.4	0.0	0.2	0.2	0.1	0.9	0.4	0.6	0.3	0.0	0.5	0.3	1.1	0.1	0.2	5.2	7.3	7.1	7.1	4.6	6.4	6.2	6.2	7.1	7.0	6.3	9.2	5.8	9.6	9.0	10.4	1.6	3.3	6.3	13.8	12.5	10.4	9.2	5.1	11.9	15.7	9.0	12.9	2.1	5.9	2.3	15.4	58.7	11.2	7.1	9.5	7.9	4.6	4.2	4.2	8.3	14.2	4.6	7.0	13.3	5.8	1.3	9.4	3.3	14.7	6.1	11.8	9.0	17.5	14.2	4.6	1.9	4.9	13.4	4.6	8.8	2.8	3.0	13.1	1.0	14.6	23.7	10.6	15.7	10.5	1.2	7.6	21.1	34.0	15.8	17.7	6.6	8.5	6.2	11.0	7.6	10.9	3.1	3.0	1.1	11.7	14.1	7.7
OCIAD2	MGC45416	ENSG00000145247	"OCIA domain containing 2"	Q56VL3	4	48885019-48906937	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 155.4"	"Cell type enhanced"	"Detected in many"		"Pancreatic endocrine cells: 1277.4;Proximal enterocytes: 702.0;Proximal tubular cells: 1384.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 325.2;U-251 MG: 399.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040979, HPA041090"	Enhanced		Enhanced	Mitochondria		No	No			"Cluster 20: T-cells - T-cell receptor"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Mitochondria		"HPA040979: AB_10795497, HPA041090: AB_10796236"	"unprognostic (4.29e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.76e-2)"	"prognostic favorable (7.37e-4)"	"unprognostic (3.49e-2)"	"unprognostic (1.66e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.00e-1)"	"prognostic favorable (6.56e-4)"	"prognostic unfavorable (6.89e-4)"	"unprognostic (1.38e-1)"	"prognostic favorable (2.67e-5)"	"unprognostic (1.10e-1)"	"unprognostic (8.54e-2)"	"unprognostic (8.24e-3)"	"prognostic favorable (2.34e-4)"	9.2	20.4	14.1	22.1	13.1	16.3	23.4	10.3	15.3	19.8	14.1	54.7	122.3	20.7	46.9	25.8	22.4	32.4	14.3	17.8	15.6	155.4	129.5	19.0	34.6	13.1	13.2	8.7	26.9	44.4	33.6	8.6	11.7	23.8	49.9	26.9	40.2	29.2	4.4	20.0	88.4	15.0	11.6	12.6	85.0	6.3	13.7	53.6	37.4	3.9	40.3	28.1	12.0	12.7	208.9	108.5	1.6	0.0	0.0	0.0	2.7	53.3	23.9	28.4	26.9	0.0	249.4	35.7	230.1	30.5	248.0	65.5	29.7	325.2	29.1	83.8	22.6	0.1	78.6	0.1	25.6	101.7	0.3	14.7	150.8	0.1	61.1	81.4	115.5	140.2	0.1	17.6	30.3	78.3	172.2	70.2	102.5	234.2	145.2	38.5	0.1	59.4	288.7	135.0	230.3	69.5	75.4	25.5	5.4	0.8	26.2	25.2	195.6	0.2	215.1	1.2	399.5	49.5	59.6	113.3	163.0	0.3	0.4	208.4	3.5	69.1	101.6	1.5	136.9	168.0	191.0	147.3	18.1	156.7	247.2	165.0	11.2	156.0	1.3	122.4	338.7	137.7	14.1	13.1	10.3	15.3	17.8	15.6	13.1	13.2	11.7	11.6	13.7	12.7	135.9	28.9	70.6	2.0	102.5	109.0	146.6	401.4	81.4	17.6	152.7	190.6	39.2	194.5	224.2	176.6	29.2	46.2	66.3	359.7	217.2	510.5	1.4	197.5	22.9	103.3	306.4	38.9	10.1	570.2	11.4	14.9	157.5	190.8	36.8	75.3	31.1	193.9	44.3	1.7	11.6	301.3	341.8	6.4	27.0	2.5	5.0	21.7	65.8	5.6	15.9	49.9	82.4	2.5	1.8	1277.4	311.6	21.4	53.5	180.1	702.0	1384.9	171.4	77.6	0.0	3.7	41.8	2.6	3.2	105.2	131.4	15.3	129.8	52.1	188.6	239.2
OR2A7	HSDJ0798C17	ENSG00000243896	"Olfactory receptor family 2 subfamily A member 7"	Q96R45	7	144257663-144264792	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in some"	6	"basophil: 12.3"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 12.3"	"Cell line enhanced"	"Detected in some"		"A-431: 12.7;hTCEpi: 6.2;RT4: 5.0;SK-BR-3: 5.3"									HPA058272	Uncertain					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA058272: AB_2683662"	"unprognostic (6.48e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.05e-1)"	"unprognostic (4.13e-2)"	"unprognostic (5.75e-2)"	"unprognostic (7.28e-2)"	"unprognostic (3.33e-1)"	"unprognostic (9.08e-2)"	"unprognostic (3.58e-3)"	"unprognostic (5.52e-2)"	"unprognostic (5.13e-2)"	"unprognostic (3.06e-1)"	"unprognostic (3.22e-1)"	1.9	0.7	0.6	1.1	0.7	3.1	5.9	0.4	0.4	4.5	2.2	5.8	10.5	1.7	3.8	5.2	3.4	3.0	1.4	0.1	0.5	6.1	3.2	3.1	1.4	0.8	1.1	3.3	6.1	3.1	2.0	1.7	0.8	4.7	5.4	1.8	5.4	1.4	0.2	11.5	7.5	1.1	0.6	1.8	6.4	0.9	0.8	0.9	10.0	0.3	1.4	2.3	4.4	0.6	12.7	0.0	0.0	0.0	0.0	0.0	2.6	0.2	0.1	0.0	0.0	0.6	3.4	0.0	0.0	0.0	0.0	2.2	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	6.2	0.4	3.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	2.7	0.0	0.0	0.0	0.0	3.2	5.0	0.0	0.0	3.1	5.3	0.8	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	12.3	0.1	0.0	0.7	0.0	0.2	0.6	1.0	0.5	0.0	2.0	0.6	0.5	0.0	1.5	0.0	0.0	0.7	0.0	0.6	0.7	0.4	0.4	0.1	0.5	0.8	1.1	0.8	0.6	0.8	0.6	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
P2RX4	P2X4	ENSG00000135124	"Purinergic receptor P2X 4"	Q99571	12	121209861-121234106	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 135.3;Distal enterocytes: 133.7;Hofbauer cells: 129.5;Syncytiotrophoblasts: 155.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039494	Enhanced					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA039494: AB_10969132"	"unprognostic (4.02e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.43e-2)"	"prognostic favorable (6.30e-10)"	"unprognostic (2.98e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.42e-2)"	"unprognostic (7.71e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.06e-2)"	"unprognostic (1.42e-2)"	"unprognostic (4.76e-3)"	10.1	9.9	4.8	15.1	5.0	14.1	12.7	8.3	5.6	18.8	4.6	33.5	28.9	8.5	3.7	5.0	15.3	16.8	7.2	5.1	5.3	13.0	11.5	20.4	15.9	6.7	5.4	18.1	37.4	33.1	5.1	32.7	6.0	12.1	30.2	2.0	30.1	12.0	1.0	4.5	32.8	10.7	6.3	12.6	20.2	6.0	6.3	7.8	12.9	2.3	8.9	12.1	4.1	7.6	6.6	15.4	1.1	21.7	10.3	8.3	40.6	4.9	26.1	6.7	13.3	10.9	23.1	6.4	18.5	17.4	48.2	2.3	4.7	3.2	4.1	17.5	11.8	3.1	0.9	12.5	25.3	7.6	42.5	11.9	6.8	11.0	14.5	20.4	24.2	7.7	6.1	16.2	5.0	31.8	4.7	10.7	5.5	31.8	10.5	6.6	29.5	34.6	3.1	18.0	6.1	9.0	16.0	8.8	55.0	5.7	38.5	21.2	2.1	10.0	11.2	1.2	5.2	28.0	26.1	3.7	19.6	10.2	9.1	72.3	59.1	10.7	13.6	63.1	15.1	11.3	21.9	13.3	32.5	7.1	16.4	9.6	0.8	29.6	54.6	4.4	17.1	32.6	4.8	5.0	8.3	5.6	5.1	5.3	6.7	5.4	6.0	6.3	6.3	7.6	8.4	6.4	19.2	6.5	14.0	3.8	8.9	11.9	6.8	11.1	17.7	11.9	3.8	21.5	11.2	20.2	2.1	135.3	13.7	133.7	0.0	69.7	15.2	9.8	8.9	9.2	21.5	2.1	6.4	35.4	73.8	14.3	19.4	15.1	13.9	14.3	23.6	9.4	129.5	15.2	5.3	90.3	20.3	43.7	20.8	25.1	8.7	53.7	10.6	18.7	57.9	6.5	19.6	4.5	8.0	33.1	80.6	9.8	21.9	10.2	98.7	23.2	6.4	8.6	19.7	7.4	12.0	8.1	6.6	3.4	4.0	155.7	17.8	15.4	24.7	9.7
PAQR5	"FLJ20190, MPRG"	ENSG00000137819	"Progestin and adipoQ receptor family member 5"	Q9NXK6	15	69298912-69407780	"Predicted membrane proteins"	"Differentiation, Oogenesis"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 52.9"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 32.9;Distal tubular cells: 46.9;Early spermatids: 38.2;granulocytes: 67.2;Late spermatids: 123.0;Proximal tubular cells: 42.3"	"Cancer enhanced"	"Detected in many"		"renal cancer: 8.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	6	"basophil: 1.1"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"A549: 38.1;CAPAN-2: 46.4;fHDF/TERT166: 33.1;HMC-1: 79.8;U-87 MG: 33.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076729			Approved	Vesicles		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles		"HPA076729: AB_2686813"	"unprognostic (4.47e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.05e-4)"	"unprognostic (1.53e-1)"	"unprognostic (8.28e-2)"	"unprognostic (3.58e-3)"	"unprognostic (6.12e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (2.15e-5)"	"unprognostic (2.00e-1)"	"prognostic favorable (1.47e-14)"	"unprognostic (5.64e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.16e-4)"	"unprognostic (4.94e-2)"	0.6	16.0	3.5	2.6	2.8	1.2	1.2	2.7	3.0	1.7	12.0	19.0	2.3	1.0	0.2	12.4	0.9	2.0	0.8	3.1	2.8	52.9	1.1	9.1	0.3	3.4	3.1	0.6	5.1	11.3	0.8	1.6	4.0	0.6	16.2	1.9	1.8	3.7	0.2	4.9	8.0	0.9	2.8	0.4	7.7	2.4	4.4	0.2	0.8	0.2	2.1	3.6	2.9	2.9	11.7	38.1	0.8	0.8	1.6	4.2	0.3	3.7	22.2	4.3	9.1	2.2	46.4	0.1	5.9	33.1	3.7	0.7	10.9	0.6	7.4	0.1	1.7	6.9	5.6	0.8	2.9	0.2	79.8	2.2	1.7	19.4	20.7	5.5	0.0	0.2	0.1	0.7	18.4	1.6	0.2	0.2	2.6	6.1	3.2	0.1	0.6	2.2	16.6	0.9	3.3	0.7	6.0	2.3	3.1	2.1	1.0	2.8	0.6	13.1	4.2	1.1	0.4	0.2	0.3	0.1	33.1	0.1	3.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	3.5	2.8	2.7	3.0	3.1	2.8	3.4	3.1	4.0	2.8	4.4	2.9	0.1	12.8	21.0	1.0	0.5	0.9	1.3	0.4	1.2	0.7	1.3	0.8	0.7	32.9	0.9	20.2	0.0	0.0	0.0	31.1	46.9	19.0	38.2	0.7	0.1	1.9	0.0	0.0	0.5	0.4	0.0	2.8	2.0	1.5	67.2	2.2	0.0	0.0	3.7	0.0	0.7	4.8	0.0	0.3	0.7	123.0	0.9	1.8	0.0	20.6	0.0	5.9	0.0	1.0	0.5	2.6	6.9	1.2	0.0	1.4	26.8	42.3	0.8	0.1	6.6	0.1	0.6	0.5	0.5	15.1	1.8	0.1	0.4	19.6	13.7	0.8
PARP3	"ADPRT3, ADPRTL3, ARTD3, hPARP-3, IRT1, pADPRT-3"	ENSG00000041880	"Poly(ADP-ribose) polymerase family member 3"	Q9Y6F1	3	51942345-51948867	"FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Glycosyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 33.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020984, HPA067657"	Supported		Supported	"Nucleoplasm,Nuclear bodies"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Nuclear bodies"		"HPA020984: , HPA067657: AB_2685881"	"prognostic favorable (6.39e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.85e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.13e-1)"	"unprognostic (3.53e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.01e-1)"	"unprognostic (7.44e-3)"	"unprognostic (4.30e-1)"	"prognostic favorable (1.25e-8)"	"unprognostic (5.63e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.65e-3)"	16.0	33.4	12.7	9.9	13.5	3.1	15.3	12.9	14.6	9.6	14.4	17.1	28.1	11.4	5.9	10.4	11.2	11.3	13.6	11.6	14.2	21.2	29.2	13.4	10.9	13.8	14.9	8.9	4.4	35.8	10.9	5.9	13.7	14.6	10.2	4.7	14.5	15.5	15.8	7.5	25.2	9.3	12.9	14.8	16.4	5.4	14.9	8.2	19.6	17.6	8.0	15.4	10.8	12.4	10.0	6.6	2.0	17.3	17.8	30.0	4.8	15.4	29.0	23.1	24.9	3.9	28.1	14.1	4.5	29.4	12.6	1.6	5.0	14.5	9.1	34.8	1.2	7.8	15.1	13.2	18.8	5.3	10.9	24.4	12.4	16.2	9.1	35.7	10.8	10.2	3.5	14.7	19.9	3.4	4.6	12.5	2.4	4.2	16.4	7.3	2.8	13.9	14.0	13.5	2.0	6.4	16.3	4.8	10.7	1.4	6.5	5.9	24.0	42.5	9.9	7.4	10.4	22.5	26.0	6.0	27.2	14.4	13.6	0.0	1.6	1.2	2.4	3.0	2.2	6.3	2.6	1.8	2.6	2.5	3.6	3.5	0.1	5.7	1.6	0.9	3.2	1.8	12.7	13.5	12.9	14.6	11.6	14.2	13.8	14.9	13.7	12.9	14.9	12.4	5.3	6.4	10.0	6.2	8.1	2.7	10.6	15.9	21.1	2.0	8.6	8.9	7.4	8.6	8.6	0.0	0.0	0.6	2.1	13.1	7.9	9.7	7.8	2.4	3.8	5.3	3.0	1.7	2.6	6.3	0.4	4.7	17.3	2.7	4.5	0.8	2.5	9.5	3.7	0.0	3.0	11.3	6.1	3.2	2.2	15.3	4.7	3.7	7.2	3.7	5.0	3.8	0.0	1.0	1.8	11.5	6.5	1.5	4.9	4.3	33.4	20.6	9.5	2.1	6.6	4.1	5.7	3.4	3.3	7.8	1.4	0.5	5.9	1.6	13.8	9.3
PBLD	"FLJ14767, MAWBP, MAWDBP"	ENSG00000108187	"Phenazine biosynthesis like protein domain containing"	P30039	10	68282660-68333049	"Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"intestine: 171.5;kidney: 270.0;liver: 335.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 97.5;Distal tubular cells: 109.5;Hepatocytes: 216.9;Proximal enterocytes: 380.2;Proximal tubular cells: 426.5"	"Cancer enhanced"	"Detected in all"		"liver cancer: 16.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA038035, HPA038036"	Enhanced		Approved	Vesicles		NA	NA		1100000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"HPA038035: AB_10672470, HPA038036: AB_10675625"	"unprognostic (1.00e-1)"	"unprognostic (8.30e-2)"	"unprognostic (6.14e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.78e-1)"	"prognostic favorable (1.44e-4)"	"unprognostic (8.25e-2)"	"unprognostic (3.62e-2)"	"unprognostic (3.36e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.26e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.07e-2)"	"unprognostic (8.28e-2)"	"unprognostic (6.68e-2)"	8.9	11.2	2.9	8.4	5.5	9.3	4.5	5.3	5.3	3.9	4.2	33.2	171.5	5.9	3.8	3.4	7.2	9.4	6.2	3.0	4.6	270.0	335.2	3.9	5.5	4.9	4.1	3.6	63.0	5.6	2.3	4.2	4.2	5.6	27.6	8.7	4.5	5.1	5.6	5.6	146.4	5.0	3.0	4.6	54.8	3.8	4.4	2.1	5.5	3.1	2.2	5.4	2.1	8.9	3.8	7.5	7.1	4.9	6.4	3.6	3.3	15.1	9.5	5.6	5.8	6.9	9.5	4.2	5.6	10.6	2.3	5.8	3.3	3.9	4.8	2.0	5.4	3.3	9.3	6.4	3.0	5.0	3.3	6.4	4.0	3.4	4.2	10.1	3.5	4.0	3.1	9.2	8.9	5.9	4.7	8.7	2.1	3.0	3.2	8.0	9.4	7.1	11.3	5.4	4.1	5.5	10.1	5.8	7.0	2.0	20.0	5.9	10.9	5.5	3.9	2.7	2.5	5.5	4.3	6.3	6.6	2.7	1.4	2.6	2.8	1.5	0.4	1.4	0.8	0.8	0.6	0.4	2.8	0.6	1.1	0.7	3.3	1.8	0.9	1.2	1.1	1.2	2.9	5.5	5.3	5.3	3.0	4.6	4.9	4.1	4.2	3.0	4.4	8.9	1.6	3.2	4.2	3.6	4.5	1.9	1.7	2.2	1.2	5.0	6.2	2.8	3.5	24.3	4.3	55.2	10.4	3.9	3.7	97.5	109.5	8.8	1.2	17.9	5.7	3.4	7.2	6.6	1.8	31.8	2.0	3.2	33.1	6.5	1.3	8.2	6.4	216.9	3.1	10.1	2.8	42.6	2.0	10.4	4.4	0.4	4.1	5.5	1.8	3.7	5.0	5.5	3.1	3.0	7.5	12.5	46.4	3.0	1.5	2.0	380.2	426.5	12.9	17.2	0.0	2.0	6.6	1.6	1.4	1.8	0.6	3.1	2.8	9.6	57.3	3.0
PDZD3	"FLJ22756, IKEPP, PDZK2"	ENSG00000172367	"PDZ domain containing 3"	Q86UT5	11	119185457-119190223	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 19.3;kidney: 17.4"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 93.4;Gastric mucus-secreting cells: 30.5;Paneth cells: 74.8;Proximal enterocytes: 79.1;Proximal tubular cells: 29.5;Undifferentiated cells: 21.0"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 2.3;renal cancer: 2.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"OE19: 1.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA077887	Enhanced					NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA077887: "	"unprognostic (2.42e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.65e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.39e-2)"	"unprognostic (6.07e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.86e-2)"	"unprognostic (6.58e-3)"	"unprognostic (9.00e-2)"	"unprognostic (6.08e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.41e-3)"	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	17.1	0.0	0.0	0.0	1.0	2.8	0.1	0.0	0.0	17.4	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	19.3	0.1	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	1.0	0.1	0.0	0.1	0.0	0.0	0.1	0.4	0.3	8.6	0.0	0.0	6.2	0.0	0.0	93.4	3.9	0.1	0.0	0.2	0.1	0.2	1.2	0.0	0.0	0.2	0.0	0.4	30.5	0.1	0.0	0.1	1.1	0.1	0.2	0.0	0.0	8.5	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	74.8	0.0	0.2	0.1	79.1	29.5	0.7	0.7	0.0	0.5	0.1	0.0	0.0	0.3	0.1	0.0	0.2	0.1	21.0	0.1
PEPD		ENSG00000124299	"Peptidase D"	P12955	19	33386950-33521791	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Collagen degradation"	"Dipeptidase, Hydrolase, Metalloprotease, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 209.5;kidney: 277.7"	"Group enriched"	"Detected in all"	4	"Proximal enterocytes: 833.0;Proximal tubular cells: 1278.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015599, HPA072045"	Enhanced		Approved	Nucleoplasm		NA	NA		860000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA015599: AB_1855192, HPA072045: AB_2732194"	"unprognostic (1.39e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.01e-2)"	"unprognostic (2.98e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.96e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.99e-1)"	"prognostic favorable (6.50e-9)"	"unprognostic (4.38e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.29e-1)"	53.2	56.0	28.5	26.9	35.5	14.3	43.6	35.6	30.5	36.9	33.5	44.2	180.5	49.7	9.9	42.8	34.2	31.2	24.3	28.7	30.9	277.7	117.8	38.1	30.7	36.2	30.8	35.9	27.1	29.3	42.5	21.9	36.3	23.6	14.8	11.8	33.6	22.9	35.6	43.1	209.5	24.5	34.6	38.2	33.6	18.3	33.4	20.8	37.0	23.2	21.3	40.1	28.2	43.4	43.2	118.7	26.4	53.1	114.9	44.9	80.6	37.4	65.3	45.6	52.7	104.7	34.2	18.8	53.5	73.2	33.9	11.2	39.5	28.5	23.4	51.3	50.4	107.7	24.6	108.3	91.6	29.6	128.8	63.6	29.0	38.2	18.3	27.8	56.4	34.4	22.7	49.4	44.2	54.3	19.0	11.7	46.2	79.6	48.8	45.3	41.0	51.2	39.4	108.8	40.3	106.4	64.2	31.3	62.5	18.2	25.1	36.3	56.6	48.3	46.6	62.3	41.8	45.2	59.1	13.1	49.5	48.2	65.8	113.7	117.2	8.3	75.5	123.6	65.5	49.6	74.0	69.8	100.6	50.5	47.1	55.6	6.1	55.6	92.5	31.0	76.1	119.6	28.5	35.5	35.6	30.5	28.7	30.9	36.2	30.8	36.3	34.6	33.4	43.4	56.9	22.4	27.4	11.4	29.0	19.4	32.9	36.0	11.4	33.3	16.2	24.4	13.3	52.9	23.8	73.5	4.2	21.4	32.6	17.6	197.6	77.2	8.0	15.0	20.1	50.7	17.3	25.4	19.9	44.2	67.3	38.6	18.3	13.0	57.6	41.9	52.8	180.3	227.2	62.2	14.9	35.6	30.5	59.7	40.9	13.2	49.4	75.3	67.6	15.9	102.2	73.6	34.0	21.6	24.3	33.8	79.3	60.5	31.5	22.9	833.0	1278.3	27.1	33.7	39.5	37.0	43.1	10.2	44.5	34.3	20.3	30.4	33.7	48.7	44.6	22.2
PLEK2		ENSG00000100558	"Pleckstrin 2"	Q9NYT0	14	67386984-67412167	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 51.1"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 149.0;Pancreatic endocrine cells: 179.8;Suprabasal keratinocytes: 90.6;Theca cells: 107.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"memory CD4 T-cell: 2.0;naive CD4 T-cell: 3.1"	"Lineage enriched"	"Detected in single"	7	"T-cells: 3.1"	"Cell line enhanced"	"Detected in many"		"A-431: 91.0;CAPAN-2: 94.4;HBEC3-KT: 177.4;PC-3: 64.1;TIME: 69.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA001208	Enhanced		Uncertain	Vesicles,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Vesicles	Cytosol	"HPA001208: AB_1079631"	"unprognostic (4.41e-3)"	"unprognostic (3.77e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.23e-2)"	"unprognostic (6.88e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.18e-2)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (1.97e-1)"	"unprognostic (9.21e-3)"	"prognostic unfavorable (8.26e-5)"	"unprognostic (1.06e-1)"	"unprognostic (3.09e-3)"	"unprognostic (2.90e-1)"	"unprognostic (1.29e-1)"	"unprognostic (8.98e-2)"	"unprognostic (4.59e-2)"	0.8	51.1	0.3	5.5	0.3	12.7	3.9	0.8	0.6	3.9	0.1	25.1	29.6	1.5	32.4	16.4	1.7	3.9	0.3	0.4	0.2	9.7	29.7	1.6	0.2	0.3	0.2	0.6	7.9	7.0	1.3	1.5	0.3	7.7	28.7	0.1	6.8	4.2	0.3	26.5	32.6	1.3	0.2	0.6	20.6	3.1	0.4	22.9	23.5	0.2	5.5	12.1	7.9	0.4	91.0	13.4	0.0	0.1	0.0	1.0	8.4	17.9	2.7	4.2	5.2	48.8	94.4	0.0	17.3	2.5	0.2	42.4	0.1	177.4	9.6	0.1	0.7	0.0	19.4	0.4	3.8	0.0	0.0	1.9	12.3	4.6	55.4	0.0	14.8	0.0	0.4	0.4	3.0	28.9	0.0	0.2	0.3	57.4	64.1	0.0	0.1	14.0	30.0	2.4	0.7	0.2	17.0	7.9	5.2	0.9	11.6	0.9	69.3	0.0	54.1	0.3	0.4	0.3	0.2	0.3	10.7	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.3	0.4	0.0	3.1	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.3	0.8	0.6	0.4	0.2	0.3	0.2	0.3	0.2	0.4	0.4	0.1	0.0	1.1	1.0	0.6	149.0	29.0	69.9	37.0	0.0	4.9	6.0	0.5	10.0	11.8	5.5	0.0	1.0	0.0	25.0	3.9	42.1	0.1	2.3	0.2	2.0	8.4	16.0	0.8	46.3	5.5	4.2	37.2	2.2	0.0	24.0	0.0	11.5	6.8	0.0	0.6	68.5	26.4	1.3	57.1	0.3	0.3	7.4	21.4	0.0	5.2	0.0	0.0	0.5	0.3	179.8	23.9	0.0	0.0	15.8	47.9	3.2	4.5	0.0	0.0	0.0	4.6	0.4	2.3	21.2	90.6	1.5	1.3	107.7	54.8	25.5
POLD3	"KIAA0039, P66, P68, PPP1R128"	ENSG00000077514	"DNA polymerase delta 3, accessory subunit"	Q15054	11	74493851-74669117	"Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA excision, DNA repair, DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA058846	Enhanced		Supported	Nucleoplasm		NA	Yes			"Cluster 14: Monocytes - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA058846: AB_2683833"	"unprognostic (3.68e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.05e-3)"	"unprognostic (3.28e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.49e-1)"	"prognostic unfavorable (9.17e-4)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (5.48e-4)"	"unprognostic (3.99e-3)"	"unprognostic (1.54e-3)"	"unprognostic (9.21e-3)"	"prognostic unfavorable (7.90e-6)"	"unprognostic (7.92e-3)"	"unprognostic (2.65e-1)"	"unprognostic (9.11e-2)"	"unprognostic (1.23e-1)"	7.9	6.2	6.1	14.6	6.0	10.1	11.1	6.0	7.3	10.6	7.6	17.2	15.7	16.5	12.0	12.9	16.3	14.9	8.9	5.9	6.1	44.5	7.1	11.5	14.5	4.9	5.6	16.0	11.4	7.8	4.6	11.5	5.6	8.3	17.9	14.9	6.8	10.1	7.7	11.6	14.4	15.3	5.1	11.4	15.4	19.6	5.5	15.7	15.0	12.5	15.2	12.7	7.5	7.4	32.2	28.6	43.6	29.8	13.2	22.5	30.9	42.7	23.9	43.7	37.0	37.8	40.8	45.7	30.9	20.5	25.3	41.2	36.3	28.0	54.6	34.5	23.3	29.1	44.3	12.8	9.5	56.4	25.3	10.0	17.3	51.1	27.3	13.8	17.1	39.8	26.7	35.5	25.6	25.3	63.4	25.3	26.4	95.3	29.1	60.0	109.4	37.9	20.2	30.6	29.0	19.5	50.7	25.3	49.7	26.2	29.5	35.7	16.4	42.9	30.8	48.8	34.2	24.8	56.6	102.4	24.5	35.1	33.2	7.3	22.6	15.9	9.2	18.5	9.1	10.1	11.7	8.2	17.7	8.0	11.6	9.6	19.4	10.8	19.0	5.2	13.7	13.0	6.1	6.0	6.0	7.3	5.9	6.1	4.9	5.6	5.6	5.1	5.5	7.4	14.8	12.8	20.0	13.1	9.7	5.9	7.0	11.4	12.5	12.3	10.5	12.8	7.8	7.2	17.7	9.2	8.4	19.7	11.1	17.9	5.9	17.2	28.3	24.8	17.1	14.2	5.4	24.2	20.1	32.1	26.7	13.1	16.8	14.4	19.0	20.9	8.2	4.9	15.6	23.5	15.3	12.7	12.2	12.9	7.2	23.1	12.5	16.9	3.6	15.0	25.3	15.3	9.2	6.6	18.7	17.4	13.4	8.6	11.4	11.4	10.7	39.1	45.2	19.1	6.6	13.7	12.4	60.3	37.7	11.2	5.4	13.0	11.8	10.0	19.9	10.5
PPCS	FLJ11838	ENSG00000127125	"Phosphopantothenoylcysteine synthetase"	Q9HAB8	1	42456117-42473385	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Ligase	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 397.2;Proximal tubular cells: 316.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031361, HPA031363"	Approved		Approved	Mitochondria		NA	NA		17000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA031361: AB_10602150, HPA031363: AB_2673844"	"unprognostic (1.49e-1)"	"unprognostic (6.71e-2)"	"unprognostic (8.15e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.84e-3)"	"unprognostic (1.68e-2)"	"prognostic unfavorable (5.96e-5)"	"unprognostic (2.71e-1)"	"unprognostic (7.79e-3)"	"unprognostic (9.13e-3)"	"unprognostic (3.24e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.41e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.80e-1)"	"unprognostic (4.30e-2)"	51.0	62.7	28.2	34.6	29.3	27.1	65.0	29.8	34.6	44.2	36.8	63.5	58.0	35.8	71.0	48.4	31.7	43.1	42.5	28.6	32.0	88.1	99.6	39.8	43.5	30.1	28.8	30.2	66.9	59.8	27.8	38.0	29.1	52.3	58.0	22.4	59.3	44.2	45.9	47.0	56.4	29.0	31.6	42.2	64.7	15.0	29.9	27.8	64.8	40.4	38.2	43.3	40.1	32.9	83.4	34.3	17.2	28.8	52.3	55.0	72.1	40.7	43.3	49.1	44.2	30.7	93.3	22.6	80.7	46.2	30.3	48.8	11.5	62.5	40.3	66.2	35.1	39.9	34.7	31.3	72.5	39.9	69.4	48.8	98.9	35.8	62.4	58.2	48.3	29.9	16.9	17.0	50.5	47.3	20.4	40.1	22.6	70.0	49.8	22.6	18.8	45.3	106.2	70.7	23.0	25.0	47.9	113.2	129.4	50.2	56.7	167.8	31.1	28.2	41.1	42.9	46.5	58.6	37.3	17.5	12.6	44.4	61.0	298.8	231.5	325.6	114.5	245.4	135.2	171.5	141.1	128.0	195.9	182.4	149.5	132.9	159.5	185.6	237.2	135.8	160.9	262.8	28.2	29.3	29.8	34.6	28.6	32.0	30.1	28.8	29.1	31.6	29.9	32.9	61.0	57.7	84.1	5.9	62.6	23.3	42.3	99.4	42.7	12.1	91.3	100.2	104.3	84.4	90.8	64.4	6.2	172.2	52.6	129.2	397.2	96.5	3.5	66.7	43.9	48.7	31.3	29.0	7.4	136.8	131.0	52.9	61.7	59.3	57.0	52.8	44.6	120.1	107.4	11.8	7.0	124.9	103.7	84.4	44.3	4.6	60.6	76.3	81.8	6.5	127.0	64.8	79.3	8.0	8.7	98.5	125.2	63.6	41.8	51.7	159.7	316.3	63.2	28.0	26.3	26.2	48.9	10.3	20.8	66.3	36.2	134.6	62.5	103.2	101.2	60.1
PRR13	"DKFZP564J157, FLJ23818"	ENSG00000205352	"Proline rich 13"	Q9NZ81	12	53441678-53446645	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 884.9;Distal tubular cells: 1365.6;Paneth cells: 858.1;Proximal enterocytes: 1642.7;Proximal tubular cells: 1097.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA039396, HPA046219"	Uncertain		Supported	Nucleoplasm		NA	Yes			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm		"HPA039396: AB_2676484, HPA046219: AB_10963936"	"unprognostic (1.09e-1)"	"prognostic favorable (9.08e-4)"	"unprognostic (1.15e-1)"	"unprognostic (3.26e-1)"	"unprognostic (8.97e-3)"	"unprognostic (4.88e-3)"	"unprognostic (1.86e-3)"	"unprognostic (7.23e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.41e-2)"	"unprognostic (5.41e-2)"	"unprognostic (6.81e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.34e-1)"	"prognostic favorable (7.55e-4)"	143.8	207.8	110.8	159.2	110.1	279.1	139.2	112.6	147.7	118.9	109.7	316.1	451.6	104.6	110.8	143.4	139.2	147.1	110.6	105.8	147.8	457.9	192.8	164.3	185.3	126.6	132.1	118.8	133.3	76.0	114.6	95.2	126.3	139.6	265.7	44.0	115.5	86.6	131.6	108.7	432.6	91.4	114.3	230.2	247.8	46.4	118.4	139.0	131.8	59.6	190.4	143.7	111.7	117.1	171.7	339.6	82.6	89.4	135.3	185.3	178.4	142.5	213.0	185.6	179.4	623.1	373.6	265.1	453.5	206.8	225.4	146.6	167.8	225.0	217.9	263.1	124.6	382.4	166.4	294.6	340.7	573.2	489.5	232.6	221.2	326.5	223.6	192.6	195.3	166.1	340.1	254.6	285.1	472.5	325.8	563.8	127.5	229.2	230.7	287.6	67.8	273.9	406.2	283.8	72.3	56.5	202.5	276.7	237.2	169.5	394.0	436.2	196.3	117.2	114.0	201.3	138.0	190.7	241.6	386.4	153.3	345.1	220.2	851.3	824.0	1620.1	511.1	941.9	503.0	888.2	563.7	545.8	649.3	855.6	520.6	557.7	2095.7	584.5	1014.6	539.0	824.8	1573.1	110.8	110.1	112.6	147.7	105.8	147.8	126.6	132.1	126.3	114.3	118.4	117.1	66.8	83.3	110.4	6.8	219.1	47.5	147.8	204.8	82.6	11.1	114.3	95.2	26.4	198.8	145.1	187.6	29.2	225.3	159.1	884.9	1365.6	228.0	12.6	182.7	67.1	80.3	169.8	99.2	6.3	253.9	337.7	76.6	263.0	127.4	186.7	53.4	78.1	152.8	355.2	18.5	7.1	346.9	193.3	345.0	174.4	8.7	58.1	266.8	108.5	9.4	384.7	85.3	297.6	4.5	12.9	332.3	858.1	45.9	120.9	174.7	1642.7	1097.6	215.9	20.9	78.9	33.6	67.1	29.7	22.8	107.1	56.0	291.0	212.7	88.4	340.0	193.1
PRRG2	PRGP2	ENSG00000126460	"Proline rich and Gla domain 2"	O14669	19	49580646-49591004	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 28.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 47.2;Proximal enterocytes: 46.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 14.9;OE19: 18.0;RT4: 11.7;SK-BR-3: 13.3;T-47d: 14.4;U-266/84: 18.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010702	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		No	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 16: U-266 - Nucleosome"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA010702: AB_1079693"	"unprognostic (2.25e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.55e-2)"	"unprognostic (5.60e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.67e-1)"	"prognostic favorable (3.82e-9)"	"unprognostic (4.89e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.58e-3)"	"unprognostic (3.68e-2)"	1.2	0.4	0.9	1.2	0.9	0.1	7.0	1.3	2.6	4.9	0.6	8.4	12.0	1.5	12.9	13.5	4.9	4.3	1.2	0.9	1.0	11.8	6.4	3.9	0.9	1.2	0.9	0.3	13.1	28.4	15.6	2.1	1.1	6.2	7.7	0.1	11.3	9.0	0.9	12.9	11.0	1.1	0.9	1.0	9.8	0.9	1.1	2.3	13.4	0.1	3.9	6.7	5.5	1.0	11.1	0.4	0.3	0.9	1.3	0.0	4.6	0.2	0.0	0.4	0.4	2.2	14.9	0.7	1.6	0.1	0.3	8.5	0.3	8.5	0.4	1.1	1.2	0.5	0.8	0.7	0.9	0.4	1.1	0.9	7.4	0.3	0.3	0.7	3.4	0.9	0.2	0.8	0.0	2.4	0.2	0.7	0.6	18.0	1.4	0.2	0.3	8.7	6.5	11.7	2.4	0.3	1.3	13.3	0.1	1.0	14.4	0.2	0.6	0.8	0.7	0.4	0.1	5.1	18.7	0.5	0.2	0.3	0.4	0.0	0.2	0.1	0.4	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.2	0.2	0.5	0.0	0.2	1.2	0.2	0.1	0.9	0.9	1.3	2.6	0.9	1.0	1.2	0.9	1.1	0.9	1.1	1.0	6.4	6.4	13.4	0.7	3.4	4.1	11.6	20.2	29.6	2.2	21.5	22.6	0.9	8.6	14.2	12.9	2.1	13.0	4.1	47.2	3.9	31.9	0.7	10.8	4.1	6.4	16.2	1.3	0.5	33.2	6.5	1.6	16.8	16.1	2.5	2.3	1.1	6.8	2.3	5.0	0.4	18.0	8.2	1.9	1.2	0.4	0.3	3.3	1.8	1.9	8.2	0.9	2.1	2.0	0.4	27.4	29.4	0.0	4.4	14.5	46.3	15.5	8.8	4.1	0.0	0.8	3.9	1.9	2.1	23.3	4.7	12.7	4.1	4.6	20.7	14.6
PTER		ENSG00000165983	"Phosphotriesterase related"	Q96BW5	10	16436943-16513745	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 31.5"	"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 190.5"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"amygdala: 6.9;basal ganglia: 16.5;cerebral cortex: 8.7;hippocampal formation: 14.1"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 43.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038044, HPA038045"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		8600	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA038044: AB_2675803, HPA038045: AB_10672616"	"unprognostic (5.57e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.14e-2)"	"unprognostic (9.72e-3)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (1.17e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.05e-3)"	"unprognostic (1.86e-1)"	"prognostic favorable (6.52e-6)"	"unprognostic (2.24e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.36e-3)"	6.8	5.5	6.9	5.6	16.5	2.3	10.3	1.0	8.7	5.9	0.0	8.3	12.7	4.9	4.4	4.5	5.1	5.3	7.1	14.1	1.3	31.5	14.0	6.0	7.9	0.0	0.0	2.0	7.5	9.2	1.3	5.6	0.0	7.1	8.0	11.8	8.3	4.6	9.2	5.4	10.0	3.3	0.0	6.9	14.1	1.1	0.8	7.3	10.6	10.0	7.9	9.0	3.7	0.0	26.9	11.7	0.1	4.8	7.0	13.0	14.7	6.9	0.7	2.6	3.5	10.7	20.9	25.0	5.9	4.5	1.2	11.4	8.3	4.3	4.3	30.2	9.9	24.9	6.1	5.6	7.2	8.2	8.0	8.2	17.0	8.0	1.3	0.1	1.5	22.9	17.5	8.4	4.1	7.8	17.8	9.5	5.7	15.9	2.5	13.7	2.4	13.1	43.2	6.4	22.7	1.4	12.5	3.7	23.3	5.2	8.6	30.4	3.4	0.2	6.3	5.5	0.1	6.3	7.6	25.2	3.3	14.7	8.7	3.4	7.2	4.7	7.5	11.6	8.1	9.2	8.8	8.1	7.6	5.8	6.8	7.1	2.2	5.6	10.3	6.7	14.2	5.9	6.9	16.5	1.0	8.7	14.1	1.3	0.0	0.0	0.0	0.0	0.8	0.0	12.1	28.9	26.3	2.9	13.5	11.0	14.7	7.7	9.6	0.9	13.6	9.4	29.5	15.7	20.6	29.5	0.0	19.6	10.2	19.5	52.8	22.5	0.3	10.7	5.5	8.3	11.5	9.4	0.5	34.4	18.7	10.2	41.8	17.8	24.1	5.1	11.4	24.3	15.6	0.0	0.2	13.1	18.3	17.1	6.5	0.3	0.9	12.3	8.8	10.3	14.6	13.9	33.0	0.0	0.2	26.8	26.7	0.0	8.1	11.4	19.8	190.5	14.4	9.9	6.6	7.7	16.0	1.1	6.5	7.6	12.4	12.0	13.2	3.0	19.2	22.2
PTPN9	MEG2	ENSG00000169410	"Protein tyrosine phosphatase non-receptor type 9"	P43378	15	75463251-75579315	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 63.0;Excitatory neurons: 66.1;Inhibitory neurons: 63.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041922	Approved		Approved	Vesicles		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"HPA041922: AB_10795269"	"unprognostic (9.58e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.54e-2)"	"unprognostic (6.80e-2)"	"unprognostic (7.38e-2)"	"unprognostic (5.95e-2)"	"unprognostic (3.93e-1)"	"unprognostic (3.14e-1)"	"unprognostic (9.25e-3)"	"unprognostic (6.35e-2)"	"prognostic favorable (2.49e-6)"	"unprognostic (2.26e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.39e-1)"	15.9	12.0	14.8	13.0	16.3	10.8	15.1	11.9	18.8	16.6	11.7	18.0	17.9	16.5	13.3	9.9	16.2	12.1	11.0	16.9	18.4	18.2	14.7	15.8	14.5	18.6	14.4	14.0	10.2	17.9	9.7	19.9	15.1	16.6	19.7	8.9	13.0	21.2	6.4	11.0	20.0	18.0	13.6	13.4	13.5	7.2	17.0	16.1	32.8	13.1	15.0	18.1	13.8	14.5	20.3	24.1	36.7	24.6	26.8	29.3	12.0	29.8	46.2	36.9	33.4	14.5	30.0	32.6	23.3	51.1	29.5	30.0	79.9	34.3	37.0	40.5	19.8	18.4	16.2	15.7	40.2	28.2	27.1	38.4	35.2	29.6	45.9	37.7	31.4	21.3	12.4	11.5	42.1	13.5	20.0	26.3	33.6	18.2	12.1	38.9	18.2	9.1	46.6	32.5	14.4	29.9	42.4	23.3	46.3	34.9	12.1	47.8	36.5	35.2	11.3	23.3	32.2	16.9	18.9	30.0	20.5	41.9	35.3	3.2	2.2	2.3	3.4	3.0	2.8	1.7	2.4	3.0	3.0	1.3	1.0	1.8	0.3	3.9	2.9	2.0	1.6	1.7	14.8	16.3	11.9	18.8	16.9	18.4	18.6	14.4	15.1	13.6	17.0	14.5	12.7	6.4	13.4	63.0	9.2	3.3	8.2	6.6	5.7	12.1	8.0	7.1	3.7	10.0	8.1	11.0	8.4	20.0	7.3	25.0	15.6	10.8	3.0	7.9	19.4	10.0	7.2	13.7	66.1	9.9	4.2	20.6	10.7	11.4	15.2	23.6	17.5	12.6	18.8	3.3	63.2	11.5	6.1	18.9	18.1	4.7	12.5	16.5	7.2	46.9	24.2	5.6	19.6	48.7	19.6	18.2	12.6	27.4	9.7	12.1	24.9	14.0	8.1	17.1	13.1	11.7	20.8	10.6	9.4	6.6	3.3	10.1	13.4	11.6	13.2	13.1
PTPRO	"GLEPP1, NPHS6, PTP-oc, PTP-U2, PTPU2"	ENSG00000151490	"Protein tyrosine phosphatase receptor type O"	Q16827	12	15322257-15602175	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 26.8;kidney: 36.3"	"Group enriched"	"Detected in many"	7	"Excitatory neurons: 193.6;Inhibitory neurons: 231.1;Oligodendrocyte precursor cells: 126.7"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 8.7"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"GAMG: 9.9;NTERA-2: 5.8;SH-SY5Y: 6.1;THP-1: 2.7"	"Region enhanced"	"Detected in all"		"olfactory bulb: 175.9"	"Low region specificity"	"Detected in all"			HPA034525	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA034525: AB_10669785"	"unprognostic (3.68e-2)"	"unprognostic (3.49e-1)"	"unprognostic (9.64e-2)"	"unprognostic (1.25e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.08e-1)"	"unprognostic (5.93e-3)"	"unprognostic (5.37e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.72e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.43e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.44e-1)"	1.8	0.8	8.7	3.0	9.4	0.2	0.8	0.0	10.3	1.3	0.1	10.4	1.7	4.8	1.4	0.4	1.0	1.2	0.5	9.8	8.9	36.3	1.3	6.8	3.1	2.2	3.3	0.4	0.4	0.3	2.4	4.4	5.3	0.5	26.8	7.5	0.5	0.8	0.3	0.4	2.0	6.6	0.9	3.4	0.8	0.5	9.5	1.2	0.3	0.5	3.2	1.5	0.4	2.9	0.0	0.1	0.3	0.1	0.2	0.0	0.2	0.0	0.0	0.5	1.3	0.0	0.0	0.1	0.1	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	5.8	1.2	0.0	0.0	0.0	0.0	0.1	0.2	1.5	6.1	0.9	0.0	0.1	0.1	0.1	2.7	0.0	0.0	0.3	0.0	0.2	0.4	0.0	0.3	0.0	0.1	1.2	0.0	6.0	0.0	0.0	12.3	0.0	8.9	1.7	0.4	8.5	8.6	2.8	1.2	0.1	0.1	12.7	10.9	1.4	3.2	8.7	9.4	0.0	10.3	9.8	8.9	2.2	3.3	5.3	0.9	9.5	2.9	0.2	0.0	0.5	7.5	7.0	0.3	1.3	0.5	0.0	25.2	0.0	0.1	0.7	0.0	1.8	16.5	0.0	0.2	4.0	3.9	0.0	0.4	0.0	0.8	0.2	1.1	3.6	0.0	193.6	0.0	0.2	0.9	0.0	0.6	0.0	0.0	1.1	0.2	26.1	25.2	231.1	8.3	0.0	21.1	10.6	0.6	0.6	10.5	0.0	17.8	13.8	0.6	1.0	126.7	6.3	0.1	9.8	0.4	1.0	0.1	0.1	0.2	0.0	4.8	0.0	2.1	0.7	0.6	1.1	0.1	0.4	0.3	1.0	0.1	22.4	0.8
PXMP4	PMP24	ENSG00000101417	"Peroxisomal membrane protein 4"	Q9Y6I8	20	33702758-33720319	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Alveolar cells type 2: 73.6;Late spermatids: 44.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 42.3;SK-BR-3: 75.8;T-47d: 64.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050077	Approved		Approved	"Nucleoli fibrillar center,Peroxisomes"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 11: Alveolar cells - Smell perception"	Peroxisomes	"Nucleoli fibrillar center"	"HPA050077: AB_2681006"	"unprognostic (3.41e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (3.88e-4)"	"unprognostic (3.53e-1)"	"unprognostic (4.47e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.86e-1)"	"prognostic favorable (4.03e-10)"	"unprognostic (3.84e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.08e-2)"	"unprognostic (2.20e-1)"	4.1	11.2	5.1	3.0	5.2	3.2	11.9	3.8	5.6	5.6	4.3	6.2	8.2	4.1	5.1	6.3	6.0	3.3	6.4	5.0	4.0	4.9	8.9	13.9	3.6	4.6	4.5	6.8	6.8	14.7	3.5	3.2	4.1	8.7	5.7	4.4	15.2	6.4	8.0	11.1	7.4	5.1	4.2	4.6	6.8	2.5	5.3	3.5	11.5	6.9	3.9	5.4	5.8	6.5	2.8	12.1	3.3	11.9	5.7	8.3	8.5	8.7	4.7	6.6	2.9	42.3	13.2	0.1	16.2	7.3	16.1	12.5	9.0	10.1	4.7	3.7	3.4	14.0	9.7	0.1	5.3	0.7	10.3	6.4	10.8	9.0	3.0	3.3	4.3	4.4	7.9	8.6	4.7	26.4	12.9	9.8	0.3	21.7	0.0	6.8	16.3	1.7	4.2	9.0	10.7	5.4	24.2	75.8	7.9	1.9	64.0	4.7	8.2	4.7	5.4	11.9	8.2	5.5	13.2	0.2	9.0	4.6	8.1	2.2	11.1	17.5	10.8	22.2	11.3	7.6	10.9	10.9	8.8	9.9	8.3	11.2	2.9	9.1	34.2	5.3	8.5	8.6	5.1	5.2	3.8	5.6	5.0	4.0	4.6	4.5	4.1	4.2	5.3	6.5	5.2	19.2	73.6	7.2	5.5	1.7	4.3	9.4	4.0	11.1	16.8	12.3	12.6	7.2	17.8	18.4	14.6	12.9	3.5	14.2	9.8	8.2	28.7	6.3	6.1	7.6	4.2	9.9	6.4	9.9	24.3	8.5	6.6	5.7	3.8	6.7	8.9	36.0	15.1	5.0	5.7	10.8	6.1	7.5	1.6	44.0	10.5	6.2	3.6	6.5	7.5	13.6	9.2	9.0	10.8	8.5	10.3	11.3	7.0	4.5	23.0	11.2	7.8	11.4	6.6	8.8	7.8	4.6	9.8	9.5	2.4	4.4	5.8	16.9	13.0	4.0
PYROXD1	"DKFZp762G094, FLJ22028"	ENSG00000121350	"Pyridine nucleotide-disulphide oxidoreductase domain 1"	Q8WU10	12	21437615-21471250	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, Limb-girdle muscular dystrophy, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 179.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038319, HPA038320"	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 18: U-2197 - ECM organization"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nuclear speckles"		"HPA038319: AB_10669522, HPA038320: AB_2675956"	"unprognostic (1.48e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.15e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.64e-3)"	"unprognostic (1.50e-1)"	"unprognostic (9.31e-2)"	"unprognostic (8.94e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.00e-1)"	"prognostic favorable (1.70e-4)"	7.9	10.0	3.8	9.2	4.3	9.3	10.4	5.1	5.4	7.1	5.3	11.9	13.9	7.1	8.6	8.3	7.1	8.7	10.7	3.7	5.2	16.8	12.3	8.6	10.6	5.4	5.2	6.6	13.4	10.4	5.2	5.9	5.3	9.9	11.2	14.0	11.9	5.9	12.4	10.0	16.0	6.4	4.7	7.9	12.8	5.8	4.2	7.5	15.6	9.6	8.5	7.6	6.1	5.4	9.3	3.5	5.2	5.8	3.7	6.8	11.8	14.5	6.7	5.2	4.0	4.5	8.6	10.2	6.0	11.0	4.4	11.3	5.8	11.4	5.8	12.1	5.1	11.8	9.2	5.7	17.2	17.7	12.0	11.3	13.5	3.3	14.3	6.7	7.8	11.0	5.8	4.2	10.7	5.9	8.3	24.3	8.6	8.2	6.5	1.4	11.2	11.2	16.3	9.2	1.7	13.1	6.7	12.2	27.0	7.1	14.5	20.8	11.2	6.2	5.9	13.5	13.4	6.4	4.8	12.7	25.4	13.1	7.5	1.2	0.8	0.6	1.7	1.5	1.9	1.2	2.0	2.1	0.8	0.9	1.6	1.7	0.3	1.6	2.7	1.1	1.6	0.9	3.8	4.3	5.1	5.4	3.7	5.2	5.4	5.2	5.3	4.7	4.2	5.4	12.5	12.8	28.4	12.7	18.3	6.6	10.2	10.7	8.0	21.8	15.1	10.8	11.7	27.1	13.6	27.6	25.0	15.4	22.9	40.0	23.5	24.7	179.8	26.0	13.0	9.4	20.4	13.3	14.0	33.4	14.2	10.4	19.9	21.1	25.3	8.6	8.9	21.2	16.2	8.4	17.0	21.3	12.2	21.8	5.8	32.6	10.5	18.1	5.4	17.8	15.6	14.5	17.5	13.0	34.2	41.2	25.1	6.4	19.5	12.0	39.4	43.8	28.6	28.2	13.1	15.0	13.8	49.7	18.8	14.5	7.7	19.4	20.1	10.6	20.6	14.1
RAB17		ENSG00000124839	"RAB17, member RAS oncogene family"	Q9H0T7	2	237574322-237601614	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 76.7;liver: 107.6"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 106.3;Distal tubular cells: 137.0;Hepatocytes: 121.7;Proximal enterocytes: 222.5;Proximal tubular cells: 170.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 42.4;Hep G2: 39.9;MCF7: 52.0;SK-BR-3: 48.1;SK-MEL-30: 86.7;T-47d: 34.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA035176	Approved					NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA035176: AB_10696368"	"unprognostic (8.66e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.44e-3)"	"unprognostic (9.14e-2)"	"unprognostic (2.48e-3)"	"unprognostic (1.26e-3)"	"unprognostic (1.33e-1)"	"unprognostic (5.36e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.68e-2)"	"prognostic favorable (4.14e-4)"	"unprognostic (5.87e-2)"	"prognostic favorable (3.33e-13)"	"unprognostic (1.17e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.44e-1)"	"prognostic favorable (2.51e-4)"	0.8	1.0	0.9	1.6	0.6	0.4	15.0	0.6	1.3	6.7	25.8	16.4	76.7	2.3	19.4	2.1	11.1	14.7	1.5	2.2	0.7	49.8	107.6	23.1	0.4	0.8	0.7	0.6	38.7	36.9	3.0	13.8	0.7	7.0	15.6	4.2	34.8	15.3	1.4	0.9	73.7	1.0	0.6	0.5	33.5	0.7	0.9	1.0	33.4	0.0	0.8	3.8	0.3	0.7	9.5	0.3	0.0	17.7	0.1	0.2	42.4	0.2	0.1	0.0	0.1	28.7	26.6	0.0	5.6	0.2	0.1	0.4	0.0	12.5	0.2	0.0	0.0	0.0	0.1	39.9	0.0	0.2	0.0	0.0	7.8	0.0	0.9	0.7	0.0	0.1	0.0	0.0	1.0	52.0	0.0	0.6	0.5	28.6	0.1	1.1	0.0	3.4	13.7	25.1	10.5	0.1	0.0	48.1	86.7	9.4	34.8	0.7	0.0	0.2	0.6	0.1	0.1	0.1	1.2	0.0	0.1	2.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.6	0.6	1.3	2.2	0.7	0.8	0.7	0.7	0.6	0.9	0.7	1.2	60.9	34.3	0.3	0.5	1.8	3.4	3.3	22.8	1.7	32.2	18.3	1.0	65.8	11.9	46.0	106.3	16.0	0.1	49.6	137.0	40.0	0.0	18.2	1.6	1.8	30.3	0.0	0.8	28.0	3.8	0.7	29.0	22.1	0.0	0.4	2.5	121.7	1.9	0.0	1.5	23.9	24.4	2.2	0.6	0.7	8.7	1.3	5.4	0.0	0.6	0.2	0.0	1.0	0.1	27.9	50.1	3.8	0.1	5.3	222.5	170.2	13.7	0.6	0.0	0.3	0.7	0.0	0.2	6.6	0.6	12.3	1.3	0.7	21.9	6.5
RBM47	"FLJ20273, NET18"	ENSG00000163694	"RNA binding motif protein 47"	A0AV96	4	40423267-40630875	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 442.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 136.2"	"Group enriched"	"Detected in many"	12	"dendritic cells: 34.4;granulocytes: 136.2;monocytes: 45.5"	"Cell line enhanced"	"Detected in many"		"BEWO: 134.0;CAPAN-2: 63.5;OE19: 56.7;SK-BR-3: 58.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA006347	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"		"HPA006347: AB_2181208"	"unprognostic (2.28e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.49e-3)"	"unprognostic (2.38e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.52e-2)"	"unprognostic (7.35e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.42e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (3.33e-16)"	"unprognostic (1.62e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.77e-2)"	9.3	49.7	2.2	20.3	1.9	9.6	24.7	1.8	3.0	15.3	44.9	61.0	68.4	3.5	23.1	42.2	17.7	17.9	1.3	2.8	2.3	67.6	34.5	21.0	8.2	6.0	3.2	2.2	25.9	27.8	3.2	20.1	4.9	33.2	50.5	0.4	59.4	13.4	0.5	9.0	64.1	4.7	4.1	14.7	64.6	6.7	5.7	4.4	49.5	1.1	11.4	22.6	15.5	6.8	31.9	47.8	0.0	1.8	0.2	0.0	134.0	0.8	1.6	0.1	0.6	28.3	63.5	0.2	23.0	1.2	3.8	14.2	0.9	11.8	0.3	0.2	7.6	0.0	3.1	7.9	0.6	0.3	0.3	0.8	6.0	0.1	0.1	1.8	0.0	0.0	1.8	7.0	0.1	18.1	0.2	1.1	13.5	56.7	2.4	0.2	0.0	34.7	46.8	41.6	1.6	0.3	17.3	58.4	0.3	14.8	23.9	9.0	0.0	0.5	1.9	0.3	1.0	23.5	37.7	4.1	5.0	3.9	0.2	0.5	45.5	0.5	0.2	33.1	0.3	5.9	0.2	0.1	34.4	5.4	0.4	0.1	136.2	0.5	26.2	14.1	0.2	16.9	2.2	1.9	1.8	3.0	2.8	2.3	6.0	3.2	4.9	4.1	5.7	6.8	1.1	80.1	116.6	0.7	21.2	58.9	75.2	42.9	95.0	0.1	145.7	63.5	1.9	75.8	92.2	112.2	0.0	99.6	16.3	442.8	64.6	90.6	1.3	132.6	9.5	6.0	121.9	2.5	2.5	115.4	84.3	7.7	174.8	143.7	7.0	8.7	23.6	140.4	92.6	1.7	1.9	234.2	59.0	138.8	92.8	2.6	2.5	119.9	37.4	82.4	80.6	0.3	1.0	2.5	0.8	108.0	228.1	1.2	40.1	164.7	218.1	143.6	118.3	0.1	0.0	1.4	5.1	2.6	10.4	178.1	75.4	262.6	4.8	16.9	203.8	295.4
RHPN2		ENSG00000131941	"Rhophilin Rho GTPase binding protein 2"	Q8IUC4	19	32978592-33064888	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 61.0;Endometrial ciliated cells: 90.2;Gastric mucus-secreting cells: 94.8;Glandular and luminal cells: 108.8;Muller glia cells: 76.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 52.4;OE19: 50.7;RPTEC TERT1: 52.9;SK-BR-3: 54.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051749	Uncertain					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"			"HPA051749: AB_2681589"	"unprognostic (1.18e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.17e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (3.52e-2)"	"unprognostic (2.08e-3)"	"unprognostic (2.32e-1)"	"unprognostic (5.07e-3)"	"unprognostic (3.01e-3)"	"unprognostic (1.26e-1)"	"prognostic favorable (1.22e-8)"	"unprognostic (3.74e-2)"	"unprognostic (4.44e-2)"	"unprognostic (5.81e-2)"	"unprognostic (4.40e-2)"	3.0	0.8	5.5	4.4	5.9	0.0	12.7	5.8	6.6	8.4	7.8	23.6	21.7	5.4	2.4	1.2	15.0	13.6	1.5	5.2	5.8	14.5	19.6	4.1	1.3	6.3	6.9	1.7	12.4	16.9	4.8	8.2	6.1	27.1	19.0	20.2	19.4	2.2	0.3	10.5	17.8	1.8	5.1	0.9	35.2	0.7	7.2	1.9	5.4	0.9	2.6	11.5	1.1	6.4	28.6	52.4	4.9	8.6	1.0	0.1	24.5	6.6	5.0	10.0	10.5	45.9	28.6	0.0	41.1	3.7	8.8	13.5	15.9	5.8	12.4	13.2	9.7	3.2	5.9	17.9	6.6	0.0	4.1	1.2	11.5	8.4	4.7	7.6	1.3	1.2	7.2	0.0	3.0	24.4	0.1	2.9	10.5	50.7	8.4	0.0	6.0	5.6	52.9	14.0	11.0	5.8	11.2	54.5	13.4	13.9	15.2	1.4	0.7	0.1	12.7	3.6	11.2	6.3	4.6	2.1	1.6	0.0	16.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	5.9	5.8	6.6	5.2	5.8	6.3	6.9	6.1	5.1	7.2	6.4	0.3	22.4	1.1	20.2	3.9	1.3	6.3	6.2	7.4	1.9	30.4	15.4	0.9	17.2	14.7	12.9	12.5	18.2	2.1	61.0	3.9	31.0	0.4	90.2	11.1	1.1	4.8	0.0	1.3	13.1	6.8	6.4	94.8	108.8	1.3	0.2	3.3	13.0	1.9	0.0	1.4	22.2	18.3	3.0	0.0	0.3	2.1	1.6	1.8	4.7	0.0	76.8	0.0	9.5	1.6	33.8	52.6	1.2	6.1	23.5	11.7	19.8	51.9	10.1	0.0	0.6	3.7	0.0	1.4	3.8	1.8	3.4	1.1	0.0	23.3	36.1
RNF121	FLJ11099	ENSG00000137522	"Ring finger protein 121"	Q9H920	11	71929018-71997597	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046041	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"	"Nucleoplasm, Vesicles"	"HPA046041: AB_10965850"	"unprognostic (1.36e-2)"	"unprognostic (8.84e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.54e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.90e-1)"	"prognostic favorable (2.72e-6)"	"unprognostic (1.54e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.57e-2)"	"unprognostic (1.70e-1)"	7.2	9.5	8.8	6.6	8.7	5.8	11.3	8.5	9.2	9.8	9.7	8.1	15.9	8.4	20.0	7.4	11.6	7.8	10.0	8.8	9.0	16.4	11.5	7.6	8.1	8.8	9.1	11.2	10.9	24.3	9.5	11.1	8.8	10.6	10.3	15.7	15.1	13.6	17.2	8.3	13.9	11.8	9.0	6.7	9.2	8.7	9.1	7.7	12.9	14.9	10.4	9.1	7.1	8.7	10.9	22.7	20.5	14.6	19.1	15.2	13.8	16.7	17.7	25.4	26.9	46.0	20.9	9.2	14.9	18.5	26.7	22.1	22.7	21.2	26.7	13.8	13.1	14.0	21.5	21.9	14.3	12.8	11.5	14.8	17.9	28.7	18.2	27.9	46.7	13.5	23.2	8.6	22.7	23.5	9.0	14.1	13.7	43.4	21.9	11.0	44.5	7.9	28.3	18.4	13.7	14.6	22.9	20.4	30.4	20.6	22.5	9.5	32.8	19.0	17.2	11.8	14.6	9.6	10.2	9.4	16.5	8.3	17.1	4.4	2.2	2.2	3.0	2.9	3.5	3.2	2.3	2.4	2.3	1.3	2.7	2.9	1.2	3.2	2.1	3.7	2.1	2.9	8.8	8.7	8.5	9.2	8.8	9.0	8.8	9.1	8.8	9.0	9.1	8.7	9.6	6.4	9.6	12.7	9.4	8.8	11.2	22.8	10.2	16.1	12.1	10.9	9.7	12.8	13.3	20.2	20.9	32.0	17.9	15.2	7.9	26.0	6.3	8.9	10.3	6.5	9.6	13.0	19.3	32.3	26.5	11.8	9.2	10.9	7.0	11.6	8.9	14.4	14.2	10.1	16.9	13.2	26.4	6.6	12.9	3.0	13.1	7.6	10.6	15.0	15.0	19.0	10.3	18.1	19.0	29.0	11.0	12.4	17.1	10.3	31.0	20.9	10.3	21.1	19.7	10.0	14.2	25.1	19.6	6.4	5.8	31.1	10.0	13.4	9.4	9.9
RNF43	"DKFZp781H0392, FLJ20315, URCC"	ENSG00000108375	"Ring finger protein 43"	Q68DV7	17	58353676-58417595	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	"Developmental protein, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 22.7"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 67.7;Intestinal goblet cells: 41.6;Undifferentiated cells: 63.6"	"Cancer enriched"	"Detected in many"	4	"colorectal cancer: 41.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 17.0;CACO-2: 24.7;Hep G2: 49.4;OE19: 54.7"									HPA008079	Uncertain					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA008079: AB_1856371"	"unprognostic (2.53e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.46e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.62e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.69e-2)"	"unprognostic (3.79e-1)"	"prognostic favorable (6.04e-9)"	"unprognostic (3.61e-3)"	"unprognostic (2.56e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.04e-2)"	0.2	10.9	1.7	2.0	3.1	0.7	5.5	9.6	2.7	2.6	1.5	13.4	22.7	1.7	4.4	10.4	4.8	2.7	2.7	2.0	1.3	6.1	9.1	3.6	0.4	1.8	3.4	0.9	8.2	5.2	4.3	4.8	1.9	9.4	19.3	1.2	9.3	4.8	0.3	11.3	16.9	0.6	1.4	0.5	5.8	3.4	2.3	3.7	1.9	0.0	1.5	2.1	5.2	1.4	1.1	17.0	2.7	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	24.7	8.2	0.0	8.5	0.0	1.9	4.6	0.6	6.8	0.0	8.6	11.3	1.9	0.8	49.4	0.0	0.2	0.1	0.0	13.4	0.0	2.1	0.0	0.0	0.2	0.2	0.4	0.0	0.2	0.1	0.2	0.4	54.7	1.0	0.3	0.0	2.2	5.9	9.0	1.6	0.1	1.6	0.7	0.5	5.4	2.0	0.1	0.0	0.0	1.8	0.0	0.0	0.6	1.4	0.1	0.3	0.0	3.8	0.1	0.0	0.0	0.2	0.0	0.3	0.2	0.1	0.3	0.0	0.1	0.2	0.1	0.1	0.3	0.0	0.0	0.2	0.0	1.7	3.1	9.6	2.7	2.0	1.3	1.8	3.4	1.9	1.4	2.3	1.4	0.3	3.2	8.9	29.0	2.5	9.6	17.5	14.1	67.7	2.5	17.3	13.6	4.0	17.2	5.8	18.4	2.1	26.0	2.2	33.0	15.6	5.3	1.2	14.6	1.1	1.8	15.5	0.8	1.8	2.7	3.1	0.7	9.7	12.7	0.0	7.2	0.7	11.9	2.6	5.0	1.3	41.6	12.2	0.8	0.9	1.5	0.3	1.3	14.2	4.7	2.8	12.0	10.3	0.0	0.7	6.2	21.1	0.4	1.0	9.9	28.7	2.9	5.6	2.8	0.0	0.5	1.1	1.0	0.8	28.4	6.1	5.9	3.1	0.4	63.6	6.3
SCIN	KIAA1905	ENSG00000006747	Scinderin	Q9Y6U3	7	12570577-12660182	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 46.4;kidney: 47.1;placenta: 77.6"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 334.8;Distal enterocytes: 100.7;Early spermatids: 124.6;Hofbauer cells: 99.9;Paneth cells: 138.6;Proximal enterocytes: 318.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 13.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"RPTEC TERT1: 94.3;SK-BR-3: 102.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA020518, HPA024264"	Enhanced		Approved	"Plasma membrane,Cytosol"		No	No		2300000	"Cluster 17: Basophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"	Cytosol	"HPA020518: AB_1856619, HPA024264: AB_1856621"	"unprognostic (3.68e-1)"	"unprognostic (4.98e-2)"	"unprognostic (5.05e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.98e-2)"	"unprognostic (3.64e-5)"	"unprognostic (1.31e-2)"	"unprognostic (3.09e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (4.26e-8)"	"unprognostic (3.87e-1)"	"unprognostic (4.99e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.18e-1)"	2.9	1.0	3.6	1.3	4.5	1.3	0.9	4.6	5.3	1.3	2.9	18.3	26.7	1.3	0.5	17.9	4.1	2.8	0.3	3.8	4.8	47.1	0.3	4.1	0.6	9.4	6.8	0.7	0.9	1.1	2.6	77.6	9.7	3.2	16.0	2.4	10.7	1.1	0.5	3.6	46.4	1.1	7.1	0.5	19.6	7.1	5.7	0.6	1.1	1.7	4.3	3.5	1.3	12.3	0.2	0.2	0.2	0.8	0.0	0.0	0.3	0.3	0.1	0.1	0.5	0.1	0.5	0.3	0.2	0.0	0.1	0.2	0.1	0.0	0.0	0.1	10.4	0.1	1.3	0.2	0.1	0.4	0.3	0.2	1.4	0.4	0.0	0.2	0.1	0.2	0.4	20.8	0.5	0.5	0.2	1.4	0.2	5.7	3.2	0.3	0.5	0.1	94.3	3.6	4.1	0.2	1.0	102.8	0.1	0.7	10.8	0.6	0.1	0.3	0.8	2.0	0.2	3.4	0.2	0.2	0.1	0.4	0.1	1.2	0.2	0.2	0.3	0.2	0.3	1.1	0.3	0.3	0.2	0.5	0.3	0.3	0.6	0.4	0.3	0.3	0.2	0.1	3.6	4.5	4.6	5.3	3.8	4.8	9.4	6.8	9.7	7.1	5.7	12.3	3.5	0.0	23.6	0.0	0.7	2.8	1.5	1.6	0.6	3.2	3.3	1.7	1.2	4.3	8.5	334.8	0.0	23.8	0.2	100.7	82.2	0.6	124.6	25.5	1.0	6.7	9.1	0.0	0.1	0.2	4.7	2.7	55.5	11.3	39.9	0.0	0.4	0.1	99.9	0.0	0.2	62.9	46.8	3.0	0.5	87.8	0.3	2.8	10.6	15.0	1.7	0.4	0.0	0.0	0.3	8.6	138.6	1.2	1.4	4.7	318.4	3.2	17.2	3.0	0.0	0.9	1.0	3.8	5.5	26.6	6.5	65.8	2.2	0.1	21.4	23.1
SGK2		ENSG00000101049	"Serum/glucocorticoid regulated kinase 2"	Q9HBY8	20	43558968-43588237	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 40.5;kidney: 53.6;liver: 63.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 76.5;Distal tubular cells: 76.3;Hepatocytes: 32.8;Paneth cells: 21.7;Proximal enterocytes: 23.8;Proximal tubular cells: 25.5"	"Cancer enhanced"	"Detected in many"		"liver cancer: 8.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 20.5;CAPAN-2: 14.2;Hep G2: 18.7;OE19: 61.7;RPTEC TERT1: 25.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA008859, HPA011387"	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA008859: AB_2668159, HPA011387: AB_1856744"	"unprognostic (1.82e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.86e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.98e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.30e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.72e-4)"	"unprognostic (4.15e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.11e-2)"	"prognostic favorable (5.65e-4)"	23.5	1.4	4.9	1.5	14.8	0.5	6.1	12.6	10.5	3.5	0.7	37.7	31.6	1.8	33.8	1.0	3.7	10.0	1.2	6.0	7.7	53.6	63.2	1.0	0.2	18.1	13.3	6.6	16.2	0.5	3.0	0.8	14.3	2.6	40.5	5.6	1.8	2.9	0.4	6.2	20.1	1.6	11.8	1.1	22.8	1.8	13.3	0.3	1.7	0.4	0.3	4.2	3.0	24.5	0.0	20.5	0.3	0.1	0.3	0.0	0.1	0.2	0.0	0.2	0.0	0.6	14.2	0.1	8.7	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.3	0.4	0.0	18.7	0.4	0.0	0.1	0.0	0.5	0.0	0.0	0.7	0.0	0.4	0.2	0.1	0.0	0.1	0.1	0.5	0.1	61.7	0.0	0.1	0.1	0.0	25.4	4.2	0.2	1.0	0.0	1.2	0.1	0.4	0.0	0.1	0.9	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	14.8	12.6	10.5	6.0	7.7	18.1	13.3	14.3	11.8	13.3	24.5	0.3	0.0	0.0	4.9	0.2	0.1	0.1	0.2	0.0	0.8	0.3	0.8	4.9	8.6	0.0	11.0	0.0	5.1	0.0	76.5	76.3	6.8	0.3	0.9	0.5	0.6	1.8	0.0	0.7	6.3	1.3	0.4	11.2	2.4	0.0	0.7	0.7	32.8	0.7	6.7	1.3	4.1	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	3.5	20.7	2.5	21.7	0.4	0.0	0.1	23.8	25.5	0.2	0.8	0.0	0.2	0.4	0.1	0.1	0.0	0.1	17.1	0.2	0.0	7.7	0.3
SHLD2	"bA163M19.1, FAM35A, FAM35A1, MGC5560, RINN2"	ENSG00000122376	"Shieldin complex subunit 2"	Q86V20	10	87094161-87191465	"Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 31.3;Endometrial stromal cells: 28.6;Glandular and luminal cells: 29.0;Proximal tubular cells: 48.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036582	Uncertain		Approved	"Nucleoplasm,Actin filaments"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Actin filaments"	"HPA036582: AB_10670233"	"unprognostic (1.08e-1)"	"unprognostic (2.72e-1)"	"prognostic favorable (6.06e-4)"	"unprognostic (1.77e-1)"	"prognostic favorable (3.09e-4)"	"unprognostic (5.34e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.20e-2)"	"unprognostic (2.53e-1)"	"unprognostic (9.18e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.44e-3)"	"unprognostic (3.61e-2)"	15.6	20.1	10.8	12.6	8.4	9.6	17.3	7.3	10.0	11.9	10.2	15.7	22.3	11.4	7.0	12.8	11.2	10.7	10.3	8.6	10.5	32.1	37.2	11.6	13.1	27.5	10.9	12.7	12.4	6.1	10.9	9.7	8.8	14.9	16.5	15.6	14.3	9.5	10.6	12.0	24.8	12.2	9.3	11.9	12.0	8.0	10.1	10.4	23.3	11.7	14.4	13.3	11.2	8.7	33.6	26.7	14.9	34.4	16.4	15.8	21.7	22.1	31.0	29.0	31.8	30.8	25.2	24.4	12.1	30.2	17.0	21.9	37.2	16.9	29.8	35.1	24.6	33.9	24.3	29.1	25.4	53.4	28.5	14.5	30.4	26.6	45.4	25.6	19.6	26.3	43.7	42.7	27.2	19.2	43.7	37.8	17.2	24.2	18.4	26.8	29.6	27.0	26.6	27.7	7.4	30.6	17.1	19.9	29.8	13.7	44.0	29.6	19.4	16.5	15.0	24.8	44.7	23.9	55.8	58.5	27.8	65.4	9.1	7.1	7.3	2.8	6.7	11.8	13.7	9.2	10.0	10.0	11.3	8.8	10.0	10.1	0.1	12.5	9.5	3.9	10.4	8.7	10.8	8.4	7.3	10.0	8.6	10.5	27.5	10.9	8.8	9.3	10.1	8.7	21.2	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	20.9	13.2	0.0	0.0	0.0	5.5	0.0	7.2	17.4	0.0	31.3	12.6	0.0	16.7	28.6	4.2	0.0	0.0	0.0	13.7	15.1	7.9	0.0	29.0	0.0	20.2	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	8.8	0.0	0.0	0.0	0.0	14.7	0.0	0.0	7.6	0.0	0.0	48.2	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	2.2	7.8	19.1	0.0	0.0
SIAE	"CSE-C, LSE, MGC87009, YSG2"	ENSG00000110013	"Sialic acid acetylesterase"	Q9HAT2	11	124633113-124695707	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Serine esterase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 104.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 58.0;Cardiomyocytes: 59.5;Distal enterocytes: 102.4;Paneth cells: 53.0;Proximal enterocytes: 51.6;Undifferentiated cells: 63.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 7.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 88.6;ASC TERT1: 91.3;HSkMC: 98.9;OE19: 97.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038052, HPA038053"	Approved				"Intracellular and membrane"	NA	NA		2200000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA038052: AB_10671518, HPA038053: AB_10673039"	"unprognostic (9.97e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.48e-3)"	"prognostic favorable (4.66e-5)"	"unprognostic (3.30e-2)"	"unprognostic (5.20e-2)"	"unprognostic (4.90e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.45e-1)"	"unprognostic (9.19e-2)"	"prognostic favorable (4.42e-11)"	"unprognostic (7.24e-2)"	"unprognostic (3.22e-1)"	"unprognostic (4.49e-2)"	"unprognostic (1.92e-2)"	18.7	17.3	16.8	11.8	21.6	3.7	15.9	26.9	19.8	13.0	38.9	97.8	34.3	7.1	34.3	13.6	19.3	16.7	43.8	16.1	27.1	62.1	43.4	20.6	5.8	25.3	23.7	5.7	17.3	45.3	14.4	11.8	24.7	20.4	104.4	6.2	18.4	15.3	26.7	13.0	35.8	10.4	23.0	9.1	19.0	10.3	24.9	3.7	54.0	33.3	6.7	16.8	7.8	26.3	8.9	14.0	8.0	34.6	88.6	91.3	20.9	16.8	24.0	4.3	2.6	10.9	61.4	5.5	24.2	21.5	9.4	17.3	12.8	18.7	4.2	26.0	3.9	8.6	3.7	11.1	41.8	0.7	7.2	98.9	24.9	11.4	17.3	58.5	30.6	11.0	7.1	37.5	14.8	16.5	0.2	0.6	5.0	97.7	28.5	3.2	0.2	8.4	51.4	12.1	2.4	5.1	46.5	18.6	8.0	24.0	36.8	3.2	34.1	23.6	4.3	26.5	4.0	9.4	7.5	0.7	8.3	4.6	9.8	7.6	2.9	0.1	0.4	2.1	0.3	0.5	1.3	0.6	1.9	0.7	1.7	1.1	0.5	0.2	3.7	0.5	0.6	1.8	16.8	21.6	26.9	19.8	16.1	27.1	25.3	23.7	24.7	23.0	24.9	26.3	4.2	19.2	58.0	11.8	2.4	3.2	6.3	6.7	7.4	6.5	10.1	4.3	59.5	12.8	9.4	36.8	0.0	7.6	0.6	102.4	9.8	15.2	14.0	9.1	9.3	6.9	14.5	5.2	15.0	3.8	8.8	7.5	12.8	14.0	1.3	3.9	8.9	30.0	4.5	5.0	9.1	31.0	4.1	3.5	1.6	12.0	3.1	4.3	3.6	6.5	4.5	1.9	1.0	8.0	6.7	5.2	53.0	1.2	3.9	7.4	51.6	26.2	11.9	1.8	0.0	4.9	7.9	14.8	9.6	12.2	5.3	6.7	2.0	8.9	63.6	7.1
SLC11A2	"DCT1, DMT1, NRAMP2"	ENSG00000110911	"Solute carrier family 11 member 2"	P49281	12	50979401-51028566	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Iron transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Respiratory ciliated cells: 109.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032139, HPA032140"	Uncertain		Supported	Mitochondria		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Mitochondria		"HPA032139: AB_10964213, HPA032140: AB_10962932"	"unprognostic (4.40e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.07e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.09e-1)"	"prognostic favorable (3.07e-6)"	"unprognostic (1.06e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.24e-1)"	12.1	17.0	12.8	14.0	21.6	15.9	30.3	19.6	18.1	29.3	12.7	16.4	53.8	15.7	17.6	23.9	21.4	17.7	14.7	13.2	16.5	22.5	25.6	23.2	10.3	22.8	18.3	12.8	22.6	42.5	10.9	23.7	22.9	24.4	16.2	23.1	31.2	19.3	18.4	20.3	13.8	15.3	19.1	8.7	17.8	13.3	18.5	19.2	41.6	20.3	17.2	20.4	13.9	31.1	19.0	22.4	31.4	28.7	33.5	28.6	106.3	19.7	73.9	19.0	21.8	30.6	35.3	11.8	38.8	22.8	35.7	25.3	26.6	19.2	21.9	17.1	17.4	27.4	29.2	35.5	35.7	19.0	54.5	31.6	24.3	32.7	35.1	45.6	22.8	23.6	24.4	5.6	22.4	21.7	21.8	12.9	46.6	19.8	15.5	14.7	28.6	21.1	23.4	27.7	21.6	19.0	16.3	47.1	20.9	36.2	50.8	12.6	26.8	19.2	15.8	21.5	10.9	14.1	20.4	4.7	54.1	10.2	8.3	0.6	4.7	1.9	4.2	6.8	3.7	2.6	3.3	4.3	7.0	3.3	4.6	4.3	2.3	6.0	4.8	2.9	2.9	3.4	12.8	21.6	19.6	18.1	13.2	16.5	22.8	18.3	22.9	19.1	18.5	31.1	9.8	38.5	46.1	32.7	6.9	15.4	24.8	84.0	22.2	26.6	37.6	18.5	15.5	25.8	69.4	57.0	18.8	27.0	11.9	14.0	3.9	30.6	1.5	31.7	11.6	13.1	16.4	64.8	33.6	28.3	22.5	17.3	15.3	43.6	71.4	20.1	11.4	41.3	35.2	28.6	38.1	14.3	42.7	16.9	25.4	1.7	9.6	30.1	26.6	26.2	15.7	26.5	6.2	51.8	94.5	20.6	15.0	8.6	8.2	47.8	13.2	9.0	109.6	17.8	6.6	14.2	13.2	9.0	12.2	14.3	13.4	19.4	10.7	10.4	15.0	23.1
SLC1A1	"EAAC1, EAAT3"	ENSG00000106688	"Solute carrier family 1 member 1"	P43005	9	4490468-4587469	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		"Disease variant, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 45.0;intestine: 64.7;kidney: 51.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 163.5;Glandular and luminal cells: 98.7;Hepatocytes: 68.4;Microglial cells: 67.5;Oligodendrocyte precursor cells: 161.4;Proximal enterocytes: 110.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 29.1;HDLM-2: 70.9;HUVEC TERT2: 32.5;RPTEC TERT1: 66.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062356	Enhanced					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"			"HPA062356: "	"unprognostic (1.28e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.83e-3)"	"unprognostic (3.07e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.25e-2)"	"prognostic favorable (2.86e-8)"	"unprognostic (2.68e-1)"	"unprognostic (9.49e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.64e-1)"	4.6	1.7	13.2	2.3	15.4	0.1	4.1	9.5	14.8	5.8	12.9	12.4	34.8	3.7	45.0	2.3	2.6	25.5	2.8	16.5	12.6	51.0	41.2	20.9	2.6	10.8	13.0	0.6	2.1	0.3	6.8	8.1	13.6	6.3	10.2	6.0	4.8	3.2	1.4	1.5	64.7	3.2	10.9	0.4	5.2	0.8	13.9	0.4	29.5	1.3	8.2	5.6	1.5	10.1	0.1	2.0	1.6	9.5	24.3	29.1	8.3	10.4	21.4	3.2	3.1	17.2	0.5	13.7	0.6	5.4	3.9	0.0	3.6	5.7	2.9	70.9	4.5	0.0	13.6	0.1	0.8	0.9	0.0	2.0	0.2	12.1	0.0	1.6	32.5	0.2	0.0	0.0	2.2	0.3	0.0	0.3	4.2	10.5	1.8	0.0	0.0	0.2	66.4	6.1	2.2	2.0	0.8	3.8	0.0	7.7	1.4	0.5	17.6	4.9	0.4	9.5	3.0	0.1	0.1	0.0	23.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	13.2	15.4	9.5	14.8	16.5	12.6	10.8	13.0	13.6	10.9	13.9	10.1	12.2	163.5	3.2	4.2	0.4	0.0	1.1	0.6	4.6	3.9	2.0	0.8	2.3	28.6	6.1	0.0	0.0	0.1	0.0	52.4	3.9	8.1	4.3	10.7	13.3	10.6	0.0	0.0	48.4	0.8	0.0	1.8	2.0	98.7	0.0	0.6	2.5	68.4	0.1	0.0	50.3	10.1	0.0	1.3	0.3	11.2	0.3	1.1	0.0	67.5	0.0	0.8	0.0	161.4	3.5	9.3	10.6	0.0	0.0	2.4	110.6	43.1	3.3	1.1	0.0	0.5	3.1	0.1	0.2	1.0	0.6	0.1	1.4	0.4	8.5	1.8
SLC23A1	"SLC23A2, SVCT1, YSPL3"	ENSG00000170482	"Solute carrier family 23 member 1"	Q9UHI7	5	139367196-139384553	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"fallopian tube: 54.2;intestine: 65.3;kidney: 40.2;liver: 22.5"	"Cell type enhanced"	"Detected in some"		"Endometrial ciliated cells: 65.2;Hepatocytes: 19.3;Proximal enterocytes: 131.7;Proximal tubular cells: 27.0"	"Group enriched"	"Detected in many"	5	"endometrial cancer: 2.1;liver cancer: 7.7;prostate cancer: 4.0;renal cancer: 3.9"	"Region enhanced"	"Detected in some"		"midbrain: 3.2"	"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CACO-2: 9.4;HDLM-2: 8.3;Hep G2: 13.6;JURKAT: 15.5;Karpas-707: 10.9;RPMI-8226: 10.9;U-266/70: 16.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA047612	Enhanced					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 45: Enterocytes - Digestion"			"HPA047612: AB_2680102"	"unprognostic (4.00e-3)"	"unprognostic (2.66e-3)"	"unprognostic (2.63e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.93e-1)"	"unprognostic (6.36e-6)"	"unprognostic (7.41e-2)"	"unprognostic (6.55e-2)"	"unprognostic (5.88e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.51e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.65e-3)"	0.2	0.1	0.1	1.2	0.2	2.8	0.2	1.1	0.2	2.3	0.1	3.3	26.3	0.7	0.0	0.3	54.2	2.4	0.1	0.2	0.4	40.2	22.5	0.9	1.7	1.1	3.2	0.3	1.2	0.3	0.2	0.1	0.8	6.3	1.5	0.6	3.2	0.6	0.4	1.9	65.3	0.2	0.1	1.3	1.5	0.2	0.2	5.5	0.2	0.0	1.2	0.4	0.3	0.6	0.3	2.1	0.4	0.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	9.4	1.3	5.8	3.0	0.0	0.1	0.3	0.0	0.0	0.1	8.3	0.1	0.2	0.8	13.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	15.5	0.1	10.9	0.0	0.2	5.7	1.0	0.1	0.8	0.1	6.8	0.3	10.9	0.5	0.4	0.3	0.3	0.3	1.9	0.0	0.7	5.0	0.1	0.3	0.3	0.3	0.1	0.0	16.6	2.2	7.6	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	1.3	0.1	0.0	0.1	0.2	1.1	0.2	0.2	0.4	1.1	3.2	0.8	0.1	0.2	0.6	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.3	0.0	0.1	0.3	0.3	0.3	1.5	2.0	0.0	4.2	0.4	0.4	1.9	5.9	0.2	0.0	65.2	0.7	0.1	0.0	0.0	1.1	0.2	0.0	0.0	0.0	1.5	0.0	0.1	0.4	19.3	0.1	0.0	1.2	3.6	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	1.4	0.1	3.1	0.0	0.4	0.9	131.7	27.0	13.4	0.7	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.8	0.2	0.0	4.2	0.2
SLC23A3	"FLJ31168, SVCT3, Yspl1"	ENSG00000213901	"Solute carrier family 23 member 3"	Q6PIS1	2	219161465-219170095	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in many"	8	"intestine: 18.4;kidney: 45.6"	"Group enriched"	"Detected in many"	5	"Proximal enterocytes: 55.9;Proximal tubular cells: 14.4"	"Cancer enriched"	"Detected in some"	9	"renal cancer: 5.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTCEpi: 4.9;U-266/70: 3.1"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.3"	"Not detected"	"Not detected"			HPA019059			Approved	"Nucleoplasm,Cell Junctions"		NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	"Cell Junctions"	"HPA019059: AB_1857017"	"unprognostic (2.49e-2)"	"unprognostic (6.65e-2)"	"unprognostic (2.05e-4)"	"unprognostic (6.97e-2)"	"unprognostic (8.41e-2)"	"unprognostic (1.22e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.01e-2)"	"unprognostic (4.35e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.12e-4)"	"unprognostic (9.42e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.34e-1)"	"unprognostic (6.52e-5)"	1.1	0.4	1.0	0.9	1.0	0.1	0.9	1.2	0.9	2.8	1.0	3.8	7.6	1.6	0.5	2.2	1.5	0.5	1.0	1.0	1.0	45.6	4.0	1.3	0.7	1.1	1.0	1.8	1.1	0.8	0.5	1.0	1.0	2.4	1.5	0.2	1.0	0.6	0.2	1.9	18.4	0.7	1.0	1.5	1.2	0.1	1.1	0.3	2.4	0.1	0.8	1.1	2.3	1.0	0.5	0.2	0.1	0.6	2.0	1.1	0.4	1.2	0.3	0.2	0.7	1.1	0.7	0.2	0.4	0.8	0.0	1.7	0.4	0.1	0.3	1.1	0.9	1.1	1.2	0.1	0.4	0.1	0.4	0.4	4.9	0.4	1.5	1.9	0.6	0.6	0.1	0.4	0.3	0.2	0.0	0.5	0.0	0.4	0.1	0.3	0.3	0.4	1.6	1.9	0.2	0.5	0.1	0.0	1.3	0.5	0.5	0.5	1.4	1.1	0.7	1.0	0.4	3.1	0.1	1.5	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.0	1.2	0.9	1.0	1.0	1.1	1.0	1.0	1.0	1.1	1.0	0.6	0.0	0.5	0.0	1.7	1.5	1.4	0.5	0.6	1.1	0.9	1.1	0.3	1.5	0.3	1.8	0.0	0.3	0.5	3.8	1.9	0.2	0.0	0.2	0.8	1.0	1.8	0.4	0.3	0.0	0.1	0.8	0.0	0.9	0.0	0.5	1.1	1.2	0.2	0.0	0.3	4.0	0.0	0.9	0.8	0.0	1.5	1.0	1.8	1.0	1.1	1.2	0.0	0.0	0.0	0.4	6.0	1.2	0.2	1.5	55.9	14.4	0.1	0.2	0.0	0.8	1.0	0.0	0.2	0.7	1.6	0.4	0.8	0.6	3.9	0.9
SLC34A3	"FLJ38680, NPTIIc"	ENSG00000198569	"Solute carrier family 34 member 3"	Q8N130	9	137230757-137236555	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 9.7;kidney: 13.6"	"Group enriched"	"Detected in some"	9	"Proximal enterocytes: 83.7;Proximal tubular cells: 40.3"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 4.0;HDLM-2: 2.8;HeLa: 3.3;MCF7: 7.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA023776	Enhanced					NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA023776: AB_1857102"	"unprognostic (2.69e-1)"	"unprognostic (4.16e-1)"	"unprognostic (9.08e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.29e-3)"	"unprognostic (4.02e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.05e-2)"	"unprognostic (9.84e-3)"	"unprognostic (2.05e-2)"	"unprognostic (2.20e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.94e-2)"	"unprognostic (9.12e-2)"	"unprognostic (5.80e-2)"	"unprognostic (2.20e-1)"	0.0	0.1	0.1	0.1	0.3	0.3	0.0	0.0	0.5	0.2	0.0	0.1	0.5	0.2	0.0	2.9	0.4	0.5	0.2	0.2	0.2	13.6	0.0	0.3	0.2	1.8	2.0	0.0	0.6	0.0	1.2	0.0	0.5	0.3	0.0	0.2	1.6	0.0	0.1	0.4	9.7	0.0	0.5	0.2	0.4	0.4	0.8	0.0	0.3	0.0	0.0	0.1	0.5	1.1	0.6	1.2	0.7	1.5	0.0	0.0	0.3	0.4	0.0	0.1	0.0	0.5	4.0	0.5	0.1	0.0	0.1	1.8	0.0	0.0	0.1	2.8	0.3	0.1	3.3	1.5	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.5	0.0	0.2	0.3	0.6	0.0	7.6	0.0	0.1	0.3	0.7	0.8	0.9	0.5	0.0	0.0	0.6	0.0	1.3	0.4	0.9	0.2	0.6	2.2	0.0	0.3	0.3	0.3	1.5	0.1	0.7	0.3	0.3	0.7	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.5	0.2	0.2	1.8	2.0	0.5	0.5	0.8	1.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.3	0.0	0.0	0.0	83.7	40.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0
SLC6A19		ENSG00000174358	"Solute carrier family 6 member 19"	Q695T7	5	1201595-1225111	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	35	"intestine: 142.4;kidney: 88.7"	"Cell type enriched"	"Detected in some"	5	"Proximal enterocytes: 561.5"	"Group enriched"	"Detected in many"	4	"renal cancer: 7.9;stomach cancer: 5.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BEWO: 14.3;HEL: 18.3;OE19: 5.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA037415, HPA043207"	Enhanced					NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 45: Enterocytes - Digestion"			"HPA037415: AB_10672346, HPA043207: AB_2678363"			"unprognostic (1.26e-1)"				"unprognostic (1.01e-3)"				"unprognostic (6.04e-2)"	"unprognostic (3.64e-1)"	"prognostic favorable (4.14e-6)"	"unprognostic (1.37e-1)"	"unprognostic (7.36e-2)"			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	139.7	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	88.7	0.9	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	5.6	0.0	0.0	0.0	0.0	0.0	142.4	0.3	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.4	0.0	5.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	64.3	0.6	1.8	0.0	0.0	0.0	104.4	1.9	0.1	0.1	0.0	0.0	0.1	4.8	2.7	0.0	0.0	14.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	13.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.1	0.0	0.0	0.0	561.5	76.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.4	0.0	8.7	0.0
SLC7A7	"LPI, y+LAT-1"	ENSG00000155465	"Solute carrier family 7 member 7"	Q9UM01	14	22773222-22829820	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 131.6;kidney: 300.6"	"Group enriched"	"Detected in many"	4	"Hofbauer cells: 216.5;Kupffer cells: 410.6;Macrophages: 146.2;monocytes: 164.0;Proximal enterocytes: 423.1;Proximal tubular cells: 327.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 299.9;intermediate monocyte: 410.0;non-classical monocyte: 457.1"	"Lineage enriched"	"Detected in many"	5	"monocytes: 457.1"	"Group enriched"	"Detected in many"	4	"BEWO: 217.2;CACO-2: 385.7;OE19: 329.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA036227	Enhanced					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA036227: AB_10696653"	"unprognostic (1.34e-1)"	"unprognostic (7.65e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.52e-1)"	"unprognostic (6.12e-2)"	"unprognostic (3.69e-2)"	"unprognostic (7.84e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.60e-3)"	"unprognostic (7.15e-2)"	"prognostic unfavorable (6.28e-6)"	"unprognostic (2.68e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.12e-1)"	15.1	9.0	3.1	37.4	3.2	19.7	6.8	3.8	7.5	7.3	4.3	13.8	107.0	5.3	2.0	3.7	7.8	17.0	5.1	2.8	3.8	300.6	16.4	54.1	29.1	6.9	4.7	2.1	5.2	78.4	1.4	18.2	6.4	3.5	15.0	1.0	5.4	2.8	2.0	3.2	131.6	15.6	5.1	56.8	8.6	32.8	7.1	9.6	4.6	2.8	25.2	14.7	4.1	8.1	0.2	11.2	1.2	0.5	1.9	3.7	217.2	2.2	16.3	0.4	1.4	385.7	34.4	17.0	72.2	1.4	1.2	13.3	0.1	0.0	0.6	0.6	0.2	0.9	0.4	3.7	9.1	1.9	1.6	7.1	1.0	1.0	0.5	1.8	25.3	1.5	0.1	12.8	2.9	0.6	0.4	1.7	3.6	329.0	0.1	2.9	35.5	9.8	0.8	1.3	0.4	0.8	0.6	0.5	2.5	9.4	0.4	8.3	1.3	0.8	1.7	0.6	0.5	2.7	0.9	8.9	0.9	0.8	0.2	0.2	299.9	1.1	0.5	410.0	0.4	19.1	0.2	0.2	99.5	13.8	0.7	0.4	36.5	0.3	457.1	3.4	0.9	155.1	3.1	3.2	3.8	7.5	2.8	3.8	6.9	4.7	6.4	5.1	7.1	8.1	5.3	12.8	7.1	2.0	14.3	1.0	0.2	6.7	1.8	0.2	0.5	1.7	0.9	67.2	5.6	3.7	0.0	1.2	5.7	3.0	11.7	8.2	61.1	1.7	1.2	5.0	1.2	0.0	0.6	6.4	5.2	4.4	2.6	0.4	1.3	0.7	16.1	3.0	216.5	0.0	1.4	7.2	2.0	410.6	16.8	11.8	3.7	146.2	5.4	20.6	164.0	0.4	4.1	0.0	0.8	8.9	12.5	0.0	20.1	0.1	423.1	327.6	9.2	1.3	6.6	0.8	1.4	17.8	2.2	0.4	0.4	1.8	2.7	38.8	6.4	0.1
SLC7A9	CSNU3	ENSG00000021488	"Solute carrier family 7 member 9"	P82251	19	32830509-32869767	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Cystinuria, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 124.6;kidney: 68.2"	"Cell type enriched"	"Detected in some"	7	"Proximal enterocytes: 772.0"	"Group enriched"	"Detected in some"	7	"liver cancer: 6.6;renal cancer: 5.2;stomach cancer: 1.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	16	"BEWO: 3.4;CACO-2: 8.2;Hep G2: 8.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042591	Enhanced					NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"			"HPA042591: AB_10962500"	"unprognostic (4.12e-2)"	"unprognostic (5.40e-2)"	"unprognostic (6.19e-2)"	"unprognostic (3.37e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.39e-1)"	"unprognostic (9.69e-2)"	"unprognostic (5.97e-2)"	"unprognostic (3.20e-1)"	"unprognostic (4.94e-3)"	"unprognostic (5.10e-5)"	0.2	0.1	0.7	0.1	0.7	0.0	0.3	0.7	0.9	0.8	0.6	0.8	78.3	0.4	1.4	0.2	0.5	0.2	0.1	0.7	0.7	68.2	17.3	0.2	0.1	0.7	0.7	0.6	0.3	0.0	0.7	0.1	0.7	1.0	0.2	1.0	0.2	0.2	0.0	0.3	124.6	0.2	0.6	0.3	0.2	0.4	0.7	0.2	0.8	0.0	0.0	0.3	0.5	0.7	0.0	0.1	0.0	0.0	0.1	0.0	3.4	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.7	0.9	0.7	0.7	0.7	0.7	0.7	0.6	0.7	0.7	0.1	0.0	0.0	2.3	0.5	0.0	0.1	0.0	0.0	1.3	0.2	0.6	0.4	0.0	0.0	5.5	4.2	0.2	0.1	0.0	1.9	0.1	1.6	0.3	0.2	0.1	0.0	0.0	3.1	7.2	8.8	0.2	0.0	0.2	0.0	0.4	0.0	12.2	0.2	0.0	3.0	18.2	0.0	0.0	0.0	0.1	0.6	0.5	0.0	2.8	0.0	0.2	0.0	0.0	1.7	0.6	27.5	0.0	0.0	0.0	772.0	97.8	1.8	1.2	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.5	0.1	11.7	0.0
SLC9A3	NHE3	ENSG00000066230	"Solute carrier family 9 member A3"	P48764	5	470456-524449	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 45.4;intestine: 94.3;kidney: 62.5;stomach 1: 50.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 16.0;Collecting duct cells: 16.5;Proximal tubular cells: 40.7"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 14.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 37.8"	"Region enriched"	"Detected in single"	14	"cerebellum: 4.1"	"Low region specificity"	"Detected in many"			"HPA036493, HPA036669"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"		"HPA036493: AB_10673353, HPA036669: AB_10670843"	"unprognostic (1.27e-1)"	"unprognostic (4.88e-1)"	"unprognostic (9.35e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.51e-1)"	"unprognostic (9.40e-2)"	"prognostic unfavorable (8.49e-4)"	"unprognostic (5.18e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.69e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.32e-1)"	2.9	4.4	3.0	10.4	2.5	1.9	3.1	6.1	5.0	3.8	1.7	94.3	46.0	2.9	4.0	8.7	4.9	45.4	3.2	4.7	2.5	62.5	2.4	2.8	3.8	3.8	2.3	4.3	6.7	6.2	0.7	2.1	3.7	7.3	10.8	1.7	9.9	3.8	6.2	19.0	68.1	3.3	1.3	3.7	50.1	5.8	3.4	3.5	4.9	3.9	3.4	2.5	2.5	2.6	6.7	5.1	10.4	10.5	2.5	3.0	7.8	5.3	3.9	8.0	5.0	11.0	7.4	14.0	7.5	3.0	5.5	10.0	6.1	4.0	3.9	37.8	10.7	6.7	23.4	5.4	3.9	5.5	8.2	4.2	8.1	3.5	5.4	3.9	2.4	6.3	9.6	7.5	2.9	9.0	6.0	24.3	4.0	17.8	8.3	8.6	9.3	8.3	2.8	4.8	11.5	5.0	19.0	5.3	4.2	4.5	12.3	4.2	2.9	8.0	7.2	5.3	3.9	12.4	5.8	8.5	5.2	21.2	5.6	0.0	0.7	0.1	2.6	0.3	2.2	0.9	3.3	2.4	0.9	1.0	3.9	3.1	0.1	2.4	0.2	1.2	2.7	1.8	3.0	2.5	6.1	5.0	4.7	2.5	3.8	2.3	3.7	1.3	3.4	2.6	3.8	16.0	5.8	0.0	1.5	0.0	0.0	0.0	0.0	0.0	7.3	8.9	0.7	0.0	5.6	16.5	0.0	0.0	3.4	0.7	5.9	9.0	0.0	3.8	3.6	2.3	0.0	0.0	0.3	8.8	0.0	2.2	0.0	2.6	2.5	5.3	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	4.6	0.0	0.0	0.0	0.1	7.7	0.0	0.0	0.7	0.0	1.1	40.7	2.9	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	2.3	5.4	0.0	0.0
SMIM15	"C5orf43, DKFZP686E2158"	ENSG00000188725	"Small integral membrane protein 15"	Q7Z3B0	5	61157704-61162468	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"				"unprognostic (1.18e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.33e-2)"	"unprognostic (3.82e-1)"	"unprognostic (3.32e-2)"	"unprognostic (6.03e-2)"	"unprognostic (9.83e-3)"	"unprognostic (4.43e-2)"	"unprognostic (2.44e-2)"	"unprognostic (4.09e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.34e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.89e-1)"	"prognostic favorable (9.23e-4)"	19.0	23.6	13.5	24.6	14.7	22.5	29.1	14.4	17.2	26.9	12.0	49.1	42.6	22.3	23.4	32.5	30.9	25.1	15.8	12.8	15.2	31.8	43.3	24.3	26.8	14.1	13.7	33.1	27.5	36.4	16.1	30.3	14.6	30.7	41.4	21.4	27.1	27.7	11.2	18.5	40.8	23.7	15.6	19.5	46.6	15.3	13.6	27.7	35.6	15.6	28.9	40.3	21.5	17.7	95.3	79.6	51.4	84.1	48.8	58.0	52.9	78.5	86.0	77.1	103.2	69.4	141.4	46.2	133.4	82.6	101.3	54.5	0.0	94.3	90.3	97.4	42.1	72.9	60.7	67.9	95.4	54.2	65.9	69.0	85.9	95.7	108.6	58.9	62.9	57.1	87.0	61.7	87.4	99.5	27.9	0.7	63.4	38.7	92.7	9.8	63.8	106.2	83.3	112.6	71.0	67.9	90.4	48.2	99.4	35.9	90.9	58.3	72.4	46.1	73.9	58.9	100.9	62.6	117.3	85.9	63.2	29.6	96.7	33.2	56.4	20.2	34.7	70.5	38.7	41.6	38.3	39.9	51.4	33.9	46.0	32.1	11.3	58.8	57.8	41.2	55.9	39.4	13.5	14.7	14.4	17.2	12.8	15.2	14.1	13.7	14.6	15.6	13.6	17.7	26.8	57.7	37.1	4.9	39.4	86.8	122.1	58.1	60.3	25.7	45.2	33.4	21.2	35.8	53.2	42.3	8.4	71.9	34.6	79.9	135.0	70.8	23.3	35.6	40.3	25.7	55.2	29.2	3.9	61.3	62.9	50.0	57.1	40.9	23.5	35.4	25.7	40.4	73.4	40.4	4.3	74.0	42.7	40.8	30.5	24.5	46.3	40.5	40.9	2.8	33.8	59.3	44.3	4.5	8.7	75.2	116.1	42.2	41.9	108.6	73.2	93.0	37.0	20.8	26.3	28.2	37.6	18.7	12.3	78.6	82.7	47.5	34.9	45.7	82.8	152.6
SNX4	ATG24B	ENSG00000114520	"Sorting nexin 4"	O95219	3	125446650-125520202	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 163.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005709	Uncertain					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA005709: AB_1080049"	"unprognostic (1.11e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.91e-2)"	"prognostic unfavorable (6.10e-4)"	"unprognostic (1.97e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.19e-2)"	"unprognostic (6.33e-2)"	"unprognostic (4.93e-2)"	"unprognostic (4.06e-1)"	"unprognostic (3.42e-1)"	"unprognostic (6.99e-2)"	"prognostic favorable (5.01e-5)"	"unprognostic (2.40e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.13e-3)"	"unprognostic (1.05e-1)"	16.7	22.1	11.0	12.7	11.2	16.3	25.3	11.5	16.7	19.9	12.4	24.9	35.8	14.1	13.7	14.9	14.2	19.8	16.5	11.1	12.3	53.8	56.5	18.1	16.3	11.9	11.1	14.9	19.5	18.0	14.4	31.7	12.0	22.7	27.7	9.1	22.4	11.4	18.9	10.2	34.2	13.4	11.8	13.0	21.6	16.1	10.8	21.1	44.9	23.3	17.1	16.8	11.3	14.0	34.8	10.9	34.5	21.8	20.9	17.4	39.1	18.5	17.5	35.9	32.1	23.7	15.5	22.0	21.4	22.5	15.5	18.0	32.4	15.6	42.9	20.6	23.8	35.6	14.5	36.0	24.5	37.8	22.1	22.7	17.0	18.2	14.5	20.0	34.1	31.8	38.6	10.9	27.6	26.2	41.8	25.4	20.2	37.6	13.0	38.2	42.0	40.3	33.0	30.6	36.1	50.9	29.8	38.3	47.4	32.0	37.7	61.3	22.3	18.0	22.9	23.4	21.9	22.1	20.1	60.2	22.0	23.8	27.8	12.4	14.0	25.8	9.7	18.8	13.0	13.8	12.4	11.2	18.3	10.3	15.8	13.8	2.6	17.4	19.1	16.1	15.1	12.0	11.0	11.2	11.5	16.7	11.1	12.3	11.9	11.1	12.0	11.8	10.8	14.0	27.1	28.9	39.4	33.6	24.5	12.1	17.9	21.3	12.5	13.4	27.2	17.1	17.7	37.1	34.1	22.0	0.0	87.2	20.6	39.9	60.7	45.4	21.6	23.8	22.1	24.7	30.0	22.7	46.7	36.6	57.8	26.9	26.0	20.9	31.0	30.9	24.7	75.8	50.9	18.5	44.9	37.0	46.8	27.0	22.6	31.5	22.1	28.3	30.2	31.9	45.7	21.3	34.0	37.7	47.8	42.9	37.9	18.0	26.2	22.5	48.8	163.4	37.1	12.0	13.1	27.8	30.3	33.0	29.8	23.0	11.8	41.2	22.9	27.2	29.6	15.7
SUDS3	"FLJ00052, SAP45, SDS3"	ENSG00000111707	"SDS3 homolog, SIN3A corepressor complex component"	Q9H7L9	12	118376555-118418033	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 271.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040402, HPA041972"	Approved		Supported	"Nuclear bodies,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nuclear bodies, Cytosol"		"HPA040402: , HPA041972: AB_2677776"	"unprognostic (1.49e-1)"	"unprognostic (4.08e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.60e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.05e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.70e-1)"	"unprognostic (8.71e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.37e-1)"	10.8	12.3	13.3	12.0	14.2	16.9	18.7	9.6	15.2	16.6	12.1	16.5	14.3	14.9	16.0	19.9	18.1	11.7	12.8	15.8	12.9	16.1	14.0	11.9	14.7	12.7	14.6	15.0	17.3	25.3	11.6	11.5	14.1	16.2	18.3	16.3	19.2	15.7	11.3	20.1	14.1	13.7	10.6	13.7	16.2	16.4	12.2	17.9	21.7	11.9	19.5	14.4	15.2	13.2	29.4	21.9	29.4	29.4	16.1	21.1	31.5	22.5	23.2	25.8	20.4	24.1	18.6	39.8	23.5	21.8	16.0	34.3	35.3	23.8	30.3	35.3	20.9	27.7	18.4	21.6	18.4	30.9	20.5	14.6	25.0	12.8	22.7	33.5	22.2	36.9	30.8	14.1	23.9	20.2	36.7	40.2	30.5	38.8	17.0	32.9	26.4	28.3	23.7	42.7	22.9	22.7	31.9	18.7	19.9	36.7	61.1	24.9	18.7	17.5	16.6	19.7	15.5	26.2	31.4	29.2	19.4	19.4	21.4	1.8	4.3	5.9	5.0	2.8	6.1	8.8	5.4	5.7	4.7	8.4	6.4	4.4	12.6	4.3	2.8	6.8	5.5	3.9	13.3	14.2	9.6	15.2	15.8	12.9	12.7	14.6	14.1	10.6	12.2	13.2	25.5	28.9	15.9	19.6	37.8	64.7	44.7	55.0	46.1	75.4	85.6	63.0	37.5	41.5	37.1	47.8	77.2	34.6	26.9	75.1	80.3	41.5	271.9	87.6	54.4	24.6	37.3	30.3	22.4	19.3	54.5	31.5	36.7	73.2	8.2	37.5	21.0	34.1	25.0	107.7	29.1	60.2	59.0	18.2	36.1	59.4	38.5	20.8	28.4	13.1	30.5	30.0	29.9	30.2	21.6	26.4	52.6	41.0	49.1	60.5	38.3	45.7	61.9	57.3	26.3	42.8	48.5	62.6	53.4	74.1	78.7	49.1	32.9	41.6	56.8	61.9
SULT1C2	"ST1C1, SULT1C1"	ENSG00000198203	"Sulfotransferase family 1C member 2"	O00338	2	108288639-108309915	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 70.3;stomach 1: 163.3"	"Cell type enriched"	"Detected in many"	7	"Gastric mucus-secreting cells: 553.0"	"Cancer enhanced"	"Detected in many"		"renal cancer: 10.0"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"RPTEC TERT1: 25.4;RT4: 7.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA007190	Approved					NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA007190: AB_1857647"	"unprognostic (3.31e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.17e-3)"	"unprognostic (3.61e-2)"	"unprognostic (3.78e-1)"	"unprognostic (3.62e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.76e-1)"	"unprognostic (3.19e-2)"	"unprognostic (9.27e-2)"	"unprognostic (6.28e-2)"	"unprognostic (4.63e-2)"	"unprognostic (9.96e-5)"	0.7	0.0	0.2	0.6	0.2	0.0	0.9	0.2	0.6	2.4	7.5	2.5	29.2	0.5	15.9	0.3	2.0	6.2	1.1	0.5	0.2	70.3	2.8	2.2	1.8	0.3	0.4	0.2	5.3	5.9	2.9	1.3	0.6	0.5	5.2	0.0	1.4	0.9	0.6	0.1	3.3	0.8	0.2	0.5	163.3	0.1	0.7	0.4	19.4	0.6	0.8	0.7	0.5	1.2	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	2.8	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	1.0	0.0	0.0	0.2	1.8	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.3	0.0	25.4	7.3	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.6	0.5	0.2	0.3	0.4	0.6	0.2	0.7	1.2	7.0	3.2	14.1	0.3	1.0	1.5	1.6	0.0	0.0	0.9	0.3	0.1	2.2	15.7	3.1	20.2	2.1	0.3	0.0	3.9	58.7	7.6	0.1	5.7	0.8	4.8	0.0	0.0	0.4	0.2	0.3	2.6	553.0	5.6	1.3	0.2	3.3	0.9	18.6	1.7	0.2	6.4	12.2	0.3	5.4	0.2	0.0	2.7	0.0	3.7	0.1	0.1	0.0	0.0	0.1	6.2	6.8	0.0	2.0	2.8	9.6	73.4	1.0	1.5	0.0	2.9	1.2	0.7	0.3	0.0	1.8	0.1	1.1	0.1	4.9	1.3
SUMF2	DKFZp566I1024	ENSG00000129103	"Sulfatase modifying factor 2"	Q8NBJ7	7	56064002-56080670	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA024040, CAB025743, HPA074892"	Enhanced		Uncertain	"Vesicles,Plasma membrane"	"Intracellular and membrane"	Yes	No		750000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"		"CAB025743: , HPA024040: AB_1857651, HPA074892: "	"unprognostic (2.93e-1)"	"prognostic unfavorable (6.58e-6)"	"unprognostic (2.42e-2)"	"prognostic favorable (3.96e-4)"	"unprognostic (3.87e-2)"	"unprognostic (9.11e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.41e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.99e-3)"	"prognostic unfavorable (7.71e-4)"	64.1	64.6	26.1	43.0	29.7	51.5	57.5	29.3	27.1	91.3	45.0	67.4	89.2	57.5	64.8	46.8	102.6	70.6	30.8	25.1	27.8	93.4	94.8	71.6	50.2	35.2	29.6	59.7	91.8	115.8	31.8	45.5	33.4	79.3	69.1	11.0	69.5	77.1	22.4	47.5	74.4	57.7	29.9	57.0	92.7	23.7	30.8	57.6	91.2	21.4	51.3	57.2	43.6	35.9	352.3	102.9	46.0	211.8	214.4	147.5	68.9	114.5	156.1	92.6	114.5	57.2	278.0	57.1	96.5	162.4	90.4	172.3	27.4	131.3	61.1	90.6	42.9	36.4	63.5	54.2	138.4	89.7	108.7	116.8	124.5	83.7	143.3	186.9	137.7	101.4	116.4	236.6	151.3	76.8	77.2	115.7	63.5	272.0	52.2	61.5	45.4	359.0	127.7	39.1	54.0	65.6	142.4	294.2	140.9	98.9	294.5	144.5	115.2	85.6	121.1	211.1	98.6	160.8	130.8	84.0	139.7	165.7	283.2	58.1	60.3	22.0	71.1	80.5	90.9	59.8	70.9	71.8	72.3	49.1	75.3	75.2	4.4	49.0	90.3	132.6	82.7	90.2	26.1	29.7	29.3	27.1	25.1	27.8	35.2	29.6	33.4	29.9	30.8	35.9	44.0	57.7	30.5	20.5	47.3	33.8	44.1	46.1	39.9	25.7	57.9	25.4	10.4	87.2	31.0	90.1	14.6	44.5	85.3	45.1	19.6	95.3	3.8	93.1	70.2	43.7	59.3	41.7	21.2	55.7	96.7	54.7	55.5	78.9	54.5	47.0	51.0	91.3	68.1	43.7	24.4	61.8	22.4	79.8	38.7	8.0	69.6	50.4	53.4	14.0	73.0	23.8	70.0	10.6	24.2	48.4	64.6	47.4	65.0	50.7	91.8	45.6	34.5	13.5	52.6	41.6	44.1	31.6	28.6	52.8	41.9	46.7	52.7	58.7	85.8	42.7
TCN2	"D22S676, D22S750, TC2"	ENSG00000185339	"Transcobalamin 2"	P20062	22	30607003-30627271	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Cobalt transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 115.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 105.0;Hepatic stellate cells: 137.4;Kupffer cells: 144.1;Proximal enterocytes: 563.6;Proximal tubular cells: 125.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 43.8;intermediate monocyte: 66.5;non-classical monocyte: 24.4"	"Lineage enriched"	"Detected in many"	8	"monocytes: 66.5"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 117.6;HUVEC TERT2: 142.6;Karpas-707: 184.0;RPTEC TERT1: 70.7;TIME: 85.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000837			Approved	Cytosol	"Secreted to blood"	NA	NA		19000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 45: Enterocytes - Digestion"	Cytosol		"HPA000837: AB_1080235"	"unprognostic (6.43e-2)"	"prognostic favorable (3.47e-4)"	"unprognostic (1.53e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (2.64e-4)"	"unprognostic (1.52e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.59e-1)"	"unprognostic (6.95e-3)"	"unprognostic (4.94e-3)"	"unprognostic (2.09e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.50e-1)"	49.6	30.6	24.6	16.0	24.1	5.5	37.9	25.5	30.6	25.9	27.1	23.4	23.6	28.7	20.3	8.6	21.5	50.1	28.7	22.7	25.3	115.8	17.3	37.7	35.3	27.1	26.1	14.8	12.1	8.6	15.1	18.6	27.7	16.0	27.8	11.1	13.2	45.4	6.0	9.0	59.5	36.8	25.5	46.7	17.4	21.9	29.7	6.4	26.4	13.7	10.0	22.0	14.7	25.3	0.2	9.5	41.8	0.2	24.6	117.6	1.4	3.1	30.9	8.0	13.1	4.6	21.2	0.6	45.7	6.2	0.7	1.5	3.7	2.2	2.5	0.0	2.3	0.2	1.2	2.0	58.5	0.6	33.7	19.8	2.5	6.1	5.1	8.8	142.6	0.0	0.8	184.0	12.7	0.1	0.1	3.3	16.4	11.7	1.0	4.9	6.0	64.2	70.7	1.1	14.4	1.9	0.3	0.6	12.0	2.8	0.4	2.0	85.3	26.4	3.5	3.3	1.3	5.1	1.4	0.2	9.5	1.7	0.6	0.0	43.8	0.0	0.1	66.5	0.7	0.0	0.8	0.4	7.9	0.0	0.3	0.6	1.4	0.0	24.4	1.5	0.2	18.8	24.6	24.1	25.5	30.6	22.7	25.3	27.1	26.1	27.7	25.5	29.7	25.3	105.0	3.2	3.9	3.9	3.7	5.2	2.2	4.7	0.6	8.0	7.1	5.1	6.5	27.1	13.7	12.9	20.9	0.4	0.5	70.9	7.9	7.8	1.1	3.5	5.4	64.6	6.7	0.8	0.2	6.0	0.8	19.5	5.1	6.2	4.5	23.4	137.4	5.6	45.9	1.7	1.9	28.6	4.1	144.1	9.4	1.4	10.5	53.8	23.2	8.4	8.8	7.4	0.0	5.5	1.7	5.1	50.2	9.8	13.5	2.0	563.6	125.8	2.8	29.1	13.1	0.9	5.5	1.0	12.6	0.5	5.3	0.4	2.2	5.6	21.0	2.7
TFG	"FLJ36137, SPG57, TF6"	ENSG00000114354	"Trafficking from ER to golgi regulator"	Q92734	3	100709295-100748964	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, Transport"		"Cancer-related genes, Disease variant, Hereditary spastic paraplegia, Neurodegeneration, Neuropathy, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019473, HPA052206"	Approved		Supported	Vesicles,Cytosol		No	No		320000	"Cluster 38: Basophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles	Cytosol	"HPA019473: AB_1857936, HPA052206: AB_2681760"	"unprognostic (1.14e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (5.48e-4)"	"unprognostic (3.31e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.73e-2)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (4.58e-3)"	"unprognostic (3.72e-2)"	"unprognostic (2.82e-1)"	"unprognostic (8.55e-2)"	"unprognostic (3.33e-1)"	"unprognostic (8.45e-2)"	62.2	73.0	40.7	37.2	40.4	37.4	52.4	43.5	46.4	53.9	46.7	63.8	89.8	52.0	78.5	85.7	51.2	56.4	82.6	41.3	45.4	71.9	113.9	55.6	29.4	44.2	43.2	48.2	66.7	89.0	64.1	79.2	44.4	47.9	69.6	40.9	60.6	61.3	75.5	58.9	76.6	66.5	43.2	42.6	54.4	47.7	42.3	40.6	64.1	58.2	54.9	61.6	57.3	44.4	203.8	107.5	126.7	79.0	160.1	176.4	163.9	141.1	190.4	182.5	213.0	136.0	96.1	24.7	103.3	180.4	141.3	143.1	143.4	161.5	216.2	123.8	87.4	99.7	69.3	130.0	183.3	70.2	51.8	149.3	216.6	108.4	190.8	165.1	165.5	44.5	73.1	63.5	191.9	143.9	63.3	56.7	122.5	193.8	169.3	55.5	77.8	89.0	226.5	125.9	96.4	93.1	95.0	118.2	175.8	103.4	141.7	103.1	113.1	103.0	130.8	48.4	104.4	56.2	65.8	92.1	171.2	79.7	130.7	84.3	43.6	42.8	30.8	45.2	37.4	37.4	31.6	34.5	43.1	35.9	29.4	29.7	26.1	43.1	44.8	29.3	41.0	37.0	40.7	40.4	43.5	46.4	41.3	45.4	44.2	43.2	44.4	43.2	42.3	44.4	67.9	60.9	36.9	46.4	43.3	136.6	105.9	183.6	69.4	46.8	58.0	50.2	83.5	48.6	93.1	36.8	25.0	211.6	43.1	111.8	137.0	190.3	101.5	70.8	70.4	70.2	52.6	27.1	54.8	107.7	201.5	97.8	47.4	79.0	76.8	62.9	53.9	68.4	86.2	57.2	59.2	128.5	122.1	27.3	84.9	45.5	70.8	43.6	64.0	38.4	98.5	88.0	28.8	49.3	55.0	130.5	91.0	74.1	75.8	133.5	202.5	106.4	63.9	60.3	39.5	81.3	87.2	79.2	51.5	68.0	118.9	284.4	43.2	90.0	97.2	123.0
TGOLN2	"TGN38, TGN46, TGN48, TGN51, TTGN2"	ENSG00000152291	"Trans-golgi network protein 2"	O43493	2	85318020-85328296	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011489, HPA012609, HPA012723"	Enhanced		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA		12000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	Nucleoplasm	"CAB011489: AB_443302, HPA012609: AB_1857976, HPA012723: AB_1857975"	"unprognostic (3.03e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.39e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.50e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.52e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.04e-2)"	"unprognostic (5.37e-2)"	70.0	67.5	37.5	82.6	42.1	129.9	58.3	38.5	44.0	63.5	32.2	85.8	110.6	62.0	60.9	41.1	65.1	75.7	63.5	39.6	45.3	120.8	136.5	86.8	73.9	45.5	43.4	61.3	56.0	67.1	26.9	76.6	44.9	66.9	102.3	31.8	59.8	62.5	34.7	40.1	111.9	74.0	40.4	83.2	74.8	37.1	45.1	65.2	91.3	46.2	66.1	61.4	41.0	50.0	46.5	116.4	51.8	68.6	124.0	129.0	120.7	144.1	172.2	98.5	78.5	100.6	142.2	60.6	108.3	207.1	132.9	76.4	37.8	71.9	161.8	96.5	36.7	87.2	41.3	113.3	67.1	173.0	189.5	96.2	45.2	125.5	76.1	152.1	144.4	49.5	50.9	94.1	147.1	43.9	54.0	86.3	46.0	109.3	47.5	55.4	193.1	45.6	104.8	73.2	47.4	40.5	127.2	95.5	83.6	61.7	50.7	77.0	155.7	205.5	73.9	158.6	173.5	58.7	81.9	58.1	152.3	131.1	137.3	62.6	78.0	68.5	32.4	73.3	25.0	25.0	23.8	22.4	41.5	24.4	24.3	23.6	96.3	25.1	103.5	15.9	20.9	75.6	37.5	42.1	38.5	44.0	39.6	45.3	45.5	43.4	44.9	40.4	45.1	50.0	104.4	102.5	96.4	22.5	89.7	38.2	57.1	72.5	43.9	53.3	89.2	56.4	64.3	150.2	84.2	180.3	39.6	59.4	116.9	216.1	9.8	92.7	6.0	86.3	89.5	91.7	89.5	39.5	29.5	93.2	80.9	87.5	64.7	105.7	158.8	70.5	86.7	245.0	113.0	208.6	37.9	99.0	52.9	187.1	85.3	7.8	49.4	145.6	60.5	33.7	126.9	47.8	95.8	25.1	50.6	101.6	121.8	69.2	74.0	62.8	211.2	82.8	111.4	36.5	65.7	85.0	65.8	36.1	37.1	32.6	34.9	44.6	91.1	61.9	100.3	70.8
TIRAP	"Mal, wyatt"	ENSG00000150455	"TIR domain containing adaptor protein"	P58753	11	126283065-126298845	"Predicted intracellular proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054431	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytokinetic bridge, Cytosol"		"HPA054431: AB_2682486"	"unprognostic (9.30e-3)"	"unprognostic (7.39e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (1.24e-4)"	"unprognostic (2.73e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.89e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.28e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.34e-3)"	"unprognostic (4.29e-3)"	"unprognostic (3.62e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.57e-1)"	4.3	4.3	1.5	4.9	1.4	2.9	4.5	3.1	2.4	5.4	3.6	5.3	7.6	4.5	2.5	4.4	5.3	4.5	5.3	1.3	2.1	3.9	6.3	4.2	4.1	1.9	1.8	8.0	4.7	7.2	3.6	4.9	2.1	5.7	5.5	3.1	8.0	6.4	5.3	4.3	6.9	4.7	1.0	5.0	4.3	1.5	1.6	3.1	4.8	4.9	5.1	4.5	3.3	1.1	2.2	7.0	3.7	6.2	6.2	8.5	4.4	5.7	9.3	3.9	3.7	11.0	8.3	5.7	9.6	5.9	6.9	6.2	3.9	4.4	1.5	15.3	3.7	15.4	4.2	7.1	4.9	9.6	7.9	6.4	6.0	7.4	5.1	4.7	6.5	4.6	4.2	12.9	4.6	4.0	0.3	1.5	1.7	15.9	6.3	2.0	1.0	5.4	3.1	7.8	4.6	5.8	6.8	6.7	4.6	4.8	18.2	4.9	6.5	2.2	2.1	4.5	4.3	3.6	5.6	4.2	3.4	7.5	7.0	5.3	5.8	2.9	4.0	4.5	3.7	2.1	3.1	4.2	4.6	3.8	2.5	2.4	4.9	2.6	3.2	3.2	3.5	3.7	1.5	1.4	3.1	2.4	1.3	2.1	1.9	1.8	2.1	1.0	1.6	1.1	1.7	6.4	2.6	2.3	3.7	0.4	1.8	2.0	4.0	3.5	2.7	2.0	1.3	2.8	2.8	3.7	0.0	3.4	2.2	4.2	0.0	3.3	0.0	1.1	2.3	3.2	1.2	0.8	3.7	4.0	4.9	2.7	2.0	1.7	1.3	2.0	2.5	4.8	5.2	3.3	5.0	3.9	2.0	4.4	0.8	0.3	4.7	3.7	1.8	3.7	2.1	3.6	4.1	3.0	1.8	3.6	8.1	4.5	9.2	2.0	6.5	2.2	1.6	2.5	0.0	2.0	2.5	0.1	0.6	3.5	0.1	2.6	4.2	2.3	2.4	1.5
TM9SF2	P76	ENSG00000125304	"Transmembrane 9 superfamily member 2"	Q99805	13	99446311-99564048	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005657	Supported					NA	NA		2100000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA005657: AB_1080303"	"unprognostic (9.77e-3)"	"unprognostic (3.51e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.76e-1)"	"prognostic unfavorable (6.40e-4)"	"unprognostic (5.96e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.19e-2)"	"prognostic favorable (5.21e-7)"	"unprognostic (6.49e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.21e-1)"	66.6	67.2	34.4	66.7	37.4	64.6	90.6	35.9	41.4	100.2	62.5	115.8	119.4	63.6	119.0	56.1	76.6	73.6	51.0	35.8	40.3	108.4	169.4	78.6	62.1	35.9	35.1	53.2	90.2	126.8	41.5	98.2	36.6	97.8	123.7	41.9	109.6	73.2	36.3	56.6	119.3	65.7	39.8	62.4	104.1	59.6	36.9	49.7	121.2	48.3	71.3	90.0	44.4	44.9	187.3	56.7	75.8	107.8	223.2	134.8	108.2	124.1	154.5	86.6	134.8	93.1	234.7	72.1	100.0	150.1	88.4	183.1	81.1	108.7	117.8	80.8	57.8	89.6	90.9	100.2	118.0	235.8	100.0	106.2	132.4	75.1	76.8	133.2	110.4	72.8	90.7	70.0	103.0	62.8	59.1	91.9	66.3	335.7	70.0	49.3	61.0	78.7	178.9	137.3	71.7	87.5	71.7	285.6	94.8	145.5	174.0	280.5	109.1	69.6	50.7	70.5	77.8	96.6	120.8	29.0	163.8	120.0	103.0	192.4	156.4	174.9	57.7	180.5	72.8	86.9	68.4	65.3	139.6	60.1	62.8	58.4	251.3	76.0	182.1	159.6	109.6	178.1	34.4	37.4	35.9	41.4	35.8	40.3	35.9	35.1	36.6	39.8	36.9	44.9	68.9	83.3	76.3	29.0	72.5	40.9	57.3	132.8	48.9	20.6	82.9	40.5	44.0	70.1	170.7	86.5	18.8	99.3	94.5	141.1	11.7	98.6	149.2	101.0	75.6	65.4	83.0	47.9	36.6	102.7	122.8	74.6	89.2	93.9	54.5	35.2	87.4	172.9	116.0	21.9	44.4	167.9	128.1	137.6	57.2	41.8	50.1	100.7	72.9	44.0	97.4	42.7	42.2	34.2	44.8	83.4	116.7	52.3	143.1	69.0	123.5	70.8	187.7	25.3	19.7	44.1	104.1	109.7	56.3	69.8	52.1	171.4	53.2	43.2	119.4	104.0
TM9SF3	SMBP	ENSG00000077147	"Transmembrane 9 superfamily member 3"	Q9HD45	10	96518110-96587452	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039609	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA		240000	"Cluster 46: Basophils - DNA binding"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 27: Mucus-secreting cells - Mucin production"	Vesicles	"Golgi apparatus"	"HPA039609: AB_10673535"	"unprognostic (3.33e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.11e-2)"	"unprognostic (4.95e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.26e-2)"	"unprognostic (4.14e-3)"	"unprognostic (4.81e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.48e-1)"	"unprognostic (8.28e-3)"	"unprognostic (6.18e-2)"	57.0	53.4	28.5	54.6	33.0	36.7	58.4	33.2	34.8	65.3	34.9	111.8	116.9	62.5	69.2	57.5	46.0	89.9	39.7	27.7	34.4	68.0	75.0	43.2	42.0	33.8	31.2	62.9	73.3	70.1	22.5	67.8	35.2	91.7	94.5	43.4	83.2	56.4	26.6	38.5	112.4	50.8	35.7	41.8	183.5	34.6	30.7	44.7	87.4	41.1	44.9	72.8	34.8	43.6	146.8	97.2	106.5	149.3	151.4	112.4	127.7	197.8	146.7	84.0	67.5	116.4	281.6	107.3	107.0	175.8	105.5	135.3	97.6	108.1	156.8	121.3	83.6	95.3	81.8	92.0	114.5	197.7	107.2	105.0	108.6	118.6	203.7	253.2	94.7	96.4	97.0	119.9	132.2	66.4	77.1	76.2	68.9	237.9	59.6	94.6	134.4	84.8	120.1	106.8	49.6	110.3	104.1	98.6	103.0	126.2	171.0	73.7	165.3	103.5	87.1	104.6	183.1	123.7	152.3	98.4	140.9	134.9	73.5	5.7	2.2	3.8	3.5	2.3	4.0	2.1	3.6	3.9	2.7	1.5	2.7	3.6	2.4	3.9	2.4	7.1	4.0	1.3	28.5	33.0	33.2	34.8	27.7	34.4	33.8	31.2	35.2	35.7	30.7	43.6	115.7	51.3	43.0	43.1	53.2	116.8	118.8	63.2	51.8	57.8	103.1	73.0	65.0	121.5	88.2	141.6	56.3	77.5	89.5	238.7	21.5	80.7	27.6	93.0	162.0	99.8	123.9	68.8	59.9	146.1	97.6	98.7	212.0	192.2	40.6	75.0	78.9	126.9	60.0	58.9	64.0	368.3	69.2	85.6	125.3	12.8	93.2	73.5	103.2	49.6	56.8	58.1	54.6	69.9	79.2	132.1	140.6	82.4	88.9	196.1	141.5	59.3	65.9	54.7	65.7	89.2	121.0	45.8	38.4	73.2	120.6	140.9	63.0	74.5	246.7	156.2
TM9SF4	"dJ836N17.2, KIAA0255"	ENSG00000101337	"Transmembrane 9 superfamily member 4"	Q92544	20	32109714-32167258	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064099	Approved					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 10: Non-specific - Unknown function"			"HPA064099: AB_2685190"	"unprognostic (3.10e-2)"	"unprognostic (9.03e-3)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (6.37e-6)"	"unprognostic (3.85e-1)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (2.15e-4)"	"unprognostic (1.37e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.91e-1)"	"unprognostic (6.65e-2)"	"unprognostic (7.68e-2)"	"unprognostic (6.98e-3)"	"unprognostic (7.66e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.23e-2)"	23.4	21.1	16.7	23.4	16.9	16.3	22.6	14.8	19.5	26.5	20.7	32.1	29.6	25.0	30.4	30.3	34.8	22.1	24.4	17.6	17.9	26.6	33.7	24.4	18.9	15.3	15.8	28.7	30.5	52.6	17.0	39.6	16.3	28.0	37.2	17.7	30.7	26.8	23.3	32.0	29.0	31.8	14.0	23.6	29.8	18.0	18.9	21.0	24.7	24.3	24.2	27.9	22.9	16.2	59.0	41.1	46.1	53.2	88.7	71.9	59.1	47.8	71.9	65.6	63.7	122.2	71.1	41.0	88.2	78.2	102.4	94.8	52.4	101.9	56.4	23.5	29.4	94.4	34.6	93.1	78.3	45.9	52.0	76.2	76.3	49.7	79.6	80.3	59.1	48.3	60.4	74.5	51.8	62.5	46.5	36.4	41.2	71.2	50.0	43.9	65.1	51.4	57.2	41.3	39.0	45.7	88.6	57.7	51.4	61.0	72.4	52.0	48.5	119.2	36.7	63.7	59.1	74.9	65.9	38.2	94.4	149.6	54.6	24.0	48.4	9.9	20.0	50.5	24.8	16.5	17.7	22.9	41.8	13.1	19.4	16.4	11.7	18.8	67.8	13.7	19.1	34.6	16.7	16.9	14.8	19.5	17.6	17.9	15.3	15.8	16.3	14.0	18.9	16.2	16.4	25.6	25.2	33.0	16.2	7.0	17.4	27.1	17.6	12.2	15.7	16.1	16.0	14.3	36.5	9.2	16.7	29.4	11.9	25.2	1.9	19.0	53.5	18.0	25.2	18.4	13.9	12.4	31.2	18.5	21.7	20.4	23.4	24.9	8.2	19.3	16.8	26.2	24.0	8.4	37.1	31.7	20.3	19.1	10.5	57.5	16.8	22.5	7.2	24.4	25.2	14.0	10.3	28.6	34.8	19.8	25.7	10.9	23.1	22.1	29.8	14.0	32.8	12.3	6.6	19.9	25.8	26.5	9.7	21.8	11.4	37.6	16.8	23.4	27.5	21.9
TMCO1	"HP10122, TMCC4"	ENSG00000143183	"Transmembrane and coiled-coil domains 1"	Q9UM00	1	165724293-165827755	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"	"Disease variant, Glaucoma, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054768, HPA078775"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Endoplasmic reticulum"		"HPA054768: AB_2682597, HPA078775: "	"unprognostic (1.22e-2)"	"unprognostic (3.28e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.97e-1)"	"prognostic unfavorable (5.17e-7)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (5.92e-2)"	"unprognostic (4.16e-2)"	"unprognostic (7.95e-3)"	"unprognostic (1.78e-1)"	"unprognostic (5.20e-2)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (2.85e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.14e-2)"	"unprognostic (9.80e-2)"	67.5	92.5	46.4	51.6	50.2	48.4	91.1	53.8	63.5	74.0	72.2	127.0	115.7	55.9	111.5	58.5	65.9	80.1	56.4	46.4	55.6	110.3	162.5	55.0	62.4	54.1	55.5	59.5	73.5	143.6	33.8	57.4	55.0	79.6	128.7	74.3	77.8	69.9	48.7	39.3	108.9	61.4	56.6	46.5	80.7	75.4	49.8	89.3	103.8	48.0	70.8	97.7	29.1	60.6	158.4	172.1	132.2	77.9	243.9	120.7	126.9	259.4	191.7	156.0	162.1	249.9	229.2	99.1	267.4	195.9	67.1	214.7	171.8	140.3	175.1	252.0	164.2	121.1	180.3	158.7	195.1	216.6	154.1	159.0	173.9	179.5	142.6	148.4	117.1	122.6	329.7	186.0	227.3	123.1	172.1	160.6	169.4	527.6	197.3	125.0	143.4	256.1	204.7	198.4	133.5	235.4	201.3	209.2	170.9	195.0	277.1	275.7	121.5	138.9	116.5	123.8	248.3	357.4	521.1	346.5	111.4	139.7	187.4	213.3	172.2	172.9	159.7	169.4	170.4	151.8	168.7	173.1	135.5	132.6	134.3	156.5	132.1	156.6	201.7	243.8	207.1	290.3	46.4	50.2	53.8	63.5	46.4	55.6	54.1	55.5	55.0	56.6	49.8	60.6	124.0	96.1	70.7	23.8	95.6	84.8	89.8	264.5	75.1	79.1	142.9	135.9	62.6	224.4	181.1	213.3	68.8	136.1	138.9	371.5	43.0	202.3	82.2	131.4	147.9	92.7	88.6	75.5	20.7	191.7	148.4	113.1	64.2	154.7	76.5	71.9	106.7	326.0	140.9	75.7	24.9	137.0	227.9	106.4	76.0	151.6	123.6	92.7	99.6	16.9	78.9	236.7	152.4	25.6	23.3	227.0	215.7	129.4	153.5	73.6	290.0	151.5	175.2	75.9	124.9	67.7	101.7	232.1	87.7	89.4	92.9	111.4	109.2	117.6	143.6	94.5
TMEM106C	MGC5576	ENSG00000134291	"Transmembrane protein 106C"	Q9BVX2	12	47963569-47968878	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 244.8;Muller glia cells: 268.4;Paneth cells: 208.3;Proximal enterocytes: 385.7;Undifferentiated cells: 220.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-937: 876.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047204	Enhanced					NA	Yes			"Cluster 35: T-regs - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 32: U-937 - Innate immune response"	"Cluster 45: Enterocytes - Digestion"			"HPA047204: AB_2679982"	"unprognostic (1.63e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (5.27e-8)"	"unprognostic (1.05e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.52e-3)"	"unprognostic (3.60e-1)"	"unprognostic (7.29e-2)"	"prognostic favorable (4.62e-4)"	"unprognostic (1.12e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.57e-2)"	"unprognostic (1.83e-1)"	28.1	41.9	37.4	36.3	37.5	48.2	66.6	38.2	46.1	52.0	56.7	138.2	113.2	35.8	135.8	42.0	48.5	45.5	58.9	39.7	42.4	80.9	44.7	39.4	38.4	36.4	36.3	55.5	66.5	146.2	62.9	73.4	37.1	41.0	145.3	121.7	59.7	51.7	26.5	37.4	120.1	55.3	35.5	78.1	53.5	40.0	43.4	55.9	49.3	34.3	46.8	28.9	32.8	33.7	243.9	166.4	151.7	167.7	68.5	50.0	143.2	133.6	191.0	238.5	203.8	250.2	243.3	212.2	182.9	147.6	221.8	162.1	239.2	146.1	226.6	203.8	229.1	163.7	217.2	101.7	52.4	172.6	117.9	34.4	98.4	217.8	114.2	163.4	154.2	224.0	113.4	235.6	169.6	174.4	248.2	75.5	27.0	258.7	226.5	217.9	195.9	180.9	127.2	183.2	100.9	120.5	206.8	138.5	142.4	78.4	503.5	136.9	38.3	99.8	168.9	145.0	240.9	130.8	228.9	240.1	127.3	876.5	97.9	39.3	8.8	23.9	44.4	8.6	54.9	36.9	42.8	46.5	12.5	30.8	39.7	44.0	7.6	19.6	10.4	1.9	66.4	41.0	37.4	37.5	38.2	46.1	39.7	42.4	36.4	36.3	37.1	35.5	43.4	33.7	14.5	32.1	20.7	6.8	26.5	47.9	39.2	45.8	36.5	30.2	54.9	78.7	39.1	61.5	21.9	35.0	18.8	75.3	17.7	244.8	86.1	63.8	2.8	35.7	5.7	17.3	36.0	49.2	14.1	45.1	32.8	45.4	37.2	18.6	10.8	86.3	55.0	19.6	54.3	30.3	13.0	150.8	101.7	16.4	20.7	6.8	32.6	21.5	21.4	8.4	10.1	268.4	27.8	4.5	1.2	35.5	208.3	41.3	72.5	22.6	385.7	82.2	11.5	47.2	13.1	46.4	36.9	52.8	36.0	55.4	40.9	14.9	31.5	35.0	220.5	39.4
TMEM139	FLJ90586	ENSG00000178826	"Transmembrane protein 139"	Q8IV31	7	143279957-143288048	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 33.8;kidney: 32.2"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 51.5;Ductal cells: 49.0;Proximal enterocytes: 90.7;Proximal tubular cells: 89.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 22.4;CAPAN-2: 40.8;EFO-21: 27.9;RPTEC TERT1: 70.5;SK-BR-3: 25.0;T-47d: 68.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA036982, HPA036983"	Approved		Approved	"Plasma membrane,Focal adhesion sites"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"	"Focal adhesion sites"	"HPA036982: AB_2675413, HPA036983: AB_10672275"	"unprognostic (2.58e-1)"	"unprognostic (4.38e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.83e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.82e-2)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (2.89e-1)"	"prognostic favorable (3.05e-5)"	"unprognostic (1.73e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.83e-2)"	"unprognostic (9.08e-3)"	1.1	2.7	1.9	2.2	6.4	0.0	3.2	6.6	3.2	8.9	2.9	5.7	33.8	1.2	1.3	0.4	6.8	7.2	3.3	1.6	4.1	32.2	9.2	5.1	0.2	10.5	6.9	0.4	8.7	6.8	1.8	5.2	8.9	0.9	4.5	0.8	4.8	3.1	0.1	1.2	19.3	0.4	5.9	0.9	2.5	3.8	5.7	0.0	7.2	0.0	0.1	1.8	0.3	13.9	22.4	1.6	0.3	0.1	0.0	0.0	14.3	0.2	0.0	0.0	0.0	5.2	40.8	0.3	27.9	0.0	1.8	18.5	0.0	9.3	0.0	0.3	0.0	0.0	2.4	3.1	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.9	0.0	1.3	0.0	0.5	0.0	1.5	1.6	1.0	0.0	0.5	1.6	0.4	0.3	0.0	70.5	5.6	0.4	0.1	1.1	25.0	0.2	0.5	68.5	0.0	0.0	0.3	0.7	0.0	0.1	0.0	0.1	0.3	0.3	0.3	0.3	0.0	0.0	0.2	0.0	0.8	0.0	0.1	0.3	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.8	0.0	0.6	0.1	1.9	6.4	6.6	3.2	1.6	4.1	10.5	6.9	8.9	5.9	5.7	13.9	0.6	16.0	5.9	0.7	0.2	0.1	2.1	2.8	0.0	0.2	8.2	15.5	2.3	27.1	5.4	51.5	0.0	30.5	0.2	28.9	35.2	49.0	14.8	16.2	1.6	0.7	3.6	0.0	0.0	4.7	5.2	0.4	3.1	17.9	0.0	2.2	1.4	16.2	1.9	0.0	0.2	6.7	0.0	0.6	0.3	13.6	0.0	0.7	5.4	0.0	1.1	7.7	0.0	0.0	5.2	30.6	23.3	0.0	0.0	1.2	90.7	89.1	3.8	0.1	0.0	0.0	0.9	0.1	0.2	0.6	0.0	6.4	0.8	0.7	12.9	1.4
TMEM161B	MGC33214	ENSG00000164180	"Transmembrane protein 161B"	Q8NDZ6	5	88189633-88269476	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 59.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 82.1;HMC-1: 85.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044562	Uncertain					NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"			"HPA044562: AB_10794291"	"unprognostic (2.08e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.06e-2)"	"unprognostic (5.64e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.96e-3)"	"unprognostic (1.55e-2)"	"unprognostic (3.04e-1)"	"unprognostic (7.62e-3)"	"unprognostic (9.35e-2)"	4.6	5.8	5.0	5.8	4.7	6.2	16.0	7.3	6.3	6.5	3.0	9.7	12.4	6.4	14.2	7.8	7.1	5.6	4.8	4.3	3.8	9.7	11.9	10.1	9.1	3.1	3.1	11.2	14.0	23.0	4.8	8.1	3.2	12.3	11.3	18.2	14.1	8.9	6.4	15.6	11.5	5.8	3.0	6.4	22.9	12.5	4.0	8.6	20.9	7.0	9.5	7.4	6.0	5.6	11.8	8.0	8.7	9.5	5.4	10.3	18.6	10.3	15.4	14.6	21.2	8.9	30.2	18.2	5.2	7.7	26.6	12.3	10.2	13.3	18.4	16.4	10.7	82.1	10.3	5.9	14.0	15.9	85.2	9.2	19.1	12.4	18.3	10.4	6.5	11.9	40.5	16.0	12.7	5.5	11.6	13.9	5.6	8.7	14.3	9.7	10.1	19.9	13.0	16.4	11.1	9.3	5.9	16.3	24.5	7.7	9.8	14.5	5.4	9.5	8.7	13.7	18.9	19.6	33.3	14.9	23.3	15.7	13.4	1.5	1.4	1.0	2.9	2.8	2.9	2.2	2.4	2.1	0.8	2.1	2.4	1.9	0.8	2.9	1.1	2.6	2.1	1.2	5.0	4.7	7.3	6.3	4.3	3.8	3.1	3.1	3.2	3.0	4.0	5.6	9.8	28.9	16.4	37.2	19.2	7.8	8.0	12.0	5.7	15.8	13.6	9.7	16.3	11.5	15.0	9.2	16.7	9.3	17.9	14.7	3.9	8.8	3.6	10.2	11.4	7.7	14.3	10.3	43.4	9.7	4.1	9.8	12.2	14.0	16.5	14.4	15.0	23.1	5.3	6.7	46.3	13.7	6.1	11.8	5.5	3.1	10.5	8.2	0.0	28.1	7.1	15.6	22.6	59.3	55.0	11.3	6.6	12.8	13.1	9.4	11.3	6.4	9.4	22.2	6.6	8.9	8.9	35.8	12.6	9.3	7.1	15.1	15.8	11.3	14.3	7.5
TMEM168	DKFZp564C012,FLJ13576	ENSG00000146802	"Transmembrane protein 168"	Q9H0V1	7	112762377-112790423	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020389, HPA077143"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	Cytosol	"HPA020389: AB_1858101, HPA077143: "	"unprognostic (1.54e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.55e-1)"	"unprognostic (4.92e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.32e-2)"	"unprognostic (2.30e-3)"	"prognostic favorable (4.07e-6)"	"unprognostic (1.60e-3)"	"unprognostic (8.73e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.89e-3)"	"unprognostic (3.30e-2)"	12.9	10.6	6.0	12.5	7.6	6.7	15.6	7.5	7.1	11.6	9.5	22.4	13.7	13.2	17.9	14.1	10.7	12.2	13.9	5.8	6.8	12.8	8.4	12.1	11.3	8.1	6.6	12.1	6.7	28.6	8.3	14.4	8.2	16.3	24.6	20.2	20.6	13.4	9.4	26.7	14.8	15.3	7.8	12.3	12.6	10.2	6.7	13.5	17.7	9.4	11.2	10.9	12.9	10.1	16.0	13.2	12.2	10.9	20.4	41.5	17.2	17.3	16.2	6.4	5.6	17.0	16.4	16.9	11.4	17.2	14.6	16.8	12.5	15.1	16.5	26.8	12.9	14.7	16.8	9.7	13.7	16.4	17.9	20.3	38.6	7.3	10.9	6.0	18.9	13.6	19.9	15.0	23.3	25.2	14.2	10.3	9.9	16.7	10.2	9.5	6.1	24.9	16.0	29.9	9.2	18.2	23.3	30.6	14.0	14.9	17.5	14.4	27.0	30.5	15.5	14.5	22.6	25.4	23.1	18.9	19.7	14.7	40.0	21.2	14.9	11.6	12.1	12.6	14.4	10.9	12.9	11.8	16.0	13.2	18.6	13.0	8.4	13.5	13.2	11.1	13.0	9.5	6.0	7.6	7.5	7.1	5.8	6.8	8.1	6.6	8.2	7.8	6.7	10.1	17.4	12.8	22.3	43.1	18.6	31.1	19.1	12.0	27.3	31.5	16.4	14.4	18.1	10.0	18.9	33.1	27.1	35.5	14.3	16.9	0.0	5.9	2.9	9.2	22.1	17.3	20.5	14.1	29.9	9.1	8.9	17.6	18.3	11.8	12.0	19.2	18.5	12.6	8.9	16.8	32.6	34.8	16.2	13.5	9.3	1.9	18.3	10.9	24.9	41.2	10.8	16.3	15.5	70.9	71.5	6.1	17.0	14.7	10.2	21.6	15.5	6.0	7.1	29.6	6.6	19.4	16.7	18.1	13.3	24.8	26.0	14.2	13.8	21.1	30.5	14.5
TMEM252	"C9orf71, MGC34760"	ENSG00000181778	"Transmembrane protein 252"	Q8N6L7	9	68536580-68540883	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 22.0;kidney: 35.7"	"Group enriched"	"Detected in some"	5	"Proximal enterocytes: 21.6;Proximal tubular cells: 20.6"	"Cancer enriched"	"Detected in many"	17	"renal cancer: 35.7"	"Region enhanced"	"Detected in single"		"cerebellum: 1.2"	"Immune cell enriched"	"Detected in single"	8	"neutrophil: 4.1"	"Lineage enriched"	"Detected in single"	40	"granulocytes: 4.1"	"Cell line enhanced"	"Detected in some"		"PC-3: 1.2;RPTEC TERT1: 2.2;SK-BR-3: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA079457	Enhanced					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA079457: "	"unprognostic (2.64e-1)"		"unprognostic (3.28e-3)"	"unprognostic (3.72e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.53e-2)"	"unprognostic (4.00e-2)"	"unprognostic (7.79e-3)"		"unprognostic (6.47e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.42e-2)"	"prognostic favorable (1.75e-7)"	"unprognostic (7.63e-2)"	"unprognostic (6.15e-2)"	"unprognostic (7.66e-2)"	"unprognostic (2.50e-1)"	1.1	2.9	0.1	1.1	0.0	0.0	0.6	1.2	0.0	1.5	0.0	8.4	1.6	5.5	0.0	6.0	3.3	1.3	4.5	0.0	0.0	35.7	1.6	0.3	0.3	0.0	0.1	0.5	0.1	0.0	0.0	0.2	0.1	2.8	0.2	1.3	0.2	0.0	1.3	0.5	22.0	0.0	0.1	0.5	2.0	0.1	0.4	0.0	0.4	0.2	0.0	6.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.7	0.0	2.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	1.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.6	20.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.0
TMEM30B	CDC50B	ENSG00000182107	"Transmembrane protein 30B"	Q3MIR4	14	61277370-61281761	"Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 124.0;Prostatic glandular cells: 101.1;Urothelial cells: 131.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 68.7;CAPAN-2: 54.4;HaCaT: 31.7;HBEC3-KT: 39.0;hTCEpi: 29.1;MCF7: 44.6;RT4: 94.9;T-47d: 30.4"	"Not detected"	"Not detected"							HPA043162	Uncertain					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 15: RT4 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA043162: AB_10796688"	"unprognostic (4.06e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.47e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.20e-2)"	"unprognostic (2.45e-3)"	"unprognostic (3.43e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.10e-2)"	"unprognostic (2.26e-1)"	"prognostic favorable (5.89e-5)"	"unprognostic (2.21e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.85e-1)"	3.9	1.6	0.5	3.7	0.7	0.4	14.8	0.5	1.0	16.4	0.9	29.1	43.3	3.8	28.2	14.1	15.2	23.9	2.0	0.3	0.7	12.3	12.3	14.5	1.2	0.6	0.5	2.5	35.7	59.1	18.2	5.7	0.5	21.9	26.1	0.3	27.7	13.4	1.2	8.6	34.4	1.7	0.5	0.7	42.2	2.6	0.6	5.3	50.0	1.9	4.4	16.1	9.3	0.4	68.7	0.2	0.0	0.0	6.7	1.6	0.1	0.1	0.0	0.0	0.0	11.6	54.4	0.0	0.1	0.0	0.0	31.7	0.0	39.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	29.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	44.6	0.0	0.1	0.6	28.2	1.6	0.0	1.5	0.2	0.0	94.9	11.2	0.1	0.8	25.6	0.1	1.9	30.4	0.1	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.3	0.1	0.0	0.0	0.7	0.5	0.0	0.2	0.0	0.0	0.0	0.1	0.5	0.7	0.5	1.0	0.3	0.7	0.6	0.5	0.5	0.5	0.6	0.4	0.6	28.9	31.9	0.0	0.6	64.9	124.0	19.5	61.5	0.0	32.2	16.5	1.9	47.1	24.5	40.5	0.0	28.0	1.1	90.8	13.7	24.8	0.9	23.8	3.9	3.9	23.4	0.0	0.0	37.2	11.4	5.5	62.7	45.3	2.5	0.7	4.2	14.1	2.0	0.0	0.0	73.1	20.3	1.0	6.8	1.6	8.7	1.5	5.4	1.0	0.6	2.9	2.1	0.0	0.1	31.9	75.3	79.0	0.4	101.1	73.6	1.0	22.7	0.3	13.1	2.4	5.4	5.9	3.6	43.3	63.6	35.8	3.6	0.9	64.7	131.9
TMEM37	"PR, PR1"	ENSG00000171227	"Transmembrane protein 37"	Q8WXS4	2	119429901-119438504	"Predicted intracellular proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 101.1;liver: 100.0;parathyroid gland: 124.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 179.9;Hepatocytes: 184.5;Muller glia cells: 146.8;Proximal enterocytes: 575.7;Proximal tubular cells: 188.1"	"Cancer enhanced"	"Detected in all"		"renal cancer: 57.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"EFO-21: 26.9;Hep G2: 74.7;RPTEC TERT1: 60.0"	"Low region specificity"	"Detected in all"							HPA053794	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 45: Enterocytes - Digestion"	"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA053794: AB_2682265"	"unprognostic (2.54e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.59e-3)"	"unprognostic (2.56e-1)"	"unprognostic (9.60e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.83e-2)"	"unprognostic (7.30e-3)"	"unprognostic (1.93e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.61e-2)"	53.1	11.1	2.1	6.6	2.0	0.7	25.6	1.8	3.6	21.9	2.5	37.3	53.5	6.4	4.8	6.8	3.4	23.2	4.8	1.5	1.8	101.1	100.0	15.4	10.2	2.5	2.1	12.7	13.3	124.7	1.0	14.9	2.3	3.9	19.0	23.6	7.0	7.6	2.4	10.5	76.1	4.8	2.5	25.7	18.1	5.1	3.7	3.0	31.1	4.2	4.9	7.0	5.6	3.2	0.0	7.3	0.7	0.3	4.3	0.4	1.0	0.2	0.1	0.0	0.1	11.4	6.4	0.0	26.9	3.4	0.6	1.7	3.0	0.0	0.0	0.0	2.9	1.0	4.0	74.7	5.9	0.0	0.1	9.7	0.0	0.0	0.0	0.2	5.9	0.0	0.2	10.9	0.0	0.7	0.0	0.8	5.4	0.1	0.2	0.0	0.1	9.9	60.0	4.9	0.9	0.4	0.3	2.9	0.0	5.0	1.2	1.7	3.8	0.0	10.4	1.8	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	2.1	2.0	1.8	3.6	1.5	1.8	2.5	2.1	2.3	2.5	3.7	3.2	12.2	25.6	9.6	0.0	3.2	2.0	0.3	11.1	0.0	2.4	1.8	1.5	2.1	82.9	13.6	18.4	0.0	64.9	0.1	179.9	50.9	36.1	0.3	7.7	98.8	15.1	9.1	5.3	0.0	52.3	3.8	17.9	11.7	10.3	1.3	16.4	61.8	184.5	64.6	6.7	0.0	22.0	14.2	65.5	5.0	1.9	49.7	19.5	1.8	0.0	0.6	146.8	0.0	0.0	0.6	15.3	68.1	3.8	0.0	0.1	575.7	188.1	7.6	17.4	0.0	0.9	14.8	0.0	0.8	1.0	2.8	104.1	2.4	45.3	23.3	2.3
TMEM62	FLJ23375	ENSG00000137842	"Transmembrane protein 62"	Q0P6H9	15	43123279-43185144	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"OE19: 61.0;U-266/84: 67.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044461, HPA062359"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Nuclear bodies,Cytoplasmic bodies"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 16: U-266 - Nucleosome"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nucleoli fibrillar center, Nuclear bodies, Cytoplasmic bodies"		"HPA044461: AB_2678950, HPA062359: AB_2684747"	"unprognostic (7.43e-2)"	"unprognostic (4.96e-2)"	"unprognostic (4.56e-2)"	"prognostic favorable (9.72e-7)"	"unprognostic (2.53e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.41e-2)"	"unprognostic (4.83e-2)"	"unprognostic (3.30e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.67e-2)"	7.1	4.6	4.8	6.0	5.0	9.0	22.9	8.2	6.7	8.1	3.6	13.1	13.1	5.4	12.3	6.2	7.5	7.9	5.1	5.3	4.8	7.6	10.3	8.8	7.2	4.5	4.5	3.2	8.1	13.7	4.6	10.3	5.0	6.1	14.4	8.9	13.6	7.1	9.4	5.2	11.7	6.5	5.0	6.1	10.2	2.0	5.4	4.0	8.5	6.6	8.0	7.6	5.4	5.6	14.9	7.9	3.5	6.8	4.3	5.5	36.4	13.9	17.6	24.1	33.3	12.5	28.5	15.0	7.9	13.2	21.7	27.6	14.8	10.9	8.7	17.7	6.8	12.2	15.4	9.5	9.4	12.7	10.5	3.9	13.0	10.6	7.4	6.8	13.6	3.7	10.9	12.7	2.8	3.5	0.0	3.0	1.2	61.0	3.2	7.5	3.7	7.9	12.9	18.6	22.2	9.6	10.9	27.2	6.7	3.9	14.6	12.9	8.0	11.9	4.9	8.5	22.7	10.6	67.1	10.7	11.0	14.0	10.4	0.5	0.7	1.1	0.8	0.3	1.0	0.7	1.1	1.0	0.7	0.8	0.7	0.9	0.2	1.6	0.4	1.7	2.0	0.4	4.8	5.0	8.2	6.7	5.3	4.8	4.5	4.5	5.0	5.0	5.4	5.6	7.7	16.0	4.6	12.1	18.8	2.3	4.1	2.8	5.7	5.6	12.3	6.3	2.6	8.6	5.0	12.9	10.4	21.9	7.0	12.5	5.9	12.9	1.6	9.6	3.7	5.6	4.2	9.1	36.3	14.8	25.2	4.8	11.2	13.9	5.1	7.0	6.1	7.3	7.5	1.7	33.4	11.4	6.1	6.5	4.8	3.7	2.5	7.1	5.4	18.7	6.4	7.8	6.2	29.1	34.5	12.2	8.1	1.2	16.5	2.7	12.8	3.4	6.1	9.9	6.6	4.1	5.2	2.2	1.0	8.6	2.8	34.1	7.4	3.8	11.0	4.8
TMEM68	FLJ32370	ENSG00000167904	"Transmembrane protein 68"	Q96MH6	8	55696424-55773407	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018216, HPA019173"	Uncertain		Approved	Vesicles		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 49: Ciliated cells - Cilium organization"	Vesicles		"HPA018216: AB_2205185, HPA019173: AB_1858129"	"unprognostic (4.43e-2)"	"unprognostic (3.10e-2)"	"unprognostic (8.04e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.46e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.37e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.63e-1)"	8.9	12.9	5.8	8.2	6.5	10.9	13.1	13.2	8.4	10.3	14.5	13.9	12.7	10.5	14.3	13.0	22.0	10.8	6.0	6.6	5.8	17.4	12.8	10.2	9.5	5.2	5.5	13.4	10.6	17.6	5.7	11.9	4.7	13.3	14.5	11.4	12.5	10.2	5.0	14.3	12.8	9.5	4.6	8.3	11.1	8.3	5.6	11.0	16.5	5.3	9.2	11.8	7.6	10.0	22.3	13.4	21.5	13.1	17.0	20.3	38.5	19.6	14.6	18.2	17.1	18.3	41.3	24.0	21.8	12.7	22.5	27.0	17.0	25.5	20.2	33.3	19.2	29.0	12.4	19.5	19.1	12.7	15.7	14.1	38.1	18.4	43.2	26.0	16.3	24.9	29.2	23.6	26.3	11.8	31.8	17.0	24.1	46.1	6.5	22.6	8.9	15.7	29.9	16.9	18.0	16.2	12.6	20.3	39.9	27.7	30.2	16.0	13.2	13.8	17.6	23.6	16.2	20.1	27.4	31.4	18.7	20.6	21.1	35.0	7.6	5.9	7.8	5.0	11.1	10.0	9.1	8.1	8.3	9.7	7.5	10.9	8.4	9.4	9.3	7.6	7.4	4.4	5.8	6.5	13.2	8.4	6.6	5.8	5.2	5.5	4.7	4.6	5.6	10.0	10.5	12.8	12.7	10.7	13.4	34.2	28.0	38.4	19.9	18.2	14.2	12.1	5.2	15.7	30.4	25.8	14.6	32.9	14.6	15.3	13.7	16.4	2.3	42.0	10.4	11.1	15.0	20.0	17.0	8.0	21.1	12.2	13.3	10.4	5.7	12.6	11.4	12.5	13.2	21.9	21.6	26.5	40.7	12.6	11.0	1.2	13.1	9.0	7.2	20.6	13.0	17.2	9.2	26.7	16.9	15.8	21.6	13.9	14.6	26.9	17.4	22.0	66.7	15.3	26.3	9.2	10.8	16.2	15.3	17.5	35.5	22.2	11.7	15.3	15.8	29.3
TNFSF15	"MGC129934, MGC129935, TL1, TL1A, VEGI, VEGI192A"	ENSG00000181634	"TNF superfamily member 15"	O95150	9	114784652-114806039	"Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 9.5"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 25.6;Basal squamous epithelial cells: 14.8;Endometrial ciliated cells: 15.7;Glandular and luminal cells: 28.9;Squamous epithelial cells: 13.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 13.2;hTEC/SVTERT24-B: 8.6;HUVEC TERT2: 16.7;OE19: 16.0;RT4: 16.5;TIME: 7.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA012948, HPA046522"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"	"Secreted to blood"	NA	NA	1110000		"Cluster 25: Monocytes - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	"Nuclear membrane"	"Nucleoplasm, Cytosol"	"HPA012948: AB_1858024, HPA046522: AB_2679683"	"unprognostic (3.41e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.29e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.78e-2)"	"unprognostic (2.09e-1)"	"unprognostic (8.64e-5)"	"unprognostic (1.97e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.68e-3)"	"unprognostic (4.46e-3)"	0.8	0.7	0.1	2.5	0.2	0.1	0.9	0.1	0.5	1.5	0.1	2.3	9.5	1.0	0.9	1.2	0.9	1.9	0.0	0.1	0.2	4.5	0.2	4.1	0.8	0.3	0.1	0.1	0.1	0.8	0.1	4.4	0.2	4.1	2.0	0.0	4.8	1.9	0.1	0.6	3.5	2.0	0.0	0.5	2.9	0.1	0.2	0.6	0.9	0.0	1.0	4.7	0.7	0.4	0.5	4.4	0.0	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.1	0.2	3.0	1.6	0.0	0.0	0.5	13.2	0.0	0.2	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	8.6	0.0	0.0	16.7	0.0	0.0	0.9	0.4	0.6	0.0	0.0	0.3	16.0	0.0	0.0	0.1	0.0	0.1	16.5	0.1	0.0	0.0	0.7	0.0	5.6	1.2	0.0	7.7	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.1	0.1	0.2	0.1	0.5	0.1	0.2	0.3	0.1	0.2	0.0	0.2	0.4	0.2	12.8	12.1	0.0	0.1	0.5	7.7	25.6	14.8	0.3	3.7	3.7	0.6	1.5	4.9	7.3	0.0	0.7	0.4	8.0	0.0	4.9	0.7	15.7	2.9	0.3	0.0	0.0	0.1	2.0	0.2	1.2	8.2	28.9	0.0	0.0	0.0	0.0	2.3	0.0	0.7	2.4	2.0	0.3	5.1	0.1	0.0	5.0	0.0	0.0	5.3	0.1	0.0	0.0	0.1	1.3	0.5	0.4	1.2	4.9	8.9	9.3	1.0	0.3	0.0	0.4	3.0	0.0	0.0	13.7	0.6	0.3	1.0	0.1	7.4	6.5
TOM1L1	SRCASM	ENSG00000141198	"Target of myb1 like 1 membrane trafficking protein"	O75674	17	54899387-54961956	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 103.7;Late spermatids: 184.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022916	Uncertain					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA022916: AB_1858181"	"unprognostic (1.50e-1)"	"unprognostic (7.70e-3)"	"prognostic favorable (1.61e-4)"	"unprognostic (9.59e-2)"	"unprognostic (1.59e-3)"	"unprognostic (6.26e-3)"	"unprognostic (1.18e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.49e-3)"	"unprognostic (2.00e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.87e-2)"	"prognostic favorable (3.81e-6)"	"unprognostic (7.47e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.62e-2)"	7.8	16.5	5.7	7.1	6.8	1.4	32.9	7.7	6.9	36.5	19.8	33.6	106.9	12.6	45.1	21.1	35.0	19.0	8.0	4.9	6.2	78.7	108.2	17.1	5.2	4.8	5.9	4.8	42.4	64.9	12.9	6.8	4.1	32.9	36.4	19.1	32.8	20.1	2.7	20.6	60.9	8.5	6.4	4.2	54.7	15.4	6.2	7.9	57.5	3.4	12.0	12.1	12.1	6.0	48.6	50.3	8.8	59.6	0.2	0.5	0.6	25.2	39.9	24.0	33.8	33.1	48.3	0.2	62.2	22.7	36.5	31.4	47.9	52.6	36.0	1.2	59.7	72.3	43.5	52.4	50.2	0.4	0.2	21.3	83.8	22.5	124.2	44.0	14.5	14.3	30.9	0.4	23.7	45.1	2.1	0.7	21.1	90.1	36.1	0.6	39.2	29.2	108.5	61.2	42.2	48.5	24.8	41.5	60.1	41.9	102.7	7.0	17.8	13.3	1.9	31.7	45.3	0.9	37.1	1.1	22.4	0.2	28.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.1	5.7	6.8	7.7	6.9	4.9	6.2	4.8	5.9	4.1	6.4	6.2	6.0	1.1	22.4	21.6	15.3	1.9	15.8	17.2	21.3	19.4	14.3	30.4	26.7	4.9	27.1	20.6	36.8	22.9	8.9	0.8	37.4	103.7	60.8	82.5	29.4	6.0	0.9	18.7	3.8	57.0	44.9	3.7	4.2	36.7	29.7	1.3	16.4	1.8	43.2	3.1	15.2	28.6	55.2	8.2	1.3	1.2	184.0	2.8	3.1	12.4	7.5	3.2	12.7	0.0	40.7	20.2	52.0	30.4	3.0	0.7	26.0	86.1	93.2	20.1	19.0	6.6	4.9	6.5	2.5	6.6	28.0	17.8	3.1	1.2	21.5	42.8	18.5
TRIP4	"ASC-1, HsT17391, ZC2HC5"	ENSG00000103671	"Thyroid hormone receptor interactor 4"	Q15650	15	64387748-64455303	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes, Congenital muscular dystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016605, HPA050666"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Nuclear bodies"		"HPA016605: AB_1858339, HPA050666: AB_2681211"	"unprognostic (1.56e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.62e-1)"	"unprognostic (4.50e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.16e-2)"	"unprognostic (3.01e-2)"	"unprognostic (4.98e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.37e-2)"	"prognostic favorable (6.34e-6)"	"unprognostic (2.41e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.25e-1)"	14.9	12.4	13.6	13.3	14.7	15.3	17.1	14.1	20.6	13.0	14.9	17.1	17.1	13.2	11.6	19.4	14.1	11.0	15.5	13.7	14.0	27.5	14.3	15.0	16.4	14.4	14.2	13.1	16.6	20.0	13.0	16.9	14.8	12.7	19.2	16.8	13.3	12.1	8.9	18.0	17.9	16.5	14.2	16.6	15.6	12.0	14.5	19.8	25.6	9.2	18.7	17.7	14.7	15.6	18.6	27.1	23.3	16.7	18.9	24.6	21.8	19.3	24.7	32.7	31.5	22.8	40.5	13.3	6.3	29.4	26.6	25.7	38.3	22.0	30.9	27.0	10.9	19.4	19.2	24.1	33.5	21.2	35.1	30.9	28.2	25.9	27.0	18.7	28.9	19.2	22.7	16.2	30.4	21.2	13.5	21.3	13.7	32.7	14.4	20.4	17.7	22.2	31.6	35.1	12.6	19.8	17.3	20.7	35.3	43.5	26.2	31.3	25.7	23.2	15.8	15.6	27.7	13.5	25.9	13.5	19.2	21.4	29.6	70.1	22.2	54.3	20.8	29.1	17.7	16.0	19.7	21.2	20.5	16.3	16.6	17.3	30.9	21.2	42.4	16.2	23.3	16.9	13.6	14.7	14.1	20.6	13.7	14.0	14.4	14.2	14.8	14.2	14.5	15.6	12.7	22.4	13.2	15.3	10.0	8.4	9.6	23.3	2.2	11.1	7.6	7.1	10.3	7.2	18.1	12.9	12.5	22.2	20.1	15.3	13.7	25.2	20.4	21.7	10.7	13.2	11.4	9.9	32.5	27.1	26.8	10.2	10.2	16.2	19.6	12.3	10.0	4.4	21.7	15.2	25.8	8.2	24.4	12.9	7.6	3.7	11.8	15.3	14.2	22.5	27.5	10.0	27.8	18.1	30.9	33.6	10.5	12.8	6.5	6.0	13.5	44.6	26.7	17.3	6.6	9.0	15.0	19.3	21.4	5.4	6.3	24.2	14.4	12.1	8.1	7.8
TSPAN12	"NET-2, TM4SF12"	ENSG00000106025	"Tetraspanin 12"	O95859	7	120787320-120858402	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Angiogenesis		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 91.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 118.6;Collecting duct cells: 103.0;Distal tubular cells: 189.8;Glandular and luminal cells: 87.5;Proximal tubular cells: 111.1"	"Cancer enhanced"	"Detected in all"		"renal cancer: 44.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 53.0;HUVEC TERT2: 58.3;RH-30: 52.2;RPTEC TERT1: 90.5;RT4: 65.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051570, HPA058244"	Uncertain		Approved	Vesicles,Microtubules		NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Microtubules	Vesicles	"HPA051570: , HPA058244: AB_2683652"	"unprognostic (2.40e-2)"	"unprognostic (7.60e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.82e-2)"	"unprognostic (3.97e-1)"	"unprognostic (7.34e-3)"	"unprognostic (1.60e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.05e-1)"	"unprognostic (9.53e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.43e-1)"	11.9	65.9	4.1	5.3	4.4	0.4	8.7	5.2	5.2	21.4	2.8	24.0	39.4	10.5	14.9	5.0	10.9	20.4	47.7	3.3	4.7	91.6	35.8	45.8	4.5	8.0	6.2	1.7	17.4	10.7	7.5	20.3	5.2	6.8	20.4	1.8	46.8	22.4	3.3	1.6	42.0	11.9	4.6	28.2	22.1	3.9	8.1	2.7	23.4	5.5	4.3	17.5	4.0	3.6	0.0	1.4	15.1	0.2	3.1	1.0	14.7	0.3	0.6	1.2	5.0	2.5	4.0	0.0	10.4	0.4	1.8	0.2	7.7	1.6	1.9	0.0	53.0	2.8	14.5	2.2	8.1	0.1	2.5	0.3	0.0	0.4	0.3	2.1	58.3	0.0	0.7	1.8	6.8	2.0	0.2	0.4	24.5	11.1	9.4	0.1	52.2	2.0	90.5	65.4	12.5	7.4	0.7	1.3	0.0	20.0	8.0	1.9	2.5	12.3	3.8	0.1	6.5	15.8	0.0	0.2	1.7	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	4.4	5.2	5.2	3.3	4.7	8.0	6.2	5.2	4.6	8.1	3.6	40.0	118.6	45.0	18.6	1.7	2.5	20.3	1.8	14.8	0.0	19.4	3.8	62.5	64.3	19.9	103.0	0.0	40.5	0.0	18.0	189.8	6.8	0.6	63.4	9.0	38.0	9.6	2.7	1.8	7.2	53.5	10.0	14.8	87.5	2.5	1.8	18.2	32.9	4.1	0.0	2.9	16.9	6.1	0.8	3.6	1.5	4.1	1.5	5.4	3.7	0.0	0.5	0.0	10.1	0.4	4.7	30.5	0.7	2.2	9.1	68.3	111.1	5.7	0.1	0.0	11.6	16.6	0.6	8.9	13.8	2.0	24.2	1.9	9.6	35.5	28.3
UGT2A3	FLJ21934	ENSG00000135220	"UDP glucuronosyltransferase family 2 member A3"	Q6UWM9	4	68928463-68951804	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 31.4;kidney: 21.0;liver: 13.3;pancreas: 16.3"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 91.5;Distal enterocytes: 89.8;Hepatocytes: 53.5;Paneth cells: 54.7;Proximal enterocytes: 248.9;Proximal tubular cells: 130.8;Undifferentiated cells: 101.1"	"Cancer enriched"	"Detected in many"	5	"renal cancer: 46.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	59	"Hep G2: 5.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA045108	Supported					NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"			"HPA045108: AB_2679218"			"prognostic favorable (3.31e-4)"				"unprognostic (3.97e-3)"				"unprognostic (8.87e-3)"		"prognostic favorable (6.07e-7)"	"unprognostic (2.10e-2)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.7	9.4	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	21.0	13.3	0.0	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	31.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	91.5	0.0	3.7	0.0	0.0	0.0	89.8	11.7	26.3	0.0	0.0	0.0	0.0	12.2	2.7	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	53.5	0.0	0.0	0.0	34.0	0.0	1.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	54.7	0.0	0.0	0.0	248.9	130.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	101.1	0.0
UNC5CL	"MGC34763, ZUD"	ENSG00000124602	"Unc-5 family C-terminal like"	Q8IV45	6	41026895-41039221	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 37.1;kidney: 58.6;liver: 52.8;pancreas: 36.2;stomach 1: 23.6"	"Group enriched"	"Detected in many"	6	"Cholangiocytes: 30.0;Collecting duct cells: 22.0;Ductal cells: 25.7;Exocrine glandular cells: 68.6;Gastric mucus-secreting cells: 36.7;Hepatocytes: 30.0;Pancreatic endocrine cells: 19.8;Proximal enterocytes: 37.3;Proximal tubular cells: 41.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"OE19: 44.8;RPTEC TERT1: 13.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA015725	Enhanced		Approved	Centrosome		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 1: Pancreatic cells - Digestion"	Centrosome		"HPA015725: AB_2669283"	"unprognostic (1.10e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.57e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.55e-3)"	"unprognostic (3.58e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.67e-2)"	"unprognostic (9.30e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.60e-6)"	1.2	1.0	1.3	1.0	1.6	0.9	1.6	1.3	1.7	1.5	1.2	3.1	37.1	1.1	0.3	1.3	1.9	9.2	1.2	1.3	1.3	58.6	52.8	2.1	1.0	1.7	1.4	1.5	36.2	0.3	0.8	0.4	1.6	1.5	1.3	0.8	1.7	0.6	0.7	1.9	29.4	0.4	1.4	3.3	23.6	2.2	1.5	2.7	1.6	0.2	0.7	1.1	1.1	2.3	0.5	0.2	0.6	0.9	0.2	0.1	0.6	0.0	0.1	0.0	0.0	7.0	0.1	0.1	2.5	0.0	0.0	0.2	0.1	0.2	0.1	1.1	1.3	0.6	0.0	3.8	0.1	0.3	0.2	0.1	0.6	0.0	0.4	0.1	0.0	2.8	0.5	0.4	0.0	0.1	0.9	2.3	0.2	44.8	0.2	0.9	0.1	0.5	13.0	0.0	0.6	0.6	0.0	0.0	1.3	0.7	0.1	0.2	0.2	0.0	0.4	0.3	0.1	4.3	2.3	0.6	0.0	1.5	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	1.3	1.6	1.3	1.7	1.3	1.3	1.7	1.4	1.6	1.4	1.5	2.3	0.3	3.2	1.1	4.2	1.3	0.8	0.6	0.4	0.6	0.6	1.0	1.0	0.8	30.0	0.3	22.0	4.2	0.4	1.8	2.3	3.9	25.7	2.4	0.6	0.3	0.4	1.2	0.4	0.3	68.6	0.8	0.5	36.7	1.6	0.0	0.3	1.4	30.0	0.3	1.7	0.2	5.0	0.0	0.8	0.3	0.4	0.3	0.8	1.8	0.0	0.8	0.2	2.1	0.0	3.5	19.8	3.1	0.7	0.3	0.6	37.3	41.8	0.9	0.3	0.0	0.3	0.4	0.9	0.8	0.5	0.1	0.8	1.0	0.1	5.4	0.4
USH1C	"AIE-75, DFNB18, harmonin, NY-CO-37, NY-CO-38, PDZ-73, PDZ73, PDZD7C"	ENSG00000006611	"USH1 protein network component harmonin"	Q9Y6N9	11	17493895-17544416	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Hearing"		"Cancer-related genes, Deafness, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 97.8;kidney: 54.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 190.0;Muller glia cells: 163.6;Paneth cells: 203.0;Proximal enterocytes: 430.7;Proximal tubular cells: 190.3;Undifferentiated cells: 115.7"	"Group enriched"	"Detected in many"	7	"colorectal cancer: 34.5;pancreatic cancer: 18.8;renal cancer: 29.4;stomach cancer: 15.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"CACO-2: 60.6;HeLa: 21.8;OE19: 57.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB013690, HPA027398, HPA027492, HPA028033"	Enhanced		Enhanced	Cytosol		No	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Cytosol		"CAB013690: , HPA027398: AB_10601775, HPA027492: AB_10601898, HPA028033: AB_10601782"	"unprognostic (3.60e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (2.22e-1)"		"unprognostic (2.78e-1)"	"unprognostic (1.51e-2)"	"unprognostic (9.65e-2)"	"prognostic favorable (9.41e-4)"	"unprognostic (1.29e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.61e-1)"	0.4	0.3	2.8	5.9	6.8	0.0	0.2	2.8	3.9	0.1	1.5	51.5	97.8	0.1	0.3	0.0	2.9	25.9	0.1	9.0	4.7	54.0	0.6	0.1	0.1	6.1	5.7	0.0	3.9	0.0	6.7	0.0	7.0	0.0	48.3	19.0	0.0	0.3	0.0	0.0	96.5	2.1	4.1	0.0	26.7	0.2	5.9	0.1	1.1	0.0	0.0	0.6	0.1	8.3	0.0	1.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	60.6	8.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	21.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	6.8	2.8	3.9	9.0	4.7	6.1	5.7	7.0	4.1	5.9	8.3	0.0	0.0	0.0	18.3	1.6	0.0	0.1	0.0	0.0	0.7	0.0	1.3	0.6	52.9	0.7	5.5	2.1	0.0	0.0	190.0	21.5	20.5	1.0	1.7	0.0	0.4	64.0	0.0	0.6	27.5	0.0	0.3	53.5	0.0	4.5	0.0	0.0	0.0	0.0	1.7	0.2	92.9	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	163.6	0.0	0.5	36.4	56.0	203.0	0.0	0.2	0.0	430.7	190.3	1.0	4.9	0.0	0.0	0.1	0.1	1.3	0.0	0.0	0.0	0.8	0.1	115.7	0.1
WASL	"N-WASP, NWASP, WASPB"	ENSG00000106299	"WASP like actin nucleation promoting factor"	O00401	7	123681943-123749003	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Urothelial cells: 282.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 138.3;U-2197: 128.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005399, HPA005750"	Supported		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	Nucleoli	"CAB005399: AB_2288632, HPA005750: AB_1854729"	"unprognostic (1.91e-1)"	"unprognostic (3.60e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.20e-1)"	"unprognostic (4.61e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (5.30e-5)"	"unprognostic (7.32e-2)"	"prognostic favorable (4.51e-8)"	"unprognostic (9.49e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.81e-1)"	"unprognostic (5.14e-1)"	20.4	24.7	19.2	12.8	22.2	5.6	21.7	13.5	42.4	29.1	13.6	42.4	37.2	27.1	18.3	29.5	18.7	28.4	18.2	43.0	20.4	44.1	46.8	19.9	7.8	18.0	19.1	35.1	29.5	40.0	13.0	34.6	17.4	25.3	37.9	24.9	22.3	24.0	24.7	18.0	41.5	23.6	13.5	17.0	30.1	22.5	20.9	10.3	35.2	28.7	11.0	38.7	22.5	18.4	34.4	24.8	26.7	23.0	41.2	42.4	34.7	23.3	38.7	16.9	21.7	20.5	42.2	3.5	18.1	35.3	36.0	25.1	50.1	25.7	25.9	6.0	19.9	3.0	19.6	22.2	44.7	4.6	2.9	34.2	47.0	25.0	42.2	37.9	29.5	3.6	15.5	6.6	40.6	20.7	6.0	6.1	50.1	36.5	22.4	3.6	21.6	7.7	35.6	138.3	32.9	48.1	32.1	95.0	63.0	41.4	18.6	4.5	33.8	44.9	12.6	128.1	23.2	7.2	2.7	7.5	38.8	3.8	36.7	2.4	1.7	0.8	1.7	1.7	1.4	2.0	1.1	1.0	1.5	1.3	1.4	1.5	0.7	2.5	3.0	1.9	0.6	0.6	19.2	22.2	13.5	42.4	43.0	20.4	18.0	19.1	17.4	13.5	20.9	18.4	71.2	86.6	61.1	36.9	11.5	60.4	48.9	44.4	46.1	32.9	67.6	57.1	69.8	52.9	53.7	53.3	20.9	41.6	12.6	200.2	52.8	52.6	26.2	58.0	53.1	43.9	67.9	5.9	55.9	54.1	52.4	62.6	50.0	68.8	3.8	35.0	56.4	61.9	12.7	26.9	51.2	105.1	40.7	13.8	25.1	9.3	48.1	15.6	30.2	34.7	14.0	60.9	6.2	42.7	48.7	70.6	113.4	64.7	14.0	104.4	108.0	96.0	49.5	32.4	19.7	54.1	75.3	17.2	21.3	54.9	68.3	81.3	13.1	76.0	74.8	282.3
XPA	"XP1, XPAC"	ENSG00000136936	"XPA, DNA damage recognition and repair factor"	P23025	9	97674909-97697340	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding	"Cancer-related genes, Disease variant, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000155, HPA056856"	Supported		Approved	"Nucleoplasm,Cytokinetic bridge"		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Cytokinetic bridge"	"CAB000155: , HPA056856: AB_2683258"	"unprognostic (8.76e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.30e-2)"	"unprognostic (4.17e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.26e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.97e-3)"	"unprognostic (9.55e-3)"	"prognostic favorable (4.28e-5)"	"unprognostic (2.19e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.17e-1)"	15.1	13.4	9.9	9.5	10.3	9.1	13.4	12.0	15.4	13.9	10.8	23.0	15.8	14.0	11.0	14.9	13.1	9.7	9.9	9.7	10.8	18.4	18.8	11.3	14.0	10.2	10.0	13.0	11.8	18.7	9.9	9.7	9.8	14.8	9.9	10.6	12.5	12.7	19.5	12.5	13.1	12.0	9.7	12.5	21.6	5.2	10.7	11.0	23.6	8.6	17.2	15.4	13.5	10.6	35.5	8.2	11.9	14.8	14.3	13.7	8.2	9.4	14.9	16.9	11.4	21.4	28.9	19.9	8.9	10.5	11.3	17.4	9.6	11.4	14.1	13.7	19.2	15.7	17.7	12.0	15.5	18.7	18.2	12.0	12.0	7.9	8.0	11.4	19.1	16.1	22.0	15.2	9.4	11.0	24.4	22.5	8.2	33.5	13.5	24.6	25.4	17.0	27.0	13.7	16.7	16.7	13.4	10.3	12.7	9.0	14.9	11.1	12.0	5.9	14.8	23.4	20.6	26.5	22.7	12.3	14.6	13.2	11.8	12.8	21.6	22.6	25.5	23.0	30.1	34.4	27.9	25.0	23.0	40.5	33.5	29.0	2.6	35.2	29.7	39.8	33.1	19.6	9.9	10.3	12.0	15.4	9.7	10.8	10.2	10.0	9.8	9.7	10.7	10.6	32.4	25.6	37.8	49.0	36.1	17.3	23.3	39.3	31.9	101.4	24.8	31.9	36.2	45.8	39.7	22.0	81.3	32.1	47.2	10.6	121.3	36.3	1.7	22.5	29.1	30.4	22.3	11.1	49.3	38.3	9.7	31.3	22.4	17.2	30.9	28.0	28.2	48.7	36.0	84.1	63.5	24.6	30.5	27.7	20.7	4.0	44.1	24.5	14.2	40.3	49.6	87.0	64.9	74.9	96.0	29.3	19.2	47.4	26.2	18.9	32.1	55.5	28.6	97.5	32.9	38.3	39.4	18.2	17.9	28.5	18.8	14.0	34.9	36.4	24.2	23.5
XPNPEP2		ENSG00000122121	"X-prolyl aminopeptidase 2"	O43895	X	129738949-129769536	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"intestine: 166.6;kidney: 156.0"	"Cell type enriched"	"Detected in some"	6	"Proximal enterocytes: 475.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 18.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"gdT-cell: 4.3;intermediate monocyte: 1.4;MAIT T-cell: 1.2;memory CD4 T-cell: 1.3;memory CD8 T-cell: 2.8;naive CD8 T-cell: 2.0;non-classical monocyte: 2.8;T-reg: 1.4"	"Group enriched"	"Detected in many"	7	"monocytes: 2.8;T-cells: 4.3"	"Cell line enhanced"	"Detected in some"		"ASC diff: 8.2;ASC TERT1: 40.1;HSkMC: 21.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA000339, CAB025136, CAB025269, HPA064568"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		13000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane, Cytosol"		"CAB025136: , CAB025269: , HPA000339: AB_1858894, HPA064568: "	"unprognostic (7.95e-2)"	"unprognostic (5.73e-2)"	"unprognostic (2.56e-1)"	"unprognostic (6.21e-3)"	"unprognostic (3.54e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.26e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.07e-1)"	"unprognostic (9.28e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.53e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.26e-3)"	7.5	0.9	0.1	3.7	0.1	0.2	3.0	0.1	0.1	3.7	0.1	5.5	99.0	2.4	0.1	2.2	6.3	4.3	5.3	0.1	0.1	156.0	23.1	2.1	0.5	0.2	0.1	1.8	0.3	0.3	0.1	1.2	0.1	1.8	6.3	0.0	1.5	0.4	0.5	4.4	166.6	6.0	0.1	0.3	3.4	0.1	0.1	1.0	1.4	2.4	0.4	7.8	4.0	0.1	0.0	0.0	0.5	0.0	8.2	40.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.2	0.0	0.0	21.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	4.3	1.4	1.2	0.0	1.3	2.8	0.2	0.2	0.4	2.0	0.1	0.0	2.8	0.4	1.4	0.9	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	1.2	0.0	0.0	0.0	0.5	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.8	0.0	0.2	0.5	11.4	5.9	0.0	0.0	0.0	0.1	0.3	1.2	0.0	0.2	0.0	0.0	10.0	1.1	0.0	0.0	0.0	0.4	18.5	0.8	0.0	0.3	12.8	0.0	1.0	3.6	0.0	0.0	1.0	1.8	1.0	0.0	0.0	3.1	0.0	0.1	0.0	21.0	0.0	0.1	0.0	475.9	75.1	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	1.0	1.2	0.9	0.0	8.4	0.0
ZDHHC6	"FLJ21952, ZNF376"	ENSG00000023041	"Zinc finger DHHC-type palmitoyltransferase 6"	Q9H6R6	10	112424428-112446917	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014357	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 32: U-937 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA014357: AB_2304658"	"unprognostic (1.21e-1)"	"unprognostic (1.00e-1)"	"unprognostic (6.31e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.29e-2)"	"unprognostic (6.24e-2)"	"unprognostic (5.21e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.14e-3)"	"unprognostic (3.00e-2)"	"unprognostic (9.30e-2)"	"unprognostic (8.87e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.22e-2)"	19.5	19.9	15.2	24.6	16.0	21.8	22.7	16.7	18.9	21.2	20.2	24.5	44.6	24.0	33.2	23.7	19.3	23.2	17.0	15.4	16.1	59.3	29.5	20.0	30.6	15.5	15.7	25.7	21.3	21.4	15.4	25.9	15.6	22.4	29.9	21.3	23.9	20.6	14.9	20.5	45.8	17.8	15.9	24.8	25.9	13.6	16.9	25.0	26.2	18.1	30.6	23.9	20.8	17.9	51.7	39.4	40.3	50.2	38.2	28.8	28.5	49.3	46.7	38.2	45.3	37.7	89.6	28.4	22.1	30.2	43.0	60.0	33.8	31.5	44.3	67.0	41.4	29.4	46.4	47.3	24.7	67.9	49.5	21.9	20.7	41.9	48.9	58.7	48.6	42.0	32.4	46.1	41.7	43.3	38.1	75.6	23.6	57.0	32.1	31.4	51.1	26.6	45.3	28.1	15.0	20.9	25.5	40.1	49.1	31.4	22.4	49.2	34.8	43.7	27.6	29.5	47.3	25.7	31.7	37.5	38.7	118.0	29.0	10.4	17.4	21.6	14.7	16.2	18.9	16.7	16.7	18.5	16.6	14.0	14.1	15.9	11.3	16.0	13.7	13.6	23.9	15.9	15.2	16.0	16.7	18.9	15.4	16.1	15.5	15.7	15.6	15.9	16.9	17.9	21.0	22.4	20.1	11.8	35.9	20.3	31.9	23.2	23.9	11.0	21.9	16.1	14.3	31.5	27.4	35.0	8.4	34.8	25.7	31.3	60.7	35.8	72.4	14.9	15.5	18.7	11.4	26.1	15.0	29.8	46.9	17.9	16.3	23.8	23.5	17.8	19.2	21.2	34.4	15.2	15.7	22.7	10.2	20.2	35.9	17.7	16.1	28.6	12.4	12.2	22.2	21.0	23.7	15.1	14.4	31.2	27.9	19.5	23.7	25.7	66.9	39.7	13.4	15.5	6.6	13.9	18.2	11.7	12.5	27.6	22.3	36.5	33.0	10.9	28.5	47.7
ZFAND2B	AIRAPL	ENSG00000158552	"Zinc finger AN1-type containing 2B"	Q8WV99	2	219195237-219209651	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 144.0;Proximal enterocytes: 170.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035159, HPA035160"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Cytosol"	"HPA035159: AB_2674499, HPA035160: AB_10670697"	"unprognostic (3.71e-1)"	"unprognostic (5.49e-3)"	"unprognostic (2.77e-3)"	"unprognostic (2.59e-1)"	"unprognostic (2.97e-1)"	"unprognostic (6.85e-3)"	"unprognostic (1.40e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.20e-1)"	"prognostic favorable (9.38e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.32e-1)"	"unprognostic (6.21e-2)"	"unprognostic (7.02e-2)"	28.5	26.6	33.2	20.7	34.3	38.2	28.3	34.4	43.7	38.2	27.4	41.6	41.5	29.7	18.1	48.8	28.5	20.0	28.1	33.3	34.0	44.1	64.5	32.3	28.4	37.2	33.3	29.0	40.7	26.8	36.2	17.4	34.3	31.3	25.0	10.8	27.7	17.6	34.3	42.5	45.4	15.9	33.1	45.9	37.4	15.6	34.3	37.9	49.8	15.5	23.3	33.0	35.5	37.5	23.0	14.4	17.2	23.7	17.6	18.5	23.5	22.8	26.3	32.1	31.7	34.8	18.9	16.5	23.0	39.2	26.0	15.5	15.4	28.9	25.5	27.8	25.2	41.8	25.6	30.3	36.3	22.9	45.3	15.3	62.2	31.9	75.0	17.7	21.2	40.0	25.0	38.9	31.9	40.0	37.9	47.9	8.9	31.7	17.5	22.4	8.3	31.6	29.6	17.7	33.7	16.3	10.9	17.3	24.8	19.3	15.4	47.3	22.5	32.2	29.5	37.2	33.3	20.2	6.6	34.1	31.5	44.2	25.6	30.8	34.8	48.6	49.1	46.0	42.5	43.6	44.2	48.0	26.7	53.0	39.9	48.9	58.3	53.5	38.3	33.5	51.6	44.3	33.2	34.3	34.4	43.7	33.3	34.0	37.2	33.3	34.3	33.1	34.3	37.5	30.4	22.4	21.2	17.6	43.5	27.1	26.3	34.0	19.9	14.9	37.1	33.7	12.7	44.3	24.5	20.2	14.6	26.9	52.4	144.0	56.7	44.1	4.9	14.6	17.7	26.4	40.2	15.2	17.8	66.0	24.3	19.6	42.3	20.7	32.4	11.6	23.6	39.4	34.9	8.4	16.1	67.5	36.7	32.4	31.3	7.8	32.0	35.6	35.6	5.6	24.4	21.5	44.3	6.0	15.3	60.3	101.1	29.7	39.5	25.1	170.6	79.5	13.8	17.2	26.3	15.9	28.7	6.2	22.9	27.6	36.1	51.3	46.7	27.8	54.4	28.8
ZNF823	HSZFP36	ENSG00000197933	"Zinc finger protein 823"	P16415	19	11721265-11739009	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 18.6;Syncytiotrophoblasts: 21.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"																	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"				"unprognostic (2.34e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.22e-2)"	"prognostic favorable (6.76e-5)"	"unprognostic (2.50e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.69e-2)"	"unprognostic (1.02e-2)"	"unprognostic (5.50e-1)"	"unprognostic (2.36e-2)"	"prognostic favorable (4.49e-4)"	"prognostic favorable (5.05e-4)"	"unprognostic (7.96e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.47e-3)"	3.5	1.9	1.9	2.0	3.1	1.9	7.4	11.8	2.7	4.9	0.0	5.9	3.6	4.0	3.5	8.3	4.0	3.1	2.7	2.0	1.9	6.6	6.1	3.3	2.3	2.2	2.2	4.6	4.3	6.0	1.1	5.0	2.5	3.3	5.8	1.9	5.0	3.8	2.0	4.3	3.7	2.7	1.9	2.5	4.3	1.4	2.7	3.9	2.8	2.8	3.2	4.2	4.9	3.0	6.3	3.2	5.0	5.9	3.1	1.1	9.6	6.8	5.6	9.0	8.5	10.8	2.0	7.4	7.3	5.6	2.8	5.2	5.4	4.2	8.9	0.0	3.5	5.6	2.2	9.6	1.2	2.6	7.7	1.9	4.4	5.9	4.4	3.4	4.3	5.8	4.0	0.1	8.6	4.1	7.4	2.1	3.3	5.1	6.8	3.2	8.9	2.0	8.9	16.5	3.2	4.2	6.6	6.9	2.4	9.1	5.2	7.0	4.7	8.6	3.0	12.8	4.8	4.7	12.7	3.8	2.0	0.0	1.5	2.2	1.4	10.3	2.6	1.7	4.2	2.4	3.4	2.8	1.9	1.6	5.9	4.3	0.8	5.3	1.0	3.3	1.2	1.9	1.9	3.1	11.8	2.7	2.0	1.9	2.2	2.2	2.5	1.9	2.7	3.0	4.3	3.2	1.7	6.5	1.5	5.2	3.7	2.7	9.1	1.3	6.1	4.6	3.3	7.2	4.0	1.8	0.0	18.6	5.7	10.0	9.8	5.9	0.4	5.1	2.8	3.1	0.0	2.5	6.5	4.5	14.9	2.3	6.6	6.9	1.3	3.6	5.7	3.2	4.6	0.0	5.6	7.3	0.0	2.6	5.1	0.8	2.8	1.9	3.6	9.4	2.4	1.2	3.1	4.5	7.1	4.0	9.0	2.2	2.0	2.9	6.3	3.9	2.2	1.5	0.0	1.8	3.7	4.3	4.0	10.3	4.0	21.5	4.3	0.9	7.0	6.1
ZNRF2	RNF202	ENSG00000180233	"Zinc and ring finger 2"	Q8NHG8	7	30284597-30367689	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 119.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 2.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072244	Approved		Uncertain	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Vesicles"	"Nucleoli fibrillar center"	"HPA072244: AB_2732197"	"unprognostic (9.44e-2)"	"unprognostic (2.38e-2)"	"unprognostic (8.64e-2)"	"prognostic unfavorable (7.68e-4)"	"unprognostic (4.46e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.06e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.93e-2)"	"prognostic favorable (2.29e-4)"	"unprognostic (1.51e-1)"	"unprognostic (2.71e-1)"	"prognostic favorable (8.71e-4)"	"unprognostic (8.67e-2)"	7.4	6.5	4.8	11.5	5.3	13.0	9.6	5.5	4.2	5.1	14.5	18.9	13.2	8.4	10.7	10.4	4.4	9.4	5.1	4.3	4.0	22.0	21.5	7.4	15.3	7.4	6.6	3.7	10.3	9.1	5.0	9.3	6.0	5.7	16.2	4.7	9.2	5.3	5.7	10.0	15.2	9.5	7.5	10.8	15.0	24.0	7.9	8.9	11.7	6.2	13.2	11.2	4.2	8.4	13.2	4.7	3.8	3.4	4.4	3.0	19.8	4.9	5.1	5.4	7.2	2.4	21.5	13.8	12.6	4.1	14.0	12.5	12.7	8.5	5.7	13.4	11.5	8.6	9.7	6.4	2.3	6.7	15.6	4.6	14.0	3.7	9.1	5.6	4.6	10.5	10.7	26.6	5.9	5.1	13.6	17.5	8.9	13.2	5.9	11.7	8.2	23.8	16.4	28.0	13.0	12.3	9.9	41.2	8.5	22.2	11.1	26.5	5.1	5.2	8.9	5.0	10.5	44.9	41.5	18.1	5.7	14.3	7.8	0.2	0.3	0.4	0.3	0.3	0.5	0.4	0.4	0.5	0.3	0.2	0.2	0.4	0.5	0.3	0.4	2.2	1.0	0.2	4.8	5.3	5.5	4.2	4.3	4.0	7.4	6.6	6.0	7.5	7.9	8.4	11.3	9.6	8.4	19.9	13.9	15.9	7.4	4.8	8.6	11.3	26.5	10.4	3.6	14.3	5.0	16.5	41.7	10.1	40.8	60.0	7.9	4.9	5.2	32.7	7.6	6.6	31.3	6.1	54.4	10.3	11.4	5.1	14.3	43.7	3.8	4.7	8.2	41.6	10.7	1.7	32.3	14.0	0.0	23.3	16.2	10.1	2.8	23.1	12.4	119.9	13.1	5.1	4.1	41.7	39.7	7.4	19.5	2.2	11.5	8.5	22.6	32.3	5.8	5.8	6.6	7.7	9.8	18.3	7.0	7.9	18.9	11.5	17.6	7.6	23.4	14.3